log2 (113/113 ratio),log2 (114/113 ratio),log2 (115/113 ratio),log2 (116/113 ratio),log2 (117/113 ratio),log2 (118/113 ratio),log2 (119/113 ratio),log2 (121/113 ratio),Modifications,Motifs,ANOVA Significant,PEP,# PSMs,# Proteins,# Protein Groups,Area,q-Value,Xcorr,# Missed Cleavages,"P value, -log10",Protein names,Sequence,Sequence window,Accession,Gene Name,phosphoRS Site Probabilities,Protein Group Accessions,Modified amino acid,Number of Phospho (STY)
"hSAECs,Ctrl","hSAECs,Ctrl","hSAECs,TNFa","hSAECs, TNFa","EMT-hSAECs, Ctrl","EMT-hSAECs, Ctrl","EMT-hSAECs,TNFa","EMT-hSAECs,TNFa",,Linear motifs matching the sequence window.,,,,,,,,,,,,,,,,,,,
0,-0.18,-0.45,-0.45,-0.43,-0.73,-0.88,-0.97,K9(iTRAQ8plex);N-Term(iTRAQ8plex);S2(Phospho),14-3-3 domain binding motif;Akt kinase substrate motif;b-Adrenergic Receptor kinase substrate motif;Calmodulin-dependent protein kinase II substrate motif;Casein kinase II substrate motif;MAPKAPK1 kinase substrate motif;Pim1 kinase substrate sequence;PKA kinase substrate motif;PKC epsilon kinase substrate motif;PKC kinase substrate motif;Pyruvate dehydrogenase kinase substrate motif;ZIP kinase substrate motif,+,0.0215,2,1,1,316000000,0,2.66,0,1.89916723,Protein flightless-1 homolog,DSAQDDQAK,RLRRRKDSAQDDQAK,Q13045,FLII,S(2): 100.0,Q13045,S2(Phospho),1
0,-0.15,1.45,1.69,1.33,0.97,1.20,1.34,C8(Carbamidomethyl);K19(iTRAQ8plex);M7(Oxidation);S14(Phospho);Y13(Phospho);Y3(Phospho),,+,0.2073,2,1,1,0,0.008537,3,0,2.624878583,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 2, mitochondrial (EC 1.6.5.3) (EC 1.6.99.3) (Complex I-49kD) (CI-49kD) (NADH-ubiquinone oxidoreductase 49 kDa subunit)",LDYVSMMCNEQAYSLAVEK,MCNEQAYSLAVEKLL,O75306,NDUFS2,Y(3): 97.9;S(5): 93.0;Y(13): 9.8;S(14): 99.3,O75306,"S14(Phospho),Y13(Phospho),Y3(Phospho)",3
0,0.04,-0.38,-0.45,-0.38,-0.42,0.00,-0.16,N-Term(iTRAQ8plex);S3(Phospho);S6(Phospho),,+,0.002733,12,1,1,23500000,0,4.14,0,2.275967136,Collagen alpha-1(XVII) chain (180 kDa bullous pemphigoid antigen 2) (Bullous pemphigoid antigen 2) [Cleaved into: 120 kDa linear IgA disease antigen (120 kDa linear IgA dermatosis antigen) (Linear IgA disease antigen 1) (LAD-1);97 kDa linear IgA disease antigen (97 kDa linear IgA bullous dermatosis antigen) (97 kDa LAD antigen) (97-LAD) (Linear IgA bullous disease antigen of 97 kDa) (LABD97)],AHSPASTLPNSPGSTFER,RRAHSPASTLPNSPG,Q9UMD9,COL17A1,S(3): 99.6;S(6): 0.2;T(7): 0.3;S(11): 1.9;S(14): 76.9;T(15): 21.1,Q9UMD9,"S3(Phospho),S6(Phospho)",2
0,0.08,0.53,0.41,-0.12,-0.20,0.16,0.19,K10(iTRAQ8plex);K5(iTRAQ8plex);N-Term(iTRAQ8plex);S3(Phospho),14-3-3 domain binding motif;b-Adrenergic Receptor kinase substrate motif;Calmodulin-dependent protein kinase II substrate motif;Calmodulin-dependent protein kinase IV substrate motif;Chk1 kinase substrate motif;PKA kinase substrate motif;PKC kinase substrate motif,+,0.1011,2,1,1,0,0.005443,2.36,1,2.736681258,Endophilin-B2 (SH3 domain-containing GRB2-like protein B2),ADSTKNWTEK,NLLARADSTKNWTEK,Q9NR46,SH3GLB2,S(3): 49.0;T(4): 49.0;T(8): 2.0,Q9NR46,S3(Phospho),1
0,0.31,0.94,0.86,2.59,2.46,2.15,2.00,K39(iTRAQ8plex);T15(Phospho);T19(Phospho);T24(Phospho);T36(Phospho),,+,0.1384,2,1,1,1600000,0.002704,3.59,1,3.720744158,Cell adhesion molecule-related/down-regulated by oncogenes,HSGVPEAPDRPTISTASETSVYVTWIPRANGGSPITAFK,ANGGSPITAFKVEYK,Q4KMG0,CDON,,Q4KMG0,"T15(Phospho),T19(Phospho),T24(Phospho),T36(Phospho)",4
0,0.31,0.94,0.86,2.59,2.46,2.15,2.00,K39(iTRAQ8plex);T15(Phospho);T19(Phospho);T24(Phospho);T36(Phospho),Casein kinase II substrate motif;G protein-coupled receptor kinase 1 substrate motif;MDC1 BRCT domain binding motif;Plk1 PBD domain binding motif,+,0.1384,2,1,1,1600000,0.002704,3.59,1,3.720744158,Cell adhesion molecule-related/down-regulated by oncogenes,HSGVPEAPDRPTISTASETSVYVTWIPRANGGSPITAFK,PDRPTISTASETSVY,Q4KMG0,CDON,,Q4KMG0,"T15(Phospho),T19(Phospho),T24(Phospho),T36(Phospho)",4
0,0.31,0.94,0.86,2.59,2.46,2.15,2.00,K39(iTRAQ8plex);T15(Phospho);T19(Phospho);T24(Phospho);T36(Phospho),MAPKAPK2 kinase substrate motif,+,0.1384,2,1,1,1600000,0.002704,3.59,1,3.720744158,Cell adhesion molecule-related/down-regulated by oncogenes,HSGVPEAPDRPTISTASETSVYVTWIPRANGGSPITAFK,SETSVYVTWIPRANG,Q4KMG0,CDON,,Q4KMG0,"T15(Phospho),T19(Phospho),T24(Phospho),T36(Phospho)",4
0,0.31,0.94,0.86,2.59,2.46,2.15,2.00,K39(iTRAQ8plex);T15(Phospho);T19(Phospho);T24(Phospho);T36(Phospho),b-Adrenergic Receptor kinase substrate motif;Casein kinase II substrate motif,+,0.1384,2,1,1,1600000,0.002704,3.59,1,3.720744158,Cell adhesion molecule-related/down-regulated by oncogenes,HSGVPEAPDRPTISTASETSVYVTWIPRANGGSPITAFK,TISTASETSVYVTWI,Q4KMG0,CDON,,Q4KMG0,"T15(Phospho),T19(Phospho),T24(Phospho),T36(Phospho)",4
0,-0.14,-0.73,-0.80,0.16,0.05,-0.24,-0.16,K14(iTRAQ8plex);N-Term(iTRAQ8plex);S16(Phospho);S17(Phospho);S4(Phospho),Casein kinase II substrate motif;PKA kinase substrate motif;PKC kinase substrate motif,+,0.05693,3,1,1,45800000,0.005,3.3,1,2.94920311,Ladinin-1 (Lad-1) (Linear IgA disease antigen) (LADA),TQESGDQDPQEAQKASSATER,PQEAQKASSATERTQ,O00515,LAD1,T(1): 75.6;S(4): 72.5;S(16): 50.2;S(17): 55.6;T(19): 46.2,O00515,"S16(Phospho),S17(Phospho),S4(Phospho)",3
0,-0.14,-0.73,-0.80,0.16,0.05,-0.24,-0.16,K14(iTRAQ8plex);N-Term(iTRAQ8plex);S16(Phospho);S17(Phospho);S4(Phospho),Casein kinase II substrate motif;MDC1 BRCT domain binding motif;PKA kinase substrate motif;PKC kinase substrate motif;Plk1 PBD domain binding motif,+,0.05693,3,1,1,45800000,0.005,3.3,1,2.94920311,Ladinin-1 (Lad-1) (Linear IgA disease antigen) (LADA),TQESGDQDPQEAQKASSATER,QEAQKASSATERTQW,O00515,LAD1,T(1): 75.6;S(4): 72.5;S(16): 50.2;S(17): 55.6;T(19): 46.2,O00515,"S16(Phospho),S17(Phospho),S4(Phospho)",3
0,-0.14,-0.73,-0.80,0.16,0.05,-0.24,-0.16,K14(iTRAQ8plex);N-Term(iTRAQ8plex);S16(Phospho);S17(Phospho);S4(Phospho),b-Adrenergic Receptor kinase substrate motif,+,0.05693,3,1,1,45800000,0.005,3.3,1,2.94920311,Ladinin-1 (Lad-1) (Linear IgA disease antigen) (LADA),TQESGDQDPQEAQKASSATER,WISRTQESGDQDPQE,O00515,LAD1,T(1): 75.6;S(4): 72.5;S(16): 50.2;S(17): 55.6;T(19): 46.2,O00515,"S16(Phospho),S17(Phospho),S4(Phospho)",3
0,-0.05,-2.30,-2.16,-0.66,-0.74,-0.62,-0.39,N-Term(iTRAQ8plex);S2(Phospho);S4(Phospho);S6(Phospho),14-3-3 domain binding motif;Calmodulin-dependent protein kinase II substrate motif;Calmodulin-dependent protein kinase IV substrate motif;Casein kinase II substrate motif;G protein-coupled receptor kinase 1 substrate motif;GSK3 kinase substrate motif;MAPKAPK1 kinase substrate motif;PAK2 kinase substrate motif;Pim1 kinase substrate sequence;PKA kinase substrate motif;PKC epsilon kinase substrate motif;PKC kinase substrate motif;ZIP kinase substrate motif,+,0.02163,5,1,1,26600000,0,3.28,0,3.966658181,"Transformer-2 protein homolog beta (TRA-2 beta) (TRA2-beta) (hTRA2-beta) (Splicing factor, arginine/serine-rich 10) (Transformer-2 protein homolog B)",HSHSHSPMSTR,RDYRRRHSHSHSPMS,P62995,TRA2B,S(2): 100.0;S(4): 100.0;S(6): 99.5;S(9): 0.5;T(10): 0.0,P62995,"S2(Phospho),S4(Phospho),S6(Phospho)",3
0,-0.05,-2.30,-2.16,-0.66,-0.74,-0.62,-0.39,N-Term(iTRAQ8plex);S2(Phospho);S4(Phospho);S6(Phospho),"Casein kinase II substrate motif;ERK1,2 kinase substrate motif;G protein-coupled receptor kinase 1 substrate motif;GSK-3, ERK1, ERK2, CDK5 substrate motif;MAPKAPK2 kinase substrate motif;WW domain binding motif",+,0.02163,5,1,1,26600000,0,3.28,0,3.966658181,"Transformer-2 protein homolog beta (TRA-2 beta) (TRA2-beta) (hTRA2-beta) (Splicing factor, arginine/serine-rich 10) (Transformer-2 protein homolog B)",HSHSHSPMSTR,RRHSHSHSPMSTRRR,P62995,TRA2B,S(2): 100.0;S(4): 100.0;S(6): 99.5;S(9): 0.5;T(10): 0.0,P62995,"S2(Phospho),S4(Phospho),S6(Phospho)",3
0,-0.05,-2.30,-2.16,-0.66,-0.74,-0.62,-0.39,N-Term(iTRAQ8plex);S2(Phospho);S4(Phospho);S6(Phospho),Casein kinase II substrate motif,+,0.02163,5,1,1,26600000,0,3.28,0,3.966658181,"Transformer-2 protein homolog beta (TRA-2 beta) (TRA2-beta) (hTRA2-beta) (Splicing factor, arginine/serine-rich 10) (Transformer-2 protein homolog B)",HSHSHSPMSTR,YRRRHSHSHSPMSTR,P62995,TRA2B,S(2): 100.0;S(4): 100.0;S(6): 99.5;S(9): 0.5;T(10): 0.0,P62995,"S2(Phospho),S4(Phospho),S6(Phospho)",3
0,-0.13,-1.76,-1.65,-0.13,-0.02,-0.08,0.01,K13(iTRAQ8plex);N-Term(iTRAQ8plex);S11(Phospho);S5(Phospho);S6(Phospho),MDC1 BRCT domain binding motif;Plk1 PBD domain binding motif,+,0.05875,3,1,1,261000000,0.005,2.73,0,4.232975243,Histone-lysine N-methyltransferase SETDB2 (EC 2.1.1.43) (Chronic lymphocytic leukemia deletion region gene 8 protein) (Lysine N-methyltransferase 1F) (SET domain bifurcated 2),TNSHSSALHVSYK,AKTNSHSSALHVSYK,Q96T68,SETDB2,T(1): 48.3;S(3): 48.3;S(5): 57.9;S(6): 57.9;S(11): 69.6;Y(12): 18.1,Q96T68,"S11(Phospho),S5(Phospho),S6(Phospho)",3
0,-0.13,-1.76,-1.65,-0.13,-0.02,-0.08,0.01,K13(iTRAQ8plex);N-Term(iTRAQ8plex);S11(Phospho);S5(Phospho);S6(Phospho),,+,0.05875,3,1,1,261000000,0.005,2.73,0,4.232975243,Histone-lysine N-methyltransferase SETDB2 (EC 2.1.1.43) (Chronic lymphocytic leukemia deletion region gene 8 protein) (Lysine N-methyltransferase 1F) (SET domain bifurcated 2),TNSHSSALHVSYK,HAKTNSHSSALHVSY,Q96T68,SETDB2,T(1): 48.3;S(3): 48.3;S(5): 57.9;S(6): 57.9;S(11): 69.6;Y(12): 18.1,Q96T68,"S11(Phospho),S5(Phospho),S6(Phospho)",3
0,-0.13,-1.76,-1.65,-0.13,-0.02,-0.08,0.01,K13(iTRAQ8plex);N-Term(iTRAQ8plex);S11(Phospho);S5(Phospho);S6(Phospho),Casein kinase II substrate motif;G protein-coupled receptor kinase 1 substrate motif;PKA kinase substrate motif;PKC kinase substrate motif,+,0.05875,3,1,1,261000000,0.005,2.73,0,4.232975243,Histone-lysine N-methyltransferase SETDB2 (EC 2.1.1.43) (Chronic lymphocytic leukemia deletion region gene 8 protein) (Lysine N-methyltransferase 1F) (SET domain bifurcated 2),TNSHSSALHVSYK,HSSALHVSYKTPCGR,Q96T68,SETDB2,T(1): 48.3;S(3): 48.3;S(5): 57.9;S(6): 57.9;S(11): 69.6;Y(12): 18.1,Q96T68,"S11(Phospho),S5(Phospho),S6(Phospho)",3
0,-0.13,-2.99,-2.80,-1.59,-1.51,-0.69,-0.59,N-Term(iTRAQ8plex);S3(Phospho);S5(Phospho);S7(Phospho),14-3-3 domain binding motif;Calmodulin-dependent protein kinase II substrate motif;Calmodulin-dependent protein kinase IV substrate motif;Casein kinase II substrate motif;G protein-coupled receptor kinase 1 substrate motif;GSK3 kinase substrate motif;MAPKAPK1 kinase substrate motif;PAK2 kinase substrate motif;Pim1 kinase substrate sequence;PKA kinase substrate motif;PKC epsilon kinase substrate motif;PKC kinase substrate motif;ZIP kinase substrate motif,+,0.02674,30,1,1,5110000000,0,4.28,1,4.591166051,"Transformer-2 protein homolog beta (TRA-2 beta) (TRA2-beta) (hTRA2-beta) (Splicing factor, arginine/serine-rich 10) (Transformer-2 protein homolog B)",RHSHSHSPMSTR,RDYRRRHSHSHSPMS,P62995,TRA2B,S(3): 100.0;S(5): 99.9;S(7): 81.8;S(10): 3.0;T(11): 15.2,P62995,"S3(Phospho),S5(Phospho),S7(Phospho)",3
0,-0.13,-2.99,-2.80,-1.59,-1.51,-0.69,-0.59,N-Term(iTRAQ8plex);S3(Phospho);S5(Phospho);S7(Phospho),Casein kinase II substrate motif,+,0.02674,30,1,1,5110000000,0,4.28,1,4.591166051,"Transformer-2 protein homolog beta (TRA-2 beta) (TRA2-beta) (hTRA2-beta) (Splicing factor, arginine/serine-rich 10) (Transformer-2 protein homolog B)",RHSHSHSPMSTR,YRRRHSHSHSPMSTR,P62995,TRA2B,S(3): 100.0;S(5): 99.9;S(7): 81.8;S(10): 3.0;T(11): 15.2,P62995,"S3(Phospho),S5(Phospho),S7(Phospho)",3
0,-0.13,-2.99,-2.80,-1.59,-1.51,-0.69,-0.59,N-Term(iTRAQ8plex);S3(Phospho);S5(Phospho);S7(Phospho),Casein kinase II substrate motif,+,0.02674,30,1,1,5110000000,0,4.28,1,4.591166051,"Transformer-2 protein homolog beta (TRA-2 beta) (TRA2-beta) (hTRA2-beta) (Splicing factor, arginine/serine-rich 10) (Transformer-2 protein homolog B)",RHSHSHSPMSTR,YRRRHSHSHSPMSTR,P62995,TRA2B,S(3): 100.0;S(5): 99.9;S(7): 81.8;S(10): 3.0;T(11): 15.2,P62995,"S3(Phospho),S5(Phospho),S7(Phospho)",3
0,-0.07,-1.57,-1.42,-0.40,-0.31,-0.76,-0.49,N-Term(iTRAQ8plex);S5(Phospho);S7(Phospho);S9(Phospho),"14-3-3 domain binding motif;Calmodulin-dependent protein kinase II substrate motif;Casein kinase II substrate motif;DNA dependent Protein kinase substrate motif;ERK1,2 kinase substrate motif;GSK-3, ERK1, ERK2, CDK5 substrate motif;MAPKAPK2 kinase substrate motif;PKA kinase substrate motif;PKC kinase substrate motif;WW domain binding motif",+,0.118,1,1,1,0,0.006,2.48,1,3.035119002,Tight junction protein ZO-2 (Tight junction protein 2) (Zona occludens protein 2) (Zonula occludens protein 2),EHPHSRSPSPEPR,HPHSRSPSPEPRGRP,Q9UDY2,TJP2,,Q9UDY2,"S5(Phospho),S7(Phospho),S9(Phospho)",3
0,-0.07,-1.57,-1.42,-0.40,-0.31,-0.76,-0.49,N-Term(iTRAQ8plex);S5(Phospho);S7(Phospho);S9(Phospho),"Casein kinase II substrate motif;ERK1,2 kinase substrate motif;Growth associated histone HI kinase substrate motif;GSK-3, ERK1, ERK2, CDK5 substrate motif;WW domain binding motif",+,0.118,1,1,1,0,0.006,2.48,1,3.035119002,Tight junction protein ZO-2 (Tight junction protein 2) (Zona occludens protein 2) (Zonula occludens protein 2),EHPHSRSPSPEPR,REHPHSRSPSPEPRG,Q9UDY2,TJP2,,Q9UDY2,"S5(Phospho),S7(Phospho),S9(Phospho)",3
0,-0.07,-1.57,-1.42,-0.40,-0.31,-0.76,-0.49,N-Term(iTRAQ8plex);S5(Phospho);S7(Phospho);S9(Phospho),Casein kinase II substrate motif;G protein-coupled receptor kinase 1 substrate motif;GSK3 kinase substrate motif,+,0.118,1,1,1,0,0.006,2.48,1,3.035119002,Tight junction protein ZO-2 (Tight junction protein 2) (Zona occludens protein 2) (Zonula occludens protein 2),EHPHSRSPSPEPR,RSREHPHSRSPSPEP,Q9UDY2,TJP2,,Q9UDY2,"S5(Phospho),S7(Phospho),S9(Phospho)",3
0,-0.08,1.20,1.20,0.82,0.63,0.22,0.27,K18(iTRAQ8plex);N-Term(iTRAQ8plex);S7(Phospho);T14(Phospho);T15(Phospho),Casein kinase I substrate motif,+,0.07129,2,1,1,41500,0.0009818,2.12,0,3.534354344,"Dynein heavy chain 1, axonemal (Axonemal beta dynein heavy chain 1) (Ciliary dynein heavy chain 1) (Heat shock regulated protein 1) (HSRF-1) (hDHC7)",IDIEVLSVVAQQITTIQK,RIDIEVLSVVAQQIT,Q9P2D7,DNAH1,S(7): 100.0;T(14): 100.0;T(15): 100.0,Q9P2D7,"S7(Phospho),T14(Phospho),T15(Phospho)",3
0,-0.08,1.20,1.20,0.82,0.63,0.22,0.27,K18(iTRAQ8plex);N-Term(iTRAQ8plex);S7(Phospho);T14(Phospho);T15(Phospho),,+,0.07129,2,1,1,41500,0.0009818,2.12,0,3.534354344,"Dynein heavy chain 1, axonemal (Axonemal beta dynein heavy chain 1) (Ciliary dynein heavy chain 1) (Heat shock regulated protein 1) (HSRF-1) (hDHC7)",IDIEVLSVVAQQITTIQK,SVVAQQITTIQKAQQ,Q9P2D7,DNAH1,S(7): 100.0;T(14): 100.0;T(15): 100.0,Q9P2D7,"S7(Phospho),T14(Phospho),T15(Phospho)",3
0,-0.08,1.20,1.20,0.82,0.63,0.22,0.27,K18(iTRAQ8plex);N-Term(iTRAQ8plex);S7(Phospho);T14(Phospho);T15(Phospho),G protein-coupled receptor kinase 1 substrate motif,+,0.07129,2,1,1,41500,0.0009818,2.12,0,3.534354344,"Dynein heavy chain 1, axonemal (Axonemal beta dynein heavy chain 1) (Ciliary dynein heavy chain 1) (Heat shock regulated protein 1) (HSRF-1) (hDHC7)",IDIEVLSVVAQQITTIQK,VVAQQITTIQKAQQQ,Q9P2D7,DNAH1,S(7): 100.0;T(14): 100.0;T(15): 100.0,Q9P2D7,"S7(Phospho),T14(Phospho),T15(Phospho)",3
0,-0.12,-3.07,-4.28,0.82,0.58,-0.32,-0.18,K23(iTRAQ8plex);K3(iTRAQ8plex);S12(Phospho);T2(Phospho);T22(Phospho),b-Adrenergic Receptor kinase substrate motif;Casein kinase I substrate motif,+,0.0677,2,1,1,0,0.002391,3.99,1,2.687854793,Protein FAM135B,LTKSVSAPHISSPEEAAEDADTK,EAAEDADTKQQDGGF,Q49AJ0,FAM135B,T(2): 5.7;S(4): 46.9;S(6): 46.9;S(11): 50.3;S(12): 50.3;T(22): 100.0,Q49AJ0,"S12(Phospho),T2(Phospho),T22(Phospho)",3
0,-0.12,-3.07,-4.28,0.82,0.58,-0.32,-0.18,K23(iTRAQ8plex);K3(iTRAQ8plex);S12(Phospho);T2(Phospho);T22(Phospho),G protein-coupled receptor kinase 1 substrate motif;PKA kinase substrate motif;PKC kinase substrate motif,+,0.0677,2,1,1,0,0.002391,3.99,1,2.687854793,Protein FAM135B,LTKSVSAPHISSPEEAAEDADTK,EVALTKLTKSVSAPH,Q49AJ0,FAM135B,T(2): 5.7;S(4): 46.9;S(6): 46.9;S(11): 50.3;S(12): 50.3;T(22): 100.0,Q49AJ0,"S12(Phospho),T2(Phospho),T22(Phospho)",3
0,-0.12,-3.07,-4.28,0.82,0.58,-0.32,-0.18,K23(iTRAQ8plex);K3(iTRAQ8plex);S12(Phospho);T2(Phospho);T22(Phospho),"Casein kinase II substrate motif;ERK1,2 kinase substrate motif;G protein-coupled receptor kinase 1 substrate motif;GSK-3, ERK1, ERK2, CDK5 substrate motif;MDC1 BRCT domain binding motif;Plk1 PBD domain binding motif;WW domain binding motif",+,0.0677,2,1,1,0,0.002391,3.99,1,2.687854793,Protein FAM135B,LTKSVSAPHISSPEEAAEDADTK,VSAPHISSPEEAAED,Q49AJ0,FAM135B,T(2): 5.7;S(4): 46.9;S(6): 46.9;S(11): 50.3;S(12): 50.3;T(22): 100.0,Q49AJ0,"S12(Phospho),T2(Phospho),T22(Phospho)",3
0,-0.40,-1.02,-1.52,0.31,0.57,0.15,0.11,C10(Carbamidomethyl);N-Term(iTRAQ8plex);S7(Phospho);T13(Phospho);T4(Phospho),AMP-activated protein kinase substrate motif;Casein kinase II substrate motif;PKA kinase substrate motif,+,0.05841,3,1,1,1150000000,0.005,1.99,1,2.09288481,CAD protein [Includes: Glutamine-dependent carbamoyl-phosphate synthase (EC 6.3.5.5);Aspartate carbamoyltransferase (EC 2.1.3.2);Dihydroorotase (EC 3.5.2.3)],HGRTVHSLACLLTQYR,GDLKHGRTVHSLACL,P27708,CAD,T(4): 68.4;S(7): 77.2;T(13): 77.2;Y(15): 77.2,P27708,"S7(Phospho),T13(Phospho),T4(Phospho)",3
0,-0.40,-1.02,-1.52,0.31,0.57,0.15,0.11,C10(Carbamidomethyl);N-Term(iTRAQ8plex);S7(Phospho);T13(Phospho);T4(Phospho),Dual specificity protein phosphatase 6 substrate motif;PP2C delta substrate motif,+,0.05841,3,1,1,1150000000,0.005,1.99,1,2.09288481,CAD protein [Includes: Glutamine-dependent carbamoyl-phosphate synthase (EC 6.3.5.5);Aspartate carbamoyltransferase (EC 2.1.3.2);Dihydroorotase (EC 3.5.2.3)],HGRTVHSLACLLTQYR,HSLACLLTQYRVSLR,P27708,CAD,T(4): 68.4;S(7): 77.2;T(13): 77.2;Y(15): 77.2,P27708,"S7(Phospho),T13(Phospho),T4(Phospho)",3
0,-0.40,-1.02,-1.52,0.31,0.57,0.15,0.11,C10(Carbamidomethyl);N-Term(iTRAQ8plex);S7(Phospho);T13(Phospho);T4(Phospho),,+,0.05841,3,1,1,1150000000,0.005,1.99,1,2.09288481,CAD protein [Includes: Glutamine-dependent carbamoyl-phosphate synthase (EC 6.3.5.5);Aspartate carbamoyltransferase (EC 2.1.3.2);Dihydroorotase (EC 3.5.2.3)],HGRTVHSLACLLTQYR,KHGRTVHSLACLLTQ,P27708,CAD,T(4): 68.4;S(7): 77.2;T(13): 77.2;Y(15): 77.2,P27708,"S7(Phospho),T13(Phospho),T4(Phospho)",3
0,-0.15,1.45,1.69,1.33,0.97,1.20,1.34,C8(Carbamidomethyl);K19(iTRAQ8plex);M7(Oxidation);S14(Phospho);Y13(Phospho);Y3(Phospho),Casein kinase I substrate motif,+,0.2073,2,1,1,0,0.008537,3,0,2.624878583,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 2, mitochondrial (EC 1.6.5.3) (EC 1.6.99.3) (Complex I-49kD) (CI-49kD) (NADH-ubiquinone oxidoreductase 49 kDa subunit)",LDYVSMMCNEQAYSLAVEK,FDRLDYVSMMCNEQA,O75306,NDUFS2,Y(3): 97.9;S(5): 93.0;Y(13): 9.8;S(14): 99.3,O75306,"S14(Phospho),Y13(Phospho),Y3(Phospho)",3
0,-0.15,1.45,1.69,1.33,0.97,1.20,1.34,C8(Carbamidomethyl);K19(iTRAQ8plex);M7(Oxidation);S14(Phospho);Y13(Phospho);Y3(Phospho),EGFR kinase substrate motif;PI3 kinase p85 SH2 domain binding motif;TC-PTP phosphatase substrate motif,+,0.2073,2,1,1,0,0.008537,3,0,2.624878583,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 2, mitochondrial (EC 1.6.5.3) (EC 1.6.99.3) (Complex I-49kD) (CI-49kD) (NADH-ubiquinone oxidoreductase 49 kDa subunit)",LDYVSMMCNEQAYSLAVEK,PYFDRLDYVSMMCNE,O75306,NDUFS2,Y(3): 97.9;S(5): 93.0;Y(13): 9.8;S(14): 99.3,O75306,"S14(Phospho),Y13(Phospho),Y3(Phospho)",3
0,-0.01,-1.46,-1.45,-0.19,-0.43,-0.44,-0.43,N-Term(iTRAQ8plex);S10(Phospho);S16(Phospho),"ERK1,2 kinase substrate motif;GSK-3, ERK1, ERK2, CDK5 substrate motif;PKA kinase substrate motif;PKC kinase substrate motif;WW domain binding motif",+,0.003189,10,1,1,49300000,0,4.26,2,3.613977172,Protein bicaudal D homolog 2 (Bic-D 2),EGQGGAGRTSPGGRTSPEAR,QGGAGRTSPGGRTSP,Q8TD16,BICD2,T(9): 18.8;S(10): 81.1;T(15): 50.0;S(16): 50.0,Q8TD16,"S10(Phospho),S16(Phospho)",2
0,-0.01,-1.46,-1.45,-0.19,-0.43,-0.44,-0.43,N-Term(iTRAQ8plex);S10(Phospho);S16(Phospho),Casein kinase II substrate motif;G protein-coupled receptor kinase 1 substrate motif,+,0.003189,10,1,1,49300000,0,4.26,2,3.613977172,Protein bicaudal D homolog 2 (Bic-D 2),EGQGGAGRTSPGGRTSPEAR,RTSPGGRTSPEARGR,Q8TD16,BICD2,T(9): 18.8;S(10): 81.1;T(15): 50.0;S(16): 50.0,Q8TD16,"S10(Phospho),S16(Phospho)",2
0,-0.01,-0.37,-0.02,1.36,1.17,1.18,1.19,C16(Carbamidomethyl);C18(Carbamidomethyl);C7(Carbamidomethyl);N-Term(iTRAQ8plex);S10(Phospho);S20(Phospho),,+,0.1815,6,1,1,5510000,0.005199,3.85,0,3.028224767,Electroneutral sodium bicarbonate exchanger 1 (Electroneutral Na(+)-driven Cl-HCO3 exchanger) (Solute carrier family 4 member 8) (k-NBC3),DALSLQCLASFLFLYCACMSPVITFGGLLGEATEGR,LSLQCLASFLFLYCA,Q2Y0W8,SLC4A8,S(4): 12.7;S(10): 84.9;Y(15): 71.8;S(20): 19.0;T(24): 4.6;T(33): 7.0,Q2Y0W8,"S10(Phospho),S20(Phospho)",2
0,-0.01,-0.37,-0.02,1.36,1.17,1.18,1.19,C16(Carbamidomethyl);C18(Carbamidomethyl);C7(Carbamidomethyl);N-Term(iTRAQ8plex);S10(Phospho);S20(Phospho),,+,0.1815,6,1,1,5510000,0.005199,3.85,0,3.028224767,Electroneutral sodium bicarbonate exchanger 1 (Electroneutral Na(+)-driven Cl-HCO3 exchanger) (Solute carrier family 4 member 8) (k-NBC3),DALSLQCLASFLFLYCACMSPVITFGGLLGEATEGR,SLQCLASFLFLYCAC,Q2Y0W8,SLC4A8,S(4): 12.7;S(10): 84.9;Y(15): 71.8;S(20): 19.0;T(24): 4.6;T(33): 7.0,Q2Y0W8,"S10(Phospho),S20(Phospho)",2
0,0.09,-1.44,-1.24,-0.10,-0.25,-0.61,-0.51,K16(iTRAQ8plex);N-Term(iTRAQ8plex);S12(Phospho);S4(Phospho),"DNA dependent Protein kinase substrate motif;ERK1,2 kinase substrate motif;G protein-coupled receptor kinase 1 substrate motif;GSK-3, ERK1, ERK2, CDK5 substrate motif;WW domain binding motif",+,0.0171,10,1,1,137000000,0,3.72,1,3.25476064,SNW domain-containing protein 1 (Nuclear protein SkiP) (Nuclear receptor coactivator NCoA-62) (Ski-interacting protein),GPPSPPAPVMHSPSRK,KIPRGPPSPPAPVMH,Q13573,SNW1,S(4): 100.0;S(12): 99.9;S(14): 0.1,Q13573,"S12(Phospho),S4(Phospho)",2
0,0.09,-1.44,-1.24,-0.10,-0.25,-0.61,-0.51,K16(iTRAQ8plex);N-Term(iTRAQ8plex);S12(Phospho);S4(Phospho),"Casein kinase II substrate motif;Cdc2 kinase substrate motif;CDK kinase substrate motif;CDK1,2,4,6 kinase substrate motif;ERK1,2 kinase substrate motif;GSK-3, ERK1, ERK2, CDK5 substrate motif;WW domain binding motif",+,0.0171,10,1,1,137000000,0,3.72,1,3.25476064,SNW domain-containing protein 1 (Nuclear protein SkiP) (Nuclear receptor coactivator NCoA-62) (Ski-interacting protein),GPPSPPAPVMHSPSRK,PPAPVMHSPSRKMTV,Q13573,SNW1,S(4): 100.0;S(12): 99.9;S(14): 0.1,Q13573,"S12(Phospho),S4(Phospho)",2
0,-0.06,-0.39,-0.28,0.18,0.05,0.06,0.12,K12(iTRAQ8plex);N-Term(iTRAQ8plex);S2(Phospho);S4(Phospho),"14-3-3 domain binding motif;Akt kinase substrate motif;Calmodulin-dependent protein kinase II substrate motif;Casein kinase II substrate motif;DNA dependent Protein kinase substrate motif;ERK1,2 kinase substrate motif;G protein-coupled receptor kinase 1 substrate motif;GSK-3, ERK1, ERK2, CDK5 substrate motif;MAPKAPK1 kinase substrate motif;PKA kinase substrate motif;PKC kinase substrate motif;WW domain binding motif",+,0.01054,9,1,1,205000000,0,3.92,1,2.089805811,SWI/SNF complex subunit SMARCC2 (BRG1-associated factor 170) (BAF170) (SWI/SNF complex 170 kDa subunit) (SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily C member 2),RSPSPSPTPEAK,KKRKRSPSPSPTPEA,Q8TAQ2,SMARCC2,S(2): 100.0;S(4): 99.9;S(6): 0.1;T(8): 0.0,Q8TAQ2,"S2(Phospho),S4(Phospho)",2
0,-0.06,-0.39,-0.28,0.18,0.05,0.06,0.12,K12(iTRAQ8plex);N-Term(iTRAQ8plex);S2(Phospho);S4(Phospho),"14-3-3 domain binding motif;Calmodulin-dependent protein kinase II substrate motif;Casein kinase II substrate motif;ERK1,2 kinase substrate motif;G protein-coupled receptor kinase 1 substrate motif;Growth associated histone HI kinase substrate motif;GSK3 kinase substrate motif;GSK-3, ERK1, ERK2, CDK5 substrate motif;MAPKAPK1 kinase substrate motif;Pim1 kinase substrate sequence;PKA kinase substrate motif;PKC epsilon kinase substrate motif;PKC kinase substrate motif;WW domain binding motif;ZIP kinase substrate motif",+,0.01054,9,1,1,205000000,0,3.92,1,2.089805811,SWI/SNF complex subunit SMARCC2 (BRG1-associated factor 170) (BAF170) (SWI/SNF complex 170 kDa subunit) (SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily C member 2),RSPSPSPTPEAK,NYKKRKRSPSPSPTP,Q8TAQ2,SMARCC2,S(2): 100.0;S(4): 99.9;S(6): 0.1;T(8): 0.0,Q8TAQ2,"S2(Phospho),S4(Phospho)",2
0,-0.04,-0.81,-0.90,-0.44,-0.18,-0.35,-0.29,N-Term(iTRAQ8plex);S2(Phospho);S4(Phospho),"14-3-3 domain binding motif;Akt kinase substrate motif;Calmodulin-dependent protein kinase II substrate motif;Casein kinase II substrate motif;ERK1,2 kinase substrate motif;G protein-coupled receptor kinase 1 substrate motif;GSK-3, ERK1, ERK2, CDK5 substrate motif;MAPKAPK1 kinase substrate motif;Pim1 kinase substrate sequence;PKA kinase substrate motif;PKC epsilon kinase substrate motif;PKC kinase substrate motif;WW domain binding motif",+,0.03311,7,1,1,63600000,0,2.72,0,2.26321181,SWI/SNF complex subunit SMARCC1 (BRG1-associated factor 155) (BAF155) (SWI/SNF complex 155 kDa subunit) (SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily C member 1),HSPSPPPPTPTESR,NARKRKHSPSPPPPT,Q92922,SMARCC1,S(2): 100.0;S(4): 100.0;T(9): 0.0;T(11): 0.0;S(13): 0.0,Q92922,"S2(Phospho),S4(Phospho)",2
0,-0.04,-0.81,-0.90,-0.44,-0.18,-0.35,-0.29,N-Term(iTRAQ8plex);S2(Phospho);S4(Phospho),"DNA dependent Protein kinase substrate motif;ERK1,2 kinase substrate motif;G protein-coupled receptor kinase 1 substrate motif;GSK-3, ERK1, ERK2, CDK5 substrate motif;PKA kinase substrate motif;WW domain binding motif",+,0.03311,7,1,1,63600000,0,2.72,0,2.26321181,SWI/SNF complex subunit SMARCC1 (BRG1-associated factor 155) (BAF155) (SWI/SNF complex 155 kDa subunit) (SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily C member 1),HSPSPPPPTPTESR,RKRKHSPSPPPPTPT,Q92922,SMARCC1,S(2): 100.0;S(4): 100.0;T(9): 0.0;T(11): 0.0;S(13): 0.0,Q92922,"S2(Phospho),S4(Phospho)",2
0,0.25,NaN,-0.91,-1.10,-0.66,-1.42,-1.55,K10(iTRAQ8plex);K15(iTRAQ8plex);S3(Phospho);S4(Phospho),MDC1 BRCT domain binding motif;Plk1 PBD domain binding motif,+,0.1189,2,1,1,252000,0.002391,0.99,1,1.97536416,DNA helicase MCM9 (hMCM9) (EC 3.6.4.12) (Mini-chromosome maintenance deficient domain-containing protein 1) (Minichromosome maintenance 9),IISSFILENKGYPSK,DWDRIISSFILENKG,Q9NXL9,MCM9,S(3): 85.2;S(4): 85.2;Y(12): 14.8;S(14): 14.8,Q9NXL9,"S3(Phospho),S4(Phospho)",2
0,0.25,NaN,-0.91,-1.10,-0.66,-1.42,-1.55,K10(iTRAQ8plex);K15(iTRAQ8plex);S3(Phospho);S4(Phospho),14-3-3 domain binding motif;Calmodulin-dependent protein kinase II substrate motif;PKA kinase substrate motif;PKC kinase substrate motif,+,0.1189,2,1,1,252000,0.002391,0.99,1,1.97536416,DNA helicase MCM9 (hMCM9) (EC 3.6.4.12) (Mini-chromosome maintenance deficient domain-containing protein 1) (Minichromosome maintenance 9),IISSFILENKGYPSK,EDWDRIISSFILENK,Q9NXL9,MCM9,S(3): 85.2;S(4): 85.2;Y(12): 14.8;S(14): 14.8,Q9NXL9,"S3(Phospho),S4(Phospho)",2
0,0.13,0.90,0.91,0.15,0.23,0.64,0.53,K15(iTRAQ8plex);K5(iTRAQ8plex);S3(Phospho);S4(Phospho),AMP-activated protein kinase substrate motif;b-Adrenergic Receptor kinase substrate motif;Casein kinase II substrate motif;HMGCoA Reductase kinase substrate motif;PKA kinase substrate motif;PKC kinase substrate motif,+,0.06197,2,1,1,0,0.001328,3.92,2,3.173005906,Testis-specific gene 10 protein (Testis development protein NYD-SP7),LDSSKELLNRQLVAK,ELCIKLDSSKELLNR,Q9BZW7,TSGA10,S(3): 100.0;S(4): 100.0,Q9BZW7,"S3(Phospho),S4(Phospho)",2
0,0.13,0.90,0.91,0.15,0.23,0.64,0.53,K15(iTRAQ8plex);K5(iTRAQ8plex);S3(Phospho);S4(Phospho),AMP-activated protein kinase substrate motif;Casein kinase II substrate motif;MDC1 BRCT domain binding motif;PKA kinase substrate motif;Plk1 PBD domain binding motif,+,0.06197,2,1,1,0,0.001328,3.92,2,3.173005906,Testis-specific gene 10 protein (Testis development protein NYD-SP7),LDSSKELLNRQLVAK,LCIKLDSSKELLNRQ,Q9BZW7,TSGA10,S(3): 100.0;S(4): 100.0,Q9BZW7,"S3(Phospho),S4(Phospho)",2
0,0.16,-0.90,-0.72,0.36,0.56,0.27,0.32,K12(iTRAQ8plex);N-Term(iTRAQ8plex);S3(Phospho);S4(Phospho),14-3-3 domain binding motif;Akt kinase substrate motif;Calmodulin-dependent protein kinase II substrate motif;Casein kinase II substrate motif;MAPKAPK1 kinase substrate motif;PAK2 kinase substrate motif;PKA kinase substrate motif;PKC epsilon kinase substrate motif;PKC kinase substrate motif;Pyruvate dehydrogenase kinase substrate motif,+,0.1233,4,1,1,21400000,0.005689,2.76,1,2.913287123,A-kinase anchor protein 12 (AKAP-12) (A-kinase anchor protein 250 kDa) (AKAP 250) (Gravin) (Myasthenia gravis autoantigen),RGSSSDEEGGPK,KKRARRGSSSDEEGG,Q02952,AKAP12,S(3): 93.0;S(4): 53.5;S(5): 53.5,Q02952,"S3(Phospho),S4(Phospho)",2
0,0.16,-0.90,-0.72,0.36,0.56,0.27,0.32,K12(iTRAQ8plex);N-Term(iTRAQ8plex);S3(Phospho);S4(Phospho),14-3-3 domain binding motif;Akt kinase substrate motif;Calmodulin-dependent protein kinase II substrate motif;Casein kinase II substrate motif;MAPKAPK1 kinase substrate motif;PAK2 kinase substrate motif;PKA kinase substrate motif;PKC epsilon kinase substrate motif;PKC kinase substrate motif;Pyruvate dehydrogenase kinase substrate motif,+,0.1233,4,1,1,21400000,0.005689,2.76,1,2.913287123,A-kinase anchor protein 12 (AKAP-12) (A-kinase anchor protein 250 kDa) (AKAP 250) (Gravin) (Myasthenia gravis autoantigen),RGSSSDEEGGPK,KKRARRGSSSDEEGG,Q02952,AKAP12,S(3): 93.0;S(4): 53.5;S(5): 53.5,Q02952,"S3(Phospho),S4(Phospho)",2
0,-0.04,0.01,-0.05,0.25,0.32,-0.05,0.08,N-Term(iTRAQ8plex);S3(Phospho);S4(Phospho),14-3-3 domain binding motif;Calmodulin-dependent protein kinase II substrate motif;Casein kinase II substrate motif;DNA dependent Protein kinase substrate motif;MAPKAPK2 kinase substrate motif;PKA kinase substrate motif;PKC kinase substrate motif,+,0.1239,2,1,1,11600000,0.006093,3.05,0,1.814095847,182 kDa tankyrase-1-binding protein,VPSSDEEVVEEPQSR,PRASRVPSSDEEVVE,Q9C0C2,TNKS1BP1,S(3): 100.0;S(4): 100.0;S(14): 0.0,Q9C0C2,"S3(Phospho),S4(Phospho)",2
0,-0.04,0.01,-0.05,0.25,0.32,-0.05,0.08,N-Term(iTRAQ8plex);S3(Phospho);S4(Phospho),BARD1 BRCT domain binding motif;Casein kinase II substrate motif;MDC1 BRCT domain binding motif;Plk1 PBD domain binding motif,+,0.1239,2,1,1,11600000,0.006093,3.05,0,1.814095847,182 kDa tankyrase-1-binding protein,VPSSDEEVVEEPQSR,RASRVPSSDEEVVEE,Q9C0C2,TNKS1BP1,S(3): 100.0;S(4): 100.0;S(14): 0.0,Q9C0C2,"S3(Phospho),S4(Phospho)",2
0,0.15,-0.78,-0.69,-0.74,-0.78,-0.44,-0.49,K18(iTRAQ8plex);N-Term(iTRAQ8plex);S2(Phospho);S5(Phospho),Casein kinase II substrate motif;MAPKAPK2 kinase substrate motif;PKA kinase substrate motif;PKC kinase substrate motif,+,3.85E-06,4,1,1,15000000,0,6.23,0,3.17693217,Neuroblast differentiation-associated protein AHNAK (Desmoyokin),ASLGSLEGEAEAEASSPK,DLKSSKASLGSLEGE,Q09666,AHNAK,S(2): 100.0;S(5): 100.0;S(15): 0.0;S(16): 0.0,Q09666,"S2(Phospho),S5(Phospho)",2
0,0.15,-0.78,-0.69,-0.74,-0.78,-0.44,-0.49,K18(iTRAQ8plex);N-Term(iTRAQ8plex);S2(Phospho);S5(Phospho),Casein kinase II substrate motif,+,3.85E-06,4,1,1,15000000,0,6.23,0,3.17693217,Neuroblast differentiation-associated protein AHNAK (Desmoyokin),ASLGSLEGEAEAEASSPK,SSKASLGSLEGEAEA,Q09666,AHNAK,S(2): 100.0;S(5): 100.0;S(15): 0.0;S(16): 0.0,Q09666,"S2(Phospho),S5(Phospho)",2
0,-0.11,-2.27,-1.98,-0.96,-1.05,-1.05,-0.96,K16(iTRAQ8plex);N-Term(iTRAQ8plex);S3(Phospho);S5(Phospho),Casein kinase II substrate motif,+,0.004591,78,1,1,779000000,0,5.7,0,3.500170886,Prelamin-A/C [Cleaved into: Lamin-A/C (70 kDa lamin) (Renal carcinoma antigen NY-REN-32)],ASSHSSQTQGGGSVTK,RGRASSHSSQTQGGG,P02545,LMNA,S(2): 14.4;S(3): 85.6;S(5): 85.3;S(6): 14.3;T(8): 0.5;S(13): 0.0;T(15): 0.0,P02545,"S3(Phospho),S5(Phospho)",2
0,-0.11,-2.27,-1.98,-0.96,-1.05,-1.05,-0.96,K16(iTRAQ8plex);N-Term(iTRAQ8plex);S3(Phospho);S5(Phospho),14-3-3 domain binding motif;Akt kinase substrate motif;Calmodulin-dependent protein kinase II substrate motif;Casein kinase II substrate motif;MAPKAPK1 kinase substrate motif;MDC1 BRCT domain binding motif;PKA kinase substrate motif;PKC kinase substrate motif;Plk1 PBD domain binding motif,+,0.004591,78,1,1,779000000,0,5.7,0,3.500170886,Prelamin-A/C [Cleaved into: Lamin-A/C (70 kDa lamin) (Renal carcinoma antigen NY-REN-32)],ASSHSSQTQGGGSVTK,RSRGRASSHSSQTQG,P02545,LMNA,S(2): 14.4;S(3): 85.6;S(5): 85.3;S(6): 14.3;T(8): 0.5;S(13): 0.0;T(15): 0.0,P02545,"S3(Phospho),S5(Phospho)",2
0,-0.01,-1.00,-0.84,-0.17,-0.23,-0.43,-0.45,K9(iTRAQ8plex);N-Term(iTRAQ8plex);S3(Phospho);S5(Phospho),"14-3-3 domain binding motif;Akt kinase substrate motif;AMP-activated protein kinase 2 substrate motif;Calmodulin-dependent protein kinase II substrate motif;ERK1,2 kinase substrate motif;GSK-3, ERK1, ERK2, CDK5 substrate motif;MAPKAPK1 kinase substrate motif;PKA kinase substrate motif;PKC kinase substrate motif;WW domain binding motif",+,0.004151,48,1,1,1090000000,0,3.66,1,3.398706776,"Serine/arginine-rich splicing factor 6 (Pre-mRNA-splicing factor SRP55) (Splicing factor, arginine/serine-rich 6)",ARSVSPPPK,PSKARSVSPPPKRAT,Q13247,SRSF6,S(3): 100.0;S(5): 100.0,Q13247,"S3(Phospho),S5(Phospho)",2
0,0.03,-1.52,-1.00,-0.97,-1.01,0.30,0.01,K9(iTRAQ8plex);N-Term(iTRAQ8plex);S3(Phospho);S5(Phospho),"14-3-3 domain binding motif;Akt kinase substrate motif;AMP-activated protein kinase 2 substrate motif;Calmodulin-dependent protein kinase II substrate motif;ERK1,2 kinase substrate motif;GSK-3, ERK1, ERK2, CDK5 substrate motif;MAPKAPK1 kinase substrate motif;PKA kinase substrate motif;PKC kinase substrate motif;WW domain binding motif",+,0.04662,1,1,1,0,0.001,1.71,2,2.261452558,"Serine/arginine-rich splicing factor 6 (Pre-mRNA-splicing factor SRP55) (Splicing factor, arginine/serine-rich 6)",ARSVSPPPKR,PSKARSVSPPPKRAT,Q13247,SRSF6,,Q13247,"S3(Phospho),S5(Phospho)",2
0,-0.01,-1.00,-0.84,-0.17,-0.23,-0.43,-0.45,K9(iTRAQ8plex);N-Term(iTRAQ8plex);S3(Phospho);S5(Phospho),Casein kinase II substrate motif;G protein-coupled receptor kinase 1 substrate motif;MAPKAPK2 kinase substrate motif;Phosphorylase kinase substrate motif;PKA kinase substrate motif;PKC kinase substrate motif,+,0.004151,48,1,1,1090000000,0,3.66,1,3.398706776,"Serine/arginine-rich splicing factor 6 (Pre-mRNA-splicing factor SRP55) (Splicing factor, arginine/serine-rich 6)",ARSVSPPPK,VPPSKARSVSPPPKR,Q13247,SRSF6,S(3): 100.0;S(5): 100.0,Q13247,"S3(Phospho),S5(Phospho)",2
0,0.03,-1.52,-1.00,-0.97,-1.01,0.30,0.01,K9(iTRAQ8plex);N-Term(iTRAQ8plex);S3(Phospho);S5(Phospho),Casein kinase II substrate motif;G protein-coupled receptor kinase 1 substrate motif;MAPKAPK2 kinase substrate motif;Phosphorylase kinase substrate motif;PKA kinase substrate motif;PKC kinase substrate motif,+,0.04662,1,1,1,0,0.001,1.71,2,2.261452558,"Serine/arginine-rich splicing factor 6 (Pre-mRNA-splicing factor SRP55) (Splicing factor, arginine/serine-rich 6)",ARSVSPPPKR,VPPSKARSVSPPPKR,Q13247,SRSF6,,Q13247,"S3(Phospho),S5(Phospho)",2
0,0.13,-1.52,-1.67,-0.37,-0.33,-0.58,-0.65,K9(iTRAQ8plex);N-Term(iTRAQ8plex);S3(Phospho);S5(Phospho),"b-Adrenergic Receptor kinase substrate motif;Casein kinase II substrate motif;ERK1,2 kinase substrate motif;G protein-coupled receptor kinase 1 substrate motif;GSK-3, ERK1, ERK2, CDK5 substrate motif;PAK2 kinase substrate motif;PKA kinase substrate motif;PKC kinase substrate motif;WW domain binding motif",+,0.1255,2,1,1,375000000,0.006093,3.2,1,3.910908076,Serine/arginine repetitive matrix protein 1 (SR-related nuclear matrix protein of 160 kDa) (SRm160) (Ser/Arg-related nuclear matrix protein),RESPSPAPKPR,KGTEKRESPSPAPKP,Q8IYB3,SRRM1,S(3): 100.0;S(5): 100.0,Q8IYB3,"S3(Phospho),S5(Phospho)",2
0,0.10,-0.41,-0.38,-0.05,-0.15,-0.02,-0.02,K9(iTRAQ8plex);N-Term(iTRAQ8plex);S3(Phospho);S5(Phospho),"ERK1,2 kinase substrate motif;GSK-3, ERK1, ERK2, CDK5 substrate motif;WW domain binding motif",+,0.04726,8,1,1,225000000,0,2.71,1,2.496790927,Serine/arginine repetitive matrix protein 1 (SR-related nuclear matrix protein of 160 kDa) (SRm160) (Ser/Arg-related nuclear matrix protein),RVSHSPPPK,PKRRVSHSPPPKQRS,Q8IYB3,SRRM1,S(3): 100.0;S(5): 100.0,Q8IYB3,"S3(Phospho),S5(Phospho)",2
0,0.00,-0.88,-0.63,-0.13,-0.29,0.02,0.06,K9(iTRAQ8plex);N-Term(iTRAQ8plex);S3(Phospho);S5(Phospho),"ERK1,2 kinase substrate motif;GSK-3, ERK1, ERK2, CDK5 substrate motif;WW domain binding motif",+,0.003322,3,1,1,210000000,0,3.07,2,2.302163189,Serine/arginine repetitive matrix protein 1 (SR-related nuclear matrix protein of 160 kDa) (SRm160) (Ser/Arg-related nuclear matrix protein),RVSHSPPPKQR,PKRRVSHSPPPKQRS,Q8IYB3,SRRM1,S(3): 100.0;S(5): 100.0,Q8IYB3,"S3(Phospho),S5(Phospho)",2
0,0.10,-0.41,-0.38,-0.05,-0.15,-0.02,-0.02,K9(iTRAQ8plex);N-Term(iTRAQ8plex);S3(Phospho);S5(Phospho),14-3-3 domain binding motif;Calmodulin-dependent protein kinase II substrate motif;Casein kinase II substrate motif;G protein-coupled receptor kinase 1 substrate motif;PAK2 kinase substrate motif;Pim1 kinase substrate sequence;PKA kinase substrate motif;PKC epsilon kinase substrate motif;PKC kinase substrate motif,+,0.04726,8,1,1,225000000,0,2.71,1,2.496790927,Serine/arginine repetitive matrix protein 1 (SR-related nuclear matrix protein of 160 kDa) (SRm160) (Ser/Arg-related nuclear matrix protein),RVSHSPPPK,PPPKRRVSHSPPPKQ,Q8IYB3,SRRM1,S(3): 100.0;S(5): 100.0,Q8IYB3,"S3(Phospho),S5(Phospho)",2
0,0.00,-0.88,-0.63,-0.13,-0.29,0.02,0.06,K9(iTRAQ8plex);N-Term(iTRAQ8plex);S3(Phospho);S5(Phospho),14-3-3 domain binding motif;Calmodulin-dependent protein kinase II substrate motif;Casein kinase II substrate motif;G protein-coupled receptor kinase 1 substrate motif;PAK2 kinase substrate motif;Pim1 kinase substrate sequence;PKA kinase substrate motif;PKC epsilon kinase substrate motif;PKC kinase substrate motif,+,0.003322,3,1,1,210000000,0,3.07,2,2.302163189,Serine/arginine repetitive matrix protein 1 (SR-related nuclear matrix protein of 160 kDa) (SRm160) (Ser/Arg-related nuclear matrix protein),RVSHSPPPKQR,PPPKRRVSHSPPPKQ,Q8IYB3,SRRM1,S(3): 100.0;S(5): 100.0,Q8IYB3,"S3(Phospho),S5(Phospho)",2
0,0.13,-1.52,-1.67,-0.37,-0.33,-0.58,-0.65,K9(iTRAQ8plex);N-Term(iTRAQ8plex);S3(Phospho);S5(Phospho),"Casein kinase I substrate motif;DNA dependent Protein kinase substrate motif;ERK1,2 kinase substrate motif;GSK-3, ERK1, ERK2, CDK5 substrate motif;WW domain binding motif",+,0.1255,2,1,1,375000000,0.006093,3.2,1,3.910908076,Serine/arginine repetitive matrix protein 1 (SR-related nuclear matrix protein of 160 kDa) (SRm160) (Ser/Arg-related nuclear matrix protein),RESPSPAPKPR,TEKRESPSPAPKPRK,Q8IYB3,SRRM1,S(3): 100.0;S(5): 100.0,Q8IYB3,"S3(Phospho),S5(Phospho)",2
0,0.08,-2.00,-1.96,-0.45,-0.53,-0.66,-0.15,N-Term(iTRAQ8plex);S3(Phospho);S5(Phospho),14-3-3 domain binding motif;Calmodulin-dependent protein kinase II substrate motif;Calmodulin-dependent protein kinase IV substrate motif;Casein kinase II substrate motif;G protein-coupled receptor kinase 1 substrate motif;GSK3 kinase substrate motif;MAPKAPK1 kinase substrate motif;PAK2 kinase substrate motif;Pim1 kinase substrate sequence;PKA kinase substrate motif;PKC epsilon kinase substrate motif;PKC kinase substrate motif;ZIP kinase substrate motif,+,0.003853,10,1,1,49000000,0,2.42,1,2.805703545,"Transformer-2 protein homolog beta (TRA-2 beta) (TRA2-beta) (hTRA2-beta) (Splicing factor, arginine/serine-rich 10) (Transformer-2 protein homolog B)",RHSHSHSPMSTR,RDYRRRHSHSHSPMS,P62995,TRA2B,S(3): 81.8;S(5): 22.7;S(7): 94.6;S(10): 0.2;T(11): 0.6,P62995,"S3(Phospho),S5(Phospho)",2
0,0.08,-2.00,-1.96,-0.45,-0.53,-0.66,-0.15,N-Term(iTRAQ8plex);S3(Phospho);S5(Phospho),"Casein kinase II substrate motif;ERK1,2 kinase substrate motif;G protein-coupled receptor kinase 1 substrate motif;GSK-3, ERK1, ERK2, CDK5 substrate motif;MAPKAPK2 kinase substrate motif;WW domain binding motif",+,0.003853,10,1,1,49000000,0,2.42,1,2.805703545,"Transformer-2 protein homolog beta (TRA-2 beta) (TRA2-beta) (hTRA2-beta) (Splicing factor, arginine/serine-rich 10) (Transformer-2 protein homolog B)",RHSHSHSPMSTR,RRHSHSHSPMSTRRR,P62995,TRA2B,S(3): 81.8;S(5): 22.7;S(7): 94.6;S(10): 0.2;T(11): 0.6,P62995,"S3(Phospho),S5(Phospho)",2
0,-0.19,-1.00,-0.76,-0.18,-0.14,-0.33,-0.19,N-Term(iTRAQ8plex);S3(Phospho);S5(Phospho),"14-3-3 domain binding motif;Akt kinase substrate motif;Calmodulin-dependent protein kinase II substrate motif;DNA dependent Protein kinase substrate motif;ERK1,2 kinase substrate motif;G protein-coupled receptor kinase 1 substrate motif;GSK-3, ERK1, ERK2, CDK5 substrate motif;MAPKAPK1 kinase substrate motif;PKA kinase substrate motif;PKC kinase substrate motif;WW domain binding motif;ZIP kinase substrate motif",+,0.05309,5,1,1,302000000,0.001,2.62,2,2.009966449,Serine/arginine repetitive matrix protein 1 (SR-related nuclear matrix protein of 160 kDa) (SRm160) (Ser/Arg-related nuclear matrix protein),RRSPSPPPTR,GRRRRSPSPPPTRRR,Q8IYB3,SRRM1,S(3): 99.6;S(5): 99.4;T(9): 1.0,Q8IYB3,"S3(Phospho),S5(Phospho)",2
0,0.02,-1.02,-1.09,0.03,-0.18,-0.15,-0.04,N-Term(iTRAQ8plex);S3(Phospho);S5(Phospho),"Casein kinase II substrate motif;DNA dependent Protein kinase substrate motif;ERK1,2 kinase substrate motif;GSK-3, ERK1, ERK2, CDK5 substrate motif;WW domain binding motif",+,0.0743,2,1,1,40200000,0.001328,2.45,0,3.15527137,Serine/arginine repetitive matrix protein 1 (SR-related nuclear matrix protein of 160 kDa) (SRm160) (Ser/Arg-related nuclear matrix protein),AASPSPQSVR,IKKAASPSPQSVRRV,Q8IYB3,SRRM1,S(3): 100.0;S(5): 100.0;S(8): 0.0,Q8IYB3,"S3(Phospho),S5(Phospho)",2
0,0.02,-1.02,-1.09,0.03,-0.18,-0.15,-0.04,N-Term(iTRAQ8plex);S3(Phospho);S5(Phospho),"Calmodulin-dependent protein kinase II substrate motif;Casein kinase II substrate motif;Chk1 kinase substrate motif;ERK1,2 kinase substrate motif;GSK-3, ERK1, ERK2, CDK5 substrate motif;PKA kinase substrate motif;PKC kinase substrate motif;WW domain binding motif",+,0.0743,2,1,1,40200000,0.001328,2.45,0,3.15527137,Serine/arginine repetitive matrix protein 1 (SR-related nuclear matrix protein of 160 kDa) (SRm160) (Ser/Arg-related nuclear matrix protein),AASPSPQSVR,KKIKKAASPSPQSVR,Q8IYB3,SRRM1,S(3): 100.0;S(5): 100.0;S(8): 0.0,Q8IYB3,"S3(Phospho),S5(Phospho)",2
0,-0.16,-2.58,-2.28,-0.20,-0.35,-0.44,-0.40,N-Term(iTRAQ8plex);S3(Phospho);S5(Phospho),"14-3-3 domain binding motif;Calmodulin-dependent protein kinase II substrate motif;Casein kinase II substrate motif;ERK1,2 kinase substrate motif;G protein-coupled receptor kinase 1 substrate motif;Growth associated histone HI kinase substrate motif;GSK-3, ERK1, ERK2, CDK5 substrate motif;MAPKAPK1 kinase substrate motif;PAK2 kinase substrate motif;Pim1 kinase substrate sequence;PKA kinase substrate motif;PKC epsilon kinase substrate motif;PKC kinase substrate motif;WW domain binding motif;ZIP kinase substrate motif",+,0.01644,13,1,1,3250000000,0,3.1,2,3.739090759,Serine/arginine repetitive matrix protein 1 (SR-related nuclear matrix protein of 160 kDa) (SRm160) (Ser/Arg-related nuclear matrix protein),RRSPSPAPPPR,PPTRRRRSPSPAPPP,Q8IYB3,SRRM1,,Q8IYB3,"S3(Phospho),S5(Phospho)",2
0,0.13,-0.83,-1.02,0.11,0.16,0.12,0.09,N-Term(iTRAQ8plex);S3(Phospho);S5(Phospho),"Casein kinase II substrate motif;DNA dependent Protein kinase substrate motif;ERK1,2 kinase substrate motif;GSK-3, ERK1, ERK2, CDK5 substrate motif;WW domain binding motif",+,0.01902,8,1,1,838000000,0,4.36,1,3.241044899,Serine/arginine repetitive matrix protein 1 (SR-related nuclear matrix protein of 160 kDa) (SRm160) (Ser/Arg-related nuclear matrix protein),RQSPSPSTRPIR,PQRRQSPSPSTRPIR,Q8IYB3,SRRM1,S(3): 100.0;S(5): 99.8;S(7): 0.2;T(8): 0.0,Q8IYB3,"S3(Phospho),S5(Phospho)",2
0,-0.19,-1.00,-0.76,-0.18,-0.14,-0.33,-0.19,N-Term(iTRAQ8plex);S3(Phospho);S5(Phospho),"14-3-3 domain binding motif;Calmodulin-dependent protein kinase II substrate motif;Casein kinase II substrate motif;ERK1,2 kinase substrate motif;G protein-coupled receptor kinase 1 substrate motif;Growth associated histone HI kinase substrate motif;GSK-3, ERK1, ERK2, CDK5 substrate motif;MAPKAPK1 kinase substrate motif;PAK2 kinase substrate motif;Pim1 kinase substrate sequence;PKA kinase substrate motif;PKC epsilon kinase substrate motif;PKC kinase substrate motif;WW domain binding motif;ZIP kinase substrate motif",+,0.05309,5,1,1,302000000,0.001,2.62,2,2.009966449,Serine/arginine repetitive matrix protein 1 (SR-related nuclear matrix protein of 160 kDa) (SRm160) (Ser/Arg-related nuclear matrix protein),RRSPSPPPTR,PRGRRRRSPSPPPTR,Q8IYB3,SRRM1,S(3): 99.6;S(5): 99.4;T(9): 1.0,Q8IYB3,"S3(Phospho),S5(Phospho)",2
0,0.13,-0.83,-1.02,0.11,0.16,0.12,0.09,N-Term(iTRAQ8plex);S3(Phospho);S5(Phospho),"14-3-3 domain binding motif;Calmodulin-dependent protein kinase II substrate motif;Casein kinase II substrate motif;ERK1,2 kinase substrate motif;G protein-coupled receptor kinase 1 substrate motif;GSK3 kinase substrate motif;GSK-3, ERK1, ERK2, CDK5 substrate motif;PAK2 kinase substrate motif;PKA kinase substrate motif;PKC epsilon kinase substrate motif;PKC kinase substrate motif;WW domain binding motif",+,0.01902,8,1,1,838000000,0,4.36,1,3.241044899,Serine/arginine repetitive matrix protein 1 (SR-related nuclear matrix protein of 160 kDa) (SRm160) (Ser/Arg-related nuclear matrix protein),RQSPSPSTRPIR,SSPQRRQSPSPSTRP,Q8IYB3,SRRM1,S(3): 100.0;S(5): 99.8;S(7): 0.2;T(8): 0.0,Q8IYB3,"S3(Phospho),S5(Phospho)",2
0,-0.16,-2.58,-2.28,-0.20,-0.35,-0.44,-0.40,N-Term(iTRAQ8plex);S3(Phospho);S5(Phospho),"14-3-3 domain binding motif;Akt kinase substrate motif;Calmodulin-dependent protein kinase II substrate motif;DNA dependent Protein kinase substrate motif;ERK1,2 kinase substrate motif;G protein-coupled receptor kinase 1 substrate motif;GSK-3, ERK1, ERK2, CDK5 substrate motif;MAPKAPK1 kinase substrate motif;PKA kinase substrate motif;PKC kinase substrate motif;WW domain binding motif;ZIP kinase substrate motif",+,0.01644,13,1,1,3250000000,0,3.1,2,3.739090759,Serine/arginine repetitive matrix protein 1 (SR-related nuclear matrix protein of 160 kDa) (SRm160) (Ser/Arg-related nuclear matrix protein),RRSPSPAPPPR,TRRRRSPSPAPPPRR,Q8IYB3,SRRM1,,Q8IYB3,"S3(Phospho),S5(Phospho)",2
0,0.06,-1.29,-1.15,-0.02,-0.14,-0.26,-0.24,N-Term(iTRAQ8plex);S3(Phospho);S5(Phospho),14-3-3 domain binding motif;Akt kinase substrate motif;Calmodulin-dependent protein kinase II substrate motif;Casein kinase II substrate motif;G protein-coupled receptor kinase 1 substrate motif;MAPKAPK1 kinase substrate motif;PAK2 kinase substrate motif;Pim1 kinase substrate sequence;PKA kinase substrate motif;PKC epsilon kinase substrate motif;PKC kinase substrate motif;ZIP kinase substrate motif,+,0.02298,6,1,1,156000000,0,4.07,2,3.834830856,"Splicing factor, arginine/serine-rich 19 (SR-related and CTD-associated factor 1) (SR-related-CTD-associated factor) (SCAF) (Serine arginine-rich pre-mRNA splicing factor SR-A1) (SR-A1)",RRSASPPPATSSSSSSR,KRRRRRRSASPPPAT,Q9H7N4,SCAF1,,Q9H7N4,"S3(Phospho),S5(Phospho)",2
0,0.06,-1.29,-1.15,-0.02,-0.14,-0.26,-0.24,N-Term(iTRAQ8plex);S3(Phospho);S5(Phospho),"14-3-3 domain binding motif;Akt kinase substrate motif;Calmodulin-dependent protein kinase II substrate motif;ERK1,2 kinase substrate motif;G protein-coupled receptor kinase 1 substrate motif;GSK-3, ERK1, ERK2, CDK5 substrate motif;MAPKAPK1 kinase substrate motif;PKA kinase substrate motif;PKC kinase substrate motif;WW domain binding motif;ZIP kinase substrate motif",+,0.02298,6,1,1,156000000,0,4.07,2,3.834830856,"Splicing factor, arginine/serine-rich 19 (SR-related and CTD-associated factor 1) (SR-related-CTD-associated factor) (SCAF) (Serine arginine-rich pre-mRNA splicing factor SR-A1) (SR-A1)",RRSASPPPATSSSSSSR,RRRRRSASPPPATSS,Q9H7N4,SCAF1,,Q9H7N4,"S3(Phospho),S5(Phospho)",2
0,0.58,-1.12,-1.39,0.73,1.39,0.94,0.77,K10(iTRAQ8plex);K2(iTRAQ8plex);N-Term(iTRAQ8plex);S4(Phospho);S5(Phospho),Casein kinase I substrate motif;Casein kinase II substrate motif;PKA kinase substrate motif;PKC kinase substrate motif,+,0.002814,2,1,1,23500000,0,4.95,2,2.146180289,"Zinc transporter SLC39A7 (Histidine-rich membrane protein Ke4) (Really interesting new gene 5 protein) (Solute carrier family 39 member 7) (Zrt-, Irt-like protein 7) (ZIP7)",EKQSSEEEEKETR,RSTKEKQSSEEEEKE,Q92504,SLC39A7,S(4): 100.0;S(5): 100.0;T(12): 0.0,Q92504,"S4(Phospho),S5(Phospho)",2
0,0.58,-1.12,-1.39,0.73,1.39,0.94,0.77,K10(iTRAQ8plex);K2(iTRAQ8plex);N-Term(iTRAQ8plex);S4(Phospho);S5(Phospho),BARD1 BRCT domain binding motif;Casein kinase II substrate motif;G protein-coupled receptor kinase 1 substrate motif;MDC1 BRCT domain binding motif;PKA kinase substrate motif;PKC kinase substrate motif;Plk1 PBD domain binding motif,+,0.002814,2,1,1,23500000,0,4.95,2,2.146180289,"Zinc transporter SLC39A7 (Histidine-rich membrane protein Ke4) (Really interesting new gene 5 protein) (Solute carrier family 39 member 7) (Zrt-, Irt-like protein 7) (ZIP7)",EKQSSEEEEKETR,STKEKQSSEEEEKET,Q92504,SLC39A7,S(4): 100.0;S(5): 100.0;T(12): 0.0,Q92504,"S4(Phospho),S5(Phospho)",2
0,-0.02,-0.44,-0.32,0.37,0.38,0.36,0.44,K8(iTRAQ8plex);N-Term(iTRAQ8plex);S4(Phospho);S5(Phospho),Casein kinase II substrate motif;DNA dependent Protein kinase substrate motif;PKA kinase substrate motif,+,0.09832,1,1,1,0,0.004,3.05,1,3.444613162,Zinc finger protein 608 (Renal carcinoma antigen NY-REN-36),ASPSSTNKR,EDIKASPSSTNKRKN,Q9ULD9,ZNF608,,Q9ULD9,"S4(Phospho),S5(Phospho)",2
0,-0.02,-0.44,-0.32,0.37,0.38,0.36,0.44,K8(iTRAQ8plex);N-Term(iTRAQ8plex);S4(Phospho);S5(Phospho),MDC1 BRCT domain binding motif;Plk1 PBD domain binding motif,+,0.09832,1,1,1,0,0.004,3.05,1,3.444613162,Zinc finger protein 608 (Renal carcinoma antigen NY-REN-36),ASPSSTNKR,DIKASPSSTNKRKNK,Q9ULD9,ZNF608,,Q9ULD9,"S4(Phospho),S5(Phospho)",2
0,0.25,-1.34,-1.41,0.13,0.19,-0.34,-0.37,K17(iTRAQ8plex);N-Term(iTRAQ8plex);S2(Phospho);S6(Phospho),"14-3-3 domain binding motif;Calmodulin-dependent protein kinase II substrate motif;Casein kinase II substrate motif;ERK1,2 kinase substrate motif;GSK-3, ERK1, ERK2, CDK5 substrate motif;MAPKAPK2 kinase substrate motif;PKA kinase substrate motif;PKC kinase substrate motif;WW domain binding motif",+,0.001115,8,1,1,33000000,0,3.26,1,3.616081616,Periphilin-1 (Gastric cancer antigen Ga50),TSRDTSPSSGSAVSSSK,LKTSRDTSPSSGSAV,Q8NEY8,PPHLN1,T(1): 13.8;S(2): 49.7;T(5): 49.7;S(6): 85.4;S(8): 0.7;S(9): 0.7;S(11): 0.0;S(14): 0.0;S(15): 0.0;S(16): 0.0,Q8NEY8,"S2(Phospho),S6(Phospho)",2
0,0.25,-1.34,-1.41,0.13,0.19,-0.34,-0.37,K17(iTRAQ8plex);N-Term(iTRAQ8plex);S2(Phospho);S6(Phospho),Casein kinase II substrate motif;G protein-coupled receptor kinase 1 substrate motif;GSK3 kinase substrate motif;MAPKAPK2 kinase substrate motif;PKA kinase substrate motif;PKC kinase substrate motif,+,0.001115,8,1,1,33000000,0,3.26,1,3.616081616,Periphilin-1 (Gastric cancer antigen Ga50),TSRDTSPSSGSAVSSSK,PVQSLKTSRDTSPSS,Q8NEY8,PPHLN1,T(1): 13.8;S(2): 49.7;T(5): 49.7;S(6): 85.4;S(8): 0.7;S(9): 0.7;S(11): 0.0;S(14): 0.0;S(15): 0.0;S(16): 0.0,Q8NEY8,"S2(Phospho),S6(Phospho)",2
0,0.06,-0.48,-0.55,0.70,0.53,1.13,1.23,N-Term(iTRAQ8plex);S3(Phospho);S6(Phospho),"14-3-3 domain binding motif;Calmodulin-dependent protein kinase II substrate motif;Casein kinase II substrate motif;ERK1,2 kinase substrate motif;G protein-coupled receptor kinase 1 substrate motif;Growth associated histone HI kinase substrate motif;GSK-3, ERK1, ERK2, CDK5 substrate motif;MAPKAPK2 kinase substrate motif;PKA kinase substrate motif;PKC kinase substrate motif;WW domain binding motif",+,0.002169,54,1,1,2820000000,0,5.11,2,4.010495231,Palladin (SIH002) (Sarcoma antigen NY-SAR-77),GRSPRSPSGHPHVR,AVNQRGRSPRSPSGH,Q8WX93,PALLD,S(3): 100.0;S(6): 98.1;S(8): 1.9,Q8WX93,"S3(Phospho),S6(Phospho)",2
0,0.00,-0.82,-0.69,0.81,0.78,0.75,0.55,N-Term(iTRAQ8plex);S3(Phospho);S6(Phospho),14-3-3 domain binding motif;Calmodulin-dependent protein kinase II substrate motif;Calmodulin-dependent protein kinase IV substrate motif;Casein kinase II substrate motif;Chk1 kinase substrate motif;CLK1 kinase substrate motif;PKA kinase substrate motif;PKC kinase substrate motif;ZIP kinase substrate motif,+,0.04222,6,1,1,35000000,0,3.93,2,3.815472027,Palladin (SIH002) (Sarcoma antigen NY-SAR-77),SRSRDSGDENEPIQER,PHVRRPRSRSRDSGD,Q8WX93,PALLD,S(1): 84.7;S(3): 15.3;S(6): 100.0,Q8WX93,"S3(Phospho),S6(Phospho)",2
0,0.00,-0.82,-0.69,0.81,0.78,0.75,0.55,N-Term(iTRAQ8plex);S3(Phospho);S6(Phospho),b-Adrenergic Receptor kinase substrate motif;Casein kinase II substrate motif;PKA kinase substrate motif;PKC kinase substrate motif,+,0.04222,6,1,1,35000000,0,3.93,2,3.815472027,Palladin (SIH002) (Sarcoma antigen NY-SAR-77),SRSRDSGDENEPIQER,PRSRSRDSGDENEPI,Q8WX93,PALLD,S(1): 84.7;S(3): 15.3;S(6): 100.0,Q8WX93,"S3(Phospho),S6(Phospho)",2
0,0.06,-0.48,-0.55,0.70,0.53,1.13,1.23,N-Term(iTRAQ8plex);S3(Phospho);S6(Phospho),"Casein kinase II substrate motif;ERK1,2 kinase substrate motif;Growth associated histone HI kinase substrate motif;GSK-3, ERK1, ERK2, CDK5 substrate motif;WW domain binding motif",+,0.002169,54,1,1,2820000000,0,5.11,2,4.010495231,Palladin (SIH002) (Sarcoma antigen NY-SAR-77),GRSPRSPSGHPHVR,QRGRSPRSPSGHPHV,Q8WX93,PALLD,S(3): 100.0;S(6): 98.1;S(8): 1.9,Q8WX93,"S3(Phospho),S6(Phospho)",2
0,0.04,-0.38,-0.45,-0.38,-0.42,0.00,-0.16,N-Term(iTRAQ8plex);S3(Phospho);S6(Phospho),"14-3-3 domain binding motif;Calmodulin-dependent protein kinase II substrate motif;Calmodulin-dependent protein kinase IV substrate motif;Casein kinase II substrate motif;ERK1,2 kinase substrate motif;G protein-coupled receptor kinase 1 substrate motif;GSK-3, ERK1, ERK2, CDK5 substrate motif;PKA kinase substrate motif;PKC kinase substrate motif;WW domain binding motif;ZIP kinase substrate motif",+,0.002733,12,1,1,23500000,0,4.14,0,2.275967136,Collagen alpha-1(XVII) chain (180 kDa bullous pemphigoid antigen 2) (Bullous pemphigoid antigen 2) [Cleaved into: 120 kDa linear IgA disease antigen (120 kDa linear IgA dermatosis antigen) (Linear IgA disease antigen 1) (LAD-1);97 kDa linear IgA disease antigen (97 kDa linear IgA bullous dermatosis antigen) (97 kDa LAD antigen) (97-LAD) (Linear IgA bullous disease antigen of 97 kDa) (LABD97)],AHSPASTLPNSPGSTFER,SSYRRAHSPASTLPN,Q9UMD9,COL17A1,S(3): 99.6;S(6): 0.2;T(7): 0.3;S(11): 1.9;S(14): 76.9;T(15): 21.1,Q9UMD9,"S3(Phospho),S6(Phospho)",2
0,0.04,-1.33,-1.33,-0.11,-0.04,-0.31,-0.32,K10(iTRAQ8plex);N-Term(iTRAQ8plex);S4(Phospho);S6(Phospho),"ERK1,2 kinase substrate motif;GSK-3, ERK1, ERK2, CDK5 substrate motif;WW domain binding motif",+,0.05047,3,1,1,1020000000,0.001,2.35,2,5.363479143,Serine/arginine repetitive matrix protein 1 (SR-related nuclear matrix protein of 160 kDa) (SRm160) (Ser/Arg-related nuclear matrix protein),RRVSHSPPPK,PKRRVSHSPPPKQRS,Q8IYB3,SRRM1,S(4): 100.0;S(6): 100.0,Q8IYB3,"S4(Phospho),S6(Phospho)",2
0,0.04,-1.33,-1.33,-0.11,-0.04,-0.31,-0.32,K10(iTRAQ8plex);N-Term(iTRAQ8plex);S4(Phospho);S6(Phospho),14-3-3 domain binding motif;Calmodulin-dependent protein kinase II substrate motif;Casein kinase II substrate motif;G protein-coupled receptor kinase 1 substrate motif;PAK2 kinase substrate motif;Pim1 kinase substrate sequence;PKA kinase substrate motif;PKC epsilon kinase substrate motif;PKC kinase substrate motif,+,0.05047,3,1,1,1020000000,0.001,2.35,2,5.363479143,Serine/arginine repetitive matrix protein 1 (SR-related nuclear matrix protein of 160 kDa) (SRm160) (Ser/Arg-related nuclear matrix protein),RRVSHSPPPK,PPPKRRVSHSPPPKQ,Q8IYB3,SRRM1,S(4): 100.0;S(6): 100.0,Q8IYB3,"S4(Phospho),S6(Phospho)",2
0,0.01,-1.09,-1.09,-0.32,-0.26,-0.49,-0.51,N-Term(iTRAQ8plex);S4(Phospho);S6(Phospho),"Casein kinase II substrate motif;ERK1,2 kinase substrate motif;G protein-coupled receptor kinase 1 substrate motif;GSK-3, ERK1, ERK2, CDK5 substrate motif;PKA kinase substrate motif;PKC kinase substrate motif;WW domain binding motif",+,0.04527,10,1,1,562000000,0,3.49,1,5.463977752,Prelamin-A/C [Cleaved into: Lamin-A/C (70 kDa lamin) (Renal carcinoma antigen NY-REN-32)],LRLSPSPTSQR,EEERLRLSPSPTSQR,P02545,LMNA,S(4): 100.0;S(6): 99.7;T(8): 0.2;S(9): 0.0,P02545,"S4(Phospho),S6(Phospho)",2
0,0.01,-1.09,-1.09,-0.32,-0.26,-0.49,-0.51,N-Term(iTRAQ8plex);S4(Phospho);S6(Phospho),ATM kinase substrate motif;Casein kinase II substrate motif;DNA dependent Protein kinase substrate motif;PKA kinase substrate motif;PKC kinase substrate motif,+,0.04527,10,1,1,562000000,0,3.49,1,5.463977752,Prelamin-A/C [Cleaved into: Lamin-A/C (70 kDa lamin) (Renal carcinoma antigen NY-REN-32)],LRLSPSPTSQR,RLSPSPTSQRSRGRA,P02545,LMNA,S(4): 100.0;S(6): 99.7;T(8): 0.2;S(9): 0.0,P02545,"S4(Phospho),S6(Phospho)",2
0,-0.01,1.14,1.25,0.57,0.51,0.80,0.93,K20(iTRAQ8plex);N-Term(iTRAQ8plex);S11(Phospho);S7(Phospho),"Casein kinase I substrate motif;ERK1,2 kinase substrate motif;G protein-coupled receptor kinase 1 substrate motif;GSK3 kinase substrate motif;GSK-3, ERK1, ERK2, CDK5 substrate motif;MDC1 BRCT domain binding motif;Plk1 PBD domain binding motif;WW domain binding motif",+,0.03217,38,1,1,12800000,0,4.64,0,3.663573619,Niban-like protein 1 (Meg-3) (Melanoma invasion by ERK) (MINERVA) (Protein FAM129B),AAPEASSPPASPLQHLLPGK,KAAPEASSPPASPLQ,Q96TA1,FAM129B,S(6): 50.0;S(7): 50.0;S(11): 100.0,Q96TA1,"S11(Phospho),S7(Phospho)",2
0,-0.01,1.14,1.25,0.57,0.51,0.80,0.93,K20(iTRAQ8plex);N-Term(iTRAQ8plex);S11(Phospho);S7(Phospho),G protein-coupled receptor kinase 1 substrate motif,+,0.03217,38,1,1,12800000,0,4.64,0,3.663573619,Niban-like protein 1 (Meg-3) (Melanoma invasion by ERK) (MINERVA) (Protein FAM129B),AAPEASSPPASPLQHLLPGK,PKAAPEASSPPASPL,Q96TA1,FAM129B,S(6): 50.0;S(7): 50.0;S(11): 100.0,Q96TA1,"S11(Phospho),S7(Phospho)",2
0,0.15,-2.01,-2.11,0.06,0.17,-0.10,-0.09,N-Term(iTRAQ8plex);S11(Phospho);S7(Phospho),"Cdc2 kinase substrate motif;CDK kinase substrate motif;CDK1,2,4,6 kinase substrate motif;ERK1,2 kinase substrate motif;G protein-coupled receptor kinase 1 substrate motif;GSK3 kinase substrate motif;GSK-3, ERK1, ERK2, CDK5 substrate motif;WW domain binding motif",+,0.0253,6,1,1,11400000,0,4.41,1,4.63070737,ELKS/Rab6-interacting/CAST family member 1 (ERC-1) (Rab6-interacting protein 2),VEPSSQSPGRSPR,KVEPSSQSPGRSPRL,Q8IUD2,ERC1,S(4): 0.0;S(5): 2.1;S(7): 98.2;S(11): 99.7,Q8IUD2,"S11(Phospho),S7(Phospho)",2
0,0.15,-2.01,-2.11,0.06,0.17,-0.10,-0.09,N-Term(iTRAQ8plex);S11(Phospho);S7(Phospho),"ERK1,2 kinase substrate motif;G protein-coupled receptor kinase 1 substrate motif;Growth associated histone HI kinase substrate motif;GSK-3, ERK1, ERK2, CDK5 substrate motif;MAPKAPK2 kinase substrate motif;PKA kinase substrate motif;PKC kinase substrate motif;WW domain binding motif",+,0.0253,6,1,1,11400000,0,4.41,1,4.63070737,ELKS/Rab6-interacting/CAST family member 1 (ERC-1) (Rab6-interacting protein 2),VEPSSQSPGRSPR,SSQSPGRSPRLPRSP,Q8IUD2,ERC1,S(4): 0.0;S(5): 2.1;S(7): 98.2;S(11): 99.7,Q8IUD2,"S11(Phospho),S7(Phospho)",2
0,0.00,-1.91,-2.04,-0.30,-0.31,-0.62,-0.66,K10(iTRAQ8plex);N-Term(iTRAQ8plex);S3(Phospho);S7(Phospho),14-3-3 domain binding motif;Calmodulin-dependent protein kinase II substrate motif;CLK1 kinase substrate motif;G protein-coupled receptor kinase 1 substrate motif;MAPKAPK1 kinase substrate motif;PAK2 kinase substrate motif;Pim1 kinase substrate sequence;PKA kinase substrate motif;PKC epsilon kinase substrate motif;PKC kinase substrate motif;ZIP kinase substrate motif,+,0.04257,6,1,1,599000000,0.0006395,2.99,1,5.062699768,40S ribosomal protein S6 (Phosphoprotein NP33),LSSLRASTSK,IAKRRRLSSLRASTS,P62753,RPS6,S(2): 84.8;S(3): 15.3;S(7): 98.3;T(8): 0.8;S(9): 0.8,P62753,"S3(Phospho),S7(Phospho)",2
0,0.00,-1.91,-2.04,-0.30,-0.31,-0.62,-0.66,K10(iTRAQ8plex);N-Term(iTRAQ8plex);S3(Phospho);S7(Phospho),Casein kinase II substrate motif;G protein-coupled receptor kinase 1 substrate motif;GSK3 kinase substrate motif;MAPKAPK2 kinase substrate motif;PKA kinase substrate motif;PKC kinase substrate motif,+,0.04257,6,1,1,599000000,0.0006395,2.99,1,5.062699768,40S ribosomal protein S6 (Phosphoprotein NP33),LSSLRASTSK,RLSSLRASTSKSESS,P62753,RPS6,S(2): 84.8;S(3): 15.3;S(7): 98.3;T(8): 0.8;S(9): 0.8,P62753,"S3(Phospho),S7(Phospho)",2
0,0.02,0.55,0.35,-0.30,-0.38,-0.04,0.07,N-Term(iTRAQ8plex);S3(Phospho);S7(Phospho),Casein kinase I substrate motif;Casein kinase II substrate motif,+,0.001667,9,1,1,209000000,0,6.08,1,2.408720301,Transcriptional coactivator YAP1 (Yes-associated protein 1) (Protein yorkie homolog) (Yes-associated protein YAP65 homolog),SHSRQASTDAGTAGALTPQHVR,FKPPEPKSHSRQAST,P46937,YAP1,S(1): 81.1;S(3): 18.9;S(7): 50.0;T(8): 50.0;T(12): 0.1;T(17): 0.0,P46937,"S3(Phospho),S7(Phospho)",2
0,0.02,0.55,0.35,-0.30,-0.38,-0.04,0.07,N-Term(iTRAQ8plex);S3(Phospho);S7(Phospho),14-3-3 domain binding motif;Calmodulin-dependent protein kinase II substrate motif;MAPKAPK2 kinase substrate motif;PKA kinase substrate motif;PKC kinase substrate motif,+,0.001667,9,1,1,209000000,0,6.08,1,2.408720301,Transcriptional coactivator YAP1 (Yes-associated protein 1) (Protein yorkie homolog) (Yes-associated protein YAP65 homolog),SHSRQASTDAGTAGALTPQHVR,KSHSRQASTDAGTAG,P46937,YAP1,S(1): 81.1;S(3): 18.9;S(7): 50.0;T(8): 50.0;T(12): 0.1;T(17): 0.0,P46937,"S3(Phospho),S7(Phospho)",2
0,-0.18,-1.87,-1.97,-0.03,-0.31,-0.53,-0.70,N-Term(iTRAQ8plex);S5(Phospho);S7(Phospho),14-3-3 domain binding motif;Akt kinase substrate motif;b-Adrenergic Receptor kinase substrate motif;Calmodulin-dependent protein kinase II substrate motif;Casein kinase II substrate motif;G protein-coupled receptor kinase 1 substrate motif;MAPKAPK1 kinase substrate motif;PKA kinase substrate motif;PKC kinase substrate motif;ZIP kinase substrate motif,+,0.02723,4,1,1,26500000,0,4.24,2,3.306845238,Uncharacterized protein C9orf78 (Hepatocellular carcinoma-associated antigen 59),RRGDSESEEDEQDSEEVR,FRRRRGDSESEEDEQ,Q9NZ63,C9orf78,S(5): 100.0;S(7): 97.0;S(14): 3.0,Q9NZ63,"S5(Phospho),S7(Phospho)",2
0,-0.18,-1.87,-1.97,-0.03,-0.31,-0.53,-0.70,N-Term(iTRAQ8plex);S5(Phospho);S7(Phospho),b-Adrenergic Receptor kinase substrate motif;Casein kinase I substrate motif;Casein kinase II substrate motif;G protein-coupled receptor kinase 1 substrate motif;Pyruvate dehydrogenase kinase substrate motif,+,0.02723,4,1,1,26500000,0,4.24,2,3.306845238,Uncharacterized protein C9orf78 (Hepatocellular carcinoma-associated antigen 59),RRGDSESEEDEQDSEEVR,RRRGDSESEEDEQDS,Q9NZ63,C9orf78,S(5): 100.0;S(7): 97.0;S(14): 3.0,Q9NZ63,"S5(Phospho),S7(Phospho)",2
0,0.09,0.49,0.23,-0.40,-0.38,-0.08,-0.18,N-Term(iTRAQ8plex);S12(Phospho);S8(Phospho),"14-3-3 domain binding motif;Calmodulin-dependent protein kinase II substrate motif;Cdc2 kinase substrate motif;CDK kinase substrate motif;CDK1,2,4,6 kinase substrate motif;CLK1 kinase substrate motif;ERK1,2 kinase substrate motif;G protein-coupled receptor kinase 1 substrate motif;GSK3 kinase substrate motif;GSK-3, ERK1, ERK2, CDK5 substrate motif;MAPKAPK2 kinase substrate motif;PKA kinase substrate motif;PKC epsilon kinase substrate motif;PKC kinase substrate motif;WW domain binding motif",+,0.006115,14,1,1,139000000,0,5.18,1,2.043041365,BAG family molecular chaperone regulator 3 (BAG-3) (Bcl-2-associated athanogene 3) (Bcl-2-binding protein Bis) (Docking protein CAIR-1),SSVQGASSREGSPAR,GASSREGSPARSSTP,O95817,BAG3,S(1): 0.0;S(2): 0.0;S(7): 0.0;S(8): 100.0;S(12): 100.0,O95817,"S12(Phospho),S8(Phospho)",2
0,0.09,0.49,0.23,-0.40,-0.38,-0.08,-0.18,N-Term(iTRAQ8plex);S12(Phospho);S8(Phospho),Casein kinase II substrate motif;G protein-coupled receptor kinase 1 substrate motif;GSK3 kinase substrate motif;MDC1 BRCT domain binding motif;Plk1 PBD domain binding motif,+,0.006115,14,1,1,139000000,0,5.18,1,2.043041365,BAG family molecular chaperone regulator 3 (BAG-3) (Bcl-2-associated athanogene 3) (Bcl-2-binding protein Bis) (Docking protein CAIR-1),SSVQGASSREGSPAR,SSVQGASSREGSPAR,O95817,BAG3,S(1): 0.0;S(2): 0.0;S(7): 0.0;S(8): 100.0;S(12): 100.0,O95817,"S12(Phospho),S8(Phospho)",2
0,0.00,0.49,0.60,0.25,0.27,0.43,0.49,N-Term(iTRAQ8plex);S12(Phospho);S8(Phospho),"Casein kinase II substrate motif;G protein-coupled receptor kinase 1 substrate motif;GSK-3, ERK1, ERK2, CDK5 substrate motif;WW domain binding motif",+,0.01705,6,1,1,24300000,0,4.8,1,3.075973979,Protein FAM122B,RIDFTPVSPAPSPTR,SPKRIDFTPVSPAPS,Q7Z309,FAM122B,T(5): 87.4;S(8): 12.6;S(12): 87.4;T(14): 12.6,Q7Z309,"S12(Phospho),S8(Phospho)",2
0,0.00,0.49,0.60,0.25,0.27,0.43,0.49,N-Term(iTRAQ8plex);S12(Phospho);S8(Phospho),"Casein kinase II substrate motif;Cdc2 kinase substrate motif;CDK kinase substrate motif;CDK1,2,4,6 kinase substrate motif;DNA dependent Protein kinase substrate motif;ERK1,2 kinase substrate motif;GSK-3, ERK1, ERK2, CDK5 substrate motif;MAPKAPK2 kinase substrate motif;WW domain binding motif",+,0.01705,6,1,1,24300000,0,4.8,1,3.075973979,Protein FAM122B,RIDFTPVSPAPSPTR,TPVSPAPSPTRGFGK,Q7Z309,FAM122B,T(5): 87.4;S(8): 12.6;S(12): 87.4;T(14): 12.6,Q7Z309,"S12(Phospho),S8(Phospho)",2
0,-0.13,0.61,0.81,-0.13,0.09,0.67,0.71,N-Term(iTRAQ8plex);S12(Phospho);S8(Phospho),"Casein kinase II substrate motif;Cdc2 kinase substrate motif;CDK kinase substrate motif;CDK1,2,4,6 kinase substrate motif;DNA dependent Protein kinase substrate motif;ERK1,2 kinase substrate motif;GSK-3, ERK1, ERK2, CDK5 substrate motif;MAPKAPK2 kinase substrate motif;WW domain binding motif",+,0.0003887,23,1,1,77200000,0,6.64,1,2.416873442,Protein FAM122A,RIDFIPVSPAPSPTR,IPVSPAPSPTRGIGK,Q96E09,FAM122A,S(8): 100.0;S(12): 99.0;T(14): 1.0,Q96E09,"S12(Phospho),S8(Phospho)",2
0,-0.13,0.61,0.81,-0.13,0.09,0.67,0.71,N-Term(iTRAQ8plex);S12(Phospho);S8(Phospho),"ERK1,2 kinase substrate motif;G protein-coupled receptor kinase 1 substrate motif;GSK3 kinase substrate motif;GSK-3, ERK1, ERK2, CDK5 substrate motif;WW domain binding motif",+,0.0003887,23,1,1,77200000,0,6.64,1,2.416873442,Protein FAM122A,RIDFIPVSPAPSPTR,RIDFIPVSPAPSPTR,Q96E09,FAM122A,S(8): 100.0;S(12): 99.0;T(14): 1.0,Q96E09,"S12(Phospho),S8(Phospho)",2
0,0.28,-1.27,-1.27,-0.03,0.09,-0.42,-0.33,N-Term(iTRAQ8plex);S2(Phospho);S8(Phospho),,+,0.01377,5,1,1,29400000,0,3.61,1,3.1048162,Protein bicaudal D homolog 2 (Bic-D 2),TSPGGRTSPEAR,GQGGAGRTSPGGRTS,Q8TD16,BICD2,T(1): 50.0;S(2): 50.0;T(7): 18.4;S(8): 81.6,Q8TD16,"S2(Phospho),S8(Phospho)",2
0,0.28,-1.27,-1.27,-0.03,0.09,-0.42,-0.33,N-Term(iTRAQ8plex);S2(Phospho);S8(Phospho),"Casein kinase II substrate motif;ERK1,2 kinase substrate motif;GSK-3, ERK1, ERK2, CDK5 substrate motif;PKA kinase substrate motif;PKC kinase substrate motif;WW domain binding motif",+,0.01377,5,1,1,29400000,0,3.61,1,3.1048162,Protein bicaudal D homolog 2 (Bic-D 2),TSPGGRTSPEAR,TSPGGRTSPEARGRR,Q8TD16,BICD2,T(1): 50.0;S(2): 50.0;T(7): 18.4;S(8): 81.6,Q8TD16,"S2(Phospho),S8(Phospho)",2
0,0.06,-0.94,-1.04,0.10,-0.02,-0.18,-0.20,N-Term(iTRAQ8plex);S4(Phospho);S8(Phospho),"ERK1,2 kinase substrate motif;Growth associated histone HI kinase substrate motif;GSK-3, ERK1, ERK2, CDK5 substrate motif;MAPKAPK2 kinase substrate motif;PKA kinase substrate motif;PKC kinase substrate motif;WW domain binding motif",+,0.02064,4,1,1,42300000,0,3.15,0,3.717648063,La-related protein 1 (La ribonucleoprotein domain family member 1),ETESAPGSPR,ETESAPGSPRAVTPV,Q6PKG0,LARP1,T(2): 14.8;S(4): 85.2;S(8): 100.0,Q6PKG0,"S4(Phospho),S8(Phospho)",2
0,0.06,-0.94,-1.04,0.10,-0.02,-0.18,-0.20,N-Term(iTRAQ8plex);S4(Phospho);S8(Phospho),"ERK1,2 kinase substrate motif;Growth associated histone HI kinase substrate motif;GSK-3, ERK1, ERK2, CDK5 substrate motif;MAPKAPK2 kinase substrate motif;PKA kinase substrate motif;PKC kinase substrate motif;WW domain binding motif",+,0.02064,4,1,1,42300000,0,3.15,0,3.717648063,La-related protein 1 (La ribonucleoprotein domain family member 1),ETESAPGSPR,ETESAPGSPRAVTPV,Q6PKG0,LARP1,T(2): 14.8;S(4): 85.2;S(8): 100.0,Q6PKG0,"S4(Phospho),S8(Phospho)",2
0,0.26,-1.31,-1.35,0.04,0.19,-0.26,-0.33,N-Term(iTRAQ8plex);S6(Phospho);S8(Phospho),"Casein kinase II substrate motif;DNA dependent Protein kinase substrate motif;ERK1,2 kinase substrate motif;GSK-3, ERK1, ERK2, CDK5 substrate motif;PKA kinase substrate motif;PKC kinase substrate motif;WW domain binding motif",+,0.01779,3,1,1,0,0,3.64,0,3.292517832,Serine/arginine repetitive matrix protein 2 (300 kDa nuclear matrix antigen) (Serine/arginine-rich splicing factor-related nuclear matrix protein of 300 kDa) (SR-related nuclear matrix protein of 300 kDa) (Ser/Arg-related nuclear matrix protein of 300 kDa) (Splicing coactivator subunit SRm300) (Tax-responsive enhancer element-binding protein 803) (TaxREB803),SATRPSPSPER,EKSATRPSPSPERSS,Q9UQ35,SRRM2,,Q9UQ35,"S6(Phospho),S8(Phospho)",2
0,0.55,-1.67,-1.75,0.49,1.21,-0.96,-1.22,K1(iTRAQ8plex);K13(iTRAQ8plex);N-Term(iTRAQ8plex);S7(Phospho);S8(Phospho),Casein kinase II substrate motif,+,0.02318,2,1,1,50500000,0,4.63,1,2.319457719,Hepatoma-derived growth factor (HDGF) (High mobility group protein 1-like 2) (HMG-1L2),KGNAEGSSDEEGK,KKGNAEGSSDEEGKL,P51858,HDGF,S(7): 100.0;S(8): 100.0,P51858,"S7(Phospho),S8(Phospho)",2
0,0.55,-1.67,-1.75,0.49,1.21,-0.96,-1.22,K1(iTRAQ8plex);K13(iTRAQ8plex);N-Term(iTRAQ8plex);S7(Phospho);S8(Phospho),Casein kinase II substrate motif,+,0.02318,2,1,1,50500000,0,4.63,1,2.319457719,Hepatoma-derived growth factor (HDGF) (High mobility group protein 1-like 2) (HMG-1L2),KGNAEGSSDEEGK,KKGNAEGSSDEEGKL,P51858,HDGF,S(7): 100.0;S(8): 100.0,P51858,"S7(Phospho),S8(Phospho)",2
0,0.06,0.35,0.34,0.34,0.39,0.33,0.38,N-Term(iTRAQ8plex);S14(Phospho);S9(Phospho),"ERK1,2 kinase substrate motif;Growth associated histone HI kinase substrate motif;GSK-3, ERK1, ERK2, CDK5 substrate motif;PKA kinase substrate motif;PKC kinase substrate motif;WW domain binding motif",+,0.05486,4,1,1,47800000,0.0006395,4.33,0,2.798459972,Tensin-4 (C-terminal tensin-like protein),ASSPHGLGSPLVASPR,LGSPLVASPRLEKRL,Q8IZW8,TNS4,S(2): 0.1;S(3): 0.0;S(9): 99.9;S(14): 100.0,Q8IZW8,"S14(Phospho),S9(Phospho)",2
0,0.06,0.35,0.34,0.34,0.39,0.33,0.38,N-Term(iTRAQ8plex);S14(Phospho);S9(Phospho),"ERK1,2 kinase substrate motif;G protein-coupled receptor kinase 1 substrate motif;GSK-3, ERK1, ERK2, CDK5 substrate motif;WW domain binding motif",+,0.05486,4,1,1,47800000,0.0006395,4.33,0,2.798459972,Tensin-4 (C-terminal tensin-like protein),ASSPHGLGSPLVASPR,SSPHGLGSPLVASPR,Q8IZW8,TNS4,S(2): 0.1;S(3): 0.0;S(9): 99.9;S(14): 100.0,Q8IZW8,"S14(Phospho),S9(Phospho)",2
0,0.23,0.95,1.21,-0.02,0.34,0.77,0.88,K18(iTRAQ8plex);T12(Phospho);T13(Phospho),,+,0.1143,1,1,1,0,0.006,2.82,0,1.890824273,Protein SON (Bax antagonist selected in saccharomyces 1) (BASS1) (Negative regulatory element-binding protein) (NRE-binding protein) (Protein DBP-5) (SON3),ILDSFAAAPVPTTTLVLK,AAAPVPTTTLVLKSS,P18583,SON,,P18583,"T12(Phospho),T13(Phospho)",2
0,0.23,0.95,1.21,-0.02,0.34,0.77,0.88,K18(iTRAQ8plex);T12(Phospho);T13(Phospho),DNA dependent Protein kinase substrate motif,+,0.1143,1,1,1,0,0.006,2.82,0,1.890824273,Protein SON (Bax antagonist selected in saccharomyces 1) (BASS1) (Negative regulatory element-binding protein) (NRE-binding protein) (Protein DBP-5) (SON3),ILDSFAAAPVPTTTLVLK,FAAAPVPTTTLVLKS,P18583,SON,,P18583,"T12(Phospho),T13(Phospho)",2
0,0.03,0.24,0.51,-0.34,-0.21,0.27,0.21,N-Term(iTRAQ8plex);T13(Phospho);T18(Phospho),"Dual specificity protein phosphatase 1 substrate motif;Dual specificity protein phosphatase 6 substrate motif;ERK1 kinase substrate motif;G protein-coupled receptor kinase 1 substrate motif;MAPK 11,13,14 kinase substrate motif;PP2C delta substrate motif",+,0.02774,6,1,1,503000,0,3.04,0,1.841931107,Mitogen-activated protein kinase 1 (MAP kinase 1) (MAPK 1) (EC 2.7.11.24) (ERT1) (Extracellular signal-regulated kinase 2) (ERK-2) (MAP kinase isoform p42) (p42-MAPK) (Mitogen-activated protein kinase 2) (MAP kinase 2) (MAPK 2),VADPDHDHTGFLTEYVATR,HDHTGFLTEYVATRW,P28482,MAPK1,T(9): 0.1;T(13): 89.7;Y(15): 55.1;T(18): 55.1,P28482,"T13(Phospho),T18(Phospho)",2
0,0.03,0.24,0.51,-0.34,-0.21,0.27,0.21,N-Term(iTRAQ8plex);T13(Phospho);T18(Phospho),EGFR kinase substrate motif;TC-PTP phosphatase substrate motif,+,0.02774,6,1,1,503000,0,3.04,0,1.841931107,Mitogen-activated protein kinase 1 (MAP kinase 1) (MAPK 1) (EC 2.7.11.24) (ERT1) (Extracellular signal-regulated kinase 2) (ERK-2) (MAP kinase isoform p42) (p42-MAPK) (Mitogen-activated protein kinase 2) (MAP kinase 2) (MAPK 2),VADPDHDHTGFLTEYVATR,HTGFLTEYVATRWYR,P28482,MAPK1,T(9): 0.1;T(13): 89.7;Y(15): 55.1;T(18): 55.1,P28482,"T13(Phospho),T18(Phospho)",2
0,0.41,-2.20,-2.19,0.03,0.25,-0.56,-0.55,N-Term(iTRAQ8plex);S13(Phospho);T2(Phospho),"GSK-3, ERK1, ERK2, CDK5 substrate motif;MAPKAPK2 kinase substrate motif;PKA kinase substrate motif;PKC kinase substrate motif;WW domain binding motif",+,3.83E-05,9,1,1,80900000,0,5.77,0,3.423498968,Bcl-2-associated transcription factor 1 (Btf),NTPSQHSHSIQHSPER,TVHSAKNTPSQHSHS,Q9NYF8,BCLAF1,T(2): 99.5;S(4): 0.5;S(7): 0.0;S(9): 0.1;S(13): 99.9,Q9NYF8,"S13(Phospho),T2(Phospho)",2
0,0.41,-2.20,-2.19,0.03,0.25,-0.56,-0.55,N-Term(iTRAQ8plex);S13(Phospho);T2(Phospho),"GSK-3, ERK1, ERK2, CDK5 substrate motif;MAPKAPK2 kinase substrate motif;PKA kinase substrate motif;PKC kinase substrate motif;WW domain binding motif",+,3.83E-05,9,1,1,80900000,0,5.77,0,3.423498968,Bcl-2-associated transcription factor 1 (Btf),NTPSQHSHSIQHSPER,TVHSAKNTPSQHSHS,Q9NYF8,BCLAF1,T(2): 99.5;S(4): 0.5;S(7): 0.0;S(9): 0.1;S(13): 99.9,Q9NYF8,"S13(Phospho),T2(Phospho)",2
0,0.11,1.34,1.66,1.57,1.04,0.58,0.66,K12(iTRAQ8plex);K18(iTRAQ8plex);N-Term(iTRAQ8plex);S16(Phospho);T2(Phospho),G protein-coupled receptor kinase 1 substrate motif;PKA kinase substrate motif;PKC kinase substrate motif,+,0.1852,2,1,1,1480000,0.00691,3.34,1,2.039076769,Alstrom syndrome protein 1,GTDGQPLLLPYKPSGSTKMYYVPQLR,QVTFSRGTDGQPLLL,Q8TCU4,ALMS1,T(2): 81.4;Y(11): 51.3;S(14): 19.2;S(16): 19.2;T(17): 10.3;Y(20): 10.3;Y(21): 8.4,Q8TCU4,"S16(Phospho),T2(Phospho)",2
0,0.11,1.34,1.66,1.57,1.04,0.58,0.66,K12(iTRAQ8plex);K18(iTRAQ8plex);N-Term(iTRAQ8plex);S16(Phospho);T2(Phospho),G protein-coupled receptor kinase 1 substrate motif;PKA kinase substrate motif;PKC kinase substrate motif,+,0.1852,2,1,1,1480000,0.00691,3.34,1,2.039076769,Alstrom syndrome protein 1,GTDGQPLLLPYKPSGSTKMYYVPQLR,QVTFSRGTDGQPLLL,Q8TCU4,ALMS1,T(2): 81.4;Y(11): 51.3;S(14): 19.2;S(16): 19.2;T(17): 10.3;Y(20): 10.3;Y(21): 8.4,Q8TCU4,"S16(Phospho),T2(Phospho)",2
0,-0.23,1.40,1.07,0.24,0.01,-0.32,-0.18,K11(iTRAQ8plex);K25(iTRAQ8plex);S19(Phospho);T2(Phospho),AMP-activated protein kinase substrate motif,+,0.01415,4,1,1,360000,0,2.33,1,2.50254855,Solute carrier family 25 member 40 (Mitochondrial carrier family protein),QTQLWTYESHKISMPLHMSTWIIMK,ISMPLHMSTWIIMKN,Q8TBP6,SLC25A40,T(2): 41.7;T(6): 26.2;Y(7): 26.2;S(9): 24.0;S(13): 24.0;S(19): 28.9;T(20): 28.9,Q8TBP6,"S19(Phospho),T2(Phospho)",2
0,-0.23,1.40,1.07,0.24,0.01,-0.32,-0.18,K11(iTRAQ8plex);K25(iTRAQ8plex);S19(Phospho);T2(Phospho),G protein-coupled receptor kinase 1 substrate motif;PKA kinase substrate motif;PKC kinase substrate motif,+,0.01415,4,1,1,360000,0,2.33,1,2.50254855,Solute carrier family 25 member 40 (Mitochondrial carrier family protein),QTQLWTYESHKISMPLHMSTWIIMK,VVKTQKQTQLWTYES,Q8TBP6,SLC25A40,T(2): 41.7;T(6): 26.2;Y(7): 26.2;S(9): 24.0;S(13): 24.0;S(19): 28.9;T(20): 28.9,Q8TBP6,"S19(Phospho),T2(Phospho)",2
0,0.26,1.25,1.38,1.31,1.19,1.15,1.11,K3(iTRAQ8plex);M16(Oxidation);T15(Phospho);T2(Phospho),Calmodulin-dependent protein kinase II substrate motif;Casein kinase II substrate motif;PAK2 kinase substrate motif;PKA kinase substrate motif;PKC kinase substrate motif,+,0.1646,2,1,1,326000,0.007446,3.62,1,2.918384342,U6 snRNA-associated Sm-like protein LSm5,ITKLDQILLNGNNITMLVPGGEGPEV,TPEGRRITKLDQILL,Q9Y4Y9,LSM5,T(2): 100.0;T(15): 100.0,Q9Y4Y9,"T15(Phospho),T2(Phospho)",2
0,0.26,1.25,1.38,1.31,1.19,1.15,1.11,K3(iTRAQ8plex);M16(Oxidation);T15(Phospho);T2(Phospho),G protein-coupled receptor kinase 1 substrate motif,+,0.1646,2,1,1,326000,0.007446,3.62,1,2.918384342,U6 snRNA-associated Sm-like protein LSm5,ITKLDQILLNGNNITMLVPGGEGPEV,LLNGNNITMLVPGGE,Q9Y4Y9,LSM5,T(2): 100.0;T(15): 100.0,Q9Y4Y9,"T15(Phospho),T2(Phospho)",2
0,0.05,-1.17,-1.05,-0.07,-0.02,-0.29,-0.22,K11(iTRAQ8plex);N-Term(iTRAQ8plex);S5(Phospho);T3(Phospho),"14-3-3 domain binding motif;Akt kinase substrate motif;Calmodulin-dependent protein kinase II substrate motif;ERK1,2 kinase substrate motif;G protein-coupled receptor kinase 1 substrate motif;GSK-3, ERK1, ERK2, CDK5 substrate motif;MAPKAPK1 kinase substrate motif;PKA kinase substrate motif;PKC kinase substrate motif;WW domain binding motif;ZIP kinase substrate motif",+,0.03978,13,1,1,159000000,0,3.99,2,4.013179748,Serine/arginine repetitive matrix protein 1 (SR-related nuclear matrix protein of 160 kDa) (SRm160) (Ser/Arg-related nuclear matrix protein),RRTASPPPPPK,PPKRRTASPPPPPKR,Q8IYB3,SRRM1,T(3): 100.0;S(5): 100.0,Q8IYB3,"S5(Phospho),T3(Phospho)",2
0,0.05,-1.17,-1.05,-0.07,-0.02,-0.29,-0.22,K11(iTRAQ8plex);N-Term(iTRAQ8plex);S5(Phospho);T3(Phospho),"14-3-3 domain binding motif;Akt kinase substrate motif;Calmodulin-dependent protein kinase II substrate motif;ERK1,2 kinase substrate motif;G protein-coupled receptor kinase 1 substrate motif;GSK-3, ERK1, ERK2, CDK5 substrate motif;MAPKAPK1 kinase substrate motif;PKA kinase substrate motif;PKC kinase substrate motif;WW domain binding motif;ZIP kinase substrate motif",+,0.03978,13,1,1,159000000,0,3.99,2,4.013179748,Serine/arginine repetitive matrix protein 1 (SR-related nuclear matrix protein of 160 kDa) (SRm160) (Ser/Arg-related nuclear matrix protein),RRTASPPPPPK,PPKRRTASPPPPPKR,Q8IYB3,SRRM1,T(3): 100.0;S(5): 100.0,Q8IYB3,"S5(Phospho),T3(Phospho)",2
0,-0.11,-0.71,-0.52,-0.03,-0.16,0.28,0.13,N-Term(iTRAQ8plex);S5(Phospho);T3(Phospho),"Calmodulin-dependent protein kinase II substrate motif;G protein-coupled receptor kinase 1 substrate motif;Growth associated histone HI kinase substrate motif;GSK-3, ERK1, ERK2, CDK5 substrate motif;PAK2 kinase substrate motif;Pim1 kinase substrate sequence;PKA kinase substrate motif;PKC kinase substrate motif;WW domain binding motif",+,0.1149,2,1,1,3570000000,0.005305,1.75,2,2.201895456,Serine/arginine repetitive matrix protein 1 (SR-related nuclear matrix protein of 160 kDa) (SRm160) (Ser/Arg-related nuclear matrix protein),RRTPSPPPR,PPPRRRRTPTPPPRR,Q8IYB3,SRRM1,T(3): 100.0;S(5): 100.0,Q8IYB3,"S5(Phospho),T3(Phospho)",2
0,-0.11,-0.71,-0.52,-0.03,-0.16,0.28,0.13,N-Term(iTRAQ8plex);S5(Phospho);T3(Phospho),"Calmodulin-dependent protein kinase II substrate motif;G protein-coupled receptor kinase 1 substrate motif;Growth associated histone HI kinase substrate motif;GSK-3, ERK1, ERK2, CDK5 substrate motif;PAK2 kinase substrate motif;PKA kinase substrate motif;PKC kinase substrate motif;WW domain binding motif",+,0.1149,2,1,1,3570000000,0.005305,1.75,2,2.201895456,Serine/arginine repetitive matrix protein 1 (SR-related nuclear matrix protein of 160 kDa) (SRm160) (Ser/Arg-related nuclear matrix protein),RRTPSPPPR,TPPPRRRTPSPPPRR,Q8IYB3,SRRM1,T(3): 100.0;S(5): 100.0,Q8IYB3,"S5(Phospho),T3(Phospho)",2
0,-0.06,-1.76,-1.31,-0.47,-0.39,-0.49,-0.39,N-Term(iTRAQ8plex);S6(Phospho);T4(Phospho),"b-Adrenergic Receptor kinase substrate motif;Calmodulin-dependent protein kinase II substrate motif;GSK-3, ERK1, ERK2, CDK5 substrate motif;PAK2 kinase substrate motif;Pim1 kinase substrate sequence;PKA kinase substrate motif;PKC kinase substrate motif;WW domain binding motif",+,0.0711,3,1,1,493000000,0.007,3.9,2,2.477900896,Serine/arginine repetitive matrix protein 2 (300 kDa nuclear matrix antigen) (Serine/arginine-rich splicing factor-related nuclear matrix protein of 300 kDa) (SR-related nuclear matrix protein of 300 kDa) (Ser/Arg-related nuclear matrix protein of 300 kDa) (Splicing coactivator subunit SRm300) (Tax-responsive enhancer element-binding protein 803) (TaxREB803),RRETPSPRPMR,SHKRRRETPSPRPMR,Q9UQ35,SRRM2,T(4): 100.0;S(6): 100.0,Q9UQ35,"S6(Phospho),T4(Phospho)",2
0,-0.06,-1.76,-1.31,-0.47,-0.39,-0.49,-0.39,N-Term(iTRAQ8plex);S6(Phospho);T4(Phospho),"Casein kinase I substrate motif;DNA dependent Protein kinase substrate motif;ERK1,2 kinase substrate motif;Growth associated histone HI kinase substrate motif;GSK-3, ERK1, ERK2, CDK5 substrate motif;PKA kinase substrate motif;PKC kinase substrate motif;WW domain binding motif",+,0.0711,3,1,1,493000000,0.007,3.9,2,2.477900896,Serine/arginine repetitive matrix protein 2 (300 kDa nuclear matrix antigen) (Serine/arginine-rich splicing factor-related nuclear matrix protein of 300 kDa) (SR-related nuclear matrix protein of 300 kDa) (Ser/Arg-related nuclear matrix protein of 300 kDa) (Splicing coactivator subunit SRm300) (Tax-responsive enhancer element-binding protein 803) (TaxREB803),RRETPSPRPMR,KRRRETPSPRPMRHR,Q9UQ35,SRRM2,T(4): 100.0;S(6): 100.0,Q9UQ35,"S6(Phospho),T4(Phospho)",2
0,0.23,-1.10,-0.88,-0.05,-0.20,-0.07,-0.09,N-Term(iTRAQ8plex);T3(Phospho);T5(Phospho),"Calmodulin-dependent protein kinase II substrate motif;G protein-coupled receptor kinase 1 substrate motif;Growth associated histone HI kinase substrate motif;GSK-3, ERK1, ERK2, CDK5 substrate motif;PAK2 kinase substrate motif;Pim1 kinase substrate sequence;PKA kinase substrate motif;PKC kinase substrate motif;WW domain binding motif",+,0.08494,4,1,1,2360000000,0.00264,2.14,2,2.493940228,Serine/arginine repetitive matrix protein 1 (SR-related nuclear matrix protein of 160 kDa) (SRm160) (Ser/Arg-related nuclear matrix protein),RRTPTPPPR,PPPRRRRTPTPPPRR,Q8IYB3,SRRM1,T(3): 100.0;T(5): 100.0,Q8IYB3,"T3(Phospho),T5(Phospho)",2
0,0.23,-1.10,-0.88,-0.05,-0.20,-0.07,-0.09,N-Term(iTRAQ8plex);T3(Phospho);T5(Phospho),"Calmodulin-dependent protein kinase II substrate motif;G protein-coupled receptor kinase 1 substrate motif;Growth associated histone HI kinase substrate motif;GSK-3, ERK1, ERK2, CDK5 substrate motif;PAK2 kinase substrate motif;PKA kinase substrate motif;PKC kinase substrate motif;WW domain binding motif",+,0.08494,4,1,1,2360000000,0.00264,2.14,2,2.493940228,Serine/arginine repetitive matrix protein 1 (SR-related nuclear matrix protein of 160 kDa) (SRm160) (Ser/Arg-related nuclear matrix protein),RRTPTPPPR,TPPPRRRTPSPPPRR,Q8IYB3,SRRM1,T(3): 100.0;T(5): 100.0,Q8IYB3,"T3(Phospho),T5(Phospho)",2
0,0.11,-0.39,-0.29,-0.13,-0.08,-0.21,-0.32,K10(iTRAQ8plex);N-Term(iTRAQ8plex);T3(Phospho);T6(Phospho),PKA kinase substrate motif;PKC kinase substrate motif,+,0.06497,1,1,1,0,0.002,2.13,0,1.805721499,MutS protein homolog 4 (hMSH4),LFTLITENFK,GNSTKLFTLITENFK,O15457,MSH4,,O15457,"T3(Phospho),T6(Phospho)",2
0,0.11,-0.39,-0.29,-0.13,-0.08,-0.21,-0.32,K10(iTRAQ8plex);N-Term(iTRAQ8plex);T3(Phospho);T6(Phospho),G protein-coupled receptor kinase 1 substrate motif,+,0.06497,1,1,1,0,0.002,2.13,0,1.805721499,MutS protein homolog 4 (hMSH4),LFTLITENFK,TKLFTLITENFKNVN,O15457,MSH4,,O15457,"T3(Phospho),T6(Phospho)",2
0,-0.08,-0.87,-0.81,-0.05,-0.17,-0.08,-0.06,K12(iTRAQ8plex);N-Term(iTRAQ8plex);S4(Phospho);T8(Phospho),"ERK1,2 kinase substrate motif;GSK3, Erk1, Erk2 and CDK5 kinase motif;GSK-3, ERK1, ERK2, CDK5 substrate motif;MAPKAPK2 kinase substrate motif;WW domain binding motif",+,0.0242,26,1,1,388000000,0,4.32,0,3.386791447,Serine/arginine repetitive matrix protein 1 (SR-related nuclear matrix protein of 160 kDa) (SRm160) (Ser/Arg-related nuclear matrix protein),HRPSPPATPPPK,HRPSPPATPPPKTRH,Q8IYB3,SRRM1,S(4): 100.0;T(8): 100.0,Q8IYB3,"S4(Phospho),T8(Phospho)",2
0,-0.08,-0.87,-0.81,-0.05,-0.17,-0.08,-0.06,K12(iTRAQ8plex);N-Term(iTRAQ8plex);S4(Phospho);T8(Phospho),"DNA dependent Protein kinase substrate motif;ERK1,2 kinase substrate motif;G protein-coupled receptor kinase 1 substrate motif;GSK-3, ERK1, ERK2, CDK5 substrate motif;PKA kinase substrate motif;PKC kinase substrate motif;WW domain binding motif",+,0.0242,26,1,1,388000000,0,4.32,0,3.386791447,Serine/arginine repetitive matrix protein 1 (SR-related nuclear matrix protein of 160 kDa) (SRm160) (Ser/Arg-related nuclear matrix protein),HRPSPPATPPPK,PRRRHRPSPPATPPP,Q8IYB3,SRRM1,S(4): 100.0;T(8): 100.0,Q8IYB3,"S4(Phospho),T8(Phospho)",2
0,0.15,0.90,0.91,0.02,-0.24,1.44,1.36,K14(iTRAQ8plex);N-Term(iTRAQ8plex);S20(Phospho);T9(Phospho),"ERK1,2 kinase substrate motif;GSK-3, ERK1, ERK2, CDK5 substrate motif;WW domain binding motif",+,0.0108,2,1,1,32200000,0,4.94,1,3.363244161,Arf-GAP domain and FG repeat-containing protein 1 (HIV-1 Rev-binding protein) (Nucleoporin-like protein RIP) (Rev-interacting protein) (Rev/Rex activation domain-binding protein),SLLGDSAPTLHLNKGTPSQSPVVGR,NKGTPSQSPVVGRSQ,P52594,AGFG1,S(1): 0.0;S(6): 0.0;T(9): 0.4;T(16): 99.3;S(18): 19.1;S(20): 81.2,P52594,"S20(Phospho),T9(Phospho)",2
0,0.15,0.90,0.91,0.02,-0.24,1.44,1.36,K14(iTRAQ8plex);N-Term(iTRAQ8plex);S20(Phospho);T9(Phospho),"G protein-coupled receptor kinase 1 substrate motif;GSK-3, ERK1, ERK2, CDK5 substrate motif;PKA kinase substrate motif;PKC kinase substrate motif;WW domain binding motif",+,0.0108,2,1,1,32200000,0,4.94,1,3.363244161,Arf-GAP domain and FG repeat-containing protein 1 (HIV-1 Rev-binding protein) (Nucleoporin-like protein RIP) (Rev-interacting protein) (Rev/Rex activation domain-binding protein),SLLGDSAPTLHLNKGTPSQSPVVGR,TLHLNKGTPSQSPVV,P52594,AGFG1,S(1): 0.0;S(6): 0.0;T(9): 0.4;T(16): 99.3;S(18): 19.1;S(20): 81.2,P52594,"S20(Phospho),T9(Phospho)",2
0,1.07,2.02,2.08,3.84,3.31,3.19,3.28,C19(Carbamidomethyl);K21(iTRAQ8plex);S15(Phospho);Y10(Phospho),,+,0.1411,2,1,1,0,0.005552,2.07,0,2.183133657,Tetratricopeptide repeat protein 7A (TPR repeat protein 7A),FAFGEFHLWYQVALSMVACGK,FGEFHLWYQVALSMV,Q9ULT0,TTC7A,Y(10): 100.0;S(15): 100.0,Q9ULT0,"S15(Phospho),Y10(Phospho)",2
0,1.07,2.02,2.08,3.84,3.31,3.19,3.28,C19(Carbamidomethyl);K21(iTRAQ8plex);S15(Phospho);Y10(Phospho),,+,0.1411,2,1,1,0,0.005552,2.07,0,2.183133657,Tetratricopeptide repeat protein 7A (TPR repeat protein 7A),FAFGEFHLWYQVALSMVACGK,LWYQVALSMVACGKS,Q9ULT0,TTC7A,Y(10): 100.0;S(15): 100.0,Q9ULT0,"S15(Phospho),Y10(Phospho)",2
0,-0.06,-1.01,-1.10,-0.13,-0.21,-0.16,-0.12,K9(iTRAQ8plex);N-Term(iTRAQ8plex);S5(Phospho);Y2(Phospho),"DNA dependent Protein kinase substrate motif;ERK1,2 kinase substrate motif;GSK-3, ERK1, ERK2, CDK5 substrate motif;WW domain binding motif",+,0.03437,36,1,1,452000000,0,3.59,1,3.977658994,Serine/arginine repetitive matrix protein 1 (SR-related nuclear matrix protein of 160 kDa) (SRm160) (Ser/Arg-related nuclear matrix protein),RYSPSPPPK,IQRRYSPSPPPKRRT,Q8IYB3,SRRM1,Y(2): 92.3;S(3): 7.7;S(5): 100.0,Q8IYB3,"S5(Phospho),Y2(Phospho)",2
0,-0.29,0.71,0.79,0.51,0.45,0.33,0.06,K10(iTRAQ8plex);T8(Phospho);Y2(Phospho),Casein kinase II substrate motif;DNA dependent Protein kinase substrate motif;PKA kinase substrate motif;PKC kinase substrate motif,+,0.1099,2,1,1,0,0.006341,1.93,1,1.880498145,PH and SEC7 domain-containing protein 4 (Exchange factor for ADP-ribosylation factor guanine nucleotide factor 6 B) (Exchange factor for ARF6 B) (Pleckstrin homology and SEC7 domain-containing protein 4) (Telomeric of interleukin-1 cluster protein),LYLFQAPTAKEMSSWIAR,LYLFQAPTAKEMSSW,Q8NDX1,PSD4,Y(2): 99.7;T(8): 77.6;S(13): 20.6;S(14): 2.1,Q8NDX1,"T8(Phospho),Y2(Phospho)",2
0,-0.29,0.71,0.79,0.51,0.45,0.33,0.06,K10(iTRAQ8plex);T8(Phospho);Y2(Phospho),STAT3 SH2 domain binding motif,+,0.1099,2,1,1,0,0.006341,1.93,1,1.880498145,PH and SEC7 domain-containing protein 4 (Exchange factor for ADP-ribosylation factor guanine nucleotide factor 6 B) (Exchange factor for ARF6 B) (Pleckstrin homology and SEC7 domain-containing protein 4) (Telomeric of interleukin-1 cluster protein),LYLFQAPTAKEMSSWIAR,RTADWRLYLFQAPTA,Q8NDX1,PSD4,Y(2): 99.7;T(8): 77.6;S(13): 20.6;S(14): 2.1,Q8NDX1,"T8(Phospho),Y2(Phospho)",2
0,0.15,-1.56,-1.48,0.31,0.36,-0.25,-0.08,C13(Carbamidomethyl);C15(Carbamidomethyl);C19(Carbamidomethyl);C5(Carbamidomethyl);C7(Carbamidomethyl);K20(iTRAQ8plex);N-Term(iTRAQ8plex);S8(Phospho),G protein-coupled receptor kinase 1 substrate motif;MAPKAPK2 kinase substrate motif,+,0.1722,4,1,1,1990000,0.004488,2.85,0,3.988536946,Metallothionein-1X (MT-1X) (Metallothionein-IX) (MT-IX),MDPNCSCSPVGSCACAGSCK,CSCSPVGSCACAGSC,P80297,MT1X,S(6): 1.5;S(8): 5.1;S(12): 74.6;S(18): 18.8,P80297,S8(Phospho),1
0,0.19,-1.17,-0.93,0.22,0.08,-0.29,-0.29,K1(iTRAQ8plex);K13(iTRAQ8plex);N-Term(iTRAQ8plex);S10(Phospho),"b-Adrenergic Receptor kinase substrate motif;Cdc2 kinase substrate motif;CDK kinase substrate motif;CDK1,2,4,6 kinase substrate motif;ERK1,2 kinase substrate motif;G protein-coupled receptor kinase 1 substrate motif;GSK3 kinase substrate motif;GSK-3, ERK1, ERK2, CDK5 substrate motif;WW domain binding motif",+,0.02958,2,1,1,10900000,0,2.39,1,2.778239408,Bcl-2-associated transcription factor 1 (Btf),KAEGEPQEESPLK,EGEPQEESPLKSKSQ,Q9NYF8,BCLAF1,S(10): 100.0,Q9NYF8,S10(Phospho),1
0,0.06,0.54,0.48,-0.24,-0.16,0.30,0.21,C2(Carbamidomethyl);K14(iTRAQ8plex);N-Term(iTRAQ8plex);S10(Phospho),,+,0.01032,14,1,1,61500000,0,4.55,0,3.171500538,Phosphoglucomutase-2 (PGM 2) (EC 5.4.2.2) (Glucose phosphomutase 2) (Phosphodeoxyribomutase) (Phosphopentomutase) (EC 5.4.2.7),LCAGIMITASHNPK,LCAGIMITASHNPKQ,Q96G03,PGM2,T(8): 0.0;S(10): 100.0,Q96G03,S10(Phospho),1
0,0.19,-0.89,-0.80,-0.45,-0.24,-0.46,-0.53,K12(iTRAQ8plex);K7(iTRAQ8plex);N-Term(iTRAQ8plex);S10(Phospho),"ERK1,2 kinase substrate motif;Growth associated histone HI kinase substrate motif;GSK-3, ERK1, ERK2, CDK5 substrate motif;PKA kinase substrate motif;PKC kinase substrate motif;WW domain binding motif",+,0.04131,2,1,1,16700000,0.0006798,3.38,0,2.382249034,Zinc finger CCCH domain-containing protein 14 (Mammalian suppressor of tau pathology-2) (MSUT-2) (Renal carcinoma antigen NY-REN-37),DLVQPDKPASPK,VQPDKPASPKFIVTL,Q6PJT7,ZC3H14,S(10): 100.0,Q6PJT7,S10(Phospho),1
0,0.39,-1.63,-1.89,0.01,0.30,-0.18,-0.35,C7(Carbamidomethyl);N-Term(iTRAQ8plex);S10(Phospho),"Casein kinase II substrate motif;ERK1,2 kinase substrate motif;G protein-coupled receptor kinase 1 substrate motif;GSK-3, ERK1, ERK2, CDK5 substrate motif;PKA kinase substrate motif;PKC kinase substrate motif;WW domain binding motif",+,0.001535,51,1,1,505000000,0,6.18,1,2.73565445,182 kDa tankyrase-1-binding protein,TEAQDLCRASPEPPGPESSSR,AQDLCRASPEPPGPE,Q9C0C2,TNKS1BP1,T(1): 0.0;S(10): 100.0;S(18): 0.0;S(19): 0.0;S(20): 0.0,Q9C0C2,S10(Phospho),1
0,0.01,-1.06,-1.02,-0.06,-0.23,-0.11,-0.12,K1(iTRAQ8plex);N-Term(iTRAQ8plex);S10(Phospho),"Casein kinase II substrate motif;ERK1,2 kinase substrate motif;GSK-3, ERK1, ERK2, CDK5 substrate motif;WW domain binding motif",+,0.001552,53,1,1,609000000,0,5.81,1,3.658542369,Transcription elongation factor A protein 1 (Transcription elongation factor S-II protein 1) (Transcription elongation factor TFIIS.o),KEPAITSQNSPEAR,PAITSQNSPEAREES,P23193,TCEA1,T(6): 0.0;S(7): 0.0;S(10): 100.0,P23193,S10(Phospho),1
0,-0.03,-0.96,-0.83,0.08,-0.03,-0.17,-0.13,K12(iTRAQ8plex);N-Term(iTRAQ8plex);S10(Phospho),"Cdc2 kinase substrate motif;CDK kinase substrate motif;CDK1,2,4,6 kinase substrate motif;ERK1,2 kinase substrate motif;Growth associated histone HI kinase substrate motif;GSK-3, ERK1, ERK2, CDK5 substrate motif;MAPKAPK2 kinase substrate motif;PKA kinase substrate motif;PKC kinase substrate motif;WW domain binding motif",+,0.01826,4,1,1,17900000,0,4.22,1,3.417267045,Zinc finger CCHC domain-containing protein 8 (TRAMP-like complex RNA-binding factor ZCCHC8),RSSSHSSPGSPK,SSHSSPGSPKKQKNE,Q6NZY4,ZCCHC8,S(2): 0.0;S(3): 0.0;S(4): 0.0;S(6): 0.0;S(7): 11.7;S(10): 88.2,Q6NZY4,S10(Phospho),1
0,0.09,0.62,0.55,0.19,0.12,-0.03,-0.12,K13(iTRAQ8plex);N-Term(iTRAQ8plex);S10(Phospho),"Cdc2 kinase substrate motif;CDK kinase substrate motif;CDK1,2,4,6 kinase substrate motif;ERK1,2 kinase substrate motif;GSK-3, ERK1, ERK2, CDK5 substrate motif;WW domain binding motif",+,0.02614,19,1,1,848000000,0,4.28,1,2.927790225,Apoptosis inhibitor 5 (API-5) (Antiapoptosis clone 11 protein) (AAC-11) (Cell migration-inducing gene 8 protein) (Fibroblast growth factor 2-interacting factor) (FIF) (Protein XAGL),RASEDTTSGSPPK,SEDTTSGSPPKKSSA,Q9BZZ5,API5,S(3): 0.0;T(6): 0.0;T(7): 0.0;S(8): 0.0;S(10): 100.0,Q9BZZ5,S10(Phospho),1
0,-0.07,-1.63,-1.52,-0.29,-0.52,-0.91,-0.76,K17(iTRAQ8plex);N-Term(iTRAQ8plex);S10(Phospho),"Casein kinase I substrate motif;Casein kinase II substrate motif;ERK1,2 kinase substrate motif;GSK-3, ERK1, ERK2, CDK5 substrate motif;WW domain binding motif",+,0.005362,67,1,1,341000000,0,5.73,0,3.248671589,Eukaryotic translation initiation factor 4B (eIF-4B),SQSSDTEQQSPTSGGGK,SSDTEQQSPTSGGGK,P23588,EIF4B,S(1): 0.0;S(3): 0.0;S(4): 0.0;T(6): 0.0;S(10): 99.8;T(12): 0.0;S(13): 0.1,P23588,S10(Phospho),1
0,-0.31,1.71,1.72,-0.47,-0.85,0.31,0.23,K20(iTRAQ8plex);N-Term(iTRAQ8plex);S10(Phospho),"Cdc2 kinase substrate motif;CDK kinase substrate motif;CDK1,2,4,6 kinase substrate motif;ERK1,2 kinase substrate motif;GSK-3, ERK1, ERK2, CDK5 substrate motif;WW domain binding motif",+,0.1507,6,1,1,66400000,0,3.38,1,3.181661945,Elongation factor 1-delta (EF-1-delta) (Antigen NY-CO-4),ATAPQTQHVSPMRQVEPPAK,APQTQHVSPMRQVEP,P29692,EEF1D,T(2): 0.0;T(6): 0.0;S(10): 100.0,P29692,S10(Phospho),1
0,-0.17,-2.75,-2.55,0.33,-0.01,-0.56,-0.37,K23(iTRAQ8plex);N-Term(iTRAQ8plex);S10(Phospho),Casein kinase I substrate motif;Casein kinase II substrate motif;G protein-coupled receptor kinase 1 substrate motif,+,0.0148,10,1,1,59200000,0,3.87,2,3.656857657,Heterogeneous nuclear ribonucleoprotein U-like protein 2 (Scaffold-attachment factor A2) (SAF-A2),REEDEPEERSGDETPGSEVPGDK,EDEPEERSGDETPGS,Q1KMD3,HNRNPUL2,S(10): 92.2;T(14): 7.1;S(17): 0.7,Q1KMD3,S10(Phospho),1
0,-0.09,-1.63,-1.74,0.94,0.77,-0.08,0.25,K26(iTRAQ8plex);N-Term(iTRAQ8plex);S10(Phospho),b-Adrenergic Receptor kinase substrate motif,+,0.007403,4,1,1,2550000,0,6.27,1,3.612320381,Nuclear ubiquitous casein and cyclin-dependent kinase substrate 1 (P1),VVDYSQFQESDDADEDYGRDSGPPTK,DYSQFQESDDADEDY,Q9H1E3,NUCKS1,Y(4): 3.3;S(5): 16.0;S(10): 80.6;Y(17): 0.0;S(21): 0.0;T(25): 0.0,Q9H1E3,S10(Phospho),1
0,-0.03,0.37,0.56,-0.71,-0.97,-0.39,-0.43,M12(Oxidation);N-Term(iTRAQ8plex);S10(Phospho),"Cdc2 kinase substrate motif;CDK kinase substrate motif;CDK1,2,4,6 kinase substrate motif;ERK1,2 kinase substrate motif;GSK-3, ERK1, ERK2, CDK5 substrate motif;WW domain binding motif",+,0.02675,40,1,1,1910000000,0,4.25,0,2.825733013,Elongation factor 1-delta (EF-1-delta) (Antigen NY-CO-4),ATAPQTQHVSPMR,APQTQHVSPMRQVEP,P29692,EEF1D,T(2): 0.0;T(6): 0.0;S(10): 100.0,P29692,S10(Phospho),1
0,0.29,1.28,1.05,0.38,0.35,0.01,0.09,M16(Oxidation);N-Term(iTRAQ8plex);S10(Phospho),MDC1 BRCT domain binding motif;Plk1 PBD domain binding motif,+,0.007039,6,1,1,1380000,0,3.2,0,2.444620506,Gamma-interferon-inducible protein 16 (Ifi-16) (Interferon-inducible myeloid differentiation transcriptional activator),VSEEQTQPPSPAGAGMSTAMGR,PAGAGMSTAMGRSPS,Q16666,IFI16,S(2): 1.3;T(6): 11.4;S(10): 37.9;S(17): 11.4;T(18): 37.9,Q16666,S10(Phospho),1
0,-0.06,0.43,0.62,0.95,0.81,2.19,2.14,N-Term(iTRAQ8plex);S10(Phospho),MDC1 BRCT domain binding motif;Plk1 PBD domain binding motif,+,0.01517,24,1,1,76500000,0,4.52,0,4.201607329,Vimentin,ISLPLPNFSSLNLR,LPLPNFSSLNLRETN,P08670,VIM,S(2): 0.0;S(9): 8.0;S(10): 92.0,P08670,S10(Phospho),1
0,0.04,-1.97,-1.93,-0.16,-0.22,-0.46,-0.49,N-Term(iTRAQ8plex);S10(Phospho),"ERK1,2 kinase substrate motif;Growth associated histone HI kinase substrate motif;GSK-3, ERK1, ERK2, CDK5 substrate motif;PKA kinase substrate motif;PKC kinase substrate motif;WW domain binding motif",+,0.001371,520,1,1,12200000000,0,4.77,1,5.884586948,Calnexin (IP90) (Major histocompatibility complex class I antigen-binding protein p88) (p90),AEEDEILNRSPR,EDEILNRSPRNRKPR,P27824,CANX,S(10): 100.0,P27824,S10(Phospho),1
0,-0.03,0.50,0.65,-1.07,-1.32,-0.38,-0.32,N-Term(iTRAQ8plex);S10(Phospho),"Cdc2 kinase substrate motif;CDK kinase substrate motif;CDK1,2,4,6 kinase substrate motif;ERK1,2 kinase substrate motif;GSK-3, ERK1, ERK2, CDK5 substrate motif;WW domain binding motif",+,0.001501,325,1,1,9040000000,0,5.4,0,3.500041174,Elongation factor 1-delta (EF-1-delta) (Antigen NY-CO-4),ATAPQTQHVSPMR,APQTQHVSPMRQVEP,P29692,EEF1D,T(2): 0.0;T(6): 0.0;S(10): 100.0,P29692,S10(Phospho),1
0,-0.03,-2.11,-1.71,-0.15,-0.24,-0.42,-0.41,N-Term(iTRAQ8plex);S10(Phospho),"Casein kinase II substrate motif;ERK1,2 kinase substrate motif;GSK-3, ERK1, ERK2, CDK5 substrate motif;MDC1 BRCT domain binding motif;Plk1 PBD domain binding motif;WW domain binding motif",+,0.03216,20,1,1,77300000,0,4.12,0,3.220033927,Condensin complex subunit 2 (Barren homolog protein 1) (Chromosome-associated protein H) (hCAP-H) (Non-SMC condensin I complex subunit H) (XCAP-H homolog),GHPHSASSPSER,GHPHSASSPSERVFP,Q15003,NCAPH,S(5): 9.4;S(7): 0.0;S(8): 1.0;S(10): 89.6,Q15003,S10(Phospho),1
0,-0.02,-0.33,-0.31,0.14,0.07,0.01,0.07,N-Term(iTRAQ8plex);S10(Phospho),"Casein kinase I substrate motif;ERK1,2 kinase substrate motif;Growth associated histone HI kinase substrate motif;GSK-3, ERK1, ERK2, CDK5 substrate motif;PKA kinase substrate motif;PKC kinase substrate motif;WW domain binding motif",+,0.01115,24,1,1,1000000000,0,3.99,1,3.13687144,Tumor suppressor candidate gene 1 protein (TSG-9) (TSG9),DSGREDEPGSPR,GREDEPGSPRALRAR,Q2TAM9,TUSC1,S(2): 0.0;S(10): 100.0,Q2TAM9,S10(Phospho),1
0,0.06,0.09,0.00,-0.22,-0.23,-0.01,-0.08,N-Term(iTRAQ8plex);S10(Phospho),"Cdc2 kinase substrate motif;CDK kinase substrate motif;CDK1,2,4,6 kinase substrate motif;ERK1,2 kinase substrate motif;Growth associated histone HI kinase substrate motif;GSK-3, ERK1, ERK2, CDK5 substrate motif;PKA kinase substrate motif;PKC kinase substrate motif;WW domain binding motif",+,0.03686,4,1,1,19100000,0.004,3.86,0,1.921242848,ATR-interacting protein (ATM and Rad3-related-interacting protein),LAAPSVSHVSPR,APSVSHVSPRKNPSV,Q8WXE1,ATRIP,,Q8WXE1,S10(Phospho),1
0,0.06,0.32,0.49,0.18,0.12,0.03,0.02,N-Term(iTRAQ8plex);S10(Phospho),"Casein kinase II substrate motif;ERK1,2 kinase substrate motif;Growth associated histone HI kinase substrate motif;GSK-3, ERK1, ERK2, CDK5 substrate motif;PKA kinase substrate motif;PKC kinase substrate motif;WW domain binding motif",+,0.005912,16,1,1,64600000,0,3.24,1,1.779475038,Rhotekin,SVAPLPPQRSPR,APLPPQRSPRTRGLC,Q9BST9,RTKN,S(1): 0.0;S(10): 100.0,Q9BST9,S10(Phospho),1
0,-0.04,0.27,0.18,-0.39,-0.40,-0.07,-0.11,N-Term(iTRAQ8plex);S10(Phospho),"Cdc2 kinase substrate motif;CDK kinase substrate motif;CDK1,2,4,6 kinase substrate motif;ERK1,2 kinase substrate motif;G protein-coupled receptor kinase 1 substrate motif;Growth associated histone HI kinase substrate motif;GSK3 kinase substrate motif;GSK-3, ERK1, ERK2, CDK5 substrate motif;PKA kinase substrate motif;PKC kinase substrate motif;WW domain binding motif",+,0.005075,7,1,1,64600000,0,3.96,0,3.398600689,Uncharacterized protein C9orf142,LAAAEETAVSPR,AAEETAVSPRKSPRP,Q9BUH6,C9orf142,T(7): 0.0;S(10): 100.0,Q9BUH6,S10(Phospho),1
0,-0.02,0.29,0.50,0.70,0.55,0.46,0.42,N-Term(iTRAQ8plex);S10(Phospho),b-Adrenergic Receptor kinase substrate motif;Casein kinase II substrate motif;G protein-coupled receptor kinase 1 substrate motif;MAPKAPK2 kinase substrate motif,+,0.07253,2,1,1,4160000,0.001645,3,0,1.998722612,Inner nuclear membrane protein Man1 (LEM domain-containing protein 3),VLLGFSSDESDVEASPR,LGFSSDESDVEASPR,Q9Y2U8,LEMD3,S(6): 2.6;S(7): 2.6;S(10): 92.2;S(15): 2.6,Q9Y2U8,S10(Phospho),1
0,0.09,-0.28,-0.73,1.15,1.03,0.49,0.51,K1(iTRAQ8plex);K13(iTRAQ8plex);N-Term(iTRAQ8plex);S11(Phospho),"Cdc2 kinase substrate motif;CDK kinase substrate motif;CDK1,2,4,6 kinase substrate motif;DNA dependent Protein kinase substrate motif;ERK1,2 kinase substrate motif;G protein-coupled receptor kinase 1 substrate motif;Growth associated histone HI kinase substrate motif;GSK-3, ERK1, ERK2, CDK5 substrate motif;PKA kinase substrate motif;PKC kinase substrate motif;WW domain binding motif",+,0.009573,4,1,1,11600000,0,2.82,1,2.560612278,High mobility group protein HMGI-C (High mobility group AT-hook protein 2),KQQQEPTGEPSPK,QEPTGEPSPKRPRGR,P52926,HMGA2,T(7): 0.0;S(11): 100.0,P52926,S11(Phospho),1
0,0.22,-0.83,-1.04,-0.91,-0.92,-0.22,-0.24,K10(iTRAQ8plex);K14(iTRAQ8plex);N-Term(iTRAQ8plex);S11(Phospho),"Casein kinase I substrate motif;Casein kinase II substrate motif;Cdc2 kinase substrate motif;CDK kinase substrate motif;CDK1,2,4,6 kinase substrate motif;ERK1,2 kinase substrate motif;Growth associated histone HI kinase substrate motif;GSK-3, ERK1, ERK2, CDK5 substrate motif;WW domain binding motif",+,0.0124,31,1,1,394000000,0,3.96,1,2.875722681,Interleukin enhancer-binding factor 3 (Double-stranded RNA-binding protein 76) (DRBP76) (M-phase phosphoprotein 4) (MPP4) (Nuclear factor associated with dsRNA) (NFAR) (Nuclear factor of activated T-cells 90 kDa) (NF-AT-90) (Translational control protein 80) (TCP80),RPMEEDGEEKSPSK,EEDGEEKSPSKKKKK,Q12906,ILF3,S(11): 100.0;S(13): 0.0,Q12906,S11(Phospho),1
0,0.60,-2.37,-2.56,-0.12,0.06,-0.38,-0.64,K13(iTRAQ8plex);K15(iTRAQ8plex);N-Term(iTRAQ8plex);S11(Phospho),b-Adrenergic Receptor kinase substrate motif;Casein kinase II substrate motif;G protein-coupled receptor kinase 1 substrate motif;PKA kinase substrate motif;PKC kinase substrate motif,+,0.01488,8,1,1,10700000,0,3.03,1,2.908189364,"Serine/arginine-rich splicing factor 11 (Arginine-rich 54 kDa nuclear protein) (p54) (Splicing factor, arginine/serine-rich 11)",DYDEEEQGYDSEKEK,EEEQGYDSEKEKKEE,Q05519,SRSF11,Y(2): 0.0;Y(9): 0.0;S(11): 100.0,Q05519,S11(Phospho),1
0,0.11,-2.56,-3.20,-0.63,-0.90,-1.12,-1.59,C2(Carbamidomethyl);N-Term(iTRAQ8plex);S11(Phospho),BARD1 BRCT domain binding motif;Casein kinase I substrate motif;Casein kinase II substrate motif,+,0.002382,10,1,1,36100000,0,3.46,0,2.578337158,WD repeat-containing protein 55,TCEERPAEDGSDEEDPDSMEAPTR,ERPAEDGSDEEDPDS,Q9H6Y2,WDR55,T(1): 0.1;S(11): 99.9;S(18): 0.0;T(23): 0.0,Q9H6Y2,S11(Phospho),1
0,0.13,-0.69,-0.76,-0.43,-0.34,-0.27,-0.47,K14(iTRAQ8plex);N-Term(iTRAQ8plex);S11(Phospho),"Casein kinase II substrate motif;Cdc2 kinase substrate motif;CDK kinase substrate motif;CDK1,2,4,6 kinase substrate motif;ERK1,2 kinase substrate motif;G protein-coupled receptor kinase 1 substrate motif;GSK-3, ERK1, ERK2, CDK5 substrate motif;WW domain binding motif",+,0.008103,4,1,1,8360000,0,3.42,0,2.332641246,Probable 28S rRNA (cytosine(4447)-C(5))-methyltransferase (EC 2.1.1.-) (Nucleolar protein 1) (Nucleolar protein 2 homolog) (Proliferating-cell nucleolar antigen p120) (Proliferation-associated nucleolar protein p120),GTDTQTPAVLSPSK,TQTPAVLSPSKTQAT,P46087,NOP2,T(2): 0.0;T(4): 0.0;T(6): 0.1;S(11): 99.9;S(13): 0.1,P46087,S11(Phospho),1
0,-0.02,1.11,1.14,0.96,0.58,-0.11,0.05,K18(iTRAQ8plex);N-Term(iTRAQ8plex);S11(Phospho),b-Adrenergic Receptor kinase substrate motif;Casein kinase II substrate motif;G protein-coupled receptor kinase 1 substrate motif;MAPKAPK2 kinase substrate motif;Pyruvate dehydrogenase kinase substrate motif,+,0.0005585,2,1,1,905000,0,4.45,0,2.52345028,Importin subunit alpha-4 (Importin alpha Q2) (Qip2) (Karyopherin subunit alpha-3) (SRP1-gamma),NVPQEESLEDSDVDADFK,QEESLEDSDVDADFK,O00505,KPNA3,S(7): 0.0;S(11): 100.0,O00505,S11(Phospho),1
0,0.19,-0.11,-0.29,-0.63,-0.60,-0.05,-0.04,K7(iTRAQ8plex);N-Term(iTRAQ8plex);S11(Phospho),"b-Adrenergic Receptor kinase substrate motif;Cdc2 kinase substrate motif;CDK kinase substrate motif;CDK1,2,4,6 kinase substrate motif;ERK1,2 kinase substrate motif;GSK-3, ERK1, ERK2, CDK5 substrate motif;PKA kinase substrate motif;WW domain binding motif",+,0.01569,2,1,1,49700000,0,3.28,0,2.258882804,Thyroid receptor-interacting protein 11 (TR-interacting protein 11) (TRIP-11) (Clonal evolution-related gene on chromosome 14 protein) (Golgi-associated microtubule-binding protein 210) (GMAP-210) (Trip230),LSVHDMKPLDSPGR,HDMKPLDSPGRRKRD,Q15643,TRIP11,S(2): 0.1;S(11): 99.9,Q15643,S11(Phospho),1
0,0.06,0.68,0.82,1.10,0.74,0.75,0.80,K9(iTRAQ8plex);N-Term(iTRAQ8plex);S11(Phospho),Casein kinase II substrate motif;DNA dependent Protein kinase substrate motif;PKA kinase substrate motif;PKC kinase substrate motif,+,0.05469,6,1,1,14300000,0.001202,2.11,0,1.948101051,Poly(rC)-binding protein 2 (Alpha-CP2) (Heterogeneous nuclear ribonucleoprotein E2) (hnRNP E2),GVTIPYRPKPSSSPVIFAGGQDR,IPYRPKPSSSPVIFA,Q15366,PCBP2,T(3): 20.0;Y(6): 20.0;S(11): 20.0;S(12): 20.0;S(13): 20.0,Q15366,S11(Phospho),1
0,0.03,-1.40,-1.26,-0.28,-0.55,-0.84,-0.99,K19(iTRAQ8plex);S11(Phospho),,+,0.07343,18,1,1,349000000,0.002391,2.28,0,2.869319654,Protein Shroom4 (Second homolog of apical protein),ISPGQRPGQSSLGLNTWWK,PGQRPGQSSLGLNTW,Q9ULL8,SHROOM4,S(2): 2.3;S(10): 46.2;S(11): 46.2;T(16): 5.4,Q9ULL8,S11(Phospho),1
0,0.02,-1.76,-1.16,0.01,-0.19,-0.57,-0.58,N-Term(iTRAQ8plex);S11(Phospho),14-3-3 domain binding motif;b-Adrenergic Receptor kinase substrate motif;Calmodulin-dependent protein kinase II substrate motif;Calmodulin-dependent protein kinase IV substrate motif;Casein kinase II substrate motif;Chk1 kinase substrate motif;PKA kinase substrate motif;PKC epsilon kinase substrate motif;PKC kinase substrate motif,+,0.001037,20,1,1,19700000,0,4.62,1,2.036794786,"Zinc finger Ran-binding domain-containing protein 2 (Zinc finger protein 265) (Zinc finger, splicing)",ENVEYIEREESDGEYDEFGR,EYIEREESDGEYDEF,O95218,ZRANB2,Y(5): 0.1;S(11): 99.9;Y(15): 0.0,O95218,S11(Phospho),1
0,0.04,-1.42,-1.48,-0.15,-0.12,-0.44,-0.43,N-Term(iTRAQ8plex);S11(Phospho),"Casein kinase II substrate motif;Cdc2 kinase substrate motif;CDK kinase substrate motif;CDK1,2,4,6 kinase substrate motif;CDK4 kinase substrate motif;ERK1,2 kinase substrate motif;GSK-3, ERK1, ERK2, CDK5 substrate motif;MAPKAPK2 kinase substrate motif;WW domain binding motif",+,0.0006261,66,1,1,221000000,0,4.68,0,5.555785294,Prelamin-A/C [Cleaved into: Lamin-A/C (70 kDa lamin) (Renal carcinoma antigen NY-REN-32)],SGAQASSTPLSPTR,QASSTPLSPTRITRL,P02545,LMNA,S(1): 0.0;S(6): 0.0;S(7): 0.0;T(8): 0.0;S(11): 99.0;T(13): 1.0,P02545,S11(Phospho),1
0,0.02,-0.04,0.33,0.95,0.88,0.45,0.60,N-Term(iTRAQ8plex);S11(Phospho),"Casein kinase II substrate motif;ERK1,2 kinase substrate motif;Growth associated histone HI kinase substrate motif;GSK-3, ERK1, ERK2, CDK5 substrate motif;PKA kinase substrate motif;PKC kinase substrate motif;WW domain binding motif",+,0.003841,11,1,1,40300000,0,3.74,0,1.967366356,Stathmin (Leukemia-associated phosphoprotein p18) (Metablastin) (Oncoprotein 18) (Op18) (Phosphoprotein p19) (pp19) (Prosolin) (Protein Pr22) (pp17),ASGQAFELILSPR,QAFELILSPRSKESV,P16949,STMN1,S(2): 0.0;S(11): 100.0,P16949,S11(Phospho),1
0,0.34,-1.91,-1.68,0.35,0.62,-0.09,-0.11,N-Term(iTRAQ8plex);S11(Phospho),"ERK1,2 kinase substrate motif;G protein-coupled receptor kinase 1 substrate motif;Growth associated histone HI kinase substrate motif;GSK3 kinase substrate motif;GSK-3, ERK1, ERK2, CDK5 substrate motif;MDC1 BRCT domain binding motif;PKA kinase substrate motif;PKC kinase substrate motif;Plk1 PBD domain binding motif;WW domain binding motif",+,0.000111,384,1,1,12500000000,0,5.85,0,3.161772125,Heterogeneous nuclear ribonucleoprotein D0 (hnRNP D0) (AU-rich element RNA-binding protein 1),NEEDEGHSNSSPR,DEGHSNSSPRHSEAA,Q14103,HNRNPD,S(8): 0.0;S(10): 7.0;S(11): 93.0,Q14103,S11(Phospho),1
0,0.03,0.40,0.32,0.94,0.60,1.09,1.16,N-Term(iTRAQ8plex);S11(Phospho),"ERK1,2 kinase substrate motif;GSK-3, ERK1, ERK2, CDK5 substrate motif;PKA kinase substrate motif;PKC kinase substrate motif;WW domain binding motif",+,0.0047,29,1,1,504000000,0,5.14,1,2.453540475,Interferon regulatory factor 2-binding protein 2 (IRF-2-binding protein 2) (IRF-2BP2),LEEPPELNRQSPNPR,PPELNRQSPNPRRGH,Q7Z5L9,IRF2BP2,S(11): 100.0,Q7Z5L9,S11(Phospho),1
0,0.02,-1.00,-0.87,0.11,0.14,0.03,0.02,N-Term(iTRAQ8plex);S11(Phospho),"ERK1,2 kinase substrate motif;G protein-coupled receptor kinase 1 substrate motif;Growth associated histone HI kinase substrate motif;GSK-3, ERK1, ERK2, CDK5 substrate motif;MAPKAPK2 kinase substrate motif;PKA kinase substrate motif;PKC kinase substrate motif;WW domain binding motif",+,0.01491,10,1,1,402000000,0,3.58,1,4.075571518,ELKS/Rab6-interacting/CAST family member 1 (ERC-1) (Rab6-interacting protein 2),VEPSSQSPGRSPR,SSQSPGRSPRLPRSP,Q8IUD2,ERC1,S(4): 2.9;S(5): 2.9;S(7): 14.7;S(11): 79.4,Q8IUD2,S11(Phospho),1
0,0.02,0.49,0.61,0.31,0.18,0.30,0.34,N-Term(iTRAQ8plex);S11(Phospho),"Cdc2 kinase substrate motif;CDK kinase substrate motif;CDK1,2,4,6 kinase substrate motif;ERK1,2 kinase substrate motif;G protein-coupled receptor kinase 1 substrate motif;Growth associated histone HI kinase substrate motif;GSK3 kinase substrate motif;GSK-3, ERK1, ERK2, CDK5 substrate motif;PKA kinase substrate motif;PKC kinase substrate motif;WW domain binding motif",+,0.001428,22,1,1,115000000,0,5.13,1,2.299077482,Uncharacterized protein C9orf142,RLAAAEETAVSPR,AAEETAVSPRKSPRP,Q9BUH6,C9orf142,T(8): 0.8;S(11): 99.2,Q9BUH6,S11(Phospho),1
0,0.14,-0.83,-0.67,-0.37,-0.32,-0.23,-0.30,N-Term(iTRAQ8plex);S11(Phospho),"Casein kinase II substrate motif;ERK1,2 kinase substrate motif;G protein-coupled receptor kinase 1 substrate motif;GSK-3, ERK1, ERK2, CDK5 substrate motif;WW domain binding motif",+,0.0003183,35,1,1,80100000,0,5.26,0,2.583155419,Collagen alpha-1(XVII) chain (180 kDa bullous pemphigoid antigen 2) (Bullous pemphigoid antigen 2) [Cleaved into: 120 kDa linear IgA disease antigen (120 kDa linear IgA dermatosis antigen) (Linear IgA disease antigen 1) (LAD-1);97 kDa linear IgA disease antigen (97 kDa linear IgA bullous dermatosis antigen) (97 kDa LAD antigen) (97-LAD) (Linear IgA bullous disease antigen of 97 kDa) (LABD97)],AHSPASTLPNSPGSTFER,PASTLPNSPGSTFER,Q9UMD9,COL17A1,S(3): 0.0;S(6): 0.0;T(7): 0.0;S(11): 99.9;S(14): 0.1;T(15): 0.0,Q9UMD9,S11(Phospho),1
0,-0.02,0.85,1.27,-0.27,-0.29,-0.44,-0.18,N-Term(iTRAQ8plex);S11(Phospho),ALK kinase substrate motif;Cbl PTB domain binding motif;JAK2 kinase substrate motif;Shb PTB domain binding motif;SHP1 phosphatase substrate motif;Src kinase substrate motif,+,0.009799,4,1,1,317000,0,3.76,1,2.392812093,Plakophilin-3,LGPGGLDDRYSLVSEQLEPAATSTYR,PGGLDDRYSLVSEQL,Q9Y446,PKP3,Y(10): 19.0;S(11): 80.3;S(14): 0.3;T(22): 0.0;S(23): 0.0;T(24): 0.0;Y(25): 0.3,Q9Y446,S11(Phospho),1
0,0.15,-0.70,-0.53,0.36,0.21,-0.13,-0.29,N-Term(iTRAQ8plex);S11(Phospho),"DNA dependent Protein kinase substrate motif;ERK1,2 kinase substrate motif;GSK-3, ERK1, ERK2, CDK5 substrate motif;WW domain binding motif",+,0.08425,10,1,1,39700000,0.00361,3.52,0,2.330847992,"FERM, RhoGEF and pleckstrin domain-containing protein 1 (Chondrocyte-derived ezrin-like protein) (Pleckstrin homology domain-containing family C member 2) (PH domain-containing family C member 2)",VSAGEPGSHPSPAPR,GEPGSHPSPAPRRSP,Q9Y4F1,FARP1,S(2): 0.0;S(8): 0.1;S(11): 99.9,Q9Y4F1,S11(Phospho),1
0,0.38,-0.82,-0.92,-1.06,-1.00,0.08,-0.01,K11(iTRAQ8plex);K14(iTRAQ8plex);N-Term(iTRAQ8plex);S12(Phospho),"ERK1,2 kinase substrate motif;Growth associated histone HI kinase substrate motif;GSK-3, ERK1, ERK2, CDK5 substrate motif;PKA kinase substrate motif;PKC kinase substrate motif;WW domain binding motif",+,0.01952,4,1,1,71200000,0,3.63,1,2.663700671,Neuroblast differentiation-associated protein AHNAK (Desmoyokin),ISMPDLDLHLKSPK,DLDLHLKSPKAKGEV,Q09666,AHNAK,S(2): 0.0;S(12): 100.0,Q09666,S12(Phospho),1
0,0.49,-1.05,-1.26,-0.97,-1.21,-0.71,-0.95,K11(iTRAQ8plex);K14(iTRAQ8plex);N-Term(iTRAQ8plex);S12(Phospho),"Casein kinase I substrate motif;ERK1,2 kinase substrate motif;Growth associated histone HI kinase substrate motif;GSK-3, ERK1, ERK2, CDK5 substrate motif;PKA kinase substrate motif;PKC kinase substrate motif;WW domain binding motif",+,0.1002,4,1,1,7480000,0.005443,3.52,1,2.00729451,Neuroblast differentiation-associated protein AHNAK (Desmoyokin),MYFPDVEFDIKSPK,DVEFDIKSPKFKAEA,Q09666,AHNAK,Y(2): 0.0;S(12): 100.0,Q09666,S12(Phospho),1
0,0.37,-1.40,-1.56,-1.22,-1.16,-0.46,-0.48,K11(iTRAQ8plex);K14(iTRAQ8plex);N-Term(iTRAQ8plex);S12(Phospho),"ERK1,2 kinase substrate motif;Growth associated histone HI kinase substrate motif;GSK-3, ERK1, ERK2, CDK5 substrate motif;PKA kinase substrate motif;PKC kinase substrate motif;WW domain binding motif",+,0.008594,8,1,1,121000000,0,4.74,1,2.979585251,Neuroblast differentiation-associated protein AHNAK (Desmoyokin),VSMPDVELNLKSPK,DVELNLKSPKVKGDL,Q09666,AHNAK,S(2): 0.0;S(12): 100.0,Q09666,S12(Phospho),1
0,0.08,0.28,0.22,0.21,0.30,0.50,0.42,C14(Carbamidomethyl);N-Term(iTRAQ8plex);S12(Phospho),"ERK1,2 kinase substrate motif;GSK-3, ERK1, ERK2, CDK5 substrate motif;WW domain binding motif",+,0.0002149,14,1,1,57100000,0,5.33,0,2.100295449,Tensin-1,HLGGSGSVVPGSPCLDR,SGSVVPGSPCLDRHV,Q9HBL0,TNS1,S(5): 0.0;S(7): 0.0;S(12): 100.0,Q9HBL0,S12(Phospho),1
0,0.21,NaN,-0.59,3.19,3.10,2.48,2.38,K1(iTRAQ8plex);N-Term(iTRAQ8plex);S12(Phospho),ATM kinase substrate motif;Casein kinase I substrate motif;Casein kinase II substrate motif;DNA dependent Protein kinase substrate motif;G protein-coupled receptor kinase 1 substrate motif;MDC1 BRCT domain binding motif;Plk1 PBD domain binding motif,+,0.03092,30,1,1,47300000,0,3.32,0,3.763460308,High mobility group protein HMGI-C (High mobility group AT-hook protein 2),KPAQEETEETSSQESAEED,EETEETSSQESAEED,P52926,HMGA2,T(7): 0.0;T(10): 1.7;S(11): 1.7;S(12): 95.0;S(15): 1.7,P52926,S12(Phospho),1
0,0.16,0.58,0.74,0.40,0.32,0.20,0.06,K1(iTRAQ8plex);N-Term(iTRAQ8plex);S12(Phospho),"Casein kinase II substrate motif;ERK1,2 kinase substrate motif;GSK-3, ERK1, ERK2, CDK5 substrate motif;WW domain binding motif",+,0.06312,7,1,1,6290000,0.0004742,3.48,0,1.944167942,"Cytoplasmic dynein 1 light intermediate chain 1 (LIC1) (Dynein light chain A) (DLC-A) (Dynein light intermediate chain 1, cytosolic)",KPVTVSPTTPTSPTEGEAS,VSPTTPTSPTEGEAS,Q9Y6G9,DYNC1LI1,T(4): 0.3;S(6): 1.7;T(8): 4.8;T(9): 4.8;T(11): 15.1;S(12): 53.5;T(14): 15.1;S(19): 4.8,Q9Y6G9,S12(Phospho),1
0,0.17,-0.86,-0.84,-0.46,-0.35,-0.61,-0.58,K15(iTRAQ8plex);N-Term(iTRAQ8plex);S12(Phospho),Casein kinase II substrate motif,+,0.01567,10,1,1,18900000,0,4.16,0,3.058969419,Treacle protein (Treacher Collins syndrome protein),LGAGEGGEASVSPEK,AGEGGEASVSPEKTS,Q13428,TCOF1,S(10): 0.4;S(12): 99.6,Q13428,S12(Phospho),1
0,-0.13,NaN,-2.24,-1.74,-1.51,-2.62,-2.20,K15(iTRAQ8plex);N-Term(iTRAQ8plex);S12(Phospho),"Casein kinase I substrate motif;Cdc2 kinase substrate motif;CDK kinase substrate motif;CDK1,2,4,6 kinase substrate motif;ERK1,2 kinase substrate motif;GSK-3, ERK1, ERK2, CDK5 substrate motif;WW domain binding motif",+,0.03268,4,1,1,926000,0,1.51,0,2.508474442,Sister chromatid cohesion protein PDS5 homolog B (Androgen-induced proliferation inhibitor) (Androgen-induced prostate proliferative shutoff-associated protein AS3),EDILENEDEQNSPPK,ENEDEQNSPPKKGKR,Q9NTI5,PDS5B,S(12): 100.0,Q9NTI5,S12(Phospho),1
0,-0.29,0.58,NaN,1.87,1.30,2.10,2.11,K23(iTRAQ8plex);N-Term(iTRAQ8plex);S12(Phospho),"14-3-3 domain binding motif;b-Adrenergic Receptor kinase substrate motif;Calmodulin-dependent protein kinase II substrate motif;ERK1,2 kinase substrate motif;GSK-3, ERK1, ERK2, CDK5 substrate motif;PKA kinase substrate motif;PKC kinase substrate motif;WW domain binding motif",+,0.08819,2,1,1,1160000,0.002668,1.48,0,2.156628988,Intracellular hyaluronan-binding protein 4 (IHABP-4) (IHABP4) (Ki-1/57 intracellular antigen),SLPAPVAQRPDSPGGGLQAPGQK,PVAQRPDSPGGGLQA,Q5JVS0,HABP4,S(1): 3.6;S(12): 96.4,Q5JVS0,S12(Phospho),1
0,-0.02,-1.48,-1.12,-0.52,-0.63,-1.07,-1.05,K6(iTRAQ8plex);N-Term(iTRAQ8plex);S12(Phospho),"ERK1,2 kinase substrate motif;Growth associated histone HI kinase substrate motif;GSK-3, ERK1, ERK2, CDK5 substrate motif;WW domain binding motif",+,0.07833,4,1,1,349000000,0.002391,2.44,1,2.637931063,Uncharacterized protein C9orf78 (Hepatocellular carcinoma-associated antigen 59),VGDTEKPEPERSPPNR,EKPEPERSPPNRKRP,Q9NZ63,C9orf78,T(4): 0.0;S(12): 100.0,Q9NZ63,S12(Phospho),1
0,0.16,-0.49,-0.29,0.29,0.53,0.44,0.43,N-Term(iTRAQ8plex);S12(Phospho),G protein-coupled receptor kinase 1 substrate motif;GSK3 kinase substrate motif;MAPKAPK2 kinase substrate motif;MDC1 BRCT domain binding motif;Plk1 PBD domain binding motif,+,0.00064,8,1,1,23300000,0,3.91,0,2.119061059,"Heterogeneous nuclear ribonucleoprotein A1 (hnRNP A1) (Helix-destabilizing protein) (Single-strand RNA-binding protein) (hnRNP core protein A1) [Cleaved into: Heterogeneous nuclear ribonucleoprotein A1, N-terminally processed]",NQGGYGGSSSSSSYGSGR,YGGSSSSSSYGSGRR,P09651,HNRNPA1,Y(5): 0.0;S(8): 0.0;S(9): 1.1;S(10): 1.1;S(11): 6.7;S(12): 42.1;S(13): 42.1;Y(14): 6.7;S(16): 0.0,P09651,S12(Phospho),1
0,-0.01,-1.33,-1.38,-0.28,-0.25,-0.32,-0.24,N-Term(iTRAQ8plex);S12(Phospho),"ERK1,2 kinase substrate motif;G protein-coupled receptor kinase 1 substrate motif;Growth associated histone HI kinase substrate motif;GSK-3, ERK1, ERK2, CDK5 substrate motif;MDC1 BRCT domain binding motif;PKA kinase substrate motif;PKC kinase substrate motif;Plk1 PBD domain binding motif;WW domain binding motif",+,0.004656,158,1,1,1380000000,0,5.35,0,5.092486472,Alpha-taxilin,RPEGPGAQAPSSPR,PGAQAPSSPRVTEAP,P40222,TXLNA,S(11): 50.0;S(12): 50.0,P40222,S12(Phospho),1
0,-0.03,-0.39,-0.37,0.04,-0.01,0.06,0.13,N-Term(iTRAQ8plex);S12(Phospho),"Cdc2 kinase substrate motif;CDK kinase substrate motif;CDK1,2,4,6 kinase substrate motif;ERK1,2 kinase substrate motif;GSK-3, ERK1, ERK2, CDK5 substrate motif;WW domain binding motif",+,0.03437,12,1,1,7450000,0,3.85,0,3.356860557,Antigen KI-67,AQSLVISPPAPSPR,AQLEPVASPAKKPKV,P46013,MKI67,S(3): 0.0;S(7): 0.0;S(12): 100.0,P46013,S12(Phospho),1
0,0.00,0.92,1.26,0.62,0.57,0.72,0.68,N-Term(iTRAQ8plex);S12(Phospho),BARD1 BRCT domain binding motif;Casein kinase I substrate motif;Casein kinase II substrate motif,+,9.60E-05,2,1,1,0,0,4.96,0,2.369009544,Ubiquitin-like protein 7 (Bone marrow stromal cell ubiquitin-like protein) (BMSC-UbP) (Ubiquitin-like protein SB132),DMPGGFLFEGLSDDEDDFHPNTR,GFLFEGLSDDEDDFH,Q96S82,UBL7,S(12): 100.0;T(22): 0.0,Q96S82,S12(Phospho),1
0,0.05,0.06,0.07,0.04,0.19,0.43,0.39,N-Term(iTRAQ8plex);S12(Phospho),"Casein kinase II substrate motif;ERK1,2 kinase substrate motif;G protein-coupled receptor kinase 1 substrate motif;GSK-3, ERK1, ERK2, CDK5 substrate motif;WW domain binding motif",+,6.07E-05,44,1,1,65000000,0,7.05,0,2.097610575,A-kinase anchor protein 2 (AKAP-2) (AKAP-KL) (Protein kinase A-anchoring protein 2) (PRKA2),DALGDSLQVPVSPSSTTSSR,DSLQVPVSPSSTTSS,Q9Y2D5,AKAP2,S(6): 0.0;S(12): 89.0;S(14): 10.7;S(15): 0.2;T(16): 0.0;T(17): 0.2;S(18): 0.0;S(19): 0.0,Q9Y2D5,S12(Phospho),1
0,-0.04,-1.89,-1.21,0.60,0.22,-0.79,-0.30,K17(iTRAQ8plex);K5(iTRAQ8plex);N-Term(iTRAQ8plex);S13(Phospho),"b-Adrenergic Receptor kinase substrate motif;Casein kinase I substrate motif;Casein kinase II substrate motif;ERK1,2 kinase substrate motif;GSK-3, ERK1, ERK2, CDK5 substrate motif;WW domain binding motif",+,0.09671,2,1,1,100000000,0.002329,2.75,1,1.838099968,Nuclear ubiquitous casein and cyclin-dependent kinase substrate 1 (P1),TPSPKEEDEEPESPPEK,EEDEEPESPPEKKTS,Q9H1E3,NUCKS1,T(1): 0.0;S(3): 0.0;S(13): 100.0,Q9H1E3,S13(Phospho),1
0,0.14,0.74,0.86,0.09,0.00,0.71,0.76,C17(Carbamidomethyl);N-Term(iTRAQ8plex);S13(Phospho),"ERK1,2 kinase substrate motif;GSK-3, ERK1, ERK2, CDK5 substrate motif;MDC1 BRCT domain binding motif;Plk1 PBD domain binding motif;WW domain binding motif",+,0.0002372,25,1,1,13600000,0,5.76,0,3.075766329,Poly(rC)-binding protein 1 (Alpha-CP1) (Heterogeneous nuclear ribonucleoprotein E1) (hnRNP E1) (Nucleic acid-binding protein SUB2.3),VMTIPYQPMPASSPVICAGGQDR,YQPMPASSPVICAGG,Q15365,PCBP1,T(3): 0.0;Y(6): 0.0;S(12): 11.5;S(13): 88.5,Q15365,S13(Phospho),1
0,0.21,-1.63,-1.32,-2.17,-2.22,-2.44,-2.20,C18(Carbamidomethyl);N-Term(iTRAQ8plex);S13(Phospho),G protein-coupled receptor kinase 1 substrate motif;PKA kinase substrate motif;PKC kinase substrate motif,+,0.002433,22,1,1,121000000,0,4.98,1,3.483915834,"Keratin, type II cytoskeletal 5 (58 kDa cytokeratin) (Cytokeratin-5) (CK-5) (Keratin-5) (K5) (Type-II keratin Kb5)",SGGGGGGGFGRVSLAGACGVGGYGSR,GGGFGRVSLAGACGV,P13647,KRT5,S(1): 0.0;S(13): 100.0;Y(23): 0.0;S(25): 0.0,P13647,S13(Phospho),1
0,0.13,-1.83,-1.69,-0.26,-0.20,-0.45,-0.53,K10(iTRAQ8plex);N-Term(iTRAQ8plex);S13(Phospho),"Casein kinase II substrate motif;ERK1,2 kinase substrate motif;GSK-3, ERK1, ERK2, CDK5 substrate motif;PKA kinase substrate motif;PKC kinase substrate motif;WW domain binding motif",+,0.006144,19,1,1,377000000,0,4.87,0,4.177175157,LIM domain and actin-binding protein 1 (Epithelial protein lost in neoplasm),SEVQQPVHPKPLSPDSR,PVHPKPLSPDSRASS,Q9UHB6,LIMA1,S(1): 0.0;S(13): 88.7;S(16): 11.3,Q9UHB6,S13(Phospho),1
0,0.16,0.50,0.51,0.86,1.02,1.14,0.94,K15(iTRAQ8plex);N-Term(iTRAQ8plex);S13(Phospho),"b-Adrenergic Receptor kinase substrate motif;Cdc2 kinase substrate motif;CDK kinase substrate motif;CDK1,2,4,6 kinase substrate motif;ERK1,2 kinase substrate motif;Growth associated histone HI kinase substrate motif;GSK-3, ERK1, ERK2, CDK5 substrate motif;PKA kinase substrate motif;PKC kinase substrate motif;WW domain binding motif",+,3.19E-05,14,1,1,39500000,0,5.62,0,2.602820152,Chromatin complexes subunit BAP18 (BPTF-associated protein of 18 kDa),VYEDSGIPLPAESPK,GIPLPAESPKKGPKK,Q8IXM2,BAP18,Y(2): 0.0;S(5): 0.0;S(13): 100.0,Q8IXM2,S13(Phospho),1
0,0.08,1.02,1.04,-0.55,-0.70,-0.73,-0.67,K15(iTRAQ8plex);N-Term(iTRAQ8plex);S13(Phospho),"14-3-3 domain binding motif;Calmodulin-dependent protein kinase II substrate motif;ERK1,2 kinase substrate motif;G protein-coupled receptor kinase 1 substrate motif;Growth associated histone HI kinase substrate motif;GSK-3, ERK1, ERK2, CDK5 substrate motif;PKA kinase substrate motif;PKC kinase substrate motif;WW domain binding motif",+,0.008197,6,1,1,345000000,0,5.12,1,4.410851978,SH3 domain-binding protein 1 (3BP-1),ERTESEVPPRPASPK,EVPPRPASPKVTRSP,Q9Y3L3,SH3BP1,T(3): 0.0;S(5): 0.0;S(13): 100.0,Q9Y3L3,S13(Phospho),1
0,-0.10,0.18,0.13,0.09,0.00,0.30,0.26,K18(iTRAQ8plex);N-Term(iTRAQ8plex);S13(Phospho),"Casein kinase II substrate motif;ERK1,2 kinase substrate motif;G protein-coupled receptor kinase 1 substrate motif;GSK3 kinase substrate motif;GSK-3, ERK1, ERK2, CDK5 substrate motif;WW domain binding motif",+,8.15E-05,18,1,1,16500000,0,5.85,0,1.875871073,Ataxin-2-like protein (Ataxin-2 domain protein) (Ataxin-2-related protein),EVDGLLTSEPMGSPVSSK,LTSEPMGSPVSSKTE,Q8WWM7,ATXN2L,T(7): 0.0;S(8): 0.0;S(13): 98.0;S(16): 1.7;S(17): 0.2,Q8WWM7,S13(Phospho),1
0,0.36,0.06,0.21,1.24,1.03,1.80,1.21,K20(iTRAQ8plex);N-Term(iTRAQ8plex);S13(Phospho),Casein kinase II substrate motif,+,0.1981,4,1,1,3150000,0.006134,1.42,0,1.848689237,Forkhead box protein O1 (Forkhead box protein O1A) (Forkhead in rhabdomyosarcoma),ASLQSGQEGAGDSPGSQFSK,KKKASLQSGQEGAGD,Q12778,FOXO1,S(2): 0.1;S(5): 90.4;S(13): 9.3;S(16): 0.1;S(19): 0.0,Q12778,S13(Phospho),1
0,0.01,1.71,0.35,3.02,2.40,2.71,3.07,N-Term(iTRAQ8plex);S13(Phospho),b-Adrenergic Receptor kinase substrate motif;Casein kinase I substrate motif;G protein-coupled receptor kinase 1 substrate motif;PKA kinase substrate motif;PKC kinase substrate motif,+,0.197,2,1,1,0,0.007012,2.81,1,1.803211237,Protein phosphatase 1 regulatory subunit 12B (Myosin phosphatase-targeting subunit 2) (Myosin phosphatase target subunit 2),SYLTPVRDEEAESLR,VRDEEAESLRKARSR,O60237,PPP1R12B,S(1): 0.0;Y(2): 0.0;T(4): 0.0;S(13): 100.0,O60237,S13(Phospho),1
0,0.68,-0.47,-0.23,0.02,0.00,-1.76,-1.53,N-Term(iTRAQ8plex);S13(Phospho),b-Adrenergic Receptor kinase substrate motif;Casein kinase I substrate motif;Casein kinase II substrate motif;Pyruvate dehydrogenase kinase substrate motif,+,0.02569,4,1,1,14500000,0,4.11,1,2.180346161,Chromatin accessibility complex protein 1 (CHRAC-1) (Chromatin accessibility complex 15 kDa protein) (CHRAC-15) (HuCHRAC15) (DNA polymerase epsilon subunit p15),REEDEENDNDNESDHDEADS,ENDNDNESDHDEADS,Q9NRG0,CHRAC1,S(13): 99.9;S(20): 0.1,Q9NRG0,S13(Phospho),1
0,0.68,-1.97,-2.05,0.06,0.56,-0.18,-0.37,N-Term(iTRAQ8plex);S13(Phospho),"Casein kinase II substrate motif;Cdc2 kinase substrate motif;CDK kinase substrate motif;CDK1,2,4,6 kinase substrate motif;ERK1,2 kinase substrate motif;G protein-coupled receptor kinase 1 substrate motif;GSK3 kinase substrate motif;GSK-3, ERK1, ERK2, CDK5 substrate motif;MAPKAPK2 kinase substrate motif;WW domain binding motif",+,0.0001066,56,1,1,1750000000,0,6.3,0,2.353186136,Bcl-2-associated transcription factor 1 (Btf),NTPSQHSHSIQHSPER,HSHSIQHSPERSGSG,Q9NYF8,BCLAF1,T(2): 0.0;S(4): 0.0;S(7): 0.0;S(9): 0.0;S(13): 100.0,Q9NYF8,S13(Phospho),1
0,0.01,-0.74,-0.42,0.46,0.37,0.09,0.22,K15(iTRAQ8plex);K19(iTRAQ8plex);N-Term(iTRAQ8plex);S14(Phospho),Casein kinase II substrate motif;MAPKAPK2 kinase substrate motif;Pyruvate dehydrogenase kinase substrate motif,+,0.03352,16,1,1,0,0,3.14,1,2.252228241,Neuroblast differentiation-associated protein AHNAK (Desmoyokin),GGVTGSPEASISGSKGDLK,PEASISGSKGDLKSS,Q09666,AHNAK,T(4): 0.0;S(6): 0.0;S(10): 3.6;S(12): 3.6;S(14): 92.6,Q09666,S14(Phospho),1
0,-0.03,-2.40,-2.05,0.16,-0.27,-0.84,-0.47,K18(iTRAQ8plex);N-Term(iTRAQ8plex);S14(Phospho),b-Adrenergic Receptor kinase substrate motif;Casein kinase I substrate motif;Casein kinase II substrate motif,+,0.003405,18,1,1,16800000,0,3.54,0,2.690351901,H/ACA ribonucleoprotein complex subunit 4 (EC 5.4.99.-) (CBF5 homolog) (Dyskerin) (Nopp140-associated protein of 57 kDa) (Nucleolar protein NAP57) (Nucleolar protein family A member 4) (snoRNP protein DKC1),AGLESGAEPGDGDSDTTK,AEPGDGDSDTTKKKK,O60832,DKC1,S(5): 0.0;S(14): 47.8;T(16): 47.8;T(17): 4.4,O60832,S14(Phospho),1
0,-0.32,-2.09,-1.93,0.69,0.59,-0.08,0.17,K22(iTRAQ8plex);N-Term(iTRAQ8plex);S14(Phospho),"DNA dependent Protein kinase substrate motif;ERK1,2 kinase substrate motif;GSK-3, ERK1, ERK2, CDK5 substrate motif;WW domain binding motif",+,8.18E-06,2,1,1,681000,0,5.28,0,3.547963989,Intersectin-1 (SH3 domain-containing protein 1A) (SH3P17),SAFTPATATGSSPSPVLGQGEK,TATGSSPSPVLGQGE,Q15811,ITSN1,S(1): 0.0;T(4): 0.0;T(7): 0.0;T(9): 0.0;S(11): 0.0;S(12): 0.0;S(14): 100.0,Q15811,S14(Phospho),1
0,-0.03,-2.01,-2.71,0.84,0.47,-0.02,0.12,K22(iTRAQ8plex);N-Term(iTRAQ8plex);S14(Phospho),"Casein kinase II substrate motif;ERK1,2 kinase substrate motif;GSK-3, ERK1, ERK2, CDK5 substrate motif;WW domain binding motif",+,0.0001253,2,1,1,812000,0,4.89,0,2.781055733,Kinectin (CG-1 antigen) (Kinesin receptor),AAGDTTVIENSDVSPETESSEK,VIENSDVSPETESSE,Q86UP2,KTN1,T(5): 0.0;T(6): 0.0;S(11): 0.0;S(14): 100.0;T(17): 0.0;S(19): 0.0;S(20): 0.0,Q86UP2,S14(Phospho),1
0,0.36,-0.73,-1.19,-0.35,-0.29,0.52,0.37,K24(iTRAQ8plex);N-Term(iTRAQ8plex);S14(Phospho),b-Adrenergic Receptor kinase substrate motif;Casein kinase I substrate motif;Casein kinase II substrate motif;G protein-coupled receptor kinase 1 substrate motif,+,0.001079,4,1,1,752000,0,5.39,0,1.986629875,PEST proteolytic signal-containing nuclear protein (PCNP) (PEST-containing nuclear protein),TLSVAAAFNEDEDSEPEEMPPEAK,AFNEDEDSEPEEMPP,Q8WW12,PCNP,T(1): 0.0;S(3): 0.0;S(14): 100.0,Q8WW12,S14(Phospho),1
0,0.09,-2.41,-1.92,-0.22,-0.52,-1.65,-1.29,K3(iTRAQ8plex);N-Term(iTRAQ8plex);S14(Phospho),b-Adrenergic Receptor kinase substrate motif;Casein kinase II substrate motif,+,0.01338,8,1,1,3620000,0,4.25,1,2.602877411,High mobility group protein HMG-I/HMG-Y (HMG-I(Y)) (High mobility group AT-hook protein 1) (High mobility group protein A1) (High mobility group protein R),LEKEEEEGISQESSEEEQ,EEGISQESSEEEQ__,P17096,HMGA1,S(10): 0.1;S(13): 49.9;S(14): 49.9,P17096,S14(Phospho),1
0,0.05,0.33,0.44,0.47,0.36,0.52,0.51,N-Term(iTRAQ8plex);S14(Phospho),"ERK1,2 kinase substrate motif;Growth associated histone HI kinase substrate motif;GSK-3, ERK1, ERK2, CDK5 substrate motif;PKA kinase substrate motif;PKC kinase substrate motif;WW domain binding motif",+,0.0008405,64,1,1,986000000,0,5.4,0,2.423669953,Tensin-4 (C-terminal tensin-like protein),ASSPHGLGSPLVASPR,LGSPLVASPRLEKRL,Q8IZW8,TNS4,S(2): 0.0;S(3): 0.0;S(9): 0.0;S(14): 100.0,Q8IZW8,S14(Phospho),1
0,0.02,1.17,1.18,0.50,0.74,1.16,1.03,N-Term(iTRAQ8plex);S14(Phospho),b-Adrenergic Receptor kinase substrate motif;Casein kinase I substrate motif,+,0.08196,2,1,1,420000,0,3.2,0,3.052044365,Osteoclast-stimulating factor 1,TLSNAEDYLDDEDSD,DYLDDEDSD______,Q92882,OSTF1,T(1): 0.0;S(3): 0.0;Y(8): 0.0;S(14): 100.0,Q92882,S14(Phospho),1
0,0.10,-1.00,-1.12,0.08,0.24,-0.33,-0.42,N-Term(iTRAQ8plex);S14(Phospho),Casein kinase I substrate motif;Casein kinase II substrate motif;DNA dependent Protein kinase substrate motif;G protein-coupled receptor kinase 1 substrate motif,+,0.01322,12,1,1,72600000,0,4.69,1,3.354436368,"RNA-binding motif protein, X-linked 2",ADREVQAEQPSSSSPR,EVQAEQPSSSSPRRK,Q9Y388,RBMX2,S(11): 5.0;S(12): 45.0;S(13): 5.0;S(14): 45.0,Q9Y388,S14(Phospho),1
0,0.03,-3.07,-3.20,0.00,-0.28,-1.22,-1.29,K22(iTRAQ8plex);M20(Oxidation);S15(Phospho),Casein kinase II substrate motif;MAPKAPK2 kinase substrate motif,+,0.08802,2,2,1,0,0.002391,2.46,0,4.527538802,Protein FAM182B,SLPGPHPGGVSAPQSASQLMVK,GGVSAPQSASQLMVK,Q5T319,FAM182B,S(1): 1.0;S(11): 5.8;S(15): 80.5;S(17): 12.7,Q5T319,S15(Phospho),1
0,-0.15,1.03,1.41,0.13,0.47,0.47,0.60,C12(Carbamidomethyl);N-Term(iTRAQ8plex);S15(Phospho),"Cdc2 kinase substrate motif;CDK kinase substrate motif;CDK1,2,4,6 kinase substrate motif;ERK1,2 kinase substrate motif;GSK-3, ERK1, ERK2, CDK5 substrate motif;WW domain binding motif",+,0.007384,14,1,1,678000,0,3.13,1,1.970964159,"Cytoplasmic dynein 1 light intermediate chain 2 (Dynein light intermediate chain 2, cytosolic) (LIC-2) (LIC53/55)",DFQDYMEPEEGCQGSPQRR,PEEGCQGSPQRRGPL,O43237,DYNC1LI2,Y(5): 0.0;S(15): 100.0,O43237,S15(Phospho),1
0,0.01,-0.79,-0.66,-0.80,-0.81,-0.76,-0.93,K17(iTRAQ8plex);N-Term(iTRAQ8plex);S15(Phospho),MDC1 BRCT domain binding motif;PKA kinase substrate motif;PKC kinase substrate motif;Plk1 PBD domain binding motif,+,1.87E-06,140,1,1,252000000,0,6.28,0,2.996355621,"Keratin, type II cytoskeletal 5 (58 kDa cytokeratin) (Cytokeratin-5) (CK-5) (Keratin-5) (K5) (Type-II keratin Kb5)",GLGVGFGSGGGSSSSVK,SGGGSSSSVKFVSTT,P13647,KRT5,S(8): 0.0;S(12): 0.0;S(13): 0.0;S(14): 0.0;S(15): 100.0,P13647,S15(Phospho),1
0,-0.13,0.75,0.80,0.36,0.37,0.61,0.60,K18(iTRAQ8plex);N-Term(iTRAQ8plex);S15(Phospho),"Cdc2 kinase substrate motif;CDK kinase substrate motif;CDK1,2,4,6 kinase substrate motif;ERK1,2 kinase substrate motif;GSK-3, ERK1, ERK2, CDK5 substrate motif;WW domain binding motif",+,0.007052,10,1,1,32800000,0,4.38,0,3.605497984,Ribonucleoside-diphosphate reductase subunit M2 (EC 1.17.4.1) (Ribonucleotide reductase small chain) (Ribonucleotide reductase small subunit),VPLAPITDPQQLQLSPLK,DPQQLQLSPLKGLSL,P31350,RRM2,,P31350,S15(Phospho),1
0,-0.04,0.58,0.73,0.33,0.40,0.03,-0.11,K18(iTRAQ8plex);N-Term(iTRAQ8plex);S15(Phospho),"Casein kinase I substrate motif;Cdc2 kinase substrate motif;CDK kinase substrate motif;CDK1,2,4,6 kinase substrate motif;ERK1,2 kinase substrate motif;G protein-coupled receptor kinase 1 substrate motif;GSK-3, ERK1, ERK2, CDK5 substrate motif;WW domain binding motif",+,0.007636,2,1,1,1490000,0,3.17,0,2.600061551,UNC119-binding protein C5orf30,STLTTLPFPGAEANSPGK,FPGAEANSPGKAEAE,Q96GV9,C5orf30,S(1): 0.0;T(2): 0.0;T(4): 0.0;T(5): 0.0;S(15): 100.0,Q96GV9,S15(Phospho),1
0,0.67,1.11,1.31,1.92,1.88,1.60,1.34,K19(iTRAQ8plex);N-Term(iTRAQ8plex);S15(Phospho),"Casein kinase II substrate motif;ERK1,2 kinase substrate motif;GSK-3, ERK1, ERK2, CDK5 substrate motif;Pyruvate dehydrogenase kinase substrate motif;WW domain binding motif",+,0.01538,4,1,1,2140000,0,3.94,0,1.780122464,Microtubule-associated protein 1B (MAP-1B) [Cleaved into: MAP1B heavy chain;MAP1 light chain LC1],ASVSPMDEPVPDSESPIEK,ENERASVSPMDEPVP,P46821,MAP1B,S(2): 0.0;S(4): 0.0;S(13): 13.9;S(15): 86.1,P46821,S15(Phospho),1
0,0.07,-1.17,-1.39,0.06,-0.30,-0.28,-0.41,N-Term(iTRAQ8plex);S15(Phospho),Casein kinase II substrate motif,+,1.31E-05,28,1,1,79300000,0,5.68,0,2.393319353,Catenin delta-1 (Cadherin-associated Src substrate) (CAS) (p120 catenin) (p120(ctn)) (p120(cas)),HYEDGYPGGSDNYGSLSR,GGSDNYGSLSRVTRI,O60716,CTNND1,Y(2): 0.0;Y(6): 0.0;S(10): 0.0;Y(13): 0.2;S(15): 88.8;S(17): 11.0,O60716,S15(Phospho),1
0,0.11,0.39,0.43,1.15,1.14,1.63,1.55,N-Term(iTRAQ8plex);S15(Phospho),G protein-coupled receptor kinase 1 substrate motif;GSK3 kinase substrate motif;MAPKAPK2 kinase substrate motif;PKA kinase substrate motif;PKC kinase substrate motif,+,0.00464,453,1,1,2260000000,0,5.79,0,4.663145057,PDZ and LIM domain protein 4 (LIM protein RIL) (Reversion-induced LIM protein),IHIDPEIQDGSPTTSR,QDGSPTTSRRPSGTG,P50479,PDLIM4,S(11): 0.1;T(13): 0.6;T(14): 0.6;S(15): 98.7,P50479,S15(Phospho),1
0,0.22,1.40,1.86,0.91,0.73,0.52,0.75,N-Term(iTRAQ8plex);S15(Phospho),"Cdc2 kinase substrate motif;CDK kinase substrate motif;CDK1,2,4,6 kinase substrate motif;ERK1,2 kinase substrate motif;GSK-3, ERK1, ERK2, CDK5 substrate motif;WW domain binding motif",+,0.0007975,14,1,1,1890000,0,5.66,1,2.089642551,"Cytoplasmic dynein 1 light intermediate chain 1 (LIC1) (Dynein light chain A) (DLC-A) (Dynein light intermediate chain 1, cytosolic)",DFQEYVEPGEDFPASPQRR,PGEDFPASPQRRNTA,Q9Y6G9,DYNC1LI1,Y(5): 0.0;S(15): 100.0,Q9Y6G9,S15(Phospho),1
0,-0.27,-1.11,-0.92,1.46,1.27,0.90,1.02,C3(Carbamidomethyl);K20(iTRAQ8plex);N-Term(iTRAQ8plex);S16(Phospho),"Casein kinase II substrate motif;ERK1,2 kinase substrate motif;GSK-3, ERK1, ERK2, CDK5 substrate motif;WW domain binding motif",+,0.03434,2,1,1,362000,0,2.67,0,3.624630559,A-kinase anchor protein 12 (AKAP-12) (A-kinase anchor protein 250 kDa) (AKAP 250) (Gravin) (Myasthenia gravis autoantigen),ETCVSGEDPTQGADLSPDEK,PTQGADLSPDEKVLS,Q02952,AKAP12,T(2): 0.0;S(5): 0.0;T(10): 0.0;S(16): 100.0,Q02952,S16(Phospho),1
0,0.08,1.05,0.85,-0.96,-1.05,-1.43,-1.48,C7(Carbamidomethyl);K24(iTRAQ8plex);N-Term(iTRAQ8plex);S16(Phospho),G protein-coupled receptor kinase 1 substrate motif;PKA kinase substrate motif;PKC kinase substrate motif,+,2.48E-05,4,1,1,0,0,6.44,1,4.54360881,"Keratin, type II cytoskeletal 5 (58 kDa cytokeratin) (Cytokeratin-5) (CK-5) (Keratin-5) (K5) (Type-II keratin Kb5)",VSLAGACGVGGYGSRSLYNLGGSK,GGGFGRVSLAGACGV,P13647,KRT5,,P13647,S16(Phospho),1
0,0.26,-0.49,-0.60,-0.43,-0.48,-0.01,-0.03,K19(iTRAQ8plex);N-Term(iTRAQ8plex);S16(Phospho),"Cdc2 kinase substrate motif;CDK kinase substrate motif;CDK1,2,4,6 kinase substrate motif;ERK1,2 kinase substrate motif;GSK-3, ERK1, ERK2, CDK5 substrate motif;WW domain binding motif",+,0.00016,107,1,1,430000000,0,7.95,0,2.160685945,Nucleophosmin (NPM) (Nucleolar phosphoprotein B23) (Nucleolar protein NO38) (Numatrin),DELHIVEAEAMNYEGSPIK,EAMNYEGSPIKVTLA,P06748,NPM1,Y(13): 0.0;S(16): 100.0,P06748,S16(Phospho),1
0,0.28,-2.69,-2.04,0.40,0.27,-0.05,0.01,K19(iTRAQ8plex);N-Term(iTRAQ8plex);S16(Phospho),Casein kinase II substrate motif,+,0.03407,8,1,1,164000000,0,2.52,0,2.903567034,"Myristoylated alanine-rich C-kinase substrate (MARCKS) (Protein kinase C substrate, 80 kDa protein, light chain) (80K-L protein) (PKCSL)",GEAAAERPGEAAVASSPSK,PGEAAVASSPSKANG,P29966,MARCKS,S(15): 14.1;S(16): 85.4;S(18): 0.5,P29966,S16(Phospho),1
0,-0.06,-1.86,-1.59,0.06,0.19,-0.77,-0.28,K19(iTRAQ8plex);N-Term(iTRAQ8plex);S16(Phospho),"Cdc2 kinase substrate motif;CDK kinase substrate motif;CDK1,2,4,6 kinase substrate motif;ERK1,2 kinase substrate motif;Growth associated histone HI kinase substrate motif;GSK-3, ERK1, ERK2, CDK5 substrate motif;MDC1 BRCT domain binding motif;Plk1 PBD domain binding motif;WW domain binding motif",+,0.01985,4,1,1,0,0,2.57,0,2.545074157,"Spectrin beta chain, non-erythrocytic 1 (Beta-II spectrin) (Fodrin beta chain) (Spectrin, non-erythroid beta chain 1)",AQTLPTSVVTITSESSPGK,VTITSESSPGKREKD,Q01082,SPTBN1,T(3): 0.1;T(6): 3.4;S(7): 12.9;T(10): 12.9;T(12): 0.9;S(13): 3.4;S(15): 12.9;S(16): 53.5,Q01082,S16(Phospho),1
0,0.12,-1.27,-0.99,-0.04,0.12,0.19,0.17,K21(iTRAQ8plex);N-Term(iTRAQ8plex);S16(Phospho),"ERK1,2 kinase substrate motif;G protein-coupled receptor kinase 1 substrate motif;GSK3 kinase substrate motif;GSK-3, ERK1, ERK2, CDK5 substrate motif;MDC1 BRCT domain binding motif;Plk1 PBD domain binding motif;WW domain binding motif",+,1.96E-05,69,1,1,27700000,0,7.85,0,2.916859813,Ubiquitin-associated protein 2-like (Protein NICE-4),SPAVATSTAAPPPPSSPLPSK,AAPPPPSSPLPSKST,Q14157,UBAP2L,S(1): 0.0;T(6): 0.0;S(7): 0.0;T(8): 0.0;S(15): 1.1;S(16): 89.0;S(20): 9.8,Q14157,S16(Phospho),1
0,-0.04,NaN,-2.04,0.69,0.40,-1.00,-0.87,K22(iTRAQ8plex);N-Term(iTRAQ8plex);S16(Phospho),Casein kinase II substrate motif;G protein-coupled receptor kinase 1 substrate motif;GSK3 kinase substrate motif,+,0.0002808,2,1,1,355000,0,4.73,0,2.462630689,Fragile X mental retardation syndrome-related protein 2,TGGPAYGPSSDVSTASETESEK,SSDVSTASETESEKR,P51116,FXR2,T(1): 0.0;Y(6): 0.0;S(9): 0.0;S(10): 0.0;S(13): 0.0;T(14): 0.0;S(16): 88.1;T(18): 11.6;S(20): 0.2,P51116,S16(Phospho),1
0,0.25,-0.18,-0.41,-0.15,-0.12,1.28,1.16,K5(iTRAQ8plex);N-Term(iTRAQ8plex);S16(Phospho),"ERK1,2 kinase substrate motif;G protein-coupled receptor kinase 1 substrate motif;Growth associated histone HI kinase substrate motif;GSK3 kinase substrate motif;GSK-3, ERK1, ERK2, CDK5 substrate motif;MDC1 BRCT domain binding motif;PKA kinase substrate motif;PKC kinase substrate motif;Plk1 PBD domain binding motif;WW domain binding motif",+,0.01786,79,1,1,874000000,0,5.74,1,3.018806833,Heterogeneous nuclear ribonucleoprotein D0 (hnRNP D0) (AU-rich element RNA-binding protein 1),IDASKNEEDEGHSNSSPR,DEGHSNSSPRHSEAA,Q14103,HNRNPD,S(4): 0.0;S(13): 0.0;S(15): 10.2;S(16): 89.8,Q14103,S16(Phospho),1
0,0.06,1.00,1.43,0.56,0.34,0.46,0.66,K19(iTRAQ8plex);S16(Phospho),G protein-coupled receptor kinase 1 substrate motif;GSK3 kinase substrate motif,+,0.1642,2,1,1,136000,0.006047,3.02,0,1.847692713,DNA primase small subunit (EC 2.7.7.-) (DNA primase 49 kDa subunit) (p49),ILALVPETIHDELQQSFQK,IHDELQQSFQKSHNS,P49642,PRIM1,T(8): 0.1;S(16): 99.9,P49642,S16(Phospho),1
0,0.03,0.74,0.70,-0.37,-0.12,0.88,0.78,N-Term(iTRAQ8plex);S16(Phospho),b-Adrenergic Receptor kinase substrate motif;Casein kinase II substrate motif;G protein-coupled receptor kinase 1 substrate motif;GSK3 kinase substrate motif;MAPKAPK2 kinase substrate motif;PKA kinase substrate motif;PKC kinase substrate motif;Pyruvate dehydrogenase kinase substrate motif,+,0.008414,33,1,1,316000,0,4.65,1,3.016983151,Eukaryotic translation initiation factor 6 (eIF-6) (B(2)GCN homolog) (B4 integrin interactor) (CAB) (p27(BBP)),LNEAQPSTIATSMRDSLIDSLT,IATSMRDSLIDSLT_,P56537,EIF6,S(7): 0.0;T(8): 0.0;T(11): 1.6;S(12): 0.5;S(16): 97.2;S(20): 0.5;T(22): 0.1,P56537,S16(Phospho),1
0,0.16,0.73,0.60,0.48,0.46,0.57,0.51,N-Term(iTRAQ8plex);S16(Phospho),Casein kinase I substrate motif;G protein-coupled receptor kinase 1 substrate motif;GSK3 kinase substrate motif;PKA kinase substrate motif;PKC kinase substrate motif,+,0.0306,7,1,1,14800000,0.0006395,5.11,1,2.251104004,Protein EFR3 homolog A (Protein EFR3-like),LSVPYVPQVTDEDRLSR,VTDEDRLSRRKSIVD,Q14156,EFR3A,S(2): 0.0;Y(5): 0.0;T(10): 0.4;S(16): 99.6,Q14156,S16(Phospho),1
0,0.10,-1.53,-1.64,-0.65,-0.55,0.97,0.92,N-Term(iTRAQ8plex);S16(Phospho),14-3-3 domain binding motif;ATM kinase substrate motif;b-Adrenergic Receptor kinase substrate motif;Calmodulin-dependent protein kinase II substrate motif;DNA dependent Protein kinase substrate motif;G protein-coupled receptor kinase 1 substrate motif;GSK3 kinase substrate motif;PAK2 kinase substrate motif;PKA kinase substrate motif;PKC epsilon kinase substrate motif;PKC kinase substrate motif,+,0.003745,20,1,1,1180000000,0,5.42,2,4.894562633,LIM and SH3 domain protein 1 (LASP-1) (Metastatic lymph node gene 50 protein) (MLN 50),MGPSGGEGMEPERRDSQDGSSYR,MEPERRDSQDGSSYR,Q14847,LASP1,S(4): 0.4;S(16): 98.5;S(20): 0.4;S(21): 0.4;Y(22): 0.4,Q14847,S16(Phospho),1
0,-0.18,-1.33,-1.46,-0.16,-0.39,-0.64,-0.44,N-Term(iTRAQ8plex);S16(Phospho),Casein kinase I substrate motif,+,0.1538,4,1,1,0,0,2.68,2,2.644012372,Structural maintenance of chromosomes protein 4 (SMC protein 4) (SMC-4) (Chromosome-associated polypeptide C) (hCAP-C) (XCAP-C homolog),RREEGPPPPSPDGASSDAEPEPPSGR,PPSPDGASSDAEPEP,Q9NTJ3,SMC4,,Q9NTJ3,S16(Phospho),1
0,0.47,-1.73,-2.14,-1.05,-0.66,-0.62,-0.92,K6(iTRAQ8plex);N-Term(iTRAQ8plex);S17(Phospho),b-Adrenergic Receptor kinase substrate motif;Casein kinase I substrate motif;Casein kinase II substrate motif;Pyruvate dehydrogenase kinase substrate motif,+,0.003351,4,1,1,4470000,0,6.55,1,2.138844822,"Methylosome subunit pICln (Chloride channel, nucleotide sensitive 1A) (Chloride conductance regulatory protein ICln) (I(Cln)) (Chloride ion current inducer protein) (ClCI) (Reticulocyte pICln)",FEEESKEPVADEEEEDSDDDVEPITEFR,ADEEEEDSDDDVEPI,P54105,CLNS1A,S(5): 0.0;S(17): 100.0;T(25): 0.0,P54105,S17(Phospho),1
0,0.37,1.42,1.34,0.75,0.77,0.97,0.97,N-Term(iTRAQ8plex);S17(Phospho),DNA dependent Protein kinase substrate motif;G protein-coupled receptor kinase 1 substrate motif,+,0.02861,2,1,1,166000,0,2.63,0,2.413899847,GTP-binding protein 1 (G-protein 1) (GP-1) (GP1),SAMDSPVPASMFAPEPSSPGAAR,SMFAPEPSSPGAARA,O00178,GTPBP1,S(1): 0.0;S(5): 0.1;S(10): 0.7;S(17): 49.6;S(18): 49.6,O00178,S17(Phospho),1
0,0.21,-2.15,-2.25,0.36,-0.14,-0.68,-0.66,N-Term(iTRAQ8plex);S17(Phospho),Casein kinase II substrate motif,+,6.17E-05,2,1,1,2870000,0,5.94,0,3.095726034,La-related protein 1 (La ribonucleoprotein domain family member 1),ESPRPLQLPGAEGPAISDGEEGGGEPGAGGGAAGAAGAGR,GAEGPAISDGEEGGG,Q6PKG0,LARP1,S(2): 0.0;S(17): 100.0,Q6PKG0,S17(Phospho),1
0,0.07,-0.52,-0.45,-0.29,-0.21,-0.25,-0.25,N-Term(iTRAQ8plex);S17(Phospho),"Casein kinase I substrate motif;Casein kinase II substrate motif;ERK1,2 kinase substrate motif;GSK-3, ERK1, ERK2, CDK5 substrate motif;WW domain binding motif",+,0.007655,23,1,1,93800000,0,5.44,1,2.821347978,Coiled-coil domain-containing protein 86 (Cytokine-induced protein with coiled-coil domain),ALVEFESNPEETREPGSPPSVQR,EETREPGSPPSVQRA,Q9H6F5,CCDC86,S(7): 0.0;T(12): 2.2;S(17): 95.7;S(20): 2.2,Q9H6F5,S17(Phospho),1
0,0.22,0.74,0.58,-0.61,-0.22,0.67,0.57,N-Term(iTRAQ8plex);S17(Phospho),BARD1 BRCT domain binding motif;Casein kinase II substrate motif;G protein-coupled receptor kinase 1 substrate motif,+,0.0001888,6,1,1,453000,0,6.07,0,2.03469239,Charged multivesicular body protein 3 (Chromatin-modifying protein 3) (Neuroendocrine differentiation factor) (Vacuolar protein sorting-associated protein 24) (hVps24),VTDALPEPEPPGAMAASEDEEEEEEALEAMQSR,PPGAMAASEDEEEEE,Q9Y3E7,CHMP3,T(2): 0.0;S(17): 100.0;S(32): 0.0,Q9Y3E7,S17(Phospho),1
0,0.31,1.73,1.53,0.76,0.27,-0.29,-0.18,C26(Carbamidomethyl);C6(Carbamidomethyl);K12(iTRAQ8plex);K27(iTRAQ8plex);S18(Phospho),MAPKAPK2 kinase substrate motif,+,0.179,2,1,1,0,0.005849,2.23,2,2.369885846,Retrotransposon gag domain-containing protein 1 (Tumor antigen BJ-HCC-23),SLYTECQLAEEKDSPGNSSQVLPTACKR,EKDSPGNSSQVLPTA,Q8NET4,RGAG1,S(1): 8.4;Y(3): 8.5;T(4): 8.5;S(14): 13.7;S(18): 20.3;S(19): 20.3;T(24): 20.3,Q8NET4,S18(Phospho),1
0,0.10,2.79,2.78,1.79,1.23,0.82,0.97,K14(iTRAQ8plex);K19(iTRAQ8plex);N-Term(iTRAQ8plex);S18(Phospho),Casein kinase II substrate motif;G protein-coupled receptor kinase 1 substrate motif;PKA kinase substrate motif;PKC kinase substrate motif,+,0.1236,4,1,1,5500000,0.003056,1.95,1,3.093739219,EH domain-containing protein 2 (PAST homolog 2),YDEIFYNLAPADGKLSGSK,APADGKLSGSKAKTW,Q9NZN4,EHD2,Y(1): 0.0;Y(6): 0.0;S(16): 50.0;S(18): 50.0,Q9NZN4,S18(Phospho),1
0,0.14,-0.99,-1.22,-0.09,0.16,-0.13,-0.26,K20(iTRAQ8plex);N-Term(iTRAQ8plex);S18(Phospho),"Casein kinase I substrate motif;Casein kinase II substrate motif;ERK1,2 kinase substrate motif;G protein-coupled receptor kinase 1 substrate motif;Growth associated histone HI kinase substrate motif;GSK3 kinase substrate motif;GSK-3, ERK1, ERK2, CDK5 substrate motif;PKA kinase substrate motif;PKC kinase substrate motif;WW domain binding motif",+,0.1376,4,1,1,57800000,0.007344,2.61,0,2.555832594,Opioid growth factor receptor (OGFr) (Protein 7-60) (Zeta-type opioid receptor),SQGDEAGGHGEDRPEPLSPK,EDRPEPLSPKESKKR,Q9NZT2,OGFR,S(1): 74.8;S(18): 25.2,Q9NZT2,S18(Phospho),1
0,0.09,-1.87,-1.58,0.10,0.09,-0.58,-0.37,K23(iTRAQ8plex);N-Term(iTRAQ8plex);S18(Phospho),"Casein kinase II substrate motif;ERK1,2 kinase substrate motif;G protein-coupled receptor kinase 1 substrate motif;GSK3 kinase substrate motif;GSK-3, ERK1, ERK2, CDK5 substrate motif;Pyruvate dehydrogenase kinase substrate motif;WW domain binding motif",+,7.89E-05,2,1,1,541000,0,4.46,0,3.330060295,"Splicing factor, arginine/serine-rich 19 (SR-related and CTD-associated factor 1) (SR-related-CTD-associated factor) (SCAF) (Serine arginine-rich pre-mRNA splicing factor SR-A1) (SR-A1)",EAASSSSGTQPAPPAPASPWDSK,PAPPAPASPWDSKKH,Q9H7N4,SCAF1,S(4): 0.0;S(5): 0.0;S(6): 0.0;S(7): 0.0;T(9): 0.0;S(18): 100.0;S(22): 0.0,Q9H7N4,S18(Phospho),1
0,-0.06,-3.40,-3.09,-0.27,-0.55,-1.35,-1.20,K25(iTRAQ8plex);N-Term(iTRAQ8plex);S18(Phospho),Casein kinase I substrate motif;Casein kinase II substrate motif;G protein-coupled receptor kinase 1 substrate motif;MAPKAPK2 kinase substrate motif,+,0.0006447,6,1,1,11400000,0,5.88,0,3.908475585,Nucleosome assembly protein 1-like 4 (Nucleosome assembly protein 2) (NAP-2),EFITGDVEPTDAESEWHSENEEEEK,DAESEWHSENEEEEK,Q99733,NAP1L4,T(4): 0.0;T(10): 0.0;S(14): 0.0;S(18): 100.0,Q99733,S18(Phospho),1
0,0.00,-1.49,-1.45,-1.75,-1.85,-1.73,-1.78,N-Term(iTRAQ8plex);S18(Phospho),G protein-coupled receptor kinase 1 substrate motif;GSK3 kinase substrate motif;MDC1 BRCT domain binding motif;Plk1 PBD domain binding motif,+,0.0007218,216,1,1,305000000,0,6.89,0,5.319223659,"Keratin, type I cytoskeletal 14 (Cytokeratin-14) (CK-14) (Keratin-14) (K14)",LLEGEDAHLSSSQFSSGSQSSR,GEDAHLSSSQFSSGS,P02533,KRT14,S(10): 0.0;S(11): 0.0;S(12): 0.0;S(15): 0.5;S(16): 6.6;S(18): 92.8;S(20): 0.0;S(21): 0.0,P02533,S18(Phospho),1
0,0.27,1.00,1.15,0.67,0.78,0.80,1.13,N-Term(iTRAQ8plex);S18(Phospho),"ERK1,2 kinase substrate motif;Growth associated histone HI kinase substrate motif;GSK-3, ERK1, ERK2, CDK5 substrate motif;PKA kinase substrate motif;PKC kinase substrate motif;WW domain binding motif",+,0.03853,6,1,1,118000,0,3.67,0,1.793801736,Protein phosphatase 1 regulatory subunit 35,APVPEPGLDLSLSPRPDSPQPR,PGLDLSLSPRPDSPQ,Q8TAP8,PPP1R35,S(11): 5.8;S(13): 47.1;S(18): 47.1,Q8TAP8,S18(Phospho),1
0,0.09,0.71,0.52,-0.47,-0.29,0.60,0.61,K1(iTRAQ8plex);K26(iTRAQ8plex);N-Term(iTRAQ8plex);S19(Phospho),Casein kinase II substrate motif,+,3.86E-07,12,1,1,105000000,0,6.18,2,2.850644184,Elongation factor 1-delta (EF-1-delta) (Antigen NY-CO-4),KPATPAEDDEDDDIDLFGSDNEEEDKEAAQLREER,DDIDLFGSDNEEEDK,P29692,EEF1D,T(4): 0.0;S(19): 100.0,P29692,S19(Phospho),1
0,0.08,1.78,1.85,0.51,0.22,0.85,0.73,K29(iTRAQ8plex);K9(iTRAQ8plex);N-Term(iTRAQ8plex);S19(Phospho),,+,0.1201,2,1,1,0,0.002391,3.08,2,3.378464367,Elongator complex protein 4 (hELP4) (PAX6 neighbor gene protein),FGHYYDASKRMPQELIEASNWHGFFLPEK,PQELIEASNWHGFFL,Q96EB1,ELP4,Y(4): 10.0;Y(5): 10.0;S(8): 10.0;S(19): 69.9,Q96EB1,S19(Phospho),1
0,-0.09,-0.87,-0.77,-0.38,-0.49,-0.49,-0.59,N-Term(iTRAQ8plex);S19(Phospho),ATM kinase substrate motif;Casein kinase II substrate motif;DNA dependent Protein kinase substrate motif,+,0.01882,106,1,1,151000000,0,5.57,1,2.752866129,"Keratin, type I cytoskeletal 14 (Cytokeratin-14) (CK-14) (Keratin-14) (K14)",RLLEGEDAHLSSSQFSSGSQSSR,SSQFSSGSQSSRDVT,P02533,KRT14,S(11): 0.0;S(12): 0.0;S(13): 0.0;S(16): 0.1;S(17): 0.4;S(19): 99.2;S(21): 0.4;S(22): 0.1,P02533,S19(Phospho),1
0,-0.02,-0.58,-0.37,0.20,0.28,0.08,0.22,N-Term(iTRAQ8plex);S19(Phospho),Casein kinase I substrate motif;DNA dependent Protein kinase substrate motif,+,0.0003861,4,1,1,15000000,0,5.15,0,2.264594081,Insulin receptor substrate 2 (IRS-2),SSEGGVGVGPGGGDEPPTSPR,GGGDEPPTSPRQLQP,Q9Y4H2,IRS2,S(1): 0.0;S(2): 0.0;T(18): 50.0;S(19): 50.0,Q9Y4H2,S19(Phospho),1
0,0.14,0.48,0.48,0.41,0.48,0.99,0.97,K1(iTRAQ8plex);K12(iTRAQ8plex);N-Term(iTRAQ8plex);S2(Phospho),"14-3-3 domain binding motif;Calmodulin-dependent protein kinase II substrate motif;Casein kinase II substrate motif;ERK1,2 kinase substrate motif;Growth associated histone HI kinase substrate motif;GSK-3, ERK1, ERK2, CDK5 substrate motif;PKA kinase substrate motif;PKC epsilon kinase substrate motif;PKC kinase substrate motif;WW domain binding motif",+,0.02569,20,1,1,53900000,0,4.26,1,3.432983633,NSFL1 cofactor p47 (UBX domain-containing protein 2C) (p97 cofactor p47),KSPNELVDDLFK,VGPPRKKSPNELVDD,Q9UNZ2,NSFL1C,S(2): 100.0,Q9UNZ2,S2(Phospho),1
0,0.01,0.26,0.31,0.07,-0.05,0.52,0.42,K10(iTRAQ8plex);M4(Oxidation);S2(Phospho),PKA kinase substrate motif;PKC kinase substrate motif,+,0.1173,2,2,1,11100000,0.008397,2.47,0,2.487302779,Tyrosine-protein kinase CSK (EC 2.7.10.2) (C-Src kinase) (Protein-tyrosine kinase CYL),LSLMPWFHGK,VKAGTKLSLMPWFHG,P41240,CSK,S(2): 100.0,P41240,S2(Phospho),1
0,0.00,-1.55,-1.54,-1.59,-1.64,-1.52,-1.56,C7(Carbamidomethyl);N-Term(iTRAQ8plex);S2(Phospho),G protein-coupled receptor kinase 1 substrate motif;PKA kinase substrate motif;PKC kinase substrate motif,+,0.01454,59,1,1,154000000,0,4.78,0,6.190546946,"Keratin, type II cytoskeletal 5 (58 kDa cytokeratin) (Cytokeratin-5) (CK-5) (Keratin-5) (K5) (Type-II keratin Kb5)",VSLAGACGVGGYGSR,GGGFGRVSLAGACGV,P13647,KRT5,S(2): 100.0;Y(12): 0.0;S(14): 0.0,P13647,S2(Phospho),1
0,-0.09,-1.73,-1.69,-0.26,-0.56,-0.42,-0.40,K1(iTRAQ8plex);N-Term(iTRAQ8plex);S2(Phospho),"Casein kinase II substrate motif;ERK1,2 kinase substrate motif;Growth associated histone HI kinase substrate motif;GSK-3, ERK1, ERK2, CDK5 substrate motif;PKA kinase substrate motif;PKC kinase substrate motif;WW domain binding motif",+,0.08768,2,1,1,1150000000,0.00264,2.18,1,3.344114313,Thyroid hormone receptor-associated protein 3 (Thyroid hormone receptor-associated protein complex 150 kDa component) (Trap150),KSPEIHR,EAAKNKKSPEIHRRI,Q9Y2W1,THRAP3,S(2): 100.0,Q9Y2W1,S2(Phospho),1
0,0.00,-0.38,-0.35,-0.08,-0.20,-0.78,-0.71,K13(iTRAQ8plex);N-Term(iTRAQ8plex);S2(Phospho),PKA kinase substrate motif;PKC kinase substrate motif,+,0.07125,8,1,1,13100000,0.001645,2.92,0,3.327588855,DNA endonuclease RBBP8 (EC 3.1.-.-) (CtBP-interacting protein) (CtIP) (Retinoblastoma-binding protein 8) (RBBP-8) (Retinoblastoma-interacting protein and myosin-like) (RIM) (Sporulation in the absence of SPO11 protein 2 homolog) (SAE2),VSSPVFGATSSIK,EELPTRVSSPVFGAT,Q99708,RBBP8,S(2): 50.0;S(3): 50.0;T(9): 0.1;S(10): 0.0;S(11): 0.0,Q99708,S2(Phospho),1
0,0.08,0.64,0.51,0.82,0.85,0.76,0.77,K14(iTRAQ8plex);N-Term(iTRAQ8plex);S2(Phospho),14-3-3 domain binding motif;Calmodulin-dependent protein kinase II substrate motif;Casein kinase II substrate motif;MAPKAPK2 kinase substrate motif;Phosphorylase kinase substrate motif;PKA kinase substrate motif;PKC epsilon kinase substrate motif;PKC kinase substrate motif,+,1.17E-05,126,1,1,942000000,0,5.57,0,3.437559232,Triosephosphate isomerase (TIM) (EC 5.3.1.1) (Triose-phosphate isomerase),QSLGELIGTLNAAK,KMNGRKQSLGELIGT,P60174,TPI1,S(2): 100.0;T(9): 0.0,P60174,S2(Phospho),1
0,0.03,-0.01,0.02,0.72,0.57,0.70,0.50,K14(iTRAQ8plex);N-Term(iTRAQ8plex);S2(Phospho),"Casein kinase II substrate motif;ERK1,2 kinase substrate motif;GSK-3, ERK1, ERK2, CDK5 substrate motif;PKA kinase substrate motif;PKC kinase substrate motif;WW domain binding motif",+,0.06913,3,1,1,10600000,0.001183,3.02,0,2.523485626,Tight junction-associated protein 1 (Protein incorporated later into tight junctions) (Tight junction protein 4),GSPEEELPLPAFEK,SLGTARGSPEEELPL,Q5JTD0,TJAP1,S(2): 100.0,Q5JTD0,S2(Phospho),1
0,-0.32,-2.17,-1.96,-0.55,-0.84,-0.71,-0.60,K16(iTRAQ8plex);N-Term(iTRAQ8plex);S2(Phospho),Casein kinase II substrate motif;G protein-coupled receptor kinase 1 substrate motif;GSK3 kinase substrate motif;PKA kinase substrate motif;PKC kinase substrate motif,+,1.31E-06,160,1,1,918000000,0,6.05,0,2.791675778,Prelamin-A/C [Cleaved into: Lamin-A/C (70 kDa lamin) (Renal carcinoma antigen NY-REN-32)],ASSHSSQTQGGGSVTK,QRSRGRASSHSSQTQ,P02545,LMNA,S(2): 89.7;S(3): 10.3;S(5): 0.0;S(6): 0.0;T(8): 0.0;S(13): 0.0;T(15): 0.0,P02545,S2(Phospho),1
0,-0.10,0.14,0.61,0.45,0.49,1.52,1.12,K16(iTRAQ8plex);N-Term(iTRAQ8plex);S2(Phospho),"ERK1,2 kinase substrate motif;GSK-3, ERK1, ERK2, CDK5 substrate motif;MDC1 BRCT domain binding motif;PKA kinase substrate motif;PKC kinase substrate motif;Plk1 PBD domain binding motif;WW domain binding motif",+,0.03677,4,1,1,19700000,0,3.29,0,1.81825177,Paxillin,SSPGGQDEGGFMAQGK,PRDGGRSSPGGQDEG,P49023,PXN,S(1): 14.7;S(2): 85.3,P49023,S2(Phospho),1
0,0.14,0.54,0.52,1.18,1.15,1.18,1.24,K16(iTRAQ8plex);N-Term(iTRAQ8plex);S2(Phospho),"ERK1,2 kinase substrate motif;G protein-coupled receptor kinase 1 substrate motif;GSK-3, ERK1, ERK2, CDK5 substrate motif;PKA kinase substrate motif;PKC kinase substrate motif;WW domain binding motif",+,0.1217,4,1,1,701000,0.002704,2.9,0,4.016776715,Zyxin (Zyxin-2),FSPGAPGGSGSQPNQK,TPVASKFSPGAPGGS,Q15942,ZYX,S(2): 100.0;S(9): 0.0;S(11): 0.0,Q15942,S2(Phospho),1
0,-0.15,0.71,1.31,1.50,1.40,1.44,1.65,K7(iTRAQ8plex);N-Term(iTRAQ8plex);S2(Phospho),Casein kinase II substrate motif;MDC1 BRCT domain binding motif;PKA kinase substrate motif;PKC kinase substrate motif;Plk1 PBD domain binding motif,+,0.1365,4,1,1,206000000,0.005134,1.87,0,2.174505521,Alpha-endosulfine (ARPP-19e),SSLVTSK,GSFGGRSSGSPYGGG,O43768,ENSA,S(1): 9.4;S(2): 90.5;T(5): 0.0;S(6): 0.0,O43768,S2(Phospho),1
0,0.07,0.80,0.95,1.43,1.12,1.44,1.49,K7(iTRAQ8plex);N-Term(iTRAQ8plex);S2(Phospho),"Casein kinase II substrate motif;ERK1,2 kinase substrate motif;G protein-coupled receptor kinase 1 substrate motif;GSK-3, ERK1, ERK2, CDK5 substrate motif;PKA kinase substrate motif;PKC kinase substrate motif;WW domain binding motif",+,0.1282,8,1,1,153000000,0.002704,2.3,0,2.951807272,Zyxin (Zyxin-2),FSPVTPK,PAPAPKFSPVTPKFT,Q15942,ZYX,S(2): 100.0;T(5): 0.0,Q15942,S2(Phospho),1
0,-0.13,-0.05,0.03,0.64,0.45,0.50,0.51,K7(iTRAQ8plex);N-Term(iTRAQ8plex);S2(Phospho),"Casein kinase II substrate motif;ERK1,2 kinase substrate motif;Growth associated histone HI kinase substrate motif;GSK-3, ERK1, ERK2, CDK5 substrate motif;PKA kinase substrate motif;PKC kinase substrate motif;WW domain binding motif",+,0.004442,6,1,1,405000000,0,3.41,1,2.424764778,"Nuclear receptor corepressor 2 (N-CoR2) (CTG repeat protein 26) (SMAP270) (Silencing mediator of retinoic acid and thyroid hormone receptor) (SMRT) (T3 receptor-associating factor) (TRAC) (Thyroid-, retinoic-acid-receptor-associated corepressor)",RSPEPNK,HSEGGKRSPEPNKTS,Q9Y618,NCOR2,S(2): 100.0,Q9Y618,S2(Phospho),1
0,0.13,-0.23,-0.28,-0.36,-0.31,0.03,0.04,K9(iTRAQ8plex);N-Term(iTRAQ8plex);S2(Phospho),14-3-3 domain binding motif;Calmodulin-dependent protein kinase II substrate motif;G protein-coupled receptor kinase 1 substrate motif;GSK3 kinase substrate motif;MAPKAPK1 kinase substrate motif;PKA kinase substrate motif;PKC epsilon kinase substrate motif;PKC kinase substrate motif,+,0.03754,4,1,1,18800000,0.0006395,2.61,0,2.479611194,"Malate dehydrogenase, cytoplasmic (EC 1.1.1.37) (Cytosolic malate dehydrogenase) (Diiodophenylpyruvate reductase) (EC 1.1.1.96)",LSSAMSAAK,VIKARKLSSAMSAAK,P40925,MDH1,S(2): 90.4;S(3): 9.6;S(6): 0.0,P40925,S2(Phospho),1
0,0.26,0.22,0.09,-0.33,-0.11,0.71,0.57,K9(iTRAQ8plex);N-Term(iTRAQ8plex);S2(Phospho),MAPKAPK2 kinase substrate motif;PKA kinase substrate motif;PKC kinase substrate motif,+,0.1125,3,2,1,19000000,0.004872,2.75,0,1.814141654,Rho guanine nucleotide exchange factor 7 (Beta-Pix) (COOL-1) (PAK-interacting exchange factor beta) (p85),MSGFIYQGK,LSASPRMSGFIYQGK,Q14155,ARHGEF7,S(2): 100.0;Y(6): 0.0,Q14155,S2(Phospho),1
0,0.04,-1.23,-1.22,-0.16,-0.51,-1.38,-1.42,K9(iTRAQ8plex);N-Term(iTRAQ8plex);S2(Phospho),"ERK1,2 kinase substrate motif;Growth associated histone HI kinase substrate motif;GSK-3, ERK1, ERK2, CDK5 substrate motif;PKA kinase substrate motif;PKC kinase substrate motif;WW domain binding motif",+,0.1723,2,1,1,83800000,0.005524,1.37,0,3.063434662,Nucleolar and coiled-body phosphoprotein 1 (140 kDa nucleolar phosphoprotein) (Nopp140) (Hepatitis C virus NS5A-transactivated protein 13) (HCV NS5A-transactivated protein 13) (Nucleolar 130 kDa protein) (Nucleolar phosphoprotein p130),GSPRPQAPK,EKLKGKGSPRPQAPK,Q14978,NOLC1,S(2): 100.0,Q14978,S2(Phospho),1
0,-0.14,-1.02,-0.85,1.20,1.62,1.25,1.87,K9(iTRAQ8plex);N-Term(iTRAQ8plex);S2(Phospho),14-3-3 domain binding motif;b-Adrenergic Receptor kinase substrate motif;Calmodulin-dependent protein kinase II substrate motif;Casein kinase II substrate motif;Phosphorylase kinase substrate motif;PKA kinase substrate motif;PKC epsilon kinase substrate motif;PKC kinase substrate motif,+,0.2318,2,1,1,7290000,0.0099,1.99,0,2.667699671,Protein S100-A13 (S100 calcium-binding protein A13),DSLSVNEFK,RQEGRKDSLSVNEFK,Q99584,S100A13,S(2): 98.8;S(4): 1.2,Q99584,S2(Phospho),1
0,-0.12,0.44,0.66,0.03,-0.04,0.31,0.37,K9(iTRAQ8plex);S2(Phospho),MAPKAPK2 kinase substrate motif;PKA kinase substrate motif;PKC kinase substrate motif,+,0.04096,1,2,1,0,0.004,2.75,0,2.07962879,Rho guanine nucleotide exchange factor 7 (Beta-Pix) (COOL-1) (PAK-interacting exchange factor beta) (p85),MSGFIYQGK,LSASPRMSGFIYQGK,Q14155,ARHGEF7,,Q14155,S2(Phospho),1
0,-0.07,-0.59,-0.49,0.97,0.82,0.36,0.72,N-Term(iTRAQ8plex);S2(Phospho),"Calmodulin-dependent protein kinase II substrate motif;Casein kinase II substrate motif;Chk1 kinase substrate motif;ERK1,2 kinase substrate motif;G protein-coupled receptor kinase 1 substrate motif;GSK-3, ERK1, ERK2, CDK5 substrate motif;MAPKAPK2 kinase substrate motif;PKA kinase substrate motif;PKC kinase substrate motif;WW domain binding motif",+,0.0486,2,1,1,0,0.0002738,2.97,1,2.674900741,Protein PML (Promyelocytic leukemia protein) (RING finger protein 71) (Tripartite motif-containing protein 19),ASPEAASTPRDPIDVDLPEEAER,AAVSKKASPEAASTP,P29590,PML,S(2): 93.9;S(7): 1.2;T(8): 4.8,P29590,S2(Phospho),1
0,0.25,0.08,-0.18,0.82,0.80,1.28,1.21,N-Term(iTRAQ8plex);S2(Phospho),Casein kinase II substrate motif;G protein-coupled receptor kinase 1 substrate motif;PKA kinase substrate motif;PKC kinase substrate motif,+,0.1455,2,1,1,756000000,0.008873,2.01,0,2.806738062,Paxillin,ISASSATR,TQQQTRISASSATRE,P49023,PXN,S(2): 49.6;S(4): 49.6;S(5): 0.8;T(7): 0.0,P49023,S2(Phospho),1
0,0.01,-0.71,-0.66,0.01,-0.05,0.00,0.05,N-Term(iTRAQ8plex);S2(Phospho),"Casein kinase II substrate motif;ERK1,2 kinase substrate motif;GSK-3, ERK1, ERK2, CDK5 substrate motif;PKA kinase substrate motif;PKC kinase substrate motif;WW domain binding motif",+,0.003473,41,1,1,76300000,0,3.51,0,4.155593805,"Serine/arginine-rich splicing factor 9 (Pre-mRNA-splicing factor SRp30C) (Splicing factor, arginine/serine-rich 9)",GSPHYFSPFRPY,SPYQSRGSPHYFSPF,Q13242,SRSF9,S(2): 100.0;Y(5): 0.0;S(7): 0.0;Y(12): 0.0,Q13242,S2(Phospho),1
0,0.13,1.01,0.97,-0.18,-0.50,0.19,-0.06,N-Term(iTRAQ8plex);S2(Phospho),"Casein kinase I substrate motif;ERK1,2 kinase substrate motif;G protein-coupled receptor kinase 1 substrate motif;GSK-3, ERK1, ERK2, CDK5 substrate motif;MDC1 BRCT domain binding motif;PKA kinase substrate motif;PKC kinase substrate motif;Plk1 PBD domain binding motif;WW domain binding motif",+,5.90E-06,12,1,1,5430000,0,6.59,0,2.414935374,Tubulin--tyrosine ligase-like protein 12,SSPGQTPEEGAQALAEFAALHGPALR,RRPAERSSPGQTPEE,Q14166,TTLL12,S(1): 15.2;S(2): 84.8;T(6): 0.0,Q14166,S2(Phospho),1
0,0.10,0.55,0.43,0.22,0.13,-0.81,-0.73,N-Term(iTRAQ8plex);S2(Phospho),"14-3-3 domain binding motif;Akt kinase substrate motif;Calmodulin-dependent protein kinase II substrate motif;ERK1,2 kinase substrate motif;G protein-coupled receptor kinase 1 substrate motif;Growth associated histone HI kinase substrate motif;GSK3 kinase substrate motif;GSK-3, ERK1, ERK2, CDK5 substrate motif;MAPKAPK1 kinase substrate motif;PKA kinase substrate motif;PKC epsilon kinase substrate motif;PKC kinase substrate motif;WW domain binding motif",+,0.03169,10,1,1,382000000,0,3.22,1,3.685538604,Endoplasmic reticulum metallopeptidase 1 (EC 3.4.-.-) (Felix-ina),RSPGGSGGASR,GGRTRKRSPGGSGGA,Q7Z2K6,ERMP1,S(2): 100.0;S(6): 0.0;S(10): 0.0,Q7Z2K6,S2(Phospho),1
0,-0.16,-0.65,-0.80,0.04,0.26,-0.14,0.06,N-Term(iTRAQ8plex);S2(Phospho),"Casein kinase II substrate motif;ERK1,2 kinase substrate motif;G protein-coupled receptor kinase 1 substrate motif;Growth associated histone HI kinase substrate motif;GSK3 kinase substrate motif;GSK-3, ERK1, ERK2, CDK5 substrate motif;MAPKAPK2 kinase substrate motif;PKA kinase substrate motif;PKC kinase substrate motif;WW domain binding motif",+,0.04055,2,1,1,53200000,0.002,2.07,1,2.029850895,CLIP-associating protein 1 (Cytoplasmic linker-associated protein 1) (Multiple asters homolog 1) (Protein Orbit homolog 1) (hOrbit1),RSPTGSTTSR,RPLSAKRSPTGSTTS,Q7Z460,CLASP1,S(2): 99.8;T(4): 0.0;S(6): 0.0;T(7): 0.0;T(8): 0.0;S(9): 0.0,Q7Z460,S2(Phospho),1
0,0.00,-1.73,-1.54,-0.23,-0.30,-0.45,-0.37,N-Term(iTRAQ8plex);S2(Phospho),"Casein kinase II substrate motif;ERK1,2 kinase substrate motif;G protein-coupled receptor kinase 1 substrate motif;GSK-3, ERK1, ERK2, CDK5 substrate motif;PKA kinase substrate motif;PKC kinase substrate motif;WW domain binding motif",+,0.03668,4,1,1,21300000,0.0006395,2.53,0,3.95258553,182 kDa tankyrase-1-binding protein,ASPEPPGPESSSR,AQDLCRASPEPPGPE,Q9C0C2,TNKS1BP1,S(2): 100.0;S(10): 0.0;S(11): 0.0;S(12): 0.0,Q9C0C2,S2(Phospho),1
0,0.29,-0.50,-0.60,0.25,0.37,-0.02,-0.22,N-Term(iTRAQ8plex);S2(Phospho),"Casein kinase II substrate motif;ERK1,2 kinase substrate motif;GSK-3, ERK1, ERK2, CDK5 substrate motif;PKA kinase substrate motif;PKC kinase substrate motif;WW domain binding motif",+,0.1004,2,1,1,6870000,0.004589,2.09,0,1.915880939,5'-3' exoribonuclease 2 (EC 3.1.13.-) (DHM1-like protein) (DHP protein),NSPGSQVASNPR,HALGSRNSPGSQVAS,Q9H0D6,XRN2,S(2): 99.4;S(5): 0.5;S(9): 0.0,Q9H0D6,S2(Phospho),1
0,0.07,0.34,0.36,-0.46,-0.13,-0.54,-0.49,N-Term(iTRAQ8plex);S2(Phospho),Casein kinase II substrate motif;PKA kinase substrate motif;PKC kinase substrate motif,+,0.003787,26,1,1,39900000,0,6.21,1,2.145912567,Septin-9 (MLL septin-like fusion protein MSF-A) (MLL septin-like fusion protein) (Ovarian/Breast septin) (Ov/Br septin) (Septin D1),RSFEVEEVETPNSTPPR,SGPALKRSFEVEEVE,Q9UHD8,9-Sep,S(2): 100.0;T(10): 0.0;S(13): 0.0;T(14): 0.0,Q9UHD8,S2(Phospho),1
0,0.29,-0.73,-0.98,-0.26,-0.13,-0.38,-0.28,N-Term(iTRAQ8plex);S20(Phospho),"Cdc2 kinase substrate motif;CDK kinase substrate motif;CDK1,2,4,6 kinase substrate motif;ERK1,2 kinase substrate motif;GSK-3, ERK1, ERK2, CDK5 substrate motif;WW domain binding motif",+,4.85E-08,22,1,1,26700000,0,6.81,0,1.960713182,Coiled-coil domain-containing protein 86 (Cytokine-induced protein with coiled-coil domain),LQQGAGLESPQGQPEPGAASPQR,QPEPGAASPQRQQDL,Q9H6F5,CCDC86,S(9): 0.0;S(20): 100.0,Q9H6F5,S20(Phospho),1
0,0.07,1.16,0.96,0.05,-0.08,2.18,2.14,K15(iTRAQ8plex);N-Term(iTRAQ8plex);S21(Phospho),b-Adrenergic Receptor kinase substrate motif;Casein kinase II substrate motif;G protein-coupled receptor kinase 1 substrate motif;GSK3 kinase substrate motif,+,0.01594,36,1,1,80000000,0,4.86,1,4.342173545,"Ferritin heavy chain (Ferritin H subunit) (EC 1.16.3.1) (Cell proliferation-inducing gene 15 protein) [Cleaved into: Ferritin heavy chain, N-terminally processed]",MGAPESGLAEYLFDKHTLGDSDNES,DKHTLGDSDNES___,P02794,FTH1,S(6): 0.0;Y(11): 0.0;T(17): 0.0;S(21): 0.4;S(25): 99.6,P02794,S21(Phospho),1
0,0.05,-0.89,-0.82,0.00,-0.28,-0.45,-0.14,N-Term(iTRAQ8plex);S21(Phospho),Casein kinase II substrate motif;DNA dependent Protein kinase substrate motif;G protein-coupled receptor kinase 1 substrate motif;Pyruvate dehydrogenase kinase substrate motif,+,0.005514,8,1,1,14800000,0,3.58,0,1.810194652,Zinc finger and BTB domain-containing protein 7A (Factor binding IST protein 1) (FBI-1) (Factor that binds to inducer of short transcripts protein 1) (HIV-1 1st-binding protein 1) (Leukemia/lymphoma-related factor) (POZ and Krueppel erythroid myeloid ontogenic factor) (POK erythroid myeloid ontogenic factor) (Pokemon) (TTF-I-interacting peptide 21) (TIP21) (Zinc finger protein 857A),GGAPDPSPGATATPGAPAQPSSPDAR,PGAPAQPSSPDARRN,O95365,ZBTB7A,S(7): 0.0;T(11): 0.0;T(13): 0.0;S(21): 50.0;S(22): 50.0,O95365,S21(Phospho),1
0,0.13,0.34,0.31,0.34,0.30,-0.19,-0.39,N-Term(iTRAQ8plex);S22(Phospho),"DNA dependent Protein kinase substrate motif;ERK1,2 kinase substrate motif;G protein-coupled receptor kinase 1 substrate motif;Growth associated histone HI kinase substrate motif;GSK-3, ERK1, ERK2, CDK5 substrate motif;PKA kinase substrate motif;PKC kinase substrate motif;WW domain binding motif",+,4.88E-08,8,1,1,216000,0,6.05,0,2.254734098,TOM1-like protein 1 (Src-activating and signaling molecule protein) (Target of Myb-like protein 1),EATNTTSEPSAPSQDLLDLSPSPR,DLLDLSPSPRMPRAT,O75674,TOM1L1,T(3): 0.0;T(5): 0.0;T(6): 0.0;S(7): 0.0;S(10): 0.0;S(13): 0.0;S(20): 0.0;S(22): 100.0,O75674,S22(Phospho),1
0,-0.05,0.21,0.31,-0.05,-0.05,0.62,0.57,N-Term(iTRAQ8plex);S22(Phospho),Casein kinase I substrate motif,+,0.01841,4,1,1,11300000,0,4.29,1,3.410405577,Plectin (PCN) (PLTN) (Hemidesmosomal protein 1) (HD1) (Plectin-1),AGTLSITEFADMLSGNAGGFRSR,TEFADMLSGNAGGFR,Q15149,PLEC,T(3): 0.1;S(5): 0.3;T(7): 0.3;S(14): 74.9;S(22): 24.4,Q15149,S22(Phospho),1
0,0.10,1.06,1.25,1.57,1.25,1.16,1.20,K10(iTRAQ8plex);N-Term(iTRAQ8plex);S23(Phospho),"b-Adrenergic Receptor kinase substrate motif;ERK1,2 kinase substrate motif;GSK-3, ERK1, ERK2, CDK5 substrate motif;WW domain binding motif",+,6.48E-05,8,1,1,9960000,0,7.04,0,2.71267754,Golgi reassembly-stacking protein 2 (GRS2) (Golgi phosphoprotein 6) (GOLPH6) (Golgi reassembly-stacking protein of 55 kDa) (GRASP55) (p59),VGDSTPVSEKPVSAAVDANASESP,VDANASESP______,Q9H8Y8,GORASP2,S(4): 0.0;T(5): 0.0;S(8): 0.0;S(13): 0.0;S(21): 0.0;S(23): 100.0,Q9H8Y8,S23(Phospho),1
0,0.00,-0.71,-0.63,0.01,0.01,0.62,0.66,C2(Carbamidomethyl);K1(iTRAQ8plex);K14(iTRAQ8plex);N-Term(iTRAQ8plex);S3(Phospho),Phosphorylase kinase substrate motif;PKA kinase substrate motif;PKC kinase substrate motif,+,0.001609,14,1,1,74600000,0,5.19,1,5.14859351,Microtubule-associated protein 4 (MAP-4),KCSLPAEEDSVLEK,TGTGKKCSLPAEEDS,P27816,MAP4,S(3): 100.0;S(10): 0.0,P27816,S3(Phospho),1
0,0.07,-0.66,-0.65,0.10,0.26,0.17,0.09,C5(Carbamidomethyl);C8(Carbamidomethyl);N-Term(iTRAQ8plex);S3(Phospho),14-3-3 domain binding motif;Aurora-A kinase substrate motif;Calmodulin-dependent protein kinase II substrate motif;G protein-coupled receptor kinase 1 substrate motif;PAK2 kinase substrate motif;Phosphorylase kinase substrate motif;PKA kinase substrate motif;PKC epsilon kinase substrate motif;PKC kinase substrate motif,+,0.0006127,36,1,1,181000000,0,4.81,1,3.134776738,Transforming growth factor beta-1-induced transcript 1 protein (Androgen receptor coactivator 55 kDa protein) (Androgen receptor-associated protein of 55 kDa) (Hydrogen peroxide-inducible clone 5 protein) (Hic-5),RGSLCATCGLPVTGR,HFHARRGSLCATCGL,O43294,TGFB1I1,S(3): 100.0;T(7): 0.0;T(13): 0.0,O43294,S3(Phospho),1
0,-0.07,0.69,0.64,0.23,0.21,0.21,0.30,C6(Carbamidomethyl);K13(iTRAQ8plex);N-Term(iTRAQ8plex);S3(Phospho),14-3-3 domain binding motif;b-Adrenergic Receptor kinase substrate motif;Calmodulin-dependent protein kinase I substrate motif;Calmodulin-dependent protein kinase II substrate motif;Calmodulin-dependent protein kinase IV substrate motif;Casein kinase II substrate motif;Chk1 kinase substrate motif;MAPKAPK2 kinase substrate motif;PKA kinase substrate motif;PKC kinase substrate motif,+,0.004398,64,1,1,179000000,0,5.56,0,3.362464167,Glutamine--fructose-6-phosphate aminotransferase [isomerizing] 1 (EC 2.6.1.16) (D-fructose-6-phosphate amidotransferase 1) (Glutamine:fructose-6-phosphate amidotransferase 1) (GFAT 1) (GFAT1) (Hexosephosphate aminotransferase 1),VDSTTCLFPVEEK,CNLSRVDSTTCLFPV,Q06210,GFPT1,S(3): 99.6;T(4): 0.3;T(5): 0.0,Q06210,S3(Phospho),1
0,-0.10,-0.36,-0.33,0.35,0.37,0.40,0.45,C4(Carbamidomethyl);K15(iTRAQ8plex);N-Term(iTRAQ8plex);S3(Phospho),14-3-3 domain binding motif;b-Adrenergic Receptor kinase substrate motif;Calmodulin-dependent protein kinase II substrate motif;Calmodulin-dependent protein kinase IV substrate motif;Casein kinase II substrate motif;Chk1 kinase substrate motif;G protein-coupled receptor kinase 1 substrate motif;GSK3 kinase substrate motif;PAK2 kinase substrate motif;PKA kinase substrate motif;PKC epsilon kinase substrate motif;PKC kinase substrate motif,+,0.03848,14,1,1,31100000,0,4.71,1,3.8462239,Zinc finger protein 185 (LIM domain protein ZNF185) (P1-A),RESCGSSVLTDFEGK,EQLVRRESCGSSVLT,O15231,ZNF185,S(3): 97.1;S(6): 2.5;S(7): 0.4;T(10): 0.0,O15231,S3(Phospho),1
0,-0.15,1.09,1.22,-0.16,-0.28,1.05,1.13,K1(iTRAQ8plex);K15(iTRAQ8plex);N-Term(iTRAQ8plex);S3(Phospho),14-3-3 domain binding motif;Calmodulin-dependent protein kinase II substrate motif;Casein kinase II substrate motif;MAPKAPK2 kinase substrate motif;Phosphorylase kinase substrate motif;PKA kinase substrate motif;PKC epsilon kinase substrate motif;PKC kinase substrate motif,+,0.0004128,374,1,1,14800000000,0,7.14,1,3.772670861,Triosephosphate isomerase (TIM) (EC 5.3.1.1) (Triose-phosphate isomerase),KQSLGELIGTLNAAK,KMNGRKQSLGELIGT,P60174,TPI1,S(3): 100.0;T(10): 0.0,P60174,S3(Phospho),1
0,0.17,-0.31,-0.22,0.35,0.34,0.38,0.37,C11(Carbamidomethyl);K16(iTRAQ8plex);N-Term(iTRAQ8plex);S3(Phospho),14-3-3 domain binding motif;Akt kinase substrate motif;Calmodulin-dependent protein kinase II substrate motif;DNA dependent Protein kinase substrate motif;MAPKAPK1 kinase substrate motif;p70 Ribosomal S6 kinase substrate motif;Phosphorylase kinase substrate motif;PKA kinase substrate motif;PKC kinase substrate motif;PP2B substrate motif;ZIP kinase substrate motif,+,0.1252,2,1,1,13200000,0.008824,3.51,0,2.606292248,Filamin-A (FLN-A) (Actin-binding protein 280) (ABP-280) (Alpha-filamin) (Endothelial actin-binding protein) (Filamin-1) (Non-muscle filamin),APSVANVGSHCDLSLK,TRRRRAPSVANVGSH,P21333,FLNA,S(3): 99.9;S(9): 0.1;S(14): 0.0,P21333,S3(Phospho),1
0,0.01,0.57,0.74,0.04,0.10,-0.19,-0.15,C15(Carbamidomethyl);K16(iTRAQ8plex);N-Term(iTRAQ8plex);S3(Phospho),14-3-3 domain binding motif;Akt kinase substrate motif;Calmodulin-dependent protein kinase II substrate motif;MAPKAPK1 kinase substrate motif;PAK2 kinase substrate motif;Pim1 kinase substrate sequence;PKA kinase substrate motif;PKC epsilon kinase substrate motif;PKC kinase substrate motif,+,0.02141,8,1,1,30200000,0,3.89,2,3.046143684,Diphosphomevalonate decarboxylase (EC 4.1.1.33) (Mevalonate (diphospho)decarboxylase) (MDDase) (Mevalonate pyrophosphate decarboxylase),RNSRDGDPLPSSLSCK,LARKRRNSRDGDPLP,P53602,MVD,S(3): 100.0;S(11): 0.0;S(12): 0.0;S(14): 0.0,P53602,S3(Phospho),1
0,0.48,-1.48,-1.65,0.13,0.54,0.70,0.56,K12(iTRAQ8plex);K5(iTRAQ8plex);N-Term(iTRAQ8plex);S3(Phospho),"b-Adrenergic Receptor kinase substrate motif;Calmodulin-dependent protein kinase II substrate motif;Casein kinase II substrate motif;Chk1 kinase substrate motif;ERK1,2 kinase substrate motif;G protein-coupled receptor kinase 1 substrate motif;Growth associated histone HI kinase substrate motif;GSK-3, ERK1, ERK2, CDK5 substrate motif;MAPKAPK2 kinase substrate motif;PKA kinase substrate motif;PKC kinase substrate motif;WW domain binding motif",+,0.002198,28,1,1,3750000000,0,4.41,2,2.617395057,"Heterogeneous nuclear ribonucleoprotein A1 (hnRNP A1) (Helix-destabilizing protein) (Single-strand RNA-binding protein) (hnRNP core protein A1) [Cleaved into: Heterogeneous nuclear ribonucleoprotein A1, N-terminally processed]",SESPKEPEQLRK,__MSKSESPKEPEQL,P09651,HNRNPA1,S(1): 8.9;S(3): 91.1,P09651,S3(Phospho),1
0,0.06,0.08,0.24,0.75,0.71,1.43,1.36,K18(iTRAQ8plex);K6(iTRAQ8plex);N-Term(iTRAQ8plex);S3(Phospho),"14-3-3 domain binding motif;Calmodulin-dependent protein kinase II substrate motif;Cdc2 kinase substrate motif;CDK kinase substrate motif;CDK1,2,4,6 kinase substrate motif;ERK1,2 kinase substrate motif;G protein-coupled receptor kinase 1 substrate motif;GSK-3, ERK1, ERK2, CDK5 substrate motif;PKA kinase substrate motif;PKC kinase substrate motif;WW domain binding motif",+,0.0253,2,1,1,36800000,0,3.23,0,4.00971341,Synaptopodin,AASPAKPSSLDLVPNLPK,KVSPRAASPAKPSSL,Q8N3V7,SYNPO,S(3): 100.0;S(8): 0.0;S(9): 0.0,Q8N3V7,S3(Phospho),1
0,0.04,-1.29,-1.33,-0.10,0.03,0.03,0.03,K13(iTRAQ8plex);K7(iTRAQ8plex);N-Term(iTRAQ8plex);S3(Phospho),"14-3-3 domain binding motif;Akt kinase substrate motif;AMP-activated protein kinase 2 substrate motif;Calmodulin-dependent protein kinase II substrate motif;ERK1,2 kinase substrate motif;GSK-3, ERK1, ERK2, CDK5 substrate motif;MAPKAPK1 kinase substrate motif;PKA kinase substrate motif;PKC kinase substrate motif;WW domain binding motif",+,0.2097,4,1,1,0,0.002,3.2,1,4.635660995,Matrin-3,SYSPDGKESPSDK,KSRKRSYSPDGKESP,P43243,MATR3,,P43243,S3(Phospho),1
0,0.11,1.57,2.10,0.84,0.68,0.88,1.01,K22(iTRAQ8plex);K9(iTRAQ8plex);N-Term(iTRAQ8plex);S3(Phospho),Casein kinase II substrate motif;G protein-coupled receptor kinase 1 substrate motif;PKA kinase substrate motif;PKC kinase substrate motif,+,0.07661,2,1,1,3950000,0.001703,2.5,1,2.357786314,Serine/threonine-protein kinase PAK 2 (EC 2.7.11.1) (Gamma-PAK) (PAK65) (S6/H4 kinase) (p21-activated kinase 2) (PAK-2) (p58) [Cleaved into: PAK-2p27 (p27);PAK-2p34 (p34) (C-t-PAK2)],YLSFTPPEKDGFPSGTPALNAK,TVKQKYLSFTPPEKD,Q13177,PAK2,Y(1): 12.1;S(3): 85.4;T(5): 0.3;S(14): 1.8;T(16): 0.3,Q13177,S3(Phospho),1
0,0.06,0.26,0.38,0.37,0.41,0.45,0.47,C37(Carbamidomethyl);N-Term(iTRAQ8plex);S3(Phospho),"14-3-3 domain binding motif;Calmodulin-dependent protein kinase II substrate motif;Casein kinase II substrate motif;ERK1,2 kinase substrate motif;G protein-coupled receptor kinase 1 substrate motif;GSK3 kinase substrate motif;GSK-3, ERK1, ERK2, CDK5 substrate motif;PKA kinase substrate motif;PKC kinase substrate motif;WW domain binding motif",+,8.89E-12,38,1,1,485000,0,8.5,0,2.381930176,Transcription intermediary factor 1-beta (TIF1-beta) (E3 SUMO-protein ligase TRIM28) (EC 6.3.2.-) (KRAB-associated protein 1) (KAP-1) (KRAB-interacting protein 1) (KRIP-1) (Nuclear corepressor KAP-1) (RING finger protein 96) (Tripartite motif-containing protein 28),LASPSGSTSSGLEVVAPEGTSAPGGGPGTLDDSATICR,AEGPRLASPSGSTSS,Q13263,TRIM28,S(3): 97.0;S(5): 2.3;S(7): 0.4;T(8): 0.4;S(9): 0.0;S(10): 0.0;T(20): 0.0;S(21): 0.0;T(29): 0.0;S(33): 0.0;T(35): 0.0,Q13263,S3(Phospho),1
0,0.14,1.27,0.79,0.03,-0.11,0.56,0.69,C7(Carbamidomethyl);N-Term(iTRAQ8plex);S3(Phospho),Casein kinase II substrate motif;G protein-coupled receptor kinase 1 substrate motif,+,0.005909,2,1,1,14900000,0,3.35,0,1.857229872,Ras and Rab interactor 1 (Ras inhibitor JC99) (Ras interaction/interference protein 1),SMSAAFCSLLAPER,RRRPLLRSMSAAFCS,Q13671,RIN1,S(1): 89.6;S(3): 10.4;S(8): 0.0,Q13671,S3(Phospho),1
0,0.01,0.47,0.50,-0.26,-0.34,-0.05,-0.07,K1(iTRAQ8plex);N-Term(iTRAQ8plex);S3(Phospho),"14-3-3 domain binding motif;Calmodulin-dependent protein kinase II substrate motif;Calmodulin-dependent protein kinase IV substrate motif;PKA kinase substrate motif;PKA, PKG kinase substrate motif;PKC epsilon kinase substrate motif;PKC kinase substrate motif;PKG kinase substrate motif",+,0.02109,12,1,1,360000000,0,3.36,1,4.120856953,Pyruvate kinase PKM (EC 2.7.1.40) (Cytosolic thyroid hormone-binding protein) (CTHBP) (Opa-interacting protein 3) (OIP-3) (Pyruvate kinase 2/3) (Pyruvate kinase muscle isozyme) (Thyroid hormone-binding protein 1) (THBP1) (Tumor M2-PK) (p58),KASDVHEVR,ASFIRKASDVHEVRK,P14618,PKM,S(3): 100.0,P14618,S3(Phospho),1
0,0.03,0.80,0.88,-1.17,-1.49,-2.06,-2.01,K1(iTRAQ8plex);N-Term(iTRAQ8plex);S3(Phospho),"14-3-3 domain binding motif;Calmodulin-dependent protein kinase II substrate motif;Casein kinase II substrate motif;ERK1,2 kinase substrate motif;GSK-3, ERK1, ERK2, CDK5 substrate motif;PKA kinase substrate motif;PKC epsilon kinase substrate motif;PKC kinase substrate motif;WW domain binding motif",+,0.1025,4,1,1,271000000,0.002329,1.92,1,4.218715928,Protein FAM83H,KGSPTPGFSTR,AYPERKGSPTPGFST,Q6ZRV2,FAM83H,S(3): 100.0;T(5): 0.0;S(9): 0.0;T(10): 0.0,Q6ZRV2,S3(Phospho),1
0,-0.01,1.42,1.51,0.63,0.44,0.85,0.87,K10(iTRAQ8plex);N-Term(iTRAQ8plex);S3(Phospho),14-3-3 domain binding motif;Calmodulin-dependent protein kinase I substrate motif;Calmodulin-dependent protein kinase II alpha substrate motif;Calmodulin-dependent protein kinase II substrate motif;Calmodulin-dependent protein kinase IV substrate motif;Casein kinase II substrate motif;Chk1 kinase substrate motif;MDC1 BRCT domain binding motif;Phosphorylase kinase substrate motif;PKA kinase substrate motif;PKC kinase substrate motif;Plk1 PBD domain binding motif;Pyruvate dehydrogenase kinase substrate motif,+,0.03156,17,1,1,112000000,0,3.55,0,3.794202542,Helicase SKI2W (Ski2) (EC 3.6.4.-) (Helicase-like protein) (HLP),ASSLEDLVLK,APLARASSLEDLVLK,Q15477,SKIV2L,,Q15477,S3(Phospho),1
0,-0.23,-1.58,-1.40,-0.54,-0.71,-1.11,-1.04,K10(iTRAQ8plex);N-Term(iTRAQ8plex);S3(Phospho),14-3-3 domain binding motif;Akt kinase substrate motif;Calmodulin-dependent protein kinase II substrate motif;Casein kinase II substrate motif;G protein-coupled receptor kinase 1 substrate motif;MAPKAPK1 kinase substrate motif;PAK2 kinase substrate motif;Pim1 kinase substrate sequence;PKA kinase substrate motif;PKC epsilon kinase substrate motif;PKC kinase substrate motif,+,0.003738,6,1,1,162000000,0,4.23,1,2.856640585,Cell growth-regulating nucleolar protein,RHSEVETDSK,GKRKRRHSEVETDSK,Q9NX58,LYAR,S(3): 100.0;T(7): 0.0;S(9): 0.0,Q9NX58,S3(Phospho),1
0,0.05,-0.89,-0.82,0.01,-0.10,0.11,0.16,K10(iTRAQ8plex);N-Term(iTRAQ8plex);S3(Phospho),14-3-3 domain binding motif;ATM kinase substrate motif;Calmodulin-dependent protein kinase II substrate motif;Casein kinase II substrate motif;DNA dependent Protein kinase substrate motif;G protein-coupled receptor kinase 1 substrate motif;GSK3 kinase substrate motif;PAK2 kinase substrate motif;PKA kinase substrate motif;PKC epsilon kinase substrate motif;PKC kinase substrate motif,+,0.03011,14,1,1,444000000,0,3.92,1,3.90090703,Apoptotic chromatin condensation inducer in the nucleus (Acinus),RLSQPESAEK,SVQARRLSQPESAEK,Q9UKV3,ACIN1,S(3): 100.0;S(7): 0.0,Q9UKV3,S3(Phospho),1
0,0.12,-0.24,-0.19,-0.25,-0.28,-0.03,0.05,K11(iTRAQ8plex);N-Term(iTRAQ8plex);S3(Phospho),"Calmodulin-dependent protein kinase II substrate motif;Chk1 kinase substrate motif;ERK1,2 kinase substrate motif;Growth associated histone HI kinase substrate motif;GSK-3, ERK1, ERK2, CDK5 substrate motif;PAK2 kinase substrate motif;PKA kinase substrate motif;PKC kinase substrate motif;WW domain binding motif",+,0.07756,2,1,1,380000000,0.002619,3.51,2,2.061174973,Regulator of chromosome condensation (Cell cycle regulatory protein) (Chromosome condensation protein 1),RRSPPADAIPK,KRIAKRRSPPADAIP,P18754,RCC1,S(3): 100.0,P18754,S3(Phospho),1
0,0.21,1.03,1.27,0.75,0.72,0.81,0.86,K11(iTRAQ8plex);N-Term(iTRAQ8plex);S3(Phospho),"Casein kinase II substrate motif;ERK1,2 kinase substrate motif;GSK-3, ERK1, ERK2, CDK5 substrate motif;MAPKAPK2 kinase substrate motif;MDC1 BRCT domain binding motif;PKA kinase substrate motif;PKC kinase substrate motif;Plk1 PBD domain binding motif;WW domain binding motif",+,0.02694,8,1,1,0,0,2.88,0,2.421749244,Rho GTPase-activating protein 1 (CDC42 GTPase-activating protein) (GTPase-activating protein rhoOGAP) (Rho-related small GTPase protein activator) (Rho-type GTPase-activating protein 1) (p50-RhoGAP),SSSPELVTHLK,SDDSKSSSPELVTHL,Q07960,ARHGAP1,S(1): 0.8;S(2): 8.2;S(3): 91.0;T(8): 0.0,Q07960,S3(Phospho),1
0,-0.01,-0.87,-0.84,-0.13,-0.27,-0.02,-0.06,K11(iTRAQ8plex);N-Term(iTRAQ8plex);S3(Phospho),Akt kinase substrate motif;Casein kinase II substrate motif;G protein-coupled receptor kinase 1 substrate motif;GSK3 kinase substrate motif;PKA kinase substrate motif;PKC kinase substrate motif,+,0.01949,60,1,1,352000000,0,3.78,0,3.600696162,Chromobox protein homolog 3 (HECH) (Heterochromatin protein 1 homolog gamma) (HP1 gamma) (Modifier 2 protein),SLSDSESDDSK,GTKRKSLSDSESDDS,Q13185,CBX3,S(1): 0.1;S(3): 99.9;S(5): 0.1;S(7): 0.0;S(10): 0.0,Q13185,S3(Phospho),1
0,0.03,-0.55,-0.67,-0.28,-0.51,-0.45,-0.42,K11(iTRAQ8plex);N-Term(iTRAQ8plex);S3(Phospho),Casein kinase II substrate motif;MAPKAPK2 kinase substrate motif,+,0.03503,13,1,1,34000000,0,3.07,0,1.956962289,"Serine/arginine-rich splicing factor 6 (Pre-mRNA-splicing factor SRP55) (Splicing factor, arginine/serine-rich 6)",SNSPLPVPPSK,RSRSQSRSNSPLPVP,Q13247,SRSF6,S(1): 50.0;S(3): 50.0;S(10): 0.0,Q13247,S3(Phospho),1
0,0.24,-1.72,-1.46,0.63,0.72,0.13,0.13,K11(iTRAQ8plex);N-Term(iTRAQ8plex);S3(Phospho),"14-3-3 domain binding motif;b-Adrenergic Receptor kinase substrate motif;Calmodulin-dependent protein kinase II substrate motif;ERK1,2 kinase substrate motif;GSK-3, ERK1, ERK2, CDK5 substrate motif;MAPKAPK2 kinase substrate motif;PKA kinase substrate motif;PKC kinase substrate motif;WW domain binding motif",+,0.04282,6,1,1,77100000,0,2.54,0,3.626209677,Bromodomain-containing protein 3 (RING3-like protein),SESPPPLSDPK,ITASRSESPPPLSDP,Q15059,BRD3,S(1): 0.7;S(3): 99.3;S(8): 0.0,Q15059,S3(Phospho),1
0,-0.17,-2.72,-2.05,-0.61,-1.09,-0.88,-0.88,K11(iTRAQ8plex);N-Term(iTRAQ8plex);S3(Phospho),14-3-3 domain binding motif;Calmodulin-dependent protein kinase I substrate motif;Calmodulin-dependent protein kinase II substrate motif;Calmodulin-dependent protein kinase IV substrate motif;Casein kinase II substrate motif;Chk1 kinase substrate motif;PKA kinase substrate motif;PKC kinase substrate motif,+,0.1097,4,1,1,12000000,0.002704,2.08,0,2.191920505,Formin-binding protein 1-like (Transducer of Cdc42-dependent actin assembly protein 1) (Toca-1),TISDGTISASK,QHIYRTISDGTISAS,Q5T0N5,FNBP1L,T(1): 12.7;S(3): 86.9;T(6): 0.4;S(8): 0.0;S(10): 0.0,Q5T0N5,S3(Phospho),1
0,-0.03,0.24,0.16,0.86,0.79,1.57,1.50,K11(iTRAQ8plex);N-Term(iTRAQ8plex);S3(Phospho),14-3-3 domain binding motif;BARD1 BRCT domain binding motif;Calmodulin-dependent protein kinase II substrate motif;Casein kinase II substrate motif;PKA kinase substrate motif;PKC kinase substrate motif,+,0.01175,43,1,1,278000000,0,4.23,0,4.724636001,Palladin (SIH002) (Sarcoma antigen NY-SAR-77),IASDEEIQGTK,SRTARIASDEEIQGT,Q8WX93,PALLD,S(3): 100.0;T(10): 0.0,Q8WX93,S3(Phospho),1
0,0.01,-0.20,-0.26,0.09,0.09,-0.02,0.02,K11(iTRAQ8plex);N-Term(iTRAQ8plex);S3(Phospho),PKA kinase substrate motif;PKC kinase substrate motif,+,0.01139,10,1,1,110000000,0,3.24,1,3.000294834,OCIA domain-containing protein 1 (Ovarian carcinoma immunoreactive antigen),RSSPPGHYYQK,RSGQARRSSPPGHYY,Q9NX40,OCIAD1,S(2): 9.9;S(3): 90.1;Y(8): 0.0;Y(9): 0.0,Q9NX40,S3(Phospho),1
0,0.10,0.94,0.92,0.20,0.30,0.68,0.51,K12(iTRAQ8plex);N-Term(iTRAQ8plex);S3(Phospho),14-3-3 domain binding motif;Calmodulin-dependent protein kinase II substrate motif;G protein-coupled receptor kinase 1 substrate motif;GSK3 kinase substrate motif;MAPKAPK2 kinase substrate motif;PAK2 kinase substrate motif;PKA kinase substrate motif;PKC epsilon kinase substrate motif;PKC kinase substrate motif,+,0.0616,2,1,1,0,0.001645,4.25,1,2.887413994,Glutamine--tRNA ligase (EC 6.1.1.18) (Glutaminyl-tRNA synthetase) (GlnRS),RLSFLVSYIASK,LRDTRRLSFLVSYIA,P47897,QARS,S(3): 100.0;S(7): 0.0;Y(8): 0.0;S(11): 0.0,P47897,S3(Phospho),1
0,-0.01,-0.09,0.10,1.85,1.66,1.05,1.10,K12(iTRAQ8plex);N-Term(iTRAQ8plex);S3(Phospho),14-3-3 domain binding motif;Akt kinase substrate motif;Calmodulin-dependent protein kinase II substrate motif;Casein kinase II substrate motif;MAPKAPK1 kinase substrate motif;PAK2 kinase substrate motif;PKA kinase substrate motif;PKC epsilon kinase substrate motif;PKC kinase substrate motif;Pyruvate dehydrogenase kinase substrate motif,+,0.01092,12,1,1,172000000,0,4.01,1,3.842019905,A-kinase anchor protein 12 (AKAP-12) (A-kinase anchor protein 250 kDa) (AKAP 250) (Gravin) (Myasthenia gravis autoantigen),RGSSSDEEGGPK,KKRARRGSSSDEEGG,Q02952,AKAP12,S(3): 33.3;S(4): 33.3;S(5): 33.3,Q02952,S3(Phospho),1
0,0.15,-1.48,-1.22,-1.26,-1.28,-1.44,-1.54,K12(iTRAQ8plex);N-Term(iTRAQ8plex);S3(Phospho),Casein kinase II substrate motif;G protein-coupled receptor kinase 1 substrate motif;GSK3 kinase substrate motif;PKA kinase substrate motif;PKC kinase substrate motif,+,0.03722,44,1,1,458000000,0.0006395,3.65,0,3.379977404,Neuroblast differentiation-associated protein AHNAK (Desmoyokin),LSSSSSNDSGNK,ASKKSRLSSSSSNDS,Q09666,AHNAK,S(2): 74.7;S(3): 10.9;S(4): 10.9;S(5): 1.7;S(6): 1.7;S(9): 0.0,Q09666,S3(Phospho),1
0,0.06,0.40,0.46,0.09,0.03,0.12,-0.05,K12(iTRAQ8plex);N-Term(iTRAQ8plex);S3(Phospho),MAPKAPK2 kinase substrate motif,+,0.02169,8,1,1,56400000,0,4.2,1,1.893112077,Pumilio homolog 1 (HsPUM) (Pumilio-1),RDSLTGSSDLYK,RRDSLTGSSDLYKRT,Q14671,PUM1,S(3): 100.0;T(5): 0.0;S(7): 0.0;S(8): 0.0;Y(11): 0.0,Q14671,S3(Phospho),1
0,0.15,-0.02,-0.04,-0.27,-0.28,-0.63,-0.62,K12(iTRAQ8plex);N-Term(iTRAQ8plex);S3(Phospho),"14-3-3 domain binding motif;Calmodulin-dependent protein kinase II substrate motif;Casein kinase II substrate motif;ERK1,2 kinase substrate motif;GSK-3, ERK1, ERK2, CDK5 substrate motif;PAK2 kinase substrate motif;PKA kinase substrate motif;PKC epsilon kinase substrate motif;PKC kinase substrate motif;WW domain binding motif",+,0.002305,24,1,1,102000000,0,4.77,1,3.155552318,Protein FAM83H,RGSPTTGFIEQK,GFSTRRGSPTTGFIE,Q6ZRV2,FAM83H,S(3): 98.3;T(5): 0.2;T(6): 1.5,Q6ZRV2,S3(Phospho),1
0,0.04,-0.45,-0.23,0.55,0.38,0.82,0.83,K12(iTRAQ8plex);N-Term(iTRAQ8plex);S3(Phospho),Casein kinase II substrate motif;G protein-coupled receptor kinase 1 substrate motif;MAPKAPK2 kinase substrate motif,+,0.00348,9,1,1,119000000,0,4.18,1,2.927704655,Proline and serine-rich protein 2,SRSFTLDDESLK,SRSSSSRSRSFTLDD,Q86WR7,PROSER2,S(1): 1.0;S(3): 97.9;T(5): 1.0;S(10): 0.0,Q86WR7,S3(Phospho),1
0,-0.03,0.74,0.87,-0.18,-0.36,1.26,1.34,K12(iTRAQ8plex);N-Term(iTRAQ8plex);S3(Phospho),Calmodulin-dependent protein kinase II substrate motif;Casein kinase II substrate motif;Chk1 kinase substrate motif;MAPKAPK2 kinase substrate motif;MDC1 BRCT domain binding motif;PKA kinase substrate motif;PKC kinase substrate motif;Plk1 PBD domain binding motif;Pyruvate dehydrogenase kinase substrate motif,+,0.02463,30,1,1,125000000,0,3.99,0,3.828131232,Mitochondrial fission regulator 1-like,ASSFADMMGILK,VSLSKASSFADMMGI,Q9H019,MTFR1L,S(2): 50.0;S(3): 50.0,Q9H019,S3(Phospho),1
0,0.00,0.96,1.04,0.37,0.20,-0.08,-0.06,K13(iTRAQ8plex);N-Term(iTRAQ8plex);S3(Phospho),"14-3-3 domain binding motif;Calmodulin-dependent protein kinase II substrate motif;ERK1,2 kinase substrate motif;Growth associated histone HI kinase substrate motif;GSK-3, ERK1, ERK2, CDK5 substrate motif;MAPKAPK1 kinase substrate motif;PAK2 kinase substrate motif;PKA kinase substrate motif;PKC epsilon kinase substrate motif;PKC kinase substrate motif;WW domain binding motif",+,0.151,2,1,1,116000000,0,1.51,2,3.616018759,tRNA (guanine-N(7)-)-methyltransferase non-catalytic subunit WDR4 (WD repeat-containing protein 4),RRSPPPGPDGHAK,EKKQRRRSPPPGPDG,P57081,WDR4,S(3): 100.0,P57081,S3(Phospho),1
0,0.00,-0.56,-0.52,-0.01,-0.21,-0.21,-0.14,K13(iTRAQ8plex);N-Term(iTRAQ8plex);S3(Phospho),"14-3-3 domain binding motif;Calmodulin-dependent protein kinase II substrate motif;Casein kinase II substrate motif;MAPKAPK1 kinase substrate motif;PAK2 kinase substrate motif;Pim1 kinase substrate sequence;PKA kinase substrate motif;PKA, PKG kinase substrate motif;PKC epsilon kinase substrate motif;PKC kinase substrate motif;PKG kinase substrate motif;ZIP kinase substrate motif",+,0.02265,12,1,1,356000000,0,3.64,1,2.086941675,Nuclear cap-binding protein subunit 1 (80 kDa nuclear cap-binding protein) (CBP80) (NCBP 80 kDa subunit),RHSDENDGGQPHK,_MSRRRHSDENDGGQ,Q09161,NCBP1,S(3): 100.0,Q09161,S3(Phospho),1
0,0.35,-0.90,-0.89,-0.10,0.06,-0.18,-0.30,K13(iTRAQ8plex);N-Term(iTRAQ8plex);S3(Phospho),14-3-3 domain binding motif;Akt kinase substrate motif;Calmodulin-dependent protein kinase II substrate motif;Casein kinase II substrate motif;MAPKAPK1 kinase substrate motif;PKA kinase substrate motif;PKC kinase substrate motif,+,0.002686,16,1,1,195000000,0,4,1,2.214273392,182 kDa tankyrase-1-binding protein,NRSAEEGELAESK,KLRPRNRSAEEGELA,Q9C0C2,TNKS1BP1,S(3): 100.0;S(12): 0.0,Q9C0C2,S3(Phospho),1
0,-0.06,1.19,1.44,0.68,1.00,1.13,1.15,K13(iTRAQ8plex);N-Term(iTRAQ8plex);S3(Phospho),14-3-3 domain binding motif;Calmodulin-dependent protein kinase II substrate motif;Casein kinase II substrate motif;Phosphorylase kinase substrate motif;PKA kinase substrate motif;PKC kinase substrate motif,+,0.1613,2,1,1,2430000,0.007092,2.05,0,2.560116457,SH3 domain-binding protein 4 (EH-binding protein 10) (Transferrin receptor-trafficking protein),SYSLSELSVLQAK,FRSKRSYSLSELSVL,Q9P0V3,SH3BP4,S(1): 0.3;Y(2): 2.0;S(3): 97.3;S(5): 0.3;S(8): 0.0,Q9P0V3,S3(Phospho),1
0,0.14,-0.49,-0.54,0.17,0.13,0.03,0.06,K14(iTRAQ8plex);N-Term(iTRAQ8plex);S3(Phospho),14-3-3 domain binding motif;Aurora-A kinase substrate motif;Calmodulin-dependent protein kinase II substrate motif;Casein kinase II substrate motif;G protein-coupled receptor kinase 1 substrate motif;PAK2 kinase substrate motif;Phosphorylase kinase substrate motif;PKA kinase substrate motif;PKC epsilon kinase substrate motif;PKC kinase substrate motif,+,0.0464,8,1,1,15600000,0,3.76,1,3.042616323,Nardilysin (EC 3.4.24.61) (N-arginine dibasic convertase) (NRD convertase) (NRD-C),RGSLSNAGDPEIVK,EEEGRRGSLSNAGDP,O43847,NRD1,S(3): 97.6;S(5): 2.4,O43847,S3(Phospho),1
0,0.08,-0.11,-0.14,0.30,0.20,0.48,0.38,K14(iTRAQ8plex);N-Term(iTRAQ8plex);S3(Phospho),14-3-3 domain binding motif;Calmodulin-dependent protein kinase II substrate motif;DNA dependent Protein kinase substrate motif;PKA kinase substrate motif;PKC kinase substrate motif,+,0.06222,8,1,1,14900000,0.006,3.31,0,2.62493275,Src substrate cortactin (Amplaxin) (Oncogene EMS1),LPSSPVYEDAASFK,PTEERLPSSPVYEDA,Q14247,CTTN,S(3): 87.8;S(4): 12.2;Y(7): 0.1;S(12): 0.0,Q14247,S3(Phospho),1
0,-0.03,0.96,0.88,-1.10,-1.20,-1.41,-1.54,K15(iTRAQ8plex);N-Term(iTRAQ8plex);S3(Phospho),14-3-3 domain binding motif;Calmodulin-dependent protein kinase II substrate motif;Calmodulin-dependent protein kinase IV substrate motif;Casein kinase II substrate motif;Chk1 kinase substrate motif;MDC1 BRCT domain binding motif;PKA kinase substrate motif;PKC kinase substrate motif;Plk1 PBD domain binding motif;Pyruvate dehydrogenase kinase substrate motif,+,0.0002733,83,1,1,368000000,0,5.44,0,4.953222728,Plakophilin-3,LSSGFDDIDLPSAVK,RTLQRLSSGFDDIDL,Q9Y446,PKP3,S(2): 0.6;S(3): 99.4;S(12): 0.0,Q9Y446,S3(Phospho),1
0,0.20,-0.72,-0.55,0.27,0.31,0.23,0.17,K16(iTRAQ8plex);N-Term(iTRAQ8plex);S3(Phospho),14-3-3 domain binding motif;AMP-activated protein kinase substrate motif;Calmodulin-dependent protein kinase I substrate motif;Calmodulin-dependent protein kinase II substrate motif;Calmodulin-dependent protein kinase IV substrate motif;Chk1 kinase substrate motif;G protein-coupled receptor kinase 1 substrate motif;PAK2 kinase substrate motif;PKA kinase substrate motif;PKC epsilon kinase substrate motif;PKC kinase substrate motif,+,7.68E-06,14,1,1,11900000,0,6.32,1,2.668641962,182 kDa tankyrase-1-binding protein,RFSEGVLQSPSQDQEK,SLVQRRFSEGVLQSP,Q9C0C2,TNKS1BP1,S(3): 100.0;S(9): 0.0;S(11): 0.0,Q9C0C2,S3(Phospho),1
0,-0.01,0.41,0.61,0.50,0.45,0.56,0.60,K17(iTRAQ8plex);N-Term(iTRAQ8plex);S3(Phospho),AMP-activated protein kinase substrate motif;Casein kinase II substrate motif;HMGCoA Reductase kinase substrate motif;MDC1 BRCT domain binding motif;PAK2 kinase substrate motif;PKA kinase substrate motif;PKC kinase substrate motif;Plk1 PBD domain binding motif,+,0.02304,6,1,1,4750000,0,3.5,0,2.347308657,Cerebellar degeneration-related protein 2 (Major Yo paraneoplastic antigen) (Paraneoplastic cerebellar degeneration-associated antigen),SSSETILSSLAGSDIVK,RKPLKRSSSETILSS,Q01850,CDR2,S(1): 8.0;S(2): 30.6;S(3): 30.6;T(5): 30.6;S(8): 0.1;S(9): 0.0;S(13): 0.0,Q01850,S3(Phospho),1
0,0.06,0.39,0.52,0.10,0.07,0.17,0.17,K17(iTRAQ8plex);N-Term(iTRAQ8plex);S3(Phospho),"14-3-3 domain binding motif;Calmodulin-dependent protein kinase II substrate motif;ERK1,2 kinase substrate motif;G protein-coupled receptor kinase 1 substrate motif;GSK3 kinase substrate motif;GSK-3, ERK1, ERK2, CDK5 substrate motif;MAPKAPK2 kinase substrate motif;PKA kinase substrate motif;PKC kinase substrate motif;WW domain binding motif",+,0.004528,4,1,1,6390000,0,4.94,0,2.408808994,Striatin-interacting protein 1 (Protein FAM40A),AASPPASASDLIEQQQK,IRNMRAASPPASASD,Q5VSL9,STRIP1,S(3): 100.0;S(7): 0.0;S(9): 0.0,Q5VSL9,S3(Phospho),1
0,-0.11,0.95,0.97,-0.03,-0.32,0.41,0.39,K17(iTRAQ8plex);N-Term(iTRAQ8plex);S3(Phospho),14-3-3 domain binding motif;Calmodulin-dependent protein kinase II substrate motif;Casein kinase II substrate motif;G protein-coupled receptor kinase 1 substrate motif;GSK3 kinase substrate motif;MAPKAPK2 kinase substrate motif;Phosphorylase kinase substrate motif;PKA kinase substrate motif;PKC kinase substrate motif,+,0.005298,80,1,1,324000000,0,5.23,0,2.804083451,DnaJ homolog subfamily C member 5 (Cysteine string protein) (CSP),SLSTSGESLYHVLGLDK,MADQRQRSLSTSGES,Q9H3Z4,DNAJC5,S(1): 88.1;S(3): 10.6;T(4): 1.3;S(5): 0.0;S(8): 0.0;Y(10): 0.0,Q9H3Z4,S3(Phospho),1
0,-0.10,0.69,0.90,-1.20,-1.35,0.17,0.41,K18(iTRAQ8plex);N-Term(iTRAQ8plex);S3(Phospho),14-3-3 domain binding motif;AMP-activated protein kinase substrate motif;b-Adrenergic Receptor kinase substrate motif;Calmodulin-dependent protein kinase II substrate motif;Casein kinase II substrate motif;G protein-coupled receptor kinase 1 substrate motif;HMGCoA Reductase kinase substrate motif;PKA kinase substrate motif;PKC kinase substrate motif;Pyruvate dehydrogenase kinase substrate motif,+,0.008679,16,1,1,26300000,0,6.05,0,3.419561656,Transcriptional coactivator YAP1 (Yes-associated protein 1) (Protein yorkie homolog) (Yes-associated protein YAP65 homolog),GDSETDLEALFNAVMNPK,IVHVRGDSETDLEAL,P46937,YAP1,S(3): 99.4;T(5): 0.6,P46937,S3(Phospho),1
0,0.25,-1.02,-0.67,0.68,0.68,0.33,0.29,K18(iTRAQ8plex);N-Term(iTRAQ8plex);S3(Phospho),14-3-3 domain binding motif;Calmodulin-dependent protein kinase II substrate motif;G protein-coupled receptor kinase 1 substrate motif;GSK3 kinase substrate motif;PKA kinase substrate motif;PKC kinase substrate motif;ZIP kinase substrate motif,+,0.003049,17,1,1,47800000,0,4.69,0,2.629493944,ELKS/Rab6-interacting/CAST family member 1 (ERC-1) (Rab6-interacting protein 2),TNSTGGSSGSSVGGGSGK,LGHRRTNSTGGSSGS,Q8IUD2,ERC1,T(1): 1.8;S(3): 86.2;T(4): 12.1;S(7): 0.0;S(8): 0.0;S(10): 0.0;S(11): 0.0;S(16): 0.0,Q8IUD2,S3(Phospho),1
0,-0.19,0.92,0.82,0.00,0.27,0.28,0.58,K19(iTRAQ8plex);N-Term(iTRAQ8plex);S3(Phospho),14-3-3 domain binding motif;Calmodulin-dependent protein kinase II substrate motif;G protein-coupled receptor kinase 1 substrate motif;PKA kinase substrate motif;PKC kinase substrate motif,+,0.0001501,4,2,1,1520000,0,4.64,0,1.819590347,Putative 3-phosphoinositide-dependent protein kinase 2 (EC 2.7.11.1) (3-phosphoinositide-dependent protein kinase 2 pseudogene),ANSFVGTAQYVSPELLTEK,SKQARANSFVGTAQY,Q6A1A2,PDPK2P,S(3): 100.0;T(7): 0.0;Y(10): 0.0;S(12): 0.0;T(17): 0.0,Q6A1A2,S3(Phospho),1
0,-0.05,0.10,-0.13,0.39,0.53,0.45,0.61,K19(iTRAQ8plex);N-Term(iTRAQ8plex);S3(Phospho),14-3-3 domain binding motif;Calmodulin-dependent protein kinase II substrate motif;Casein kinase II substrate motif;G protein-coupled receptor kinase 1 substrate motif;MAPKAPK2 kinase substrate motif;PKA kinase substrate motif;PKC kinase substrate motif,+,6.86E-05,6,1,1,761000,0,4.83,0,1.86669743,Rab11 family-interacting protein 5 (Rab11-FIP5) (Gamma-SNAP-associated factor 1) (Gaf-1) (Phosphoprotein pp75) (Rab11-interacting protein Rip11),SNSSSEAVLGQEELSAQAK,PRGSRSNSSSEAVLG,Q9BXF6,RAB11FIP5,S(1): 9.7;S(3): 89.0;S(4): 1.1;S(5): 0.1;S(15): 0.0,Q9BXF6,S3(Phospho),1
0,0.13,-2.54,-3.69,0.22,0.17,-0.40,-0.47,K2(iTRAQ8plex);N-Term(iTRAQ8plex);S3(Phospho),Casein kinase II substrate motif;PKA kinase substrate motif;PKC kinase substrate motif,+,0.004428,8,1,1,4380000,0,4.06,1,2.43519125,Calnexin (IP90) (Major histocompatibility complex class I antigen-binding protein p88) (p90),QKSDAEEDGGTVSQEEEDR,KLEEKQKSDAEEDGG,P27824,CANX,S(3): 100.0;T(11): 0.0;S(13): 0.0,P27824,S3(Phospho),1
0,0.15,-1.21,-1.31,-1.03,-0.94,-0.51,-0.54,K2(iTRAQ8plex);N-Term(iTRAQ8plex);S3(Phospho),14-3-3 domain binding motif;Calmodulin-dependent protein kinase II substrate motif;G protein-coupled receptor kinase 1 substrate motif;MAPKAPK1 kinase substrate motif;PKA kinase substrate motif;PKC kinase substrate motif,+,0.0007578,67,1,1,294000000,0,4.77,1,3.756715564,Neuroblast differentiation-associated protein AHNAK (Desmoyokin),LKSEDGVEGDLGETQSR,KIKPRLKSEDGVEGD,Q09666,AHNAK,S(3): 100.0;T(14): 0.0;S(16): 0.0,Q09666,S3(Phospho),1
0,-0.02,-1.22,-1.11,-0.35,-0.38,-0.34,-0.31,K2(iTRAQ8plex);N-Term(iTRAQ8plex);S3(Phospho),"Calmodulin-dependent protein kinase II substrate motif;Cdc2 kinase substrate motif;CDK kinase substrate motif;CDK1,2,4,6 kinase substrate motif;ERK1,2 kinase substrate motif;Growth associated histone HI kinase substrate motif;GSK-3, ERK1, ERK2, CDK5 substrate motif;PKA kinase substrate motif;PKC kinase substrate motif;WW domain binding motif",+,0.001314,39,1,1,827000000,0,5.93,2,4.336935899,RNA-binding protein 39 (CAPER alpha) (Hepatocellular carcinoma protein 1) (RNA-binding motif protein 39) (RNA-binding region-containing protein 2) (Splicing factor HCC1),DKSPVREPIDNLTPEER,SPFRKDKSPVREPID,Q14498,RBM39,S(3): 100.0;T(13): 0.0,Q14498,S3(Phospho),1
0,0.16,0.75,0.77,0.12,-0.01,0.54,0.49,K20(iTRAQ8plex);N-Term(iTRAQ8plex);S3(Phospho),14-3-3 domain binding motif;Calmodulin-dependent protein kinase II substrate motif;Casein kinase II substrate motif;G protein-coupled receptor kinase 1 substrate motif;MDC1 BRCT domain binding motif;PKA kinase substrate motif;PKC kinase substrate motif;Plk1 PBD domain binding motif,+,4.51E-05,8,1,1,235000,0,5.64,0,2.737703366,Transcriptional coactivator YAP1 (Yes-associated protein 1) (Protein yorkie homolog) (Yes-associated protein YAP65 homolog),QSSFEIPDDVPLPAGWEMAK,AQHLRQSSFEIPDDV,P46937,YAP1,S(2): 0.9;S(3): 99.1,P46937,S3(Phospho),1
0,0.01,0.52,0.46,0.63,0.56,1.77,1.72,K20(iTRAQ8plex);N-Term(iTRAQ8plex);S3(Phospho),MDC1 BRCT domain binding motif;Phosphorylase kinase substrate motif;PKA kinase substrate motif;PKC kinase substrate motif;Plk1 PBD domain binding motif,+,9.72E-06,18,1,1,303000000,0,7.13,0,5.249686933,Zyxin (Zyxin-2),VSSIDLEIDSLSSLLDDMTK,QPREKVSSIDLEIDS,Q15942,ZYX,S(2): 1.0;S(3): 99.0;S(10): 0.0;S(12): 0.0;S(13): 0.0;T(19): 0.0,Q15942,S3(Phospho),1
0,0.05,-1.66,-1.68,-0.40,-0.48,-0.50,-0.47,K21(iTRAQ8plex);N-Term(iTRAQ8plex);S3(Phospho),Aurora-A kinase substrate motif;b-Adrenergic Receptor kinase substrate motif;Calmodulin-dependent protein kinase II substrate motif;PAK2 kinase substrate motif;Phosphorylase kinase substrate motif;PKA kinase substrate motif;PKC kinase substrate motif,+,1.23E-06,26,1,1,78600000,0,8.89,1,5.399946004,182 kDa tankyrase-1-binding protein,RDSLGAYASQDANEQGQDLGK,WEFGKRDSLGAYASQ,Q9C0C2,TNKS1BP1,S(3): 100.0;Y(7): 0.0;S(9): 0.0,Q9C0C2,S3(Phospho),1
0,0.08,0.70,0.82,0.25,0.16,0.63,0.64,K5(iTRAQ8plex);N-Term(iTRAQ8plex);S3(Phospho),AMP-activated protein kinase substrate motif;Aurora-A kinase substrate motif;Calmodulin-dependent protein kinase II substrate motif;Casein kinase II substrate motif;Chk1 kinase substrate motif;PAK2 kinase substrate motif;Phosphorylase kinase substrate motif;PKA kinase substrate motif;PKC kinase substrate motif,+,0.01035,4,1,1,49400000,0,2.83,2,3.110718364,Cytochrome b5 type B (Cytochrome b5 outer mitochondrial membrane isoform),RNSLKELWLVIHGR,EEVAKRNSLKELWLV,O43169,CYB5B,S(3): 100.0,O43169,S3(Phospho),1
0,0.39,-1.37,-1.64,0.33,0.57,0.32,0.22,K5(iTRAQ8plex);N-Term(iTRAQ8plex);S3(Phospho),"b-Adrenergic Receptor kinase substrate motif;Calmodulin-dependent protein kinase II substrate motif;Casein kinase II substrate motif;Chk1 kinase substrate motif;ERK1,2 kinase substrate motif;G protein-coupled receptor kinase 1 substrate motif;Growth associated histone HI kinase substrate motif;GSK-3, ERK1, ERK2, CDK5 substrate motif;MAPKAPK2 kinase substrate motif;PKA kinase substrate motif;PKC kinase substrate motif;WW domain binding motif",+,0.04874,16,1,1,1080000000,0.0006143,3.56,1,2.805278793,"Heterogeneous nuclear ribonucleoprotein A1 (hnRNP A1) (Helix-destabilizing protein) (Single-strand RNA-binding protein) (hnRNP core protein A1) [Cleaved into: Heterogeneous nuclear ribonucleoprotein A1, N-terminally processed]",SESPKEPEQLR,__MSKSESPKEPEQL,P09651,HNRNPA1,S(1): 16.1;S(3): 83.9,P09651,S3(Phospho),1
0,-0.09,-0.87,-0.61,-0.40,-0.39,0.06,0.02,K6(iTRAQ8plex);N-Term(iTRAQ8plex);S3(Phospho),"Casein kinase II substrate motif;Cdc2 kinase substrate motif;CDK kinase substrate motif;CDK1,2,4,6 kinase substrate motif;ERK1,2 kinase substrate motif;G protein-coupled receptor kinase 1 substrate motif;GSK-3, ERK1, ERK2, CDK5 substrate motif;PAK2 kinase substrate motif;PKA kinase substrate motif;PKC kinase substrate motif;WW domain binding motif",+,0.1311,9,1,1,2210000000,0,1.82,1,2.375484406,Microtubule-associated protein 4 (MAP-4),RASPSKPASAPASR,KAPEKRASPSKPASA,P27816,MAP4,S(3): 99.5;S(5): 0.5;S(9): 0.0;S(13): 0.0,P27816,S3(Phospho),1
0,0.11,-0.49,-0.49,0.02,-0.11,-0.21,-0.29,K7(iTRAQ8plex);N-Term(iTRAQ8plex);S3(Phospho),"14-3-3 domain binding motif;Akt kinase substrate motif;AMP-activated protein kinase 2 substrate motif;Calmodulin-dependent protein kinase II substrate motif;ERK1,2 kinase substrate motif;GSK-3, ERK1, ERK2, CDK5 substrate motif;MAPKAPK1 kinase substrate motif;PKA kinase substrate motif;PKC kinase substrate motif;WW domain binding motif",+,0.06804,6,1,1,366000000,0.001183,2.34,0,2.400929549,Matrin-3,SYSPDGK,KSRKRSYSPDGKESP,P43243,MATR3,S(1): 1.7;Y(2): 11.1;S(3): 87.2,P43243,S3(Phospho),1
0,-0.20,-0.81,-0.30,0.75,0.44,0.70,0.74,K7(iTRAQ8plex);N-Term(iTRAQ8plex);S3(Phospho),Casein kinase II substrate motif;PAK2 kinase substrate motif;PKA kinase substrate motif;PKC kinase substrate motif;Pyruvate dehydrogenase kinase substrate motif,+,0.04404,4,1,1,73800000,0.003,1.97,1,1.899134257,Inactive tyrosine-protein kinase 7 (Colon carcinoma kinase 4) (CCK-4) (Protein-tyrosine kinase 7) (Pseudo tyrosine kinase receptor 7) (Tyrosine-protein kinase-like 7),RHSTSDK,AATNKRHSTSDKMHF,Q13308,PTK7,S(3): 99.0;T(4): 1.0;S(5): 0.0,Q13308,S3(Phospho),1
0,0.16,-1.44,-0.26,2.65,2.35,2.21,2.44,K7(iTRAQ8plex);N-Term(iTRAQ8plex);S3(Phospho),Akt kinase substrate motif;Casein kinase II substrate motif;G protein-coupled receptor kinase 1 substrate motif;PKA kinase substrate motif;PKC kinase substrate motif,+,0.1618,10,2,1,64300000,0.005568,1.85,0,2.431369796,Protein Shroom2 (Apical-like protein) (Protein APXL),SYSEPEK,EQKLKSYSEPEKMNE,Q13796,SHROOM2,S(1): 5.2;Y(2): 47.4;S(3): 47.4,Q13796,S3(Phospho),1
0,-0.10,-1.13,-1.18,-0.41,-0.43,-0.65,-0.65,K7(iTRAQ8plex);N-Term(iTRAQ8plex);S3(Phospho),Casein kinase II substrate motif;MAPKAPK2 kinase substrate motif;PAK2 kinase substrate motif;PKA kinase substrate motif;PKC kinase substrate motif,+,0.04136,7,1,1,303000000,0.002,2.73,1,4.362525784,Plectin (PCN) (PLTN) (Hemidesmosomal protein 1) (HD1) (Plectin-1),RASFAEK,ELQSKRASFAEKTAQ,Q15149,PLEC,S(3): 100.0,Q15149,S3(Phospho),1
0,-0.01,-0.72,-0.63,0.20,0.11,0.08,0.07,K7(iTRAQ8plex);N-Term(iTRAQ8plex);S3(Phospho),"14-3-3 domain binding motif;Calmodulin-dependent protein kinase II substrate motif;ERK1,2 kinase substrate motif;GSK-3, ERK1, ERK2, CDK5 substrate motif;PKA kinase substrate motif;PKC epsilon kinase substrate motif;PKC kinase substrate motif;WW domain binding motif",+,0.01534,22,1,1,1560000000,0,3.18,0,3.757481222,Leucine zipper protein 1,ELSPQHK,KHTARELSPQHKRER,Q86V48,LUZP1,S(3): 100.0,Q86V48,S3(Phospho),1
0,-0.09,-1.61,-1.30,-0.19,-0.36,-0.40,-0.29,K7(iTRAQ8plex);N-Term(iTRAQ8plex);S3(Phospho),"14-3-3 domain binding motif;Calmodulin-dependent protein kinase II substrate motif;ERK1,2 kinase substrate motif;Growth associated histone HI kinase substrate motif;GSK-3, ERK1, ERK2, CDK5 substrate motif;PKA kinase substrate motif;PKC epsilon kinase substrate motif;PKC kinase substrate motif;WW domain binding motif",+,0.03983,39,1,1,2380000000,0,3.44,1,2.765742731,Thyroid hormone receptor-associated protein 3 (Thyroid hormone receptor-associated protein complex 150 kDa component) (Trap150),ERSPALK,ELSPRERSPALKSPL,Q9Y2W1,THRAP3,S(3): 100.0,Q9Y2W1,S3(Phospho),1
0,0.15,-0.51,-0.48,-0.57,-0.70,-0.49,-0.52,K8(iTRAQ8plex);N-Term(iTRAQ8plex);S3(Phospho),"14-3-3 domain binding motif;b-Adrenergic Receptor kinase substrate motif;Calmodulin-dependent protein kinase II substrate motif;Calmodulin-dependent protein kinase IV substrate motif;Casein kinase II substrate motif;ERK1,2 kinase substrate motif;GSK-3, ERK1, ERK2, CDK5 substrate motif;PKA kinase substrate motif;PKC kinase substrate motif;Pyruvate dehydrogenase kinase substrate motif;WW domain binding motif",+,0.006279,27,1,1,254000000,0,3.01,0,2.681223007,Stress-induced-phosphoprotein 1 (STI1) (Hsc70/Hsp90-organizing protein) (Hop) (Renal carcinoma antigen NY-REN-11) (Transformation-sensitive protein IEF SSP 3521),HDSPEDVK,AQYNRHDSPEDVKRR,P31948,STIP1,S(3): 100.0,P31948,S3(Phospho),1
0,0.23,0.53,0.35,0.92,1.10,1.25,1.16,K8(iTRAQ8plex);N-Term(iTRAQ8plex);S3(Phospho),14-3-3 domain binding motif;ATM kinase substrate motif;Calmodulin-dependent protein kinase II substrate motif;Casein kinase II substrate motif;DNA dependent Protein kinase substrate motif;G protein-coupled receptor kinase 1 substrate motif;GSK3 kinase substrate motif;PAK2 kinase substrate motif;PKA kinase substrate motif;PKC epsilon kinase substrate motif;PKC kinase substrate motif;Pyruvate dehydrogenase kinase substrate motif,+,0.02844,8,1,1,353000000,0,3,1,2.538480542,PDZ and LIM domain protein 5 (Enigma homolog) (Enigma-like PDZ and LIM domains protein),RGSQGDSK,AEGQRRGSQGDSKQQ,Q96HC4,PDLIM5,S(3): 100.0;S(7): 0.0,Q96HC4,S3(Phospho),1
0,-0.02,-2.78,-2.76,-0.12,-0.26,-0.49,-0.42,K8(iTRAQ8plex);N-Term(iTRAQ8plex);S3(Phospho),"Calmodulin-dependent protein kinase II substrate motif;Casein kinase II substrate motif;ERK1,2 kinase substrate motif;G protein-coupled receptor kinase 1 substrate motif;GSK-3, ERK1, ERK2, CDK5 substrate motif;PKA kinase substrate motif;PKC kinase substrate motif;WW domain binding motif",+,0.11,18,1,1,693000000,0.0033,3.05,0,5.520910048,LIM domain and actin-binding protein 1 (Epithelial protein lost in neoplasm),QQSPQEPK,NSFLKQQSPQEPKSL,Q9UHB6,LIMA1,S(3): 100.0,Q9UHB6,S3(Phospho),1
0,-0.07,0.99,1.43,1.04,0.90,0.89,0.62,K9(iTRAQ8plex);N-Term(iTRAQ8plex);S3(Phospho),"14-3-3 domain binding motif;Calmodulin-dependent protein kinase II substrate motif;Casein kinase II substrate motif;ERK1,2 kinase substrate motif;GSK-3, ERK1, ERK2, CDK5 substrate motif;MAPKAPK2 kinase substrate motif;PKA kinase substrate motif;PKC kinase substrate motif;WW domain binding motif",+,0.07885,4,1,1,142000000,0.00339,2.34,0,1.958889677,Insulin-like growth factor 2 mRNA-binding protein 3 (IGF2 mRNA-binding protein 3) (IMP-3) (IGF-II mRNA-binding protein 3) (KH domain-containing protein overexpressed in cancer) (hKOC) (VICKZ family member 3),QGSPGSVSK,RGSSRQGSPGSVSKQ,O00425,IGF2BP3,S(3): 100.0;S(6): 0.0;S(8): 0.0,O00425,S3(Phospho),1
0,0.02,-0.49,-0.33,-0.39,-0.38,-0.30,-0.36,K9(iTRAQ8plex);N-Term(iTRAQ8plex);S3(Phospho),"ERK1,2 kinase substrate motif;GSK-3, ERK1, ERK2, CDK5 substrate motif;PKA kinase substrate motif;PKC kinase substrate motif;WW domain binding motif",+,0.01937,20,1,1,25100000,0,3.76,0,2.162364161,Surfeit locus protein 6,ELSPAALEK,QGSAKELSPAALEKR,O75683,SURF6,S(3): 100.0,O75683,S3(Phospho),1
0,-0.02,-0.79,-0.80,-0.10,-0.14,-0.10,-0.03,K9(iTRAQ8plex);N-Term(iTRAQ8plex);S3(Phospho),"ERK1,2 kinase substrate motif;G protein-coupled receptor kinase 1 substrate motif;GSK-3, ERK1, ERK2, CDK5 substrate motif;PAK2 kinase substrate motif;PKA kinase substrate motif;PKC kinase substrate motif;WW domain binding motif",+,0.02365,8,1,1,106000000,0,4.1,1,4.445579392,Protein SET (HLA-DR-associated protein II) (Inhibitor of granzyme A-activated DNase) (IGAAD) (PHAPII) (Phosphatase 2A inhibitor I2PP2A) (I-2PP2A) (Template-activating factor I) (TAF-I),RQSPLPPQK,_MAPKRQSPLPPQKK,Q01105,SET,S(3): 100.0,Q01105,S3(Phospho),1
0,0.07,0.53,0.57,0.54,0.46,0.84,0.77,K9(iTRAQ8plex);N-Term(iTRAQ8plex);S3(Phospho),Casein kinase II substrate motif;G protein-coupled receptor kinase 1 substrate motif;PKA kinase substrate motif;PKC kinase substrate motif,+,0.03288,44,1,1,134000000,0,3.39,0,3.478214865,Serine/threonine-protein kinase PAK 2 (EC 2.7.11.1) (Gamma-PAK) (PAK65) (S6/H4 kinase) (p21-activated kinase 2) (PAK-2) (p58) [Cleaved into: PAK-2p27 (p27);PAK-2p34 (p34) (C-t-PAK2)],YLSFTPPEK,TVKQKYLSFTPPEKD,Q13177,PAK2,Y(1): 0.1;S(3): 99.8;T(5): 0.1,Q13177,S3(Phospho),1
0,-0.03,-0.87,-0.84,-0.23,-0.27,-0.12,-0.16,K9(iTRAQ8plex);N-Term(iTRAQ8plex);S3(Phospho),Crk SH2 domain binding motif;RasGAP C-terminal SH2 domain binding motif,+,0.004299,44,1,1,2070000000,0,3.89,1,4.856260193,RNA-binding protein 39 (CAPER alpha) (Hepatocellular carcinoma protein 1) (RNA-binding motif protein 39) (RNA-binding region-containing protein 2) (Splicing factor HCC1),YRSPYSGPK,DRRFRGRYRSPYSGP,Q14498,RBM39,Y(1): 100.0;S(3): 0.0;Y(5): 0.0;S(6): 0.0,Q14498,S3(Phospho),1
0,0.26,-0.58,-0.69,0.47,0.41,0.44,0.56,K9(iTRAQ8plex);N-Term(iTRAQ8plex);S3(Phospho),14-3-3 domain binding motif;Calmodulin-dependent protein kinase II substrate motif;Casein kinase II substrate motif;MAPKAPK2 kinase substrate motif;MDC1 BRCT domain binding motif;PAK2 kinase substrate motif;PKA kinase substrate motif;PKC epsilon kinase substrate motif;PKC kinase substrate motif;Plk1 PBD domain binding motif,+,0.01346,4,1,1,424000000,0,3.8,1,2.81888775,Leucine zipper protein 1,RSSSEGLSK,LASSRRSSSEGLSKG,Q86V48,LUZP1,S(2): 1.0;S(3): 89.8;S(4): 9.2;S(8): 0.0,Q86V48,S3(Phospho),1
0,-0.07,-0.79,-0.72,0.02,-0.16,-0.31,-0.25,K9(iTRAQ8plex);N-Term(iTRAQ8plex);S3(Phospho),"b-Adrenergic Receptor kinase substrate motif;Casein kinase II substrate motif;ERK1,2 kinase substrate motif;G protein-coupled receptor kinase 1 substrate motif;GSK-3, ERK1, ERK2, CDK5 substrate motif;PAK2 kinase substrate motif;PKA kinase substrate motif;PKC kinase substrate motif;WW domain binding motif",+,0.00943,14,1,1,179000000,0,3.85,1,2.757363299,Serine/arginine repetitive matrix protein 1 (SR-related nuclear matrix protein of 160 kDa) (SRm160) (Ser/Arg-related nuclear matrix protein),RESPSPAPKPR,KGTEKRESPSPAPKP,Q8IYB3,SRRM1,S(3): 87.9;S(5): 12.1,Q8IYB3,S3(Phospho),1
0,0.04,-0.74,-0.70,0.04,-0.02,-0.12,-0.16,K9(iTRAQ8plex);N-Term(iTRAQ8plex);S3(Phospho),"14-3-3 domain binding motif;Akt kinase substrate motif;Calmodulin-dependent protein kinase II substrate motif;ERK1,2 kinase substrate motif;G protein-coupled receptor kinase 1 substrate motif;GSK-3, ERK1, ERK2, CDK5 substrate motif;MAPKAPK1 kinase substrate motif;PKA kinase substrate motif;PKC kinase substrate motif;WW domain binding motif;ZIP kinase substrate motif",+,0.0314,32,1,1,219000000,0,2.83,0,4.306715692,Serine/arginine repetitive matrix protein 1 (SR-related nuclear matrix protein of 160 kDa) (SRm160) (Ser/Arg-related nuclear matrix protein),TASPPPPPK,PPKRRTASPPPPPKR,Q8IYB3,SRRM1,T(1): 8.8;S(3): 91.2,Q8IYB3,S3(Phospho),1
0,0.11,1.10,1.47,-2.42,-1.64,-2.24,-2.06,K9(iTRAQ8plex);N-Term(iTRAQ8plex);S3(Phospho),14-3-3 domain binding motif;Calmodulin-dependent protein kinase I substrate motif;Calmodulin-dependent protein kinase II substrate motif;Calmodulin-dependent protein kinase IV substrate motif;Chk1 kinase substrate motif;MDC1 BRCT domain binding motif;PKA kinase substrate motif;PKC kinase substrate motif;Plk1 PBD domain binding motif,+,0.02782,20,1,1,48800000,0,2.52,0,3.001822884,SH2 domain-containing protein 3A (Novel SH2-containing protein 1),TSSDPVLLK,SALPRTSSDPVLLKA,Q9BRG2,SH2D3A,T(1): 4.1;S(2): 4.1;S(3): 91.8,Q9BRG2,S3(Phospho),1
0,0.12,-0.21,-0.49,1.65,1.39,1.53,1.62,K9(iTRAQ8plex);N-Term(iTRAQ8plex);S3(Phospho),"14-3-3 domain binding motif;Calmodulin-dependent protein kinase II substrate motif;Casein kinase II substrate motif;ERK1,2 kinase substrate motif;GSK-3, ERK1, ERK2, CDK5 substrate motif;PKA kinase substrate motif;PKC kinase substrate motif;WW domain binding motif",+,0.1587,4,1,1,181000000,0.003052,2.88,0,3.45726838,Insulin receptor substrate 2 (IRS-2),VASPTSGVK,PEAARVASPTSGVKR,Q9Y4H2,IRS2,S(3): 100.0;T(5): 0.0;S(6): 0.0,Q9Y4H2,S3(Phospho),1
0,-0.08,-0.02,0.16,0.28,0.31,0.87,0.99,K17(iTRAQ8plex);S3(Phospho),Phosphorylase kinase substrate motif;PKA kinase substrate motif;PKC kinase substrate motif,+,0.005329,10,1,1,144000000,0,4.07,0,3.014149709,Microtubule-associated protein 4 (MAP-4),VGSLDNVGHLPAGGAVK,KAQAKVGSLDNVGHL,P27816,MAP4,S(3): 100.0,P27816,S3(Phospho),1
0,-0.04,-0.73,-0.55,0.12,-0.02,-0.01,0.25,N-Term(iTRAQ8plex);S3(Phospho),"14-3-3 domain binding motif;Calmodulin-dependent protein kinase II substrate motif;Calmodulin-dependent protein kinase IV substrate motif;Casein kinase II substrate motif;Chk1 kinase substrate motif;ERK1,2 kinase substrate motif;GSK-3, ERK1, ERK2, CDK5 substrate motif;PKA kinase substrate motif;PKC kinase substrate motif;Pyruvate dehydrogenase kinase substrate motif;WW domain binding motif",+,0.0001059,6,1,1,2760000,0,4.41,0,2.003970128,Small acidic protein,SASPDDDLGSSNWEAADLGNEER,HGVKRSASPDDDLGS,O00193,SMAP,S(1): 15.7;S(3): 84.3;S(10): 0.0;S(11): 0.0,O00193,S3(Phospho),1
0,0.41,-1.65,-1.39,-1.02,-0.66,-1.19,-1.39,N-Term(iTRAQ8plex);S3(Phospho),14-3-3 domain binding motif;Akt kinase substrate motif;Calmodulin-dependent protein kinase II substrate motif;Casein kinase II substrate motif;MAPKAPK1 kinase substrate motif;PKA kinase substrate motif;PKC kinase substrate motif,+,0.01542,4,1,1,6170000,0,2.96,0,2.267740406,Ladinin-1 (Lad-1) (Linear IgA disease antigen) (LADA),NLSSTTDDEAPR,RRRHRNLSSTTDDEA,O00515,LAD1,S(3): 90.9;S(4): 8.9;T(5): 0.1;T(6): 0.1,O00515,S3(Phospho),1
0,0.11,0.32,0.32,0.66,0.63,0.83,0.84,N-Term(iTRAQ8plex);S3(Phospho),14-3-3 domain binding motif;Aurora-A kinase substrate motif;b-Adrenergic Receptor kinase substrate motif;Calmodulin-dependent protein kinase II substrate motif;MAPKAPK2 kinase substrate motif;PAK2 kinase substrate motif;Phosphorylase kinase substrate motif;PKA kinase substrate motif;PKC epsilon kinase substrate motif;PKC kinase substrate motif,+,0.0132,26,1,1,198000000,0,3.61,1,3.846745384,Coatomer subunit epsilon (Epsilon-coat protein) (Epsilon-COP),RDSIVAELDR,AHESRRDSIVAELDR,O14579,COPE,S(3): 100.0,O14579,S3(Phospho),1
0,-0.01,-0.98,-0.99,-0.01,-0.09,-0.10,-0.08,N-Term(iTRAQ8plex);S3(Phospho),14-3-3 domain binding motif;Calmodulin-dependent protein kinase II substrate motif;Casein kinase II substrate motif;DNA dependent Protein kinase substrate motif;PKA kinase substrate motif;PKC kinase substrate motif;Pyruvate dehydrogenase kinase substrate motif,+,0.0001385,24,1,1,160000000,0,4.87,1,4.753913739,Catenin delta-1 (Cadherin-associated Src substrate) (CAS) (p120 catenin) (p120(ctn)) (p120(cas)),APSRQDVYGPQPQVR,MEGYRAPSRQDVYGP,O60716,CTNND1,S(3): 100.0;Y(8): 0.0,O60716,S3(Phospho),1
0,0.38,-0.11,0.08,1.46,1.42,1.67,1.71,N-Term(iTRAQ8plex);S3(Phospho),"14-3-3 domain binding motif;Calmodulin-dependent protein kinase II substrate motif;Casein kinase II substrate motif;ERK1,2 kinase substrate motif;GSK-3, ERK1, ERK2, CDK5 substrate motif;MDC1 BRCT domain binding motif;PKA kinase substrate motif;PKC kinase substrate motif;Plk1 PBD domain binding motif;WW domain binding motif;ZIP kinase substrate motif",+,0.04059,4,1,1,4690000,0.0006395,2.77,0,3.094870598,Actin-binding LIM protein 3 (abLIM-3) (Actin-binding LIM protein family member 3),ASSPGYIDSPTYSR,LRQRRASSPGYIDSP,O94929,ABLIM3,S(2): 11.7;S(3): 76.4;Y(6): 11.7;S(9): 0.1;T(11): 0.0;Y(12): 0.0;S(13): 0.0,O94929,S3(Phospho),1
0,-0.19,-0.27,-0.16,0.37,0.23,0.50,0.53,N-Term(iTRAQ8plex);S3(Phospho),14-3-3 domain binding motif;Akt kinase substrate motif;Calmodulin-dependent protein kinase II substrate motif;MAPKAPK1 kinase substrate motif;PAK2 kinase substrate motif;PKA kinase substrate motif;PKC epsilon kinase substrate motif;PKC kinase substrate motif,+,0.06279,3,1,1,79600000,0.001645,3.02,1,2.347117008,Actin-binding LIM protein 3 (abLIM-3) (Actin-binding LIM protein family member 3),RFSSGGEEDDFDR,VPRARRFSSGGEEDD,O94929,ABLIM3,S(3): 98.2;S(4): 1.8,O94929,S3(Phospho),1
0,0.02,-0.26,-0.46,-0.76,-0.60,-0.40,-0.44,N-Term(iTRAQ8plex);S3(Phospho),14-3-3 domain binding motif;Calmodulin-dependent protein kinase II substrate motif;DNA dependent Protein kinase substrate motif;PKA kinase substrate motif;PKC kinase substrate motif,+,0.002544,58,1,1,66000000,0,3.61,0,2.139833463,"Keratin, type I cytoskeletal 14 (Cytokeratin-14) (CK-14) (Keratin-14) (K14)",APSTYGGGLSVSSSR,GGSCRAPSTYGGGLS,P02533,KRT14,S(3): 98.6;T(4): 1.2;Y(5): 0.2;S(10): 0.0;S(12): 0.0;S(13): 0.0;S(14): 0.0,P02533,S3(Phospho),1
0,0.33,2.07,2.21,0.57,0.20,0.61,0.61,N-Term(iTRAQ8plex);S3(Phospho),14-3-3 domain binding motif;AMP-activated protein kinase substrate motif;Calmodulin-dependent protein kinase I substrate motif;Calmodulin-dependent protein kinase II substrate motif;Calmodulin-dependent protein kinase IV substrate motif;Chk1 kinase substrate motif;DNA dependent Protein kinase substrate motif;HMGCoA Reductase kinase substrate motif;PKA kinase substrate motif;PKC kinase substrate motif,+,0.02519,46,1,1,34900000,0,2.83,1,2.885171261,Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27),GPSWDPFRDWYPHSR,FSLLRGPSWDPFRDW,P04792,HSPB1,S(3): 100.0;Y(11): 0.0;S(14): 0.0,P04792,S3(Phospho),1
0,-0.02,1.36,1.35,-0.96,-1.24,-0.33,-0.34,N-Term(iTRAQ8plex);S3(Phospho),14-3-3 domain binding motif;Calmodulin-dependent protein kinase II substrate motif;Calmodulin-dependent protein kinase IV substrate motif;Chk1 kinase substrate motif;G protein-coupled receptor kinase 1 substrate motif;GSK3 kinase substrate motif;MAPKAPK2 kinase substrate motif;PKA kinase substrate motif;PKC kinase substrate motif,+,0.01406,536,1,1,4660000000,0,3.47,0,4.128996809,Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27),QLSSGVSEIR,RALSRQLSSGVSEIR,P04792,HSPB1,S(3): 93.5;S(4): 6.5;S(7): 0.0,P04792,S3(Phospho),1
0,0.05,1.07,0.95,0.81,0.71,1.68,1.68,N-Term(iTRAQ8plex);S3(Phospho),"Calmodulin-dependent protein kinase II substrate motif;Casein kinase II substrate motif;Chk1 kinase substrate motif;ERK1,2 kinase substrate motif;GSK-3, ERK1, ERK2, CDK5 substrate motif;PKA kinase substrate motif;PKC kinase substrate motif;WW domain binding motif",+,0.02916,10,2,1,317000000,0,2.96,0,4.41384728,Transcription factor AP-1 (Activator protein 1) (AP1) (Proto-oncogene c-Jun) (V-jun avian sarcoma virus 17 oncogene homolog) (p39),LASPELER,VGLLKLASPELERLI,P05412,JUN,S(3): 100.0,P05412,S3(Phospho),1
0,-0.09,0.03,0.33,-2.35,-2.17,-2.17,-2.18,N-Term(iTRAQ8plex);S3(Phospho),14-3-3 domain binding motif;Calmodulin-dependent protein kinase II substrate motif;DNA dependent Protein kinase substrate motif;Phosphorylase kinase substrate motif;PKA kinase substrate motif;PKC kinase substrate motif,+,0.07807,171,1,1,16500000000,0,3.39,0,4.147589158,"Keratin, type I cytoskeletal 19 (Cytokeratin-19) (CK-19) (Keratin-19) (K19)",APSIHGGSGGR,GVAFRAPSIHGGSGG,P08727,KRT19,S(3): 100.0;S(8): 0.0,P08727,S3(Phospho),1
0,0.06,0.54,0.72,-0.06,-0.09,0.21,0.25,N-Term(iTRAQ8plex);S3(Phospho),Casein kinase II substrate motif;G protein-coupled receptor kinase 1 substrate motif;PKA kinase substrate motif,+,0.02719,25,2,1,674000000,0,2.07,0,2.692559299,Serine/threonine-protein kinase A-Raf (EC 2.7.11.1) (Proto-oncogene A-Raf) (Proto-oncogene A-Raf-1) (Proto-oncogene Pks),SASEPSLHR,SLPKINRSASEPSLH,P10398,ARAF,S(1): 50.0;S(3): 50.0;S(6): 0.0,P10398,S3(Phospho),1
0,-0.09,-1.11,-1.07,-0.65,-0.63,-0.64,-0.69,N-Term(iTRAQ8plex);S3(Phospho),Aurora-A kinase substrate motif;Casein kinase II substrate motif;G protein-coupled receptor kinase 1 substrate motif;GSK3 kinase substrate motif;MAPKAPK2 kinase substrate motif;PAK2 kinase substrate motif;Phosphorylase kinase substrate motif;PKA kinase substrate motif;PKC kinase substrate motif,+,0.04625,25,1,1,156000000,0,2.88,1,4.132537948,"Keratin, type II cytoskeletal 5 (58 kDa cytokeratin) (Cytokeratin-5) (CK-5) (Keratin-5) (K5) (Type-II keratin Kb5)",RISISTSGGSFR,LGGSKRISISTSGGS,P13647,KRT5,S(3): 100.0;S(5): 0.0;T(6): 0.0;S(7): 0.0;S(10): 0.0,P13647,S3(Phospho),1
0,0.25,-0.78,-0.80,-0.16,-0.17,-0.16,-0.09,N-Term(iTRAQ8plex);S3(Phospho),14-3-3 domain binding motif;Calmodulin-dependent protein kinase II substrate motif;Calmodulin-dependent protein kinase IV substrate motif;Casein kinase II substrate motif;PKA kinase substrate motif;PKC kinase substrate motif;Pyruvate dehydrogenase kinase substrate motif,+,0.06053,2,1,1,178000,0.004,2.25,0,2.63990952,Negative elongation factor E (NELF-E) (RNA-binding protein RD),SISADDDLQESSR,QPFQRSISADDDLQE,P18615,NELFE,S(1): 0.3;S(3): 99.7;S(11): 0.0;S(12): 0.0,P18615,S3(Phospho),1
0,0.24,-0.80,-0.79,-0.17,-0.11,-0.35,-0.36,N-Term(iTRAQ8plex);S3(Phospho),14-3-3 domain binding motif;Akt kinase substrate motif;Calmodulin-dependent protein kinase II substrate motif;Casein kinase II substrate motif;G protein-coupled receptor kinase 1 substrate motif;MAPKAPK1 kinase substrate motif;MAPKAPK2 kinase substrate motif;PKA kinase substrate motif;PKC kinase substrate motif,+,0.002291,32,1,1,51100000,0,4.41,0,2.699508007,Eukaryotic translation initiation factor 4B (eIF-4B),TGSESSQTGTSTTSSR,RERSRTGSESSQTGT,P23588,EIF4B,T(1): 0.1;S(3): 99.9;S(5): 0.0;S(6): 0.0;T(8): 0.0;T(10): 0.0;S(11): 0.0;T(12): 0.0;T(13): 0.0;S(14): 0.0;S(15): 0.0,P23588,S3(Phospho),1
0,0.07,0.85,0.96,0.29,0.04,0.59,0.65,N-Term(iTRAQ8plex);S3(Phospho),Aurora-A kinase substrate motif;Casein kinase II substrate motif;G protein-coupled receptor kinase 1 substrate motif;PAK2 kinase substrate motif;Phosphorylase kinase substrate motif;Pim1 kinase substrate sequence;PKA kinase substrate motif;PKC kinase substrate motif,+,0.004007,18,1,1,117000000,0,4.03,1,2.506707793,Catenin beta-1 (Beta-catenin),RLSVELTSSLFR,QDYKKRLSVELTSSL,P35222,CTNNB1,S(3): 100.0;T(7): 0.0;S(8): 0.0;S(9): 0.0,P35222,S3(Phospho),1
0,0.36,-0.02,0.65,2.13,1.73,2.60,2.60,N-Term(iTRAQ8plex);S3(Phospho),14-3-3 domain binding motif;Calmodulin-dependent protein kinase II substrate motif;Casein kinase II substrate motif;DNA dependent Protein kinase substrate motif;G protein-coupled receptor kinase 1 substrate motif;MAPKAPK2 kinase substrate motif;PAK2 kinase substrate motif;PKA kinase substrate motif;PKC epsilon kinase substrate motif;PKC kinase substrate motif,+,0.0007101,41,1,1,275000000,0,7.33,0,2.513907921,PDZ and LIM domain protein 4 (LIM protein RIL) (Reversion-induced LIM protein),RPSGTGTGPEDGRPSLGSPYGQPPR,PTTSRRPSGTGTGPE,P50479,PDLIM4,S(3): 96.5;T(5): 3.4;T(7): 0.1;S(15): 0.0;S(18): 0.0;Y(20): 0.0,P50479,S3(Phospho),1
0,-0.06,-0.68,-0.67,0.20,0.27,-0.45,-0.28,N-Term(iTRAQ8plex);S3(Phospho),14-3-3 domain binding motif;Calmodulin-dependent protein kinase II substrate motif;Casein kinase II substrate motif;G protein-coupled receptor kinase 1 substrate motif;GSK3 kinase substrate motif;MAPKAPK1 kinase substrate motif;PAK2 kinase substrate motif;PKA kinase substrate motif;PKC epsilon kinase substrate motif;PKC kinase substrate motif,+,0.001666,11,1,1,127000000,0,3.89,1,3.17591572,Biotin--protein ligase (EC 6.3.4.-) (Biotin apo-protein ligase) [Includes: Biotin--[methylmalonyl-CoA-carboxytransferase] ligase (EC 6.3.4.9);Biotin--[propionyl-CoA-carboxylase [ATP-hydrolyzing]] ligase (EC 6.3.4.10) (Holocarboxylase synthetase) (HCS);Biotin--[methylcrotonoyl-CoA-carboxylase] ligase (EC 6.3.4.11);Biotin--[acetyl-CoA-carboxylase] ligase (EC 6.3.4.15)],RGSASGSEPAGDSDR,EPKQRRGSASGSEPA,P50747,HLCS,S(3): 98.8;S(5): 0.6;S(7): 0.6;S(13): 0.0,P50747,S3(Phospho),1
0,0.19,-1.06,-1.12,0.45,0.71,-0.04,-0.13,N-Term(iTRAQ8plex);S3(Phospho),14-3-3 domain binding motif;b-Adrenergic Receptor kinase substrate motif;Calmodulin-dependent protein kinase II substrate motif;G protein-coupled receptor kinase 1 substrate motif;MAPKAPK2 kinase substrate motif;PKA kinase substrate motif;PKC kinase substrate motif,+,0.03155,4,1,1,26200000,0,3.53,1,3.182973392,Eukaryotic translation initiation factor 3 subunit B (eIF3b) (Eukaryotic translation initiation factor 3 subunit 9) (Prt1 homolog) (hPrt1) (eIF-3-eta) (eIF3 p110) (eIF3 p116),SDSRAQAVSEDAGGNEGR,ARDERSDSRAQAVSE,P55884,EIF3B,S(1): 0.3;S(3): 99.7;S(9): 0.0,P55884,S3(Phospho),1
0,0.14,0.34,0.31,0.53,0.58,0.51,0.38,N-Term(iTRAQ8plex);S3(Phospho),PAK2 kinase substrate motif;PKA kinase substrate motif;PKC kinase substrate motif,+,0.03576,6,1,1,11900000,0,3.1,1,2.023249917,Histone H4,RISGLIYEETR,RGGVKRISGLIYEET,P62805,HIST1H4A,S(3): 100.0;Y(7): 0.0;T(10): 0.0,P62805,S3(Phospho),1
0,-0.03,-2.46,-2.37,-0.06,-0.09,-0.30,-0.25,N-Term(iTRAQ8plex);S3(Phospho),"14-3-3 domain binding motif;Calmodulin-dependent protein kinase II substrate motif;ERK1,2 kinase substrate motif;Growth associated histone HI kinase substrate motif;GSK-3, ERK1, ERK2, CDK5 substrate motif;MAPKAPK2 kinase substrate motif;PAK2 kinase substrate motif;PKA kinase substrate motif;PKC epsilon kinase substrate motif;PKC kinase substrate motif;WW domain binding motif",+,0.04158,10,1,1,226000000,0.002,1.67,2,5.882943277,"Serine/arginine-rich splicing factor 3 (Pre-mRNA-splicing factor SRP20) (Splicing factor, arginine/serine-rich 3)",RRSPPPR,RDDYRRRSPPPRRRS,P84103,SRSF3,S(3): 100.0,P84103,S3(Phospho),1
0,0.21,0.73,0.88,0.44,0.47,0.46,0.65,N-Term(iTRAQ8plex);S3(Phospho),Aurora-A kinase substrate motif;Calmodulin-dependent protein kinase II substrate motif;Chk1 kinase substrate motif;PAK2 kinase substrate motif;Phosphorylase kinase substrate motif;PKA kinase substrate motif;PKC kinase substrate motif,+,0.06343,3,2,1,39500000,0.006,3.61,1,1.819868751,Cyclin-dependent kinase 16 (EC 2.7.11.22) (Cell division protein kinase 16) (PCTAIRE-motif protein kinase 1) (Serine/threonine-protein kinase PCTAIRE-1),RLSLPADIR,EDINKRLSLPADIRL,Q00536,CDK16,S(3): 100.0,Q00536,S3(Phospho),1
0,-0.02,-0.29,-0.14,-0.56,-0.74,-0.68,-0.62,N-Term(iTRAQ8plex);S3(Phospho),Calmodulin-dependent protein kinase II substrate motif;Casein kinase II substrate motif;Chk1 kinase substrate motif;Phosphorylase kinase substrate motif;PKA kinase substrate motif;PKC kinase substrate motif,+,0.02713,13,1,1,767000000,0,3.48,1,2.444883005,Eukaryotic translation initiation factor 4 gamma 1 (eIF-4-gamma 1) (eIF-4G 1) (eIF-4G1) (p220),AASLTEDRDR,EGLRKAASLTEDRDR,Q04637,EIF4G1,S(3): 88.2;T(5): 11.8,Q04637,S3(Phospho),1
0,0.12,-0.19,-0.32,-0.18,-0.18,0.29,0.30,N-Term(iTRAQ8plex);S3(Phospho),14-3-3 domain binding motif;Calmodulin-dependent protein kinase II substrate motif;G protein-coupled receptor kinase 1 substrate motif;GSK3 kinase substrate motif;PKA kinase substrate motif;PKC kinase substrate motif,+,0.002723,74,1,1,628000000,0,4.19,0,2.59387786,"KH domain-containing, RNA-binding, signal transduction-associated protein 1 (GAP-associated tyrosine phosphoprotein p62) (Src-associated in mitosis 68 kDa protein) (Sam68) (p21 Ras GTPase-activating protein-associated p62) (p68)",SGSMDPSGAHPSVR,RSSGRSGSMDPSGAH,Q07666,KHDRBS1,S(1): 10.2;S(3): 89.7;S(7): 0.0;S(12): 0.0,Q07666,S3(Phospho),1
0,0.01,0.91,0.99,0.13,-0.06,0.58,0.63,N-Term(iTRAQ8plex);S3(Phospho),Casein kinase II substrate motif;PKA kinase substrate motif;PKC kinase substrate motif,+,0.006853,41,1,1,195000000,0,4.23,1,3.256772476,Transcription intermediary factor 1-beta (TIF1-beta) (E3 SUMO-protein ligase TRIM28) (EC 6.3.2.-) (KRAB-associated protein 1) (KAP-1) (KRAB-interacting protein 1) (KRIP-1) (Nuclear corepressor KAP-1) (RING finger protein 96) (Tripartite motif-containing protein 28),SRSGEGEVSGLMR,HVSGVKRSRSGEGEV,Q13263,TRIM28,S(1): 0.1;S(3): 99.9;S(9): 0.0,Q13263,S3(Phospho),1
0,-0.05,0.38,0.42,0.12,0.02,0.57,0.58,N-Term(iTRAQ8plex);S3(Phospho),"ERK1,2 kinase substrate motif;G protein-coupled receptor kinase 1 substrate motif;GSK-3, ERK1, ERK2, CDK5 substrate motif;MDC1 BRCT domain binding motif;PKA kinase substrate motif;PKC kinase substrate motif;Plk1 PBD domain binding motif;WW domain binding motif",+,7.87E-09,248,1,1,1780000000,0,6.88,0,3.381709769,Ras GTPase-activating protein-binding protein 1 (G3BP-1) (EC 3.6.4.12) (EC 3.6.4.13) (ATP-dependent DNA helicase VIII) (hDH VIII) (GAP SH3 domain-binding protein 1),SSSPAPADIAQTVQEDLR,EDAQKSSSPAPADIA,Q13283,G3BP1,S(1): 0.7;S(2): 7.7;S(3): 91.6;T(12): 0.0,Q13283,S3(Phospho),1
0,0.14,0.09,-0.08,1.89,1.74,0.48,1.12,N-Term(iTRAQ8plex);S3(Phospho),"14-3-3 domain binding motif;Calmodulin-dependent protein kinase II substrate motif;Casein kinase II substrate motif;ERK1,2 kinase substrate motif;G protein-coupled receptor kinase 1 substrate motif;GSK-3, ERK1, ERK2, CDK5 substrate motif;PKA kinase substrate motif;PKC kinase substrate motif;WW domain binding motif",+,0.001539,8,1,1,37800000,0,3.17,0,2.286568405,Protein Shroom2 (Apical-like protein) (Protein APXL),AQSPGSPLHAR,DLGPRAQSPGSPLHA,Q13796,SHROOM2,S(3): 100.0;S(6): 0.0,Q13796,S3(Phospho),1
0,0.20,0.00,-0.02,0.54,0.52,0.51,0.45,N-Term(iTRAQ8plex);S3(Phospho),G protein-coupled receptor kinase 1 substrate motif;MDC1 BRCT domain binding motif;PKA kinase substrate motif;PKC kinase substrate motif;Plk1 PBD domain binding motif,+,0.003816,32,1,1,22000000,0,4.71,1,2.380136014,Protein Shroom2 (Apical-like protein) (Protein APXL),SRSTVALTAAGEAEDGTGR,KLQKSRSTVALTAAG,Q13796,SHROOM2,S(1): 5.6;S(3): 47.2;T(4): 47.2;T(8): 0.0;T(17): 0.0,Q13796,S3(Phospho),1
0,-0.07,0.86,0.81,0.07,0.15,0.22,0.35,N-Term(iTRAQ8plex);S3(Phospho),Aurora-A kinase substrate motif;PAK2 kinase substrate motif;Phosphorylase kinase substrate motif;PKA kinase substrate motif;PKC kinase substrate motif,+,0.0137,2,1,1,0,0,4.32,1,3.277876323,Protein-tyrosine kinase 2-beta (EC 2.7.10.2) (Calcium-dependent tyrosine kinase) (CADTK) (Calcium-regulated non-receptor proline-rich tyrosine kinase) (Cell adhesion kinase beta) (CAK-beta) (CAKB) (Focal adhesion kinase 2) (FADK 2) (Proline-rich tyrosine kinase 2) (Related adhesion focal tyrosine kinase) (RAFTK),RNSLPQIPMLNLEAR,KDGEKRNSLPQIPML,Q14289,PTK2B,S(3): 100.0,Q14289,S3(Phospho),1
0,0.10,-1.23,-1.01,0.53,0.28,0.04,0.05,N-Term(iTRAQ8plex);S3(Phospho),14-3-3 domain binding motif;ATM kinase substrate motif;b-Adrenergic Receptor kinase substrate motif;Calmodulin-dependent protein kinase II substrate motif;DNA dependent Protein kinase substrate motif;G protein-coupled receptor kinase 1 substrate motif;GSK3 kinase substrate motif;PAK2 kinase substrate motif;PKA kinase substrate motif;PKC epsilon kinase substrate motif;PKC kinase substrate motif,+,0.05162,12,1,1,530000000,0.001,3.47,1,3.063136187,LIM and SH3 domain protein 1 (LASP-1) (Metastatic lymph node gene 50 protein) (MLN 50),RDSQDGSSYR,MEPERRDSQDGSSYR,Q14847,LASP1,S(3): 100.0;S(7): 0.0;S(8): 0.0;Y(9): 0.0,Q14847,S3(Phospho),1
0,0.02,-0.99,-1.02,0.04,0.08,-0.08,-0.16,N-Term(iTRAQ8plex);S3(Phospho),14-3-3 domain binding motif;Akt kinase substrate motif;Calmodulin-dependent protein kinase II substrate motif;Casein kinase II substrate motif;G protein-coupled receptor kinase 1 substrate motif;GSK3 kinase substrate motif;MAPKAPK1 kinase substrate motif;MAPKAPK2 kinase substrate motif;MDC1 BRCT domain binding motif;p70 Ribosomal S6 kinase substrate motif;Phosphorylase kinase substrate motif;PKA kinase substrate motif;PKC kinase substrate motif;Plk1 PBD domain binding motif,+,0.0006604,72,1,1,137000000,0,5.13,0,4.759654733,Plectin (PCN) (PLTN) (Hemidesmosomal protein 1) (HD1) (Plectin-1),SSSVGSSSSYPISPAVSR,GFRSRSSSVGSSSSY,Q15149,PLEC,S(1): 1.8;S(2): 12.1;S(3): 86.1;S(6): 0.0;S(7): 0.0;S(8): 0.0;S(9): 0.0;Y(10): 0.0;S(13): 0.0;S(17): 0.0,Q15149,S3(Phospho),1
0,-0.04,0.23,0.29,0.11,0.12,0.21,0.19,N-Term(iTRAQ8plex);S3(Phospho),14-3-3 domain binding motif;Calmodulin-dependent protein kinase II substrate motif;Casein kinase II substrate motif;MDC1 BRCT domain binding motif;Phosphorylase kinase substrate motif;PKA kinase substrate motif;PKC kinase substrate motif;Plk1 PBD domain binding motif,+,0.01403,6,1,1,3340000,0,3.81,0,2.811122821,Serine/threonine-protein kinase N2 (EC 2.7.11.13) (PKN gamma) (Protein kinase C-like 2) (Protein-kinase C-related kinase 2),ASSLGEIDESSELR,PAPPRASSLGEIDES,Q16513,PKN2,S(2): 1.1;S(3): 98.9;S(10): 0.0;S(11): 0.0,Q16513,S3(Phospho),1
0,-0.06,-0.97,-0.96,0.33,0.27,-0.22,-0.11,N-Term(iTRAQ8plex);S3(Phospho),14-3-3 domain binding motif;Calmodulin-dependent protein kinase II substrate motif;Casein kinase II substrate motif;G protein-coupled receptor kinase 1 substrate motif;GSK3 kinase substrate motif;PAK2 kinase substrate motif;PKA kinase substrate motif;PKC epsilon kinase substrate motif;PKC kinase substrate motif,+,0.008515,6,1,1,84200000,0,4.18,1,4.208407449,Echinoderm microtubule-associated protein-like 3 (EMAP-3),RNSSSSSSPSERPR,ADTPRRNSSSSSSPS,Q32P44,EML3,S(3): 100.0;S(4): 0.0;S(5): 0.0;S(6): 0.0;S(7): 0.0;S(8): 0.0;S(10): 0.0,Q32P44,S3(Phospho),1
0,-0.11,-1.19,-1.47,0.30,0.37,-0.52,-0.77,N-Term(iTRAQ8plex);S3(Phospho),14-3-3 domain binding motif;Akt kinase substrate motif;ATM kinase substrate motif;Calmodulin-dependent protein kinase II substrate motif;Casein kinase II substrate motif;DNA dependent Protein kinase substrate motif;G protein-coupled receptor kinase 1 substrate motif;GSK3 kinase substrate motif;MAPKAPK1 kinase substrate motif;PAK2 kinase substrate motif;PKA kinase substrate motif;PKC epsilon kinase substrate motif;PKC kinase substrate motif,+,3.74E-06,38,1,1,41600000,0,5.97,0,2.938033028,FK506-binding protein 15 (FKBP-15) (133 kDa FK506-binding protein) (133 kDa FKBP) (FKBP-133) (WASP and FKBP-like) (WAFL),RPSQEQSASASSGQPQAPLNR,EERPRRPSQEQSASA,Q5T1M5,FKBP15,S(3): 100.0;S(7): 0.0;S(9): 0.0;S(11): 0.0;S(12): 0.0,Q5T1M5,S3(Phospho),1
0,-0.14,0.98,1.25,0.48,0.40,1.14,1.11,N-Term(iTRAQ8plex);S3(Phospho),"14-3-3 domain binding motif;Calmodulin-dependent protein kinase II substrate motif;Casein kinase II substrate motif;DNA dependent Protein kinase substrate motif;ERK1,2 kinase substrate motif;GSK-3, ERK1, ERK2, CDK5 substrate motif;PKA kinase substrate motif;PKC kinase substrate motif;WW domain binding motif",+,0.03369,6,1,1,0,0,5.94,0,2.956958267,Rho GTPase-activating protein 17 (Rho-type GTPase-activating protein 17) (RhoGAP interacting with CIP4 homologs protein 1) (RICH-1),SPSPPTQHTGQPPGQPSAPSQLSAPR,KPPTRSPSPPTQHTG,Q68EM7,ARHGAP17,,Q68EM7,S3(Phospho),1
0,0.02,0.91,0.94,0.58,0.63,0.63,0.80,N-Term(iTRAQ8plex);S3(Phospho),MAPKAPK2 kinase substrate motif,+,1.20E-08,2,1,1,4490000,0,6.87,1,3.207974271,Enhancer of mRNA-decapping protein 4 (Autoantigen Ge-1) (Autoantigen RCD-8) (Human enhancer of decapping large subunit) (Hedls),TRSPDVISSASTALSQDIPEIASEALSR,PQASPSRTRSPDVIS,Q6P2E9,EDC4,T(1): 83.2;S(3): 16.8;S(8): 0.0;S(9): 0.0;S(11): 0.0;T(12): 0.0;S(15): 0.0;S(23): 0.0;S(27): 0.0,Q6P2E9,S3(Phospho),1
0,-0.13,0.67,0.90,-0.37,-0.56,-0.02,0.18,N-Term(iTRAQ8plex);S3(Phospho),14-3-3 domain binding motif;AMP-activated protein kinase substrate motif;Calmodulin-dependent protein kinase I substrate motif;Calmodulin-dependent protein kinase II alpha substrate motif;Calmodulin-dependent protein kinase II substrate motif;Calmodulin-dependent protein kinase IV substrate motif;Casein kinase II substrate motif;Chk1 kinase substrate motif;Phosphorylase kinase substrate motif;PKA kinase substrate motif;PKC kinase substrate motif,+,0.01231,31,1,1,49300000,0,3.96,0,2.508878248,Kinesin light chain 3 (KLC2-like) (kinesin light chain 2),AMSLNTLNVDAPR,AGMKRAMSLNTLNVD,Q6P597,KLC3,S(3): 100.0;T(6): 0.0,Q6P597,S3(Phospho),1
0,0.04,0.45,0.44,-0.11,-0.26,-0.03,-0.02,N-Term(iTRAQ8plex);S3(Phospho),"14-3-3 domain binding motif;Calmodulin-dependent protein kinase II substrate motif;ERK1,2 kinase substrate motif;G protein-coupled receptor kinase 1 substrate motif;GSK-3, ERK1, ERK2, CDK5 substrate motif;PAK2 kinase substrate motif;PKA kinase substrate motif;PKC epsilon kinase substrate motif;PKC kinase substrate motif;WW domain binding motif",+,0.02291,30,1,1,723000000,0,3.45,1,2.829536784,Protein FAM83H,RGSPVPPVPER,AYPERRGSPVPPVPE,Q6ZRV2,FAM83H,S(3): 100.0,Q6ZRV2,S3(Phospho),1
0,0.16,0.31,0.21,-0.24,-0.31,-0.08,-0.04,N-Term(iTRAQ8plex);S3(Phospho),14-3-3 domain binding motif;AMP-activated protein kinase substrate motif;Calmodulin-dependent protein kinase II substrate motif;HMGCoA Reductase kinase substrate motif;PKA kinase substrate motif;PKC kinase substrate motif,+,0.001319,53,1,1,533000000,0,3.81,0,2.115310639,Protein FAM83H,HGSDPAFAPGPR,SREVRHGSDPAFAPG,Q6ZRV2,FAM83H,S(3): 100.0,Q6ZRV2,S3(Phospho),1
0,-0.04,0.21,0.24,0.14,0.00,0.46,0.56,N-Term(iTRAQ8plex);S3(Phospho),14-3-3 domain binding motif;Akt kinase substrate motif;Calmodulin-dependent protein kinase II substrate motif;Casein kinase II substrate motif;MAPKAPK1 kinase substrate motif;p70 Ribosomal S6 kinase substrate motif;Phosphorylase kinase substrate motif;PKA kinase substrate motif;PKC kinase substrate motif,+,0.03265,11,1,1,69700000,0,3.1,0,2.380960069,B-cell CLL/lymphoma 9-like protein (B-cell lymphoma 9-like protein) (BCL9-like protein) (Protein BCL9-2),SVSVDSGEQR,VKRDRSVSVDSGEQR,Q86UU0,BCL9L,S(1): 1.1;S(3): 98.9;S(6): 0.0,Q86UU0,S3(Phospho),1
0,-0.02,-1.31,-1.29,-0.64,-0.76,-0.57,-0.60,N-Term(iTRAQ8plex);S3(Phospho),14-3-3 domain binding motif;Calmodulin-dependent protein kinase II substrate motif;Casein kinase II substrate motif;G protein-coupled receptor kinase 1 substrate motif;PKA kinase substrate motif;PKC kinase substrate motif,+,0.01274,114,1,1,893000000,0,3.79,0,4.452275764,Protein AHNAK2,SHSSSEAYEPR,PGPQRSHSSSEAYEP,Q8IVF2,AHNAK2,S(1): 0.0;S(3): 99.6;S(4): 0.4;S(5): 0.0;Y(8): 0.0,Q8IVF2,S3(Phospho),1
0,-0.05,-0.66,-0.62,-0.69,-0.67,-0.61,-0.84,N-Term(iTRAQ8plex);S3(Phospho),14-3-3 domain binding motif;AMP-activated protein kinase substrate motif;Calmodulin-dependent protein kinase I substrate motif;Calmodulin-dependent protein kinase II substrate motif;Calmodulin-dependent protein kinase IV substrate motif;Casein kinase II substrate motif;Chk1 kinase substrate motif;PKA kinase substrate motif;PKC kinase substrate motif;ZIP kinase substrate motif,+,0.02827,16,1,1,16400000,0,4.05,0,2.500785548,Mitotic interactor and substrate of PLK1 (Mitotic spindle positioning protein),ALSSDSILSPAPDAR,PGLRRALSSDSILSP,Q8IVT2,MISP,S(3): 98.7;S(4): 1.3;S(6): 0.0;S(9): 0.0,Q8IVT2,S3(Phospho),1
0,0.17,-0.94,-0.91,0.11,0.06,-0.27,-0.33,N-Term(iTRAQ8plex);S3(Phospho),14-3-3 domain binding motif;b-Adrenergic Receptor kinase substrate motif;Calmodulin-dependent protein kinase II substrate motif;G protein-coupled receptor kinase 1 substrate motif;GSK3 kinase substrate motif;PAK2 kinase substrate motif;Pim1 kinase substrate sequence;PKA kinase substrate motif;PKC epsilon kinase substrate motif;PKC kinase substrate motif,+,0.03026,2,1,1,24300000,0,3.11,1,3.502429806,Uncharacterized protein C9orf40,RDSGDNSAPSGQER,SPSKRRDSGDNSAPS,Q8IXQ3,C9orf40,S(3): 99.8;S(7): 0.2;S(10): 0.0,Q8IXQ3,S3(Phospho),1
0,-0.19,-1.61,-2.11,-0.17,-0.22,-0.57,-0.57,N-Term(iTRAQ8plex);S3(Phospho),"14-3-3 domain binding motif;Calmodulin-dependent protein kinase II substrate motif;ERK1,2 kinase substrate motif;GSK-3, ERK1, ERK2, CDK5 substrate motif;PAK2 kinase substrate motif;PKA kinase substrate motif;PKC epsilon kinase substrate motif;PKC kinase substrate motif;WW domain binding motif",+,0.006213,4,1,1,1880000000,0,2.43,1,2.649820748,Serine/arginine repetitive matrix protein 1 (SR-related nuclear matrix protein of 160 kDa) (SRm160) (Ser/Arg-related nuclear matrix protein),RYSPPIQR,SPSPRRYSPPIQRRY,Q8IYB3,SRRM1,Y(2): 0.4;S(3): 99.6,Q8IYB3,S3(Phospho),1
0,-0.03,-0.67,-0.70,0.06,-0.02,0.33,0.31,N-Term(iTRAQ8plex);S3(Phospho),"14-3-3 domain binding motif;Calmodulin-dependent protein kinase II substrate motif;ERK1,2 kinase substrate motif;GSK-3, ERK1, ERK2, CDK5 substrate motif;MAPKAPK2 kinase substrate motif;MDC1 BRCT domain binding motif;PKA kinase substrate motif;PKC kinase substrate motif;Plk1 PBD domain binding motif;WW domain binding motif",+,0.01085,16,1,1,14800000,0,3.29,0,4.704259646,Phosphatase and actin regulator 4,SSSPVQVEEEPVR,IGNARSSSPVQVEEE,Q8IZ21,PHACTR4,S(1): 6.9;S(2): 46.5;S(3): 46.5,Q8IZ21,S3(Phospho),1
0,0.06,-0.22,-0.18,0.28,0.40,0.27,0.19,N-Term(iTRAQ8plex);S3(Phospho),14-3-3 domain binding motif;Akt kinase substrate motif;Aurora-A kinase substrate motif;Calmodulin-dependent protein kinase II substrate motif;Casein kinase II substrate motif;DMPK1 kinase substrate motif;G protein-coupled receptor kinase 1 substrate motif;MAPKAPK1 kinase substrate motif;p70 Ribosomal S6 kinase substrate motif;PAK2 kinase substrate motif;Phosphorylase kinase substrate motif;PKA kinase substrate motif;PKC epsilon kinase substrate motif;PKC kinase substrate motif,+,0.04154,8,1,1,27500000,0.0006798,3.48,1,2.620692991,Serine/threonine-protein kinase 11-interacting protein (LKB1-interacting protein 1),RASISEPSDTDPEPR,RVRVRRASISEPSDT,Q8N1F8,STK11IP,S(3): 100.0;S(5): 0.0;S(8): 0.0;T(10): 0.0,Q8N1F8,S3(Phospho),1
0,0.09,-2.06,-1.96,0.08,-0.20,-0.54,-0.32,N-Term(iTRAQ8plex);S3(Phospho),"14-3-3 domain binding motif;Calmodulin-dependent protein kinase II substrate motif;Casein kinase II substrate motif;CLK1 kinase substrate motif;G protein-coupled receptor kinase 1 substrate motif;PAK2 kinase substrate motif;PKA kinase substrate motif;PKA, PKG kinase substrate motif;PKC epsilon kinase substrate motif;PKC kinase substrate motif;PKG kinase substrate motif",+,0.04215,4,1,1,290000000,0.0006395,3.91,1,3.523049541,Smad nuclear-interacting protein 1 (FHA domain-containing protein SNIP1),RTSNERPGSGQGQGR,HSHQRRTSNERPGSG,Q8TAD8,SNIP1,T(2): 97.1;S(3): 2.9;S(9): 0.0,Q8TAD8,S3(Phospho),1
0,0.11,0.34,0.36,0.65,0.63,1.37,1.28,N-Term(iTRAQ8plex);S3(Phospho),"Casein kinase II substrate motif;ERK1,2 kinase substrate motif;Growth associated histone HI kinase substrate motif;GSK-3, ERK1, ERK2, CDK5 substrate motif;WW domain binding motif",+,0.0354,23,1,1,2780000000,0,2.63,0,4.189020755,Palladin (SIH002) (Sarcoma antigen NY-SAR-77),SPSGHPHVR,QRGRSPRSPSGHPHV,Q8WX93,PALLD,S(1): 100.0;S(3): 0.0,Q8WX93,S3(Phospho),1
0,0.13,0.82,0.96,0.38,0.11,0.71,0.72,N-Term(iTRAQ8plex);S3(Phospho),14-3-3 domain binding motif;Aurora-A kinase substrate motif;Calmodulin-dependent protein kinase II substrate motif;Casein kinase II substrate motif;PAK2 kinase substrate motif;Phosphorylase kinase substrate motif;PKA kinase substrate motif;PKC epsilon kinase substrate motif;PKC kinase substrate motif;Pyruvate dehydrogenase kinase substrate motif,+,0.00074,17,1,1,12900000,0,5.87,1,2.227194637,E3 ubiquitin-protein ligase rififylin (EC 6.3.2.-) (Caspase regulator CARP2) (Caspases-8 and -10-associated RING finger protein 2) (CARP-2) (FYVE-RING finger protein Sakura) (Fring) (RING finger and FYVE-like domain-containing protein 1) (RING finger protein 189) (RING finger protein 34-like),RASLSDLTDLEDIEGLTVR,FVPGRRASLSDLTDL,Q8WZ73,RFFL,S(3): 98.9;S(5): 1.1;T(8): 0.0;T(17): 0.0,Q8WZ73,S3(Phospho),1
0,0.14,-0.77,-0.95,-0.38,-0.38,-0.47,-0.55,N-Term(iTRAQ8plex);S3(Phospho),14-3-3 domain binding motif;Akt kinase substrate motif;Calmodulin-dependent protein kinase II substrate motif;Casein kinase II substrate motif;MAPKAPK1 kinase substrate motif;MAPKAPK2 kinase substrate motif;PKA kinase substrate motif;PKC kinase substrate motif,+,0.01465,17,1,1,28500000,0,3.81,0,2.742232383,Protein NDRG1 (Differentiation-related gene 1 protein) (DRG-1) (N-myc downstream-regulated gene 1 protein) (Nickel-specific induction protein Cap43) (Reducing agents and tunicamycin-responsive protein) (RTP) (Rit42),TASGSSVTSLDGTR,LMRSRTASGSSVTSL,Q92597,NDRG1,T(1): 2.2;S(3): 84.0;S(5): 13.2;S(6): 0.4;T(8): 0.0;S(9): 0.1;T(13): 0.0,Q92597,S3(Phospho),1
0,0.11,0.22,0.18,-0.12,-0.17,0.20,0.23,N-Term(iTRAQ8plex);S3(Phospho),14-3-3 domain binding motif;Akt kinase substrate motif;Calmodulin-dependent protein kinase II substrate motif;MAPKAPK1 kinase substrate motif;PKA kinase substrate motif;PKC kinase substrate motif,+,0.0001121,25,1,1,81500000,0,4.56,1,2.320024741,Bcl2-associated agonist of cell death (BAD) (Bcl-2-binding component 6) (Bcl-2-like protein 8) (Bcl2-L-8) (Bcl-xL/Bcl-2-associated death promoter) (Bcl2 antagonist of cell death),SRSAPPNLWAAQR,PFRGRSRSAPPNLWA,Q92934,BAD,S(1): 1.0;S(3): 99.0,Q92934,S3(Phospho),1
0,-0.02,0.77,0.84,0.33,0.23,0.46,0.45,N-Term(iTRAQ8plex);S3(Phospho),14-3-3 domain binding motif;Calmodulin-dependent protein kinase II substrate motif;Casein kinase II substrate motif;G protein-coupled receptor kinase 1 substrate motif;PAK2 kinase substrate motif;PKA kinase substrate motif;PKC epsilon kinase substrate motif;PKC kinase substrate motif,+,0.0185,6,1,1,769000000,0,2.33,1,3.707859144,Protein FAM122A,RNSTTFPSR,APSARRNSTTFPSRH,Q96E09,FAM122A,S(3): 96.0;T(4): 3.2;T(5): 0.7;S(8): 0.1,Q96E09,S3(Phospho),1
0,-0.03,0.62,0.50,0.28,0.32,0.81,0.70,N-Term(iTRAQ8plex);S3(Phospho),14-3-3 domain binding motif;AMP-activated protein kinase substrate motif;Calmodulin-dependent protein kinase I substrate motif;Calmodulin-dependent protein kinase II substrate motif;Calmodulin-dependent protein kinase IV substrate motif;Chk1 kinase substrate motif;PKA kinase substrate motif;PKC kinase substrate motif;ZIP kinase substrate motif,+,0.000122,17,1,1,1580000,0,8.33,0,3.058206999,Protein FAM122A,SNSAPLIHGLSDTSPVFQAEAPSAR,GGLRRSNSAPLIHGL,Q96E09,FAM122A,S(1): 0.4;S(3): 99.6;S(11): 0.0;T(13): 0.0;S(14): 0.0;S(23): 0.0,Q96E09,S3(Phospho),1
0,0.13,1.32,1.11,-0.31,-0.17,-0.34,-0.35,N-Term(iTRAQ8plex);S3(Phospho),14-3-3 domain binding motif;Akt kinase substrate motif;Calmodulin-dependent protein kinase II substrate motif;MAPKAPK1 kinase substrate motif;p70 Ribosomal S6 kinase substrate motif;Phosphorylase kinase substrate motif;PKA kinase substrate motif;PKC kinase substrate motif,+,0.00568,34,1,1,61100000,0,3.94,0,3.50809158,Rhotekin,TFSLDAVPPDHSPR,WGRPRTFSLDAVPPD,Q9BST9,RTKN,T(1): 11.2;S(3): 88.8;S(12): 0.0,Q9BST9,S3(Phospho),1
0,-0.06,-0.38,-0.38,0.07,-0.01,0.05,0.11,N-Term(iTRAQ8plex);S3(Phospho),"14-3-3 domain binding motif;b-Adrenergic Receptor kinase substrate motif;Calmodulin-dependent protein kinase II substrate motif;Calmodulin-dependent protein kinase IV substrate motif;Casein kinase II substrate motif;Chk1 kinase substrate motif;ERK1,2 kinase substrate motif;G protein-coupled receptor kinase 1 substrate motif;GSK-3, ERK1, ERK2, CDK5 substrate motif;PKA kinase substrate motif;PKC kinase substrate motif;WW domain binding motif",+,0.02221,10,1,1,17700000,0,3.33,0,2.894859692,Uncharacterized protein C11orf84,AESPSPAPPPGLR,GGLPRAESPSPAPPP,Q9BUA3,C11orf84,S(3): 99.9;S(5): 0.1,Q9BUA3,S3(Phospho),1
0,0.01,0.48,0.35,0.30,0.37,0.34,0.33,N-Term(iTRAQ8plex);S3(Phospho),14-3-3 domain binding motif;Aurora-A kinase substrate motif;Calmodulin-dependent protein kinase II substrate motif;Casein kinase II substrate motif;PAK2 kinase substrate motif;Phosphorylase kinase substrate motif;PKA kinase substrate motif;PKC epsilon kinase substrate motif;PKC kinase substrate motif,+,0.01141,4,1,1,95000000,0,4.1,1,2.297534444,Sphingosine-1-phosphate phosphatase 1 (SPPase1) (Spp1) (hSPP1) (hSPPase1) (EC 3.1.3.-) (Sphingosine-1-phosphatase 1),RNSLTGEEGQLAR,AGALRRNSLTGEEGQ,Q9BX95,SGPP1,S(3): 100.0;T(5): 0.0,Q9BX95,S3(Phospho),1
0,0.17,-0.27,-0.12,0.11,0.15,0.59,0.55,N-Term(iTRAQ8plex);S3(Phospho),14-3-3 domain binding motif;Calmodulin-dependent protein kinase II substrate motif;Casein kinase II substrate motif;PKA kinase substrate motif;PKC kinase substrate motif,+,0.1115,4,1,1,13000000,0.007171,2.73,0,2.453950974,Rab11 family-interacting protein 5 (Rab11-FIP5) (Gamma-SNAP-associated factor 1) (Gaf-1) (Phosphoprotein pp75) (Rab11-interacting protein Rip11),TYSDEANQMR,FTHKRTYSDEANQMR,Q9BXF6,RAB11FIP5,T(1): 0.0;Y(2): 9.1;S(3): 90.9,Q9BXF6,S3(Phospho),1
0,0.01,-0.65,-0.59,0.20,0.07,-0.26,-0.06,N-Term(iTRAQ8plex);S3(Phospho),14-3-3 domain binding motif;ATM kinase substrate motif;Calmodulin-dependent protein kinase II substrate motif;DNA dependent Protein kinase substrate motif;G protein-coupled receptor kinase 1 substrate motif;MAPKAPK2 kinase substrate motif;PAK2 kinase substrate motif;PKA kinase substrate motif;PKC epsilon kinase substrate motif;PKC kinase substrate motif,+,0.04092,14,1,1,1260000000,0,3.23,0,2.42157421,182 kDa tankyrase-1-binding protein,RPSQGPPAR,AQTSRRPSQGPPARS,Q9C0C2,TNKS1BP1,S(3): 100.0,Q9C0C2,S3(Phospho),1
0,0.03,-0.55,-0.61,-0.36,-0.43,-0.22,-0.29,N-Term(iTRAQ8plex);S3(Phospho),Aurora-A kinase substrate motif;b-Adrenergic Receptor kinase substrate motif;Calmodulin-dependent protein kinase II substrate motif;Casein kinase II substrate motif;PAK2 kinase substrate motif;Phosphorylase kinase substrate motif;PKA kinase substrate motif;PKC kinase substrate motif,+,0.01123,133,1,1,2990000000,0,4.04,1,3.286724585,182 kDa tankyrase-1-binding protein,RDSLGTYSSR,QEFGKRDSLGTYSSR,Q9C0C2,TNKS1BP1,S(3): 100.0;T(6): 0.0;Y(7): 0.0;S(8): 0.0;S(9): 0.0,Q9C0C2,S3(Phospho),1
0,0.00,-1.39,-1.20,-0.08,-0.26,-0.40,-0.27,N-Term(iTRAQ8plex);S3(Phospho),ATM kinase substrate motif;b-Adrenergic Receptor kinase substrate motif;Calmodulin-dependent protein kinase II substrate motif;Casein kinase II substrate motif;DNA dependent Protein kinase substrate motif;PAK2 kinase substrate motif;Pim1 kinase substrate sequence;PKA kinase substrate motif;PKC kinase substrate motif,+,0.03071,68,1,1,2160000000,0,3.61,1,3.087536182,182 kDa tankyrase-1-binding protein,RDSQGTYSSR,WEFRKRDSQGTYSSR,Q9C0C2,TNKS1BP1,S(3): 100.0;T(6): 0.0;Y(7): 0.0;S(8): 0.0;S(9): 0.0,Q9C0C2,S3(Phospho),1
0,-0.07,NaN,-1.17,0.53,0.64,NaN,-0.81,N-Term(iTRAQ8plex);S3(Phospho),Casein kinase II substrate motif;MDC1 BRCT domain binding motif;Plk1 PBD domain binding motif,+,0.005349,4,1,1,4330000,0,3.9,1,1.966770978,Pleckstrin homology domain-containing family A member 5 (PH domain-containing family A member 5) (Phosphoinositol 3-phosphate-binding protein 2) (PEPP-2),RQSTDLPTGWEEAYTFEGAR,AKADAASSLTVDVTP,Q9HAU0,PLEKHA5,S(3): 99.2;T(4): 0.8;T(8): 0.0;Y(14): 0.0;T(15): 0.0,Q9HAU0,S3(Phospho),1
0,0.10,-0.59,-0.73,-0.52,-0.84,-1.24,-0.87,N-Term(iTRAQ8plex);S3(Phospho),14-3-3 domain binding motif;Akt kinase substrate motif;Calmodulin-dependent protein kinase II substrate motif;G protein-coupled receptor kinase 1 substrate motif;GSK3 kinase substrate motif;MAPKAPK1 kinase substrate motif;PKA kinase substrate motif;PKC kinase substrate motif,+,0.05367,4,1,1,29300000,0.001217,1.98,0,1.781284692,Chromobox protein homolog 8 (Polycomb 3 homolog) (Pc3) (hPc3) (Rectachrome 1),HGSGPPSSGGGLYR,GTRVRHGSGPPSSGG,Q9HC52,CBX8,S(3): 100.0;S(7): 0.0;S(8): 0.0;Y(13): 0.0,Q9HC52,S3(Phospho),1
0,0.03,-0.60,-0.61,-0.25,-0.18,-0.31,-0.35,N-Term(iTRAQ8plex);S3(Phospho),"14-3-3 domain binding motif;Akt kinase substrate motif;AMP-activated protein kinase 2 substrate motif;Calmodulin-dependent protein kinase II substrate motif;Casein kinase II substrate motif;ERK1,2 kinase substrate motif;GSK-3, ERK1, ERK2, CDK5 substrate motif;MAPKAPK1 kinase substrate motif;MDC1 BRCT domain binding motif;PKA kinase substrate motif;PKC kinase substrate motif;Plk1 PBD domain binding motif;Pyruvate dehydrogenase kinase substrate motif;WW domain binding motif",+,0.08448,3,1,1,7040000,0.00264,2.88,1,3.974563356,Arginine and glutamate-rich protein 1,ASSPPDRIDIFGR,RDRERASSPPDRIDI,Q9NWB6,ARGLU1,S(2): 2.2;S(3): 97.8,Q9NWB6,S3(Phospho),1
0,0.05,-0.21,-0.16,0.14,0.05,-0.10,-0.20,N-Term(iTRAQ8plex);S3(Phospho),14-3-3 domain binding motif;Akt kinase substrate motif;Calmodulin-dependent protein kinase II substrate motif;Casein kinase II substrate motif;MAPKAPK1 kinase substrate motif;PKA kinase substrate motif;PKC kinase substrate motif,+,0.006723,40,1,1,1930000000,0,3.69,1,1.768936668,BRISC and BRCA1-A complex member 1 (Mediator of RAP80 interactions and targeting subunit of 40 kDa) (New component of the BRCA1-A complex),TRSNPEGAEDR,EPRPRTRSNPEGAED,Q9NWV8,BABAM1,T(1): 0.7;S(3): 99.3,Q9NWV8,S3(Phospho),1
0,0.09,-0.96,-0.83,-0.10,-0.14,0.02,-0.04,N-Term(iTRAQ8plex);S3(Phospho),14-3-3 domain binding motif;Akt kinase substrate motif;Calmodulin-dependent protein kinase II substrate motif;MAPKAPK1 kinase substrate motif;MAPKAPK2 kinase substrate motif;p70 Ribosomal S6 kinase substrate motif;Phosphorylase kinase substrate motif;PKA kinase substrate motif;PKC kinase substrate motif,+,0.0171,28,1,1,818000000,0,3.68,1,3.569699106,Tight junction protein ZO-2 (Tight junction protein 2) (Zona occludens protein 2) (Zonula occludens protein 2),GRSIDQDYER,RDRSRGRSIDQDYER,Q9UDY2,TJP2,S(3): 100.0;Y(8): 0.0,Q9UDY2,S3(Phospho),1
0,0.04,-0.32,-0.33,-0.03,0.05,0.04,0.04,N-Term(iTRAQ8plex);S3(Phospho),14-3-3 domain binding motif;Akt kinase substrate motif;Calmodulin-dependent protein kinase II substrate motif;Casein kinase II substrate motif;G protein-coupled receptor kinase 1 substrate motif;GSK3 kinase substrate motif;MAPKAPK1 kinase substrate motif;MAPKAPK2 kinase substrate motif;PKA kinase substrate motif;PKC kinase substrate motif,+,0.0001358,28,1,1,18200000,0,4.8,0,3.028257117,Protein NDRG3 (N-myc downstream-regulated gene 3 protein),THSTSSSLGSGESPFSR,LARSRTHSTSSSLGS,Q9UGV2,NDRG3,T(1): 0.1;S(3): 87.1;T(4): 12.7;S(5): 0.1;S(6): 0.0;S(7): 0.1;S(10): 0.0;S(13): 0.0;S(16): 0.0,Q9UGV2,S3(Phospho),1
0,0.10,0.10,-0.06,-0.95,-0.94,-0.03,-0.10,N-Term(iTRAQ8plex);S3(Phospho),14-3-3 domain binding motif;Calmodulin-dependent protein kinase II alpha substrate motif;Calmodulin-dependent protein kinase II substrate motif;Calmodulin-dependent protein kinase IV substrate motif;Chk1 kinase substrate motif;MDC1 BRCT domain binding motif;PKA kinase substrate motif;PKC kinase substrate motif;Plk1 PBD domain binding motif,+,0.1824,22,1,1,324000000,0.001,3.2,0,3.389584432,Brain-specific angiogenesis inhibitor 1-associated protein 2 (BAI-associated protein 2) (BAI1-associated protein 2) (Protein BAP2) (Fas ligand-associated factor 3) (FLAF3) (Insulin receptor substrate p53/p58) (IRS-58) (IRSp53/58) (Insulin receptor substrate protein of 53 kDa) (IRSp53) (Insulin receptor substrate p53),SSSMAAGLER,KTLPRSSSMAAGLER,Q9UQB8,BAIAP2,,Q9UQB8,S3(Phospho),1
0,0.23,-0.68,-0.68,-0.14,-0.15,0.82,0.68,N-Term(iTRAQ8plex);S3(Phospho),14-3-3 domain binding motif;Akt kinase substrate motif;Calmodulin-dependent protein kinase II substrate motif;Casein kinase II substrate motif;MAPKAPK1 kinase substrate motif;p70 Ribosomal S6 kinase substrate motif;PKA kinase substrate motif;PKC kinase substrate motif,+,0.02425,17,1,1,100000000,0,3.77,0,3.266894719,A-kinase anchor protein 2 (AKAP-2) (AKAP-KL) (Protein kinase A-anchoring protein 2) (PRKA2),TLSMIEEEIR,SRKQRTLSMIEEEIR,Q9Y2D5,AKAP2,T(1): 0.0;S(3): 100.0,Q9Y2D5,S3(Phospho),1
0,0.11,-0.19,0.00,0.37,0.32,0.41,0.43,N-Term(iTRAQ8plex);S3(Phospho),14-3-3 domain binding motif;Calmodulin-dependent protein kinase II substrate motif;G protein-coupled receptor kinase 1 substrate motif;PAK2 kinase substrate motif;PKA kinase substrate motif;PKC epsilon kinase substrate motif;PKC kinase substrate motif,+,7.78E-05,18,1,1,232000000,0,5.01,1,2.091379409,Insulin receptor substrate 2 (IRS-2),RVSGDAAQDLDR,GRSYRRVSGDAAQDL,Q9Y4H2,IRS2,S(3): 100.0,Q9Y4H2,S3(Phospho),1
0,0.04,1.56,2.28,0.28,-0.13,-0.47,-0.26,C6(Carbamidomethyl);K1(iTRAQ8plex);N-Term(iTRAQ8plex);S4(Phospho),G protein-coupled receptor kinase 1 substrate motif;PKA kinase substrate motif;PKC kinase substrate motif,+,0.003211,4,3,1,855000,0,3.8,1,2.261685365,Ribosomal protein S6 kinase alpha-1 (S6K-alpha-1) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 1) (p90-RSK 1) (p90RSK1) (p90S6K) (MAP kinase-activated protein kinase 1a) (MAPK-activated protein kinase 1a) (MAPKAP kinase 1a) (MAPKAPK-1a) (Ribosomal S6 kinase 1) (RSK-1),KAYSFCGTVEYMAPEVVNR,DQEKKAYSFCGTVEY,Q15418,RPS6KA1,Y(3): 8.4;S(4): 45.8;T(8): 45.8;Y(11): 0.0,Q15418,S4(Phospho),1
0,-0.06,-1.22,-1.35,0.78,0.65,0.46,0.46,C12(Carbamidomethyl);K17(iTRAQ8plex);N-Term(iTRAQ8plex);S4(Phospho),14-3-3 domain binding motif;Akt kinase substrate motif;Calmodulin-dependent protein kinase II substrate motif;DNA dependent Protein kinase substrate motif;MAPKAPK1 kinase substrate motif;p70 Ribosomal S6 kinase substrate motif;Phosphorylase kinase substrate motif;PKA kinase substrate motif;PKC kinase substrate motif;PP2B substrate motif;ZIP kinase substrate motif,+,0.03672,13,1,1,185000000,0,4.95,1,4.551660582,Filamin-A (FLN-A) (Actin-binding protein 280) (ABP-280) (Alpha-filamin) (Endothelial actin-binding protein) (Filamin-1) (Non-muscle filamin),RAPSVANVGSHCDLSLK,TRRRRAPSVANVGSH,P21333,FLNA,S(4): 100.0;S(10): 0.0;S(15): 0.0,P21333,S4(Phospho),1
0,0.25,-1.09,-0.82,0.28,0.10,0.06,0.08,K14(iTRAQ8plex);K2(iTRAQ8plex);N-Term(iTRAQ8plex);S4(Phospho),BARD1 BRCT domain binding motif;Casein kinase II substrate motif;PKA kinase substrate motif;PKC kinase substrate motif,+,0.1403,2,1,1,25500000,0.004142,2.85,1,2.447018514,Protein PRRC2B (HLA-B-associated transcript 2-like 1) (Proline-rich coiled-coil protein 2B),LKFSDDEEEEEVVK,YSEKLKFSDDEEEEE,Q5JSZ5,PRRC2B,S(4): 100.0,Q5JSZ5,S4(Phospho),1
0,0.21,0.36,0.58,2.67,2.38,2.66,2.87,C18(Carbamidomethyl);K20(iTRAQ8plex);N-Term(iTRAQ8plex);S4(Phospho),"Casein kinase I substrate motif;ERK1,2 kinase substrate motif;G protein-coupled receptor kinase 1 substrate motif;GSK-3, ERK1, ERK2, CDK5 substrate motif;PKA kinase substrate motif;PKC kinase substrate motif;WW domain binding motif",+,0.0002586,8,1,1,66900000,0,4.29,1,3.751232672,Synaptopodin,DRASPAAAEEVVPEWASCLK,PAPRDRASPAAAEEV,Q8N3V7,SYNPO,S(4): 100.0;S(17): 0.0,Q8N3V7,S4(Phospho),1
0,0.49,-1.93,-1.88,-0.04,0.20,-0.64,-0.91,K14(iTRAQ8plex);K3(iTRAQ8plex);N-Term(iTRAQ8plex);S4(Phospho),BARD1 BRCT domain binding motif;Casein kinase II substrate motif;G protein-coupled receptor kinase 1 substrate motif;PKA kinase substrate motif,+,0.04406,6,1,1,179000000,0,3.46,1,2.742322447,Heterogeneous nuclear ribonucleoproteins C1/C2 (hnRNP C1/C2),NDKSEEEQSSSSVK,VEMKNDKSEEEQSSS,P07910,HNRNPC,S(4): 100.0;S(9): 0.0;S(10): 0.0;S(11): 0.0;S(12): 0.0,P07910,S4(Phospho),1
0,0.20,0.10,-0.22,-1.32,-1.33,1.22,1.14,K14(iTRAQ8plex);K7(iTRAQ8plex);N-Term(iTRAQ8plex);S4(Phospho),"b-Adrenergic Receptor kinase substrate motif;Casein kinase I substrate motif;Casein kinase II substrate motif;Cdc2 kinase substrate motif;CDK kinase substrate motif;CDK1,2,4,6 kinase substrate motif;ERK1,2 kinase substrate motif;GSK-3, ERK1, ERK2, CDK5 substrate motif;PKA kinase substrate motif;WW domain binding motif",+,0.03944,17,1,1,64900000,0,3.94,1,3.597064938,Microtubule-associated protein 4 (MAP-4),DMESPTKLDVTLAK,ALAKDMESPTKLDVT,P27816,MAP4,S(4): 99.9;T(6): 0.1;T(11): 0.0,P27816,S4(Phospho),1
0,0.01,1.05,1.50,-0.01,-0.18,0.42,0.22,K11(iTRAQ8plex);M9(Oxidation);N-Term(iTRAQ8plex);S4(Phospho),b-Adrenergic Receptor kinase substrate motif;Casein kinase II substrate motif;PKA kinase substrate motif,+,0.009317,8,2,1,187000000,0,3.52,0,2.25271665,Alpha-endosulfine (ARPP-19e),YFDSGDYNMAK,KGQKYFDSGDYNMAK,O43768,ENSA,Y(1): 0.7;S(4): 99.2;Y(7): 0.1,O43768,S4(Phospho),1
0,0.05,-0.15,0.20,-0.74,-0.82,-0.61,-0.71,C10(Carbamidomethyl);N-Term(iTRAQ8plex);S4(Phospho),Casein kinase II substrate motif;G protein-coupled receptor kinase 1 substrate motif;PKA kinase substrate motif;PKC kinase substrate motif,+,0.00541,18,1,1,164000000,0,3.48,1,2.205232197,Plakophilin-1 (Band 6 protein) (B6P),ASRSEPDLYCDPR,FMQKIKASRSEPDLY,Q13835,PKP1,S(2): 89.7;S(4): 10.3;Y(9): 0.0,Q13835,S4(Phospho),1
0,0.07,-0.99,-1.10,-0.37,-0.36,-0.52,-0.56,C11(Carbamidomethyl);N-Term(iTRAQ8plex);S4(Phospho),PKA kinase substrate motif;PKC kinase substrate motif,+,0.0002189,15,3,1,76300000,0,5.32,1,3.884735823,"Keratin, type II cytoskeletal 6A (Cytokeratin-6A) (CK-6A) (Cytokeratin-6D) (CK-6D) (Keratin-6A) (K6A) (Type-II keratin Kb6) (allergen Hom s 5)",SRGSGGLGGACGGAGFGSR,SVSRSRGSGGLGGAC,P02538,KRT6A,S(1): 0.5;S(4): 99.5;S(18): 0.0,P02538,S4(Phospho),1
0,0.12,-1.26,-1.33,0.06,0.03,-0.19,-0.22,K10(iTRAQ8plex);N-Term(iTRAQ8plex);S4(Phospho),"14-3-3 domain binding motif;Calmodulin-dependent protein kinase II substrate motif;Casein kinase II substrate motif;DNA dependent Protein kinase substrate motif;ERK1,2 kinase substrate motif;G protein-coupled receptor kinase 1 substrate motif;GSK3 kinase substrate motif;GSK-3, ERK1, ERK2, CDK5 substrate motif;MAPKAPK1 kinase substrate motif;PKA kinase substrate motif;PKC kinase substrate motif;WW domain binding motif;ZIP kinase substrate motif",+,0.05194,5,1,1,351000000,0.0006143,2.1,0,4.536179733,"Spectrin beta chain, non-erythrocytic 1 (Beta-II spectrin) (Fodrin beta chain) (Spectrin, non-erythroid beta chain 1)",RPPSPEPSTK,ERKRRPPSPEPSTKV,Q01082,SPTBN1,S(4): 100.0;S(8): 0.0;T(9): 0.0,Q01082,S4(Phospho),1
0,0.00,0.74,0.65,-0.43,-0.49,0.54,0.51,K11(iTRAQ8plex);N-Term(iTRAQ8plex);S4(Phospho),b-Adrenergic Receptor kinase substrate motif;Casein kinase II substrate motif;PKA kinase substrate motif,+,0.004728,92,2,1,710000000,0,4.49,0,4.50525749,Alpha-endosulfine (ARPP-19e),YFDSGDYNMAK,KGQKYFDSGDYNMAK,O43768,ENSA,Y(1): 0.3;S(4): 99.7;Y(7): 0.0,O43768,S4(Phospho),1
0,-0.01,-0.63,-0.63,-0.10,0.05,0.22,0.26,K11(iTRAQ8plex);N-Term(iTRAQ8plex);S4(Phospho),b-Adrenergic Receptor kinase substrate motif;PKA kinase substrate motif;PKC kinase substrate motif,+,0.2905,4,1,1,25200000,0.003,3.08,1,3.350634051,Kinesin light chain 1 (KLC 1),SRESLNVDVVK,EKRRSRESLNVDVVK,Q07866,KLC1,,Q07866,S4(Phospho),1
0,0.28,-1.42,-1.46,-0.12,-0.21,-0.75,-0.67,K11(iTRAQ8plex);N-Term(iTRAQ8plex);S4(Phospho),14-3-3 domain binding motif;b-Adrenergic Receptor kinase substrate motif;Calmodulin-dependent protein kinase II substrate motif;Casein kinase II substrate motif;PKA kinase substrate motif;PKC kinase substrate motif,+,0.0197,2,1,1,194000000,0,3.83,1,3.281747058,Protein PBDC1 (Polysaccharide biosynthesis domain-containing protein 1),RADSGEEENTK,GGEKRADSGEEENTK,Q9BVG4,PBDC1,S(4): 100.0;T(10): 0.0,Q9BVG4,S4(Phospho),1
0,0.06,0.62,0.61,0.29,0.20,0.30,0.29,K14(iTRAQ8plex);N-Term(iTRAQ8plex);S4(Phospho),"14-3-3 domain binding motif;Calmodulin-dependent protein kinase II substrate motif;Casein kinase II substrate motif;MAPKAPK1 kinase substrate motif;PAK2 kinase substrate motif;Pim1 kinase substrate sequence;PKA kinase substrate motif;PKA, PKG kinase substrate motif;PKC epsilon kinase substrate motif;PKC kinase substrate motif;PKG kinase substrate motif;ZIP kinase substrate motif",+,0.01175,6,1,1,940000000,0,3.3,2,3.341725248,Nuclear cap-binding protein subunit 1 (80 kDa nuclear cap-binding protein) (CBP80) (NCBP 80 kDa subunit),RRHSDENDGGQPHK,_MSRRRHSDENDGGQ,Q09161,NCBP1,S(4): 100.0,Q09161,S4(Phospho),1
0,0.12,0.17,0.20,0.13,0.13,0.53,0.50,K15(iTRAQ8plex);N-Term(iTRAQ8plex);S4(Phospho),14-3-3 domain binding motif;Calmodulin-dependent protein kinase II substrate motif;Calmodulin-dependent protein kinase IV substrate motif;Casein kinase II substrate motif;Chk1 kinase substrate motif;G protein-coupled receptor kinase 1 substrate motif;GSK3 kinase substrate motif;PAK2 kinase substrate motif;PKA kinase substrate motif;PKC epsilon kinase substrate motif;PKC kinase substrate motif,+,6.93E-07,123,1,1,525000000,0,6.6,1,2.724122758,"Hematological and neurological expressed 1 protein (Androgen-regulated protein 2) [Cleaved into: Hematological and neurological expressed 1 protein, N-terminally processed]",RNSSEASSGDFLDLK,SGLQRRNSSEASSGD,Q9UK76,HN1,S(3): 5.1;S(4): 94.9;S(7): 0.0;S(8): 0.0,Q9UK76,S4(Phospho),1
0,-0.08,0.04,0.32,1.26,0.87,1.32,0.91,K19(iTRAQ8plex);N-Term(iTRAQ8plex);S4(Phospho),"Casein kinase II substrate motif;ERK1,2 kinase substrate motif;GSK-3, ERK1, ERK2, CDK5 substrate motif;PKA kinase substrate motif;WW domain binding motif",+,0.01539,2,1,1,995000,0,3.18,0,1.835893363,Cytoplasmic polyadenylation element-binding protein 4 (CPE-BP4) (CPE-binding protein 4) (hCPEB-4),QQLSPSPGQEAGILPETEK,PLEKQQLSPSPGQEA,Q17RY0,CPEB4,S(4): 97.9;S(6): 2.1;T(17): 0.0,Q17RY0,S4(Phospho),1
0,-0.01,0.80,0.52,0.02,0.03,0.09,-0.08,K3(iTRAQ8plex);N-Term(iTRAQ8plex);S4(Phospho),"ERK1,2 kinase substrate motif;G protein-coupled receptor kinase 1 substrate motif;Growth associated histone HI kinase substrate motif;GSK-3, ERK1, ERK2, CDK5 substrate motif;WW domain binding motif",+,0.002054,18,1,1,79900000,0,4.53,1,1.919322342,"Eukaryotic translation initiation factor 2A (eIF-2A) (65 kDa eukaryotic translation initiation factor 2A) [Cleaved into: Eukaryotic translation initiation factor 2A, N-terminally processed]",SDKSPDLAPTPAPQSTPR,QEARSDKSPDLAPTP,Q9BY44,EIF2A,S(1): 0.2;S(4): 99.8;T(10): 0.0;S(15): 0.0;T(16): 0.0,Q9BY44,S4(Phospho),1
0,0.20,0.99,1.10,0.49,0.14,-0.14,0.17,K6(iTRAQ8plex);N-Term(iTRAQ8plex);S4(Phospho),"Cdc2 kinase substrate motif;CDK kinase substrate motif;CDK1,2,4,6 kinase substrate motif;ERK1,2 kinase substrate motif;G protein-coupled receptor kinase 1 substrate motif;Growth associated histone HI kinase substrate motif;GSK-3, ERK1, ERK2, CDK5 substrate motif;PKA kinase substrate motif;PKC kinase substrate motif;WW domain binding motif",+,0.1216,18,1,1,291000000,0.00315,1.91,0,1.808112967,General transcription factor II-I (GTFII-I) (TFII-I) (Bruton tyrosine kinase-associated protein 135) (BAP-135) (BTK-associated protein 135) (SRF-Phox1-interacting protein) (SPIN) (Williams-Beuren syndrome chromosomal region 6 protein),ALQSPK,INTKALQSPKRPRSP,P78347,GTF2I,S(4): 100.0,P78347,S4(Phospho),1
0,0.13,-1.95,-1.98,-1.09,-1.01,-2.41,-1.66,K7(iTRAQ8plex);N-Term(iTRAQ8plex);S4(Phospho),"Casein kinase II substrate motif;Cdc2 kinase substrate motif;CDK kinase substrate motif;CDK1,2,4,6 kinase substrate motif;ERK1,2 kinase substrate motif;GSK-3, ERK1, ERK2, CDK5 substrate motif;PKA kinase substrate motif;WW domain binding motif",+,0.115,6,1,1,68900000,0.002704,1.99,0,2.358871459,Nucleolin (Protein C23),VVVSPTK,SAKKVVVSPTKKVAV,P19338,NCL,S(4): 85.7;T(6): 14.3,P19338,S4(Phospho),1
0,0.03,-1.47,-1.37,-0.28,-0.31,0.16,0.28,K7(iTRAQ8plex);N-Term(iTRAQ8plex);S4(Phospho),"b-Adrenergic Receptor kinase substrate motif;Casein kinase I substrate motif;Casein kinase II substrate motif;Cdc2 kinase substrate motif;CDK kinase substrate motif;CDK1,2,4,6 kinase substrate motif;ERK1,2 kinase substrate motif;GSK-3, ERK1, ERK2, CDK5 substrate motif;PKA kinase substrate motif;WW domain binding motif",+,0.3074,12,1,1,5100000000,0.004,2.4,0,4.558064449,Microtubule-associated protein 4 (MAP-4),DMESPTK,ALAKDMESPTKLDVT,P27816,MAP4,,P27816,S4(Phospho),1
0,0.07,-0.49,-0.29,-0.04,-0.13,0.23,0.28,K7(iTRAQ8plex);N-Term(iTRAQ8plex);S4(Phospho),PKA kinase substrate motif,+,0.1294,6,1,1,150000000,0.003056,2.55,0,2.164165244,Neuroblast differentiation-associated protein AHNAK (Desmoyokin),IHMSGPK,KMPKIHMSGPKIKAK,Q09666,AHNAK,S(4): 100.0,Q09666,S4(Phospho),1
0,0.04,-1.82,-1.64,-0.52,-0.95,-0.76,-1.04,K7(iTRAQ8plex);N-Term(iTRAQ8plex);S4(Phospho),Casein kinase I substrate motif;PKA kinase substrate motif;PKC kinase substrate motif,+,0.1289,2,1,1,239000000,0.003056,1.56,1,2.431801606,Protein AHNAK2,ERLSWPK,QSQRERLSWPKFQSI,Q8IVF2,AHNAK2,S(4): 100.0,Q8IVF2,S4(Phospho),1
0,0.17,-2.41,-2.17,-0.63,-0.55,-0.50,-0.97,K8(iTRAQ8plex);N-Term(iTRAQ8plex);S4(Phospho),ATM kinase substrate motif;b-Adrenergic Receptor kinase substrate motif;Casein kinase II substrate motif;DNA dependent Protein kinase substrate motif;PKA kinase substrate motif,+,0.1006,2,1,1,61000000,0.002813,1.68,0,2.931249115,DNA replication licensing factor MCM3 (EC 3.6.4.12) (DNA polymerase alpha holoenzyme-associated protein P1) (P1-MCM3) (RLF subunit beta) (p102),TADSQETK,HTPKTADSQETKESQ,P25205,MCM3,T(1): 1.2;S(4): 98.6;T(7): 0.2,P25205,S4(Phospho),1
0,0.00,-1.22,-1.25,-0.17,-0.12,-0.37,-0.33,K8(iTRAQ8plex);N-Term(iTRAQ8plex);S4(Phospho),"14-3-3 domain binding motif;Akt kinase substrate motif;AMP-activated protein kinase 2 substrate motif;Calmodulin-dependent protein kinase II substrate motif;ERK1,2 kinase substrate motif;GSK-3, ERK1, ERK2, CDK5 substrate motif;MAPKAPK1 kinase substrate motif;PKA kinase substrate motif;PKC kinase substrate motif;WW domain binding motif",+,0.298,2,1,1,0,0.004,1.85,1,5.57839673,Matrin-3,RSYSPDGK,KSRKRSYSPDGKESP,P43243,MATR3,,P43243,S4(Phospho),1
0,0.08,-1.24,-1.14,-0.46,-0.54,-0.92,-0.89,K8(iTRAQ8plex);N-Term(iTRAQ8plex);S4(Phospho),"b-Adrenergic Receptor kinase substrate motif;Casein kinase I substrate motif;Casein kinase II substrate motif;ERK1,2 kinase substrate motif;GSK-3, ERK1, ERK2, CDK5 substrate motif;PKA kinase substrate motif;WW domain binding motif",+,0.1269,2,1,1,20700000,0.009221,2.78,0,4.129322067,Treacle protein (Treacher Collins syndrome protein),DSESPSQK,ASTKDSESPSQKKKK,Q13428,TCOF1,S(2): 0.0;S(4): 99.2;S(6): 0.8,Q13428,S4(Phospho),1
0,0.10,1.74,2.53,0.43,-0.01,-0.38,-0.03,K8(iTRAQ8plex);N-Term(iTRAQ8plex);S4(Phospho),14-3-3 domain binding motif;Calmodulin-dependent protein kinase II substrate motif;Casein kinase II substrate motif;G protein-coupled receptor kinase 1 substrate motif;PAK2 kinase substrate motif;Pim1 kinase substrate sequence;PKA kinase substrate motif;PKC epsilon kinase substrate motif;PKC kinase substrate motif,+,0.1702,4,1,1,161000000,0.005524,1.81,0,2.122133809,Serine/arginine repetitive matrix protein 1 (SR-related nuclear matrix protein of 160 kDa) (SRm160) (Ser/Arg-related nuclear matrix protein),VSHSPPPK,PPPKRRVSHSPPPKQ,Q8IYB3,SRRM1,S(2): 50.0;S(4): 50.0,Q8IYB3,S4(Phospho),1
0,-0.14,1.25,1.47,-1.25,-1.74,-0.81,-0.68,K8(iTRAQ8plex);N-Term(iTRAQ8plex);S4(Phospho),"b-Adrenergic Receptor kinase substrate motif;Casein kinase II substrate motif;ERK1,2 kinase substrate motif;GSK-3, ERK1, ERK2, CDK5 substrate motif;WW domain binding motif",+,0.08355,8,1,1,115000000,0.002,2.71,0,3.209186724,Epidermal growth factor receptor kinase substrate 8-like protein 2 (EPS8-like protein 2) (Epidermal growth factor receptor pathway substrate 8-related protein 2) (EPS8-related protein 2),GGDSPEAK,FQHRGGDSPEAKNRV,Q9H6S3,EPS8L2,,Q9H6S3,S4(Phospho),1
0,0.06,-0.32,-0.32,-0.09,-0.05,-0.03,-0.09,K9(iTRAQ8plex);N-Term(iTRAQ8plex);S4(Phospho),Casein kinase II substrate motif;G protein-coupled receptor kinase 1 substrate motif,+,0.1188,2,1,1,31800000,0.005689,2.04,0,2.827006634,Nuclear factor 1 B-type (NF1-B) (Nuclear factor 1/B) (CCAAT-box-binding transcription factor) (CTF) (Nuclear factor I/B) (NF-I/B) (NFI-B) (TGGCA-binding protein),SLSSPPSSK,SGVNLQRSLSSPPSS,O00712,NFIB,S(1): 86.0;S(3): 13.4;S(4): 0.5;S(7): 0.0;S(8): 0.0,O00712,S4(Phospho),1
0,0.19,-1.60,-1.58,-1.46,-1.36,-1.38,-1.27,K9(iTRAQ8plex);N-Term(iTRAQ8plex);S4(Phospho),AMP-activated protein kinase substrate motif;Casein kinase II substrate motif,+,0.001143,272,1,1,982000000,0,5.23,1,3.927248445,"Keratin, type I cytoskeletal 17 (39.1) (Cytokeratin-17) (CK-17) (Keratin-17) (K17)",QFTSSSSIKGSSGLGGGSSR,TSIRQFTSSSSIKGS,Q04695,KRT17,T(3): 0.5;S(4): 86.0;S(5): 6.5;S(6): 6.5;S(7): 0.5;S(11): 0.0;S(12): 0.0;S(18): 0.0;S(19): 0.0,Q04695,S4(Phospho),1
0,-0.12,-2.70,-2.58,-0.06,-0.25,-0.63,-0.47,K9(iTRAQ8plex);N-Term(iTRAQ8plex);S4(Phospho),"Casein kinase I substrate motif;ERK1,2 kinase substrate motif;Growth associated histone HI kinase substrate motif;GSK-3, ERK1, ERK2, CDK5 substrate motif;WW domain binding motif",+,0.1436,4,1,1,66500000,0.004142,2.74,1,4.277088019,Serine/arginine repetitive matrix protein 1 (SR-related nuclear matrix protein of 160 kDa) (SRm160) (Ser/Arg-related nuclear matrix protein),EARSPQPNK,RSTREARSPQPNKRH,Q8IYB3,SRRM1,S(4): 100.0,Q8IYB3,S4(Phospho),1
0,0.12,0.70,0.79,0.65,0.59,0.87,0.78,K9(iTRAQ8plex);N-Term(iTRAQ8plex);S4(Phospho),"ERK1,2 kinase substrate motif;G protein-coupled receptor kinase 1 substrate motif;GSK-3, ERK1, ERK2, CDK5 substrate motif;WW domain binding motif",+,0.02949,16,1,1,271000000,0,3.92,0,2.916756031,Tensin-4 (C-terminal tensin-like protein),TPHSPPLAK,GQPRTPHSPPLAKEH,Q8IZW8,TNS4,T(1): 0.0;S(4): 100.0,Q8IZW8,S4(Phospho),1
0,0.23,-0.23,-0.08,0.64,0.65,0.33,0.30,K3(iTRAQ8plex);S4(Phospho),"ERK1,2 kinase substrate motif;G protein-coupled receptor kinase 1 substrate motif;Growth associated histone HI kinase substrate motif;GSK-3, ERK1, ERK2, CDK5 substrate motif;WW domain binding motif",+,0.1191,2,1,1,0,0.008397,3.49,1,2.266771588,"Eukaryotic translation initiation factor 2A (eIF-2A) (65 kDa eukaryotic translation initiation factor 2A) [Cleaved into: Eukaryotic translation initiation factor 2A, N-terminally processed]",SDKSPDLAPTPAPQSTPR,QEARSDKSPDLAPTP,Q9BY44,EIF2A,S(1): 8.5;S(4): 91.5;T(10): 0.1;S(15): 0.0;T(16): 0.0,Q9BY44,S4(Phospho),1
0,-0.23,0.09,0.29,-0.86,-0.76,0.44,0.51,N-Term(iTRAQ8plex);S4(Phospho),b-Adrenergic Receptor kinase substrate motif;Casein kinase II substrate motif;PKA kinase substrate motif;Pyruvate dehydrogenase kinase substrate motif,+,0.1665,2,1,1,21800000,0.002301,2.2,0,2.829361601,Programmed cell death protein 5 (TF-1 cell apoptosis-related protein 19) (Protein TFAR19),VMDSDEDDDY,NRRKVMDSDEDDDY_,O14737,PDCD5,S(4): 100.0;Y(10): 0.0,O14737,S4(Phospho),1
0,0.12,-0.74,-0.79,0.12,0.02,-0.20,-0.23,N-Term(iTRAQ8plex);S4(Phospho),AMP-activated protein kinase substrate motif;Casein kinase II substrate motif;Pyruvate dehydrogenase kinase substrate motif,+,0.003892,122,1,1,847000000,0,4.34,0,3.36898365,Catenin delta-1 (Cadherin-associated Src substrate) (CAS) (p120 catenin) (p120(ctn)) (p120(cas)),VGGSSVDLHR,PQVRVGGSSVDLHRF,O60716,CTNND1,S(4): 93.2;S(5): 6.8,O60716,S4(Phospho),1
0,0.05,-0.38,-0.39,0.61,0.45,0.30,0.23,N-Term(iTRAQ8plex);S4(Phospho),"14-3-3 domain binding motif;Calmodulin-dependent protein kinase II substrate motif;Casein kinase II substrate motif;ERK1,2 kinase substrate motif;GSK-3, ERK1, ERK2, CDK5 substrate motif;MDC1 BRCT domain binding motif;PKA kinase substrate motif;PKC kinase substrate motif;Plk1 PBD domain binding motif;WW domain binding motif;ZIP kinase substrate motif",+,0.01833,28,1,1,40900000,0,3.87,1,3.283920184,Actin-binding LIM protein 3 (abLIM-3) (Actin-binding LIM protein family member 3),RASSPGYIDSPTYSR,LRQRRASSPGYIDSS,O94929,ABLIM3,S(3): 3.0;S(4): 97.0;Y(7): 0.0;S(10): 0.0;T(12): 0.0;Y(13): 0.0;S(14): 0.0,O94929,S4(Phospho),1
0,-0.04,-1.40,-1.44,0.20,0.13,-0.05,-0.11,N-Term(iTRAQ8plex);S4(Phospho),"Casein kinase II substrate motif;ERK1,2 kinase substrate motif;G protein-coupled receptor kinase 1 substrate motif;GSK-3, ERK1, ERK2, CDK5 substrate motif;PKA kinase substrate motif;PKC kinase substrate motif;WW domain binding motif",+,0.06299,82,1,1,1790000000,0,3.13,1,5.180027616,Prelamin-A/C [Cleaved into: Lamin-A/C (70 kDa lamin) (Renal carcinoma antigen NY-REN-32)],LRLSPSPTSQR,EEERLRLSPSPTSQR,P02545,LMNA,S(4): 43.9;S(6): 6.1;T(8): 43.9;S(9): 6.1,P02545,S4(Phospho),1
0,0.04,-1.25,-1.35,-0.10,-0.12,-0.26,-0.29,N-Term(iTRAQ8plex);S4(Phospho),"Casein kinase II substrate motif;DNA dependent Protein kinase substrate motif;ERK1,2 kinase substrate motif;GSK-3, ERK1, ERK2, CDK5 substrate motif;WW domain binding motif",+,0.01637,14,1,1,1240000000,0,2.67,0,4.779277633,Prelamin-A/C [Cleaved into: Lamin-A/C (70 kDa lamin) (Renal carcinoma antigen NY-REN-32)],LSPSPTSQR,ERLRLSPSPTSQRSR,P02545,LMNA,S(2): 8.2;S(4): 90.9;T(6): 0.8;S(7): 0.1,P02545,S4(Phospho),1
0,-0.43,-0.76,-0.01,3.04,2.88,2.66,2.35,N-Term(iTRAQ8plex);S4(Phospho),AMP-activated protein kinase substrate motif;MDC1 BRCT domain binding motif;PKA kinase substrate motif;PKC kinase substrate motif;Plk1 PBD domain binding motif,+,0.02858,20,1,1,1430000000,0.0007602,2.99,1,3.00722157,Vimentin,LRSSVPGVR,SAVRLRSSVPGVRLL,P08670,VIM,S(3): 1.2;S(4): 98.8,P08670,S4(Phospho),1
0,0.17,-0.85,-0.88,-0.16,-0.13,-0.38,-0.38,N-Term(iTRAQ8plex);S4(Phospho),Casein kinase II substrate motif;G protein-coupled receptor kinase 1 substrate motif,+,0.03023,13,1,1,289000000,0,2.59,0,3.337380457,Integrin beta-4 (GP150) (CD antigen CD104),SEHSHSTTLPR,SLTRSEHSHSTTLPR,P16144,ITGB4,S(1): 0.3;S(4): 42.5;S(6): 42.5;T(7): 7.3;T(8): 7.3,P16144,S4(Phospho),1
0,-0.09,-1.37,-1.22,-0.06,-0.20,-0.38,-0.36,N-Term(iTRAQ8plex);S4(Phospho),Casein kinase II substrate motif;MDC1 BRCT domain binding motif;PKA kinase substrate motif;PKC kinase substrate motif;Plk1 PBD domain binding motif,+,3.26E-07,16,1,1,66500000,0,5.95,0,3.531656523,Heterogeneous nuclear ribonucleoprotein A3 (hnRNP A3),SSGSPYGGGYGSGGGSGGYGSR,GSFGGRSSGSPYGGG,P51991,HNRNPA3,S(1): 10.9;S(2): 78.2;S(4): 10.9;Y(6): 0.0;Y(10): 0.0;S(12): 0.0;S(16): 0.0;Y(19): 0.0;S(21): 0.0,P51991,S4(Phospho),1
0,0.24,-1.06,-0.74,0.33,0.39,-0.48,-0.41,N-Term(iTRAQ8plex);S4(Phospho),b-Adrenergic Receptor kinase substrate motif;Casein kinase II substrate motif,+,0.009527,8,1,1,55000000,0,3.09,0,2.494483408,Nuclease-sensitive element-binding protein 1 (CCAAT-binding transcription factor I subunit A) (CBF-A) (DNA-binding protein B) (DBPB) (Enhancer factor I subunit A) (EFI-A) (Y-box transcription factor) (Y-box-binding protein 1) (YB-1),NEGSESAPEGQAQQR,EKNEGSESAPEGQAQ,P67809,YBX1,S(4): 50.0;S(6): 50.0,P67809,S4(Phospho),1
0,0.17,-0.35,-0.29,0.66,0.70,0.66,0.49,N-Term(iTRAQ8plex);S4(Phospho),"Casein kinase II substrate motif;DNA dependent Protein kinase substrate motif;ERK1,2 kinase substrate motif;GSK-3, ERK1, ERK2, CDK5 substrate motif;PKA kinase substrate motif;WW domain binding motif",+,0.3151,2,1,1,0,0.006,2.82,0,2.95923486,A-kinase anchor protein 12 (AKAP-12) (A-kinase anchor protein 250 kDa) (AKAP 250) (Gravin) (Myasthenia gravis autoantigen),SPPSPVER,SHAKSPPSPVEREMV,Q02952,AKAP12,,Q02952,S4(Phospho),1
0,0.00,-0.86,-0.80,0.03,-0.10,0.14,0.18,N-Term(iTRAQ8plex);S4(Phospho),"Casein kinase II substrate motif;ERK1,2 kinase substrate motif;Growth associated histone HI kinase substrate motif;GSK-3, ERK1, ERK2, CDK5 substrate motif;PKA kinase substrate motif;WW domain binding motif",+,0.00505,71,1,1,2390000000,0,4.18,1,3.839136974,Neuroblast differentiation-associated protein AHNAK (Desmoyokin),GDRSPEPGQTWTR,LHRKGDRSPEPGQTW,Q09666,AHNAK,S(4): 100.0;T(10): 0.0;T(12): 0.0,Q09666,S4(Phospho),1
0,0.10,-1.22,-1.12,0.22,-0.04,-0.40,-0.38,N-Term(iTRAQ8plex);S4(Phospho),ALK kinase substrate motif,+,0.05892,4,1,1,758000000,0.0006395,2.76,1,3.083177731,"Serine/arginine-rich splicing factor 9 (Pre-mRNA-splicing factor SRp30C) (Splicing factor, arginine/serine-rich 9)",GRDSPYQSR,SRGRDSPYQSRGSPH,Q13242,SRSF9,S(4): 11.7;Y(6): 86.6;S(8): 1.7,Q13242,S4(Phospho),1
0,0.15,-0.39,-0.31,0.37,0.37,0.76,0.80,N-Term(iTRAQ8plex);S4(Phospho),"14-3-3 domain binding motif;Akt kinase substrate motif;b-Adrenergic Receptor kinase substrate motif;Calmodulin-dependent protein kinase II substrate motif;ERK1,2 kinase substrate motif;GSK-3, ERK1, ERK2, CDK5 substrate motif;MAPKAPK1 kinase substrate motif;PKA kinase substrate motif;PKC kinase substrate motif;WW domain binding motif",+,0.07379,2,1,1,6970000,0.001716,2.99,1,3.599897569,E3 ubiquitin-protein ligase TRIP12 (EC 6.3.2.-) (E3 ubiquitin-protein ligase for Arf) (ULF) (Thyroid receptor-interacting protein 12) (TR-interacting protein 12) (TRIP-12),RSESPPAELPSLR,STKKRSESPPAELPS,Q14669,TRIP12,S(2): 7.3;S(4): 91.8;S(11): 0.9,Q14669,S4(Phospho),1
0,0.09,0.50,0.44,0.07,0.06,0.21,0.19,N-Term(iTRAQ8plex);S4(Phospho),14-3-3 domain binding motif;AMP-activated protein kinase substrate motif;Calmodulin-dependent protein kinase I substrate motif;Calmodulin-dependent protein kinase II alpha substrate motif;Calmodulin-dependent protein kinase II substrate motif;Calmodulin-dependent protein kinase IV substrate motif;Casein kinase II substrate motif;Chk1 kinase substrate motif;Phosphorylase kinase substrate motif;PKA kinase substrate motif;PKC kinase substrate motif,+,0.001561,10,1,1,55600000,0,4.69,1,2.873809682,Kinesin light chain 3 (KLC2-like) (kinesin light chain 2),RAMSLNTLNVDAPR,AGMKRAMSLNTLNVD,Q6P597,KLC3,S(4): 100.0;T(7): 0.0,Q6P597,S4(Phospho),1
0,-0.09,-0.98,-0.77,0.03,-0.02,-0.31,-0.24,N-Term(iTRAQ8plex);S4(Phospho),14-3-3 domain binding motif;b-Adrenergic Receptor kinase substrate motif;Calmodulin-dependent protein kinase II substrate motif;G protein-coupled receptor kinase 1 substrate motif;GSK3 kinase substrate motif;PAK2 kinase substrate motif;Pim1 kinase substrate sequence;PKA kinase substrate motif;PKC epsilon kinase substrate motif;PKC kinase substrate motif,+,0.06201,8,1,1,125000000,0,3.66,2,2.799070271,Uncharacterized protein C9orf40,RRDSGDNSAPSGQER,SPSKRRDSGDNSAPS,Q8IXQ3,C9orf40,S(4): 100.0;S(8): 0.0;S(11): 0.0,Q8IXQ3,S4(Phospho),1
0,-0.04,-1.89,-1.19,-0.18,-0.20,-0.45,-0.23,N-Term(iTRAQ8plex);S4(Phospho),"Casein kinase II substrate motif;ERK1,2 kinase substrate motif;GSK-3, ERK1, ERK2, CDK5 substrate motif;PKA kinase substrate motif;PKC kinase substrate motif;WW domain binding motif",+,0.0263,33,1,1,3090000000,0,3.12,1,1.8768184,Serine/arginine repetitive matrix protein 1 (SR-related nuclear matrix protein of 160 kDa) (SRm160) (Ser/Arg-related nuclear matrix protein),TRHSPTPQQSNR,PPPKTRHSPTPQQSN,Q8IYB3,SRRM1,T(1): 0.6;S(4): 98.9;T(6): 0.6;S(10): 0.0,Q8IYB3,S4(Phospho),1
0,0.03,0.40,0.50,0.94,0.92,1.03,1.14,N-Term(iTRAQ8plex);S4(Phospho),Casein kinase I substrate motif;Casein kinase II substrate motif;G protein-coupled receptor kinase 1 substrate motif;GSK3 kinase substrate motif,+,0.0327,43,1,1,72400000,0,4.72,1,3.892689095,Tensin-4 (C-terminal tensin-like protein),ETRSSSESLIFSGNQGR,DVPRETRSSSESLIF,Q8IZW8,TNS4,T(2): 4.7;S(4): 45.3;S(5): 45.3;S(6): 4.7;S(8): 0.1;S(12): 0.0,Q8IZW8,S4(Phospho),1
0,0.01,-0.43,-0.44,0.54,0.58,0.46,0.48,N-Term(iTRAQ8plex);S4(Phospho),b-Adrenergic Receptor kinase substrate motif;Casein kinase II substrate motif;PKA kinase substrate motif;PKC kinase substrate motif,+,0.0004758,10,1,1,82500000,0,5.52,1,5.836073607,Palladin (SIH002) (Sarcoma antigen NY-SAR-77),SRDSGDENEPIQER,PRSRSRDSGDENEPI,Q8WX93,PALLD,S(1): 0.0;S(4): 100.0,Q8WX93,S4(Phospho),1
0,-0.24,0.31,-0.20,1.22,1.41,1.76,1.53,N-Term(iTRAQ8plex);S4(Phospho),"Casein kinase II substrate motif;ERK1,2 kinase substrate motif;Growth associated histone HI kinase substrate motif;GSK-3, ERK1, ERK2, CDK5 substrate motif;WW domain binding motif",+,0.1049,6,1,1,1090000000,0,1.78,1,2.48558799,Palladin (SIH002) (Sarcoma antigen NY-SAR-77),SPRSPSGHPHVR,QRGRSPRSPSGHPHV,Q8WX93,PALLD,S(1): 13.9;S(4): 72.1;S(6): 13.9,Q8WX93,S4(Phospho),1
0,0.17,0.22,0.27,0.52,0.45,0.77,0.66,N-Term(iTRAQ8plex);S4(Phospho),"Casein kinase II substrate motif;ERK1,2 kinase substrate motif;GSK-3, ERK1, ERK2, CDK5 substrate motif;PKA kinase substrate motif;WW domain binding motif",+,0.004552,20,1,1,20100000,0,4.3,0,2.332425843,Far upstream element-binding protein 2 (FUSE-binding protein 2) (KH type-splicing regulatory protein) (KSRP) (p75),VQISPDSGGLPER,SGCKVQISPDSGGLP,Q92945,KHSRP,S(4): 100.0;S(7): 0.0,Q92945,S4(Phospho),1
0,0.05,-1.17,-1.08,-0.10,0.05,-0.41,-0.53,N-Term(iTRAQ8plex);S4(Phospho),Casein kinase I substrate motif;Casein kinase II substrate motif;PKA kinase substrate motif,+,0.03884,6,1,1,28500000,0.0006798,3.46,0,3.465778495,STE20-like serine/threonine-protein kinase (STE20-like kinase) (hSLK) (EC 2.7.11.1) (CTCL tumor antigen se20-9) (STE20-related serine/threonine-protein kinase) (STE20-related kinase) (Serine/threonine-protein kinase 2),DSGSISLQETR,SKTKDSGSISLQETR,Q9H2G2,SLK,S(2): 0.0;S(4): 99.8;S(6): 0.2;T(10): 0.0,Q9H2G2,S4(Phospho),1
0,0.25,-0.62,-0.78,-0.25,-0.18,-0.45,-0.50,N-Term(iTRAQ8plex);S4(Phospho),BARD1 BRCT domain binding motif;Casein kinase II substrate motif;G protein-coupled receptor kinase 1 substrate motif,+,0.01847,7,1,1,16600000,0,3.22,0,2.172041428,Suppressor of SWI4 1 homolog (Ssf-1) (Brix domain-containing protein 3) (Peter Pan homolog),VGGSDEEASGIPSR,KKARVGGSDEEASGI,Q9NQ55,PPAN,S(4): 100.0;S(9): 0.0;S(13): 0.0,Q9NQ55,S4(Phospho),1
0,0.29,1.33,1.23,-0.47,-0.43,-0.48,-0.45,N-Term(iTRAQ8plex);S4(Phospho),"Casein kinase II substrate motif;ERK1,2 kinase substrate motif;G protein-coupled receptor kinase 1 substrate motif;Growth associated histone HI kinase substrate motif;GSK-3, ERK1, ERK2, CDK5 substrate motif;PKA kinase substrate motif;WW domain binding motif",+,0.0001133,16,1,1,79200000,0,4.95,1,3.579831112,SH3 domain-binding protein 1 (3BP-1),VTRSPPETAAPVEDMAR,ASPKVTRSPPETAAP,Q9Y3L3,SH3BP1,T(2): 8.8;S(4): 91.2;T(8): 0.0,Q9Y3L3,S4(Phospho),1
0,-0.10,-1.66,-1.49,-0.11,-0.20,-0.30,-0.30,K1(iTRAQ8plex);K10(iTRAQ8plex);N-Term(iTRAQ8plex);S5(Phospho),"Casein kinase I substrate motif;Casein kinase II substrate motif;ERK1,2 kinase substrate motif;GSK-3, ERK1, ERK2, CDK5 substrate motif;PKA kinase substrate motif;WW domain binding motif",+,0.02027,11,1,1,142000000,0,3.63,1,3.954366056,Bcl-2-associated transcription factor 1 (Btf),KETQSPEQVK,TVKKETQSPEQVKSE,Q9NYF8,BCLAF1,T(3): 0.0;S(5): 100.0,Q9NYF8,S5(Phospho),1
0,-0.09,-1.27,-1.50,0.03,0.08,0.10,0.12,K1(iTRAQ8plex);K10(iTRAQ8plex);N-Term(iTRAQ8plex);S5(Phospho),"ERK1,2 kinase substrate motif;GSK-3, ERK1, ERK2, CDK5 substrate motif;PKA kinase substrate motif;WW domain binding motif",+,0.2422,2,1,1,73700000,0.006394,3.54,1,3.683626595,Ribosome-binding protein 1 (180 kDa ribosome receptor homolog) (RRp) (ES/130-related protein) (Ribosome receptor protein),KAEGSPNQGK,EGKKAEGSPNQGKKA,Q9P2E9,RRBP1,S(5): 100.0,Q9P2E9,S5(Phospho),1
0,0.05,-1.07,-1.03,0.28,0.18,0.19,0.08,K1(iTRAQ8plex);K10(iTRAQ8plex);N-Term(iTRAQ8plex);S5(Phospho),"Casein kinase II substrate motif;ERK1,2 kinase substrate motif;GSK-3, ERK1, ERK2, CDK5 substrate motif;PKA kinase substrate motif;WW domain binding motif",+,0.0496,4,1,1,52700000,0.001328,3.53,1,4.144251998,Ribosome-binding protein 1 (180 kDa ribosome receptor homolog) (RRp) (ES/130-related protein) (Ribosome receptor protein),KAEGSPSEGK,QGKKAEGSPSEGKKA,Q9P2E9,RRBP1,S(5): 100.0;S(7): 0.0,Q9P2E9,S5(Phospho),1
0,0.01,-2.19,-2.37,-0.90,-1.22,-2.13,-1.91,K13(iTRAQ8plex);K15(iTRAQ8plex);N-Term(iTRAQ8plex);S5(Phospho),BARD1 BRCT domain binding motif;Casein kinase I substrate motif;Casein kinase II substrate motif;DNA dependent Protein kinase substrate motif;G protein-coupled receptor kinase 1 substrate motif,+,0.1139,2,1,1,69600000,0.003056,2.64,0,3.431202688,Nucleolar RNA helicase 2 (EC 3.6.4.13) (DEAD box protein 21) (Gu-alpha) (Nucleolar RNA helicase Gu) (Nucleolar RNA helicase II) (RH II/Gu),NEEPSEEEIDAPKPK,VTKNEEPSEEEIDAP,Q9NR30,DDX21,S(5): 100.0,Q9NR30,S5(Phospho),1
0,0.18,-0.49,-0.48,-0.16,-0.02,0.07,-0.04,K1(iTRAQ8plex);K16(iTRAQ8plex);N-Term(iTRAQ8plex);S5(Phospho),b-Adrenergic Receptor kinase substrate motif;Casein kinase I substrate motif;Casein kinase II substrate motif;G protein-coupled receptor kinase 1 substrate motif;PKA kinase substrate motif,+,0.0004759,6,1,1,106000000,0,5.58,1,1.979740637,Serine/arginine repetitive matrix protein 1 (SR-related nuclear matrix protein of 160 kDa) (SRm160) (Ser/Arg-related nuclear matrix protein),KETESEAEDNLDDLEK,EPKKETESEAEDNLD,Q8IYB3,SRRM1,T(3): 0.1;S(5): 99.9,Q8IYB3,S5(Phospho),1
0,0.34,-0.47,-0.68,0.11,0.36,0.39,0.31,K18(iTRAQ8plex);K2(iTRAQ8plex);N-Term(iTRAQ8plex);S5(Phospho),b-Adrenergic Receptor kinase substrate motif;Casein kinase II substrate motif;PKA kinase substrate motif;PKC kinase substrate motif;Pyruvate dehydrogenase kinase substrate motif,+,0.002333,2,1,1,0,0,5.04,0,1.774620931,Leucine zipper protein 1,EKPDSDDDLDIASLVTAK,SGREKPDSDDDLDIA,Q86V48,LUZP1,,Q86V48,S5(Phospho),1
0,0.43,-0.59,-0.94,1.42,1.26,1.19,1.06,C10(Carbamidomethyl);K20(iTRAQ8plex);N-Term(iTRAQ8plex);S5(Phospho),BARD1 BRCT domain binding motif;Casein kinase I substrate motif;Casein kinase II substrate motif;G protein-coupled receptor kinase 1 substrate motif,+,0.0007675,2,1,1,565000,0,4.15,0,2.770772694,Nucleolar protein 58 (Nucleolar protein 5),EEPLSEEEPCTSTAIASPEK,HIKEEPLSEEEPCTS,Q9Y2X3,NOP58,S(5): 100.0;T(11): 0.0;S(12): 0.0;T(13): 0.0;S(17): 0.0,Q9Y2X3,S5(Phospho),1
0,0.16,2.50,2.73,0.91,0.86,0.28,0.40,K2(iTRAQ8plex);K22(iTRAQ8plex);N-Term(iTRAQ8plex);S5(Phospho),Casein kinase I substrate motif;Casein kinase II substrate motif;PKA kinase substrate motif;PKC kinase substrate motif;Pyruvate dehydrogenase kinase substrate motif,+,0.116,4,1,1,330000,0.003056,3.19,1,4.154908155,Zyxin (Zyxin-2),EKVSSIDLEIDSLSSLLDDMTK,PQPREKVSSIDLEID,Q15942,ZYX,S(4): 49.1;S(5): 49.1;S(12): 0.4;S(14): 0.4;S(15): 0.4;T(21): 0.4,Q15942,S5(Phospho),1
0,0.32,-1.55,-1.52,-0.47,-0.46,-0.38,-0.67,K4(iTRAQ8plex);K7(iTRAQ8plex);N-Term(iTRAQ8plex);S5(Phospho),"Casein kinase I substrate motif;Casein kinase II substrate motif;ERK1,2 kinase substrate motif;Growth associated histone HI kinase substrate motif;GSK-3, ERK1, ERK2, CDK5 substrate motif;PKA kinase substrate motif;PKC kinase substrate motif;WW domain binding motif",+,0.171,8,1,1,999000000,0.002301,2.49,1,2.758432016,Neuroblast differentiation-associated protein AHNAK (Desmoyokin),VDVKSPK,ALKVDVKSPKTKKTM,Q09666,AHNAK,S(5): 100.0,Q09666,S5(Phospho),1
0,0.15,-1.94,-1.84,-0.69,-0.93,-1.59,-1.54,K1(iTRAQ8plex);K8(iTRAQ8plex);N-Term(iTRAQ8plex);S5(Phospho),"Casein kinase II substrate motif;Cdc2 kinase substrate motif;CDK kinase substrate motif;CDK1,2,4,6 kinase substrate motif;ERK1,2 kinase substrate motif;GSK-3, ERK1, ERK2, CDK5 substrate motif;PKA kinase substrate motif;WW domain binding motif",+,0.1283,2,1,1,215000000,0.003056,1.76,1,3.710310115,Nucleolin (Protein C23),KVVVSPTK,SAKKVVVSPTKKVAV,P19338,NCL,S(5): 100.0;T(7): 0.0,P19338,S5(Phospho),1
0,0.04,-2.64,-2.66,0.73,0.47,0.18,0.20,K7(iTRAQ8plex);K8(iTRAQ8plex);N-Term(iTRAQ8plex);S5(Phospho),PKA kinase substrate motif;PKC kinase substrate motif,+,0.04925,10,1,1,368000000,0.0006143,2.28,1,4.903850189,"Myristoylated alanine-rich C-kinase substrate (MARCKS) (Protein kinase C substrate, 80 kDa protein, light chain) (80K-L protein) (PKCSL)",LSGFSFKK,SFKLSGFSFKKNKKE,P29966,MARCKS,S(2): 0.0;S(5): 100.0,P29966,S5(Phospho),1
0,0.00,1.15,1.44,0.28,0.06,0.84,0.73,K1(iTRAQ8plex);N-Term(iTRAQ8plex);S5(Phospho),b-Adrenergic Receptor kinase substrate motif;Casein kinase II substrate motif;PKA kinase substrate motif;Pyruvate dehydrogenase kinase substrate motif,+,0.1391,4,1,1,172000000,0.005134,3.5,1,2.703674991,Programmed cell death protein 5 (TF-1 cell apoptosis-related protein 19) (Protein TFAR19),KVMDSDEDDDY,NRRKVMDSDEDDDY_,O14737,PDCD5,S(5): 100.0;Y(11): 0.0,O14737,S5(Phospho),1
0,0.10,-1.00,-0.90,-0.34,-0.35,0.23,0.27,K1(iTRAQ8plex);N-Term(iTRAQ8plex);S5(Phospho),"Casein kinase II substrate motif;ERK1,2 kinase substrate motif;Growth associated histone HI kinase substrate motif;GSK-3, ERK1, ERK2, CDK5 substrate motif;PKA kinase substrate motif;WW domain binding motif",+,0.04328,56,1,1,1610000000,0,3.53,2,4.056767615,Neuroblast differentiation-associated protein AHNAK (Desmoyokin),KGDRSPEPGQTWTR,LHRKGDRSPEPGQTW,Q09666,AHNAK,S(5): 100.0;T(11): 0.0;T(13): 0.0,Q09666,S5(Phospho),1
0,0.10,-0.56,-0.28,0.34,0.32,0.59,0.71,K11(iTRAQ8plex);N-Term(iTRAQ8plex);S5(Phospho),G protein-coupled receptor kinase 1 substrate motif,+,0.04048,8,1,1,42700000,0.002,2.71,0,2.553382074,Vinculin (Metavinculin) (MV),GQGSSPVAMQK,LRARGQGSSPVAMQK,P18206,VCL,S(4): 50.0;S(5): 50.0,P18206,S5(Phospho),1
0,-0.05,-0.74,-0.64,-0.41,-0.39,-0.25,-0.22,K11(iTRAQ8plex);N-Term(iTRAQ8plex);S5(Phospho),"Casein kinase II substrate motif;Cdc2 kinase substrate motif;CDK kinase substrate motif;CDK1,2,4,6 kinase substrate motif;ERK1,2 kinase substrate motif;G protein-coupled receptor kinase 1 substrate motif;GSK-3, ERK1, ERK2, CDK5 substrate motif;WW domain binding motif",+,0.0115,12,1,1,317000000,0,3.54,0,3.302309535,Coiled-coil domain-containing protein 86 (Cytokine-induced protein with coiled-coil domain),AGLGSPERPPK,VQRAGLGSPERPPKT,Q9H6F5,CCDC86,S(5): 100.0,Q9H6F5,S5(Phospho),1
0,-0.84,2.07,2.21,1.76,2.09,1.39,0.65,K12(iTRAQ8plex);N-Term(iTRAQ8plex);S5(Phospho),Calmodulin-dependent protein kinase II substrate motif;G protein-coupled receptor kinase 1 substrate motif;PKC kinase substrate motif,+,0.1919,2,1,1,37100000,0.00553,1.57,0,1.958971872,TBC1 domain family member 5,EFTGSPPSSATK,LPGGREFTGSPPSSA,Q92609,TBC1D5,T(3): 49.9;S(5): 49.9;S(8): 0.2;S(9): 0.0;T(11): 0.0,Q92609,S5(Phospho),1
0,0.12,-3.11,-2.35,0.30,0.24,-0.15,-0.19,K14(iTRAQ8plex);N-Term(iTRAQ8plex);S5(Phospho),"Casein kinase II substrate motif;ERK1,2 kinase substrate motif;Growth associated histone HI kinase substrate motif;GSK-3, ERK1, ERK2, CDK5 substrate motif;PKA kinase substrate motif;PKC kinase substrate motif;Pyruvate dehydrogenase kinase substrate motif;WW domain binding motif",+,0.04135,2,2,1,34800000,0.001217,2.45,1,2.941734975,"RNA-binding motif protein, X chromosome (Glycoprotein p43) (Heterogeneous nuclear ribonucleoprotein G) (hnRNP G) [Cleaved into: RNA-binding motif protein, X chromosome, N-terminally processed]",DVYLSPRDDGYSTK,SRRDVYLSPRDDGYS,P38159,RBMX,Y(3): 11.7;S(5): 88.2;Y(11): 0.0;S(12): 0.0;T(13): 0.0,P38159,S5(Phospho),1
0,-0.04,-1.24,-1.10,-0.24,-0.29,-0.13,-0.10,K15(iTRAQ8plex);N-Term(iTRAQ8plex);S5(Phospho),"ERK1,2 kinase substrate motif;GSK-3, ERK1, ERK2, CDK5 substrate motif;WW domain binding motif",+,4.93E-08,60,1,1,228000000,0,6.96,0,3.949720602,LIM domain and actin-binding protein 1 (Epithelial protein lost in neoplasm),ETPHSPGVEDAPIAK,NARETPHSPGVEDAP,Q9UHB6,LIMA1,T(2): 0.0;S(5): 100.0,Q9UHB6,S5(Phospho),1
0,0.03,0.29,0.30,-0.66,-0.77,-0.61,-0.55,K16(iTRAQ8plex);N-Term(iTRAQ8plex);S5(Phospho),"ERK1,2 kinase substrate motif;G protein-coupled receptor kinase 1 substrate motif;GSK-3, ERK1, ERK2, CDK5 substrate motif;WW domain binding motif",+,0.02696,40,1,1,123000000,0,3.73,0,4.086259717,Protein SOX-15 (Protein SOX-12) (Protein SOX-20),EGAGSPAAPGTLPLEK,QEREGAGSPAAPGTL,O60248,SOX15,S(5): 100.0;T(11): 0.0,O60248,S5(Phospho),1
0,-0.04,-0.35,-0.25,-0.35,-0.29,-0.37,-0.33,K17(iTRAQ8plex);N-Term(iTRAQ8plex);S5(Phospho),b-Adrenergic Receptor kinase substrate motif;BARD1 BRCT domain binding motif;Casein kinase II substrate motif;G protein-coupled receptor kinase 1 substrate motif,+,0.0006917,42,1,1,64000000,0,4.32,0,2.23584492,Ribosomal L1 domain-containing protein 1 (CATX-11) (Cellular senescence-inhibited gene protein) (Protein PBK1),ATNESEDEIPQLVPIGK,QVKATNESEDEIPQL,O76021,RSL1D1,T(2): 0.1;S(5): 99.9,O76021,S5(Phospho),1
0,0.22,-2.09,-1.54,-0.11,0.05,-0.27,-0.17,K18(iTRAQ8plex);N-Term(iTRAQ8plex);S5(Phospho),b-Adrenergic Receptor kinase substrate motif;BARD1 BRCT domain binding motif;Casein kinase II substrate motif,+,2.24E-06,14,1,1,26300000,0,7.37,0,2.558636131,CD2 antigen cytoplasmic tail-binding protein 2 (CD2 cytoplasmic domain-binding protein 2) (CD2 tail-binding protein 2) (U5 snRNP 52K protein) (U5-52K),HSLDSDEEEDDDDGGSSK,KGKHSLDSDEEEDDD,O95400,CD2BP2,S(2): 50.0;S(5): 50.0;S(16): 0.0;S(17): 0.0,O95400,S5(Phospho),1
0,0.00,-2.85,-2.76,-0.65,-0.69,-1.39,-1.34,K3(iTRAQ8plex);N-Term(iTRAQ8plex);S5(Phospho),"Casein kinase II substrate motif;Growth associated histone HI kinase substrate motif;GSK-3, ERK1, ERK2, CDK5 substrate motif;MDC1 BRCT domain binding motif;PKA kinase substrate motif;PKC kinase substrate motif;Plk1 PBD domain binding motif;WW domain binding motif",+,0.06022,32,1,1,1530000000,0.001183,3.13,0,6.129230971,Nucleophosmin (NPM) (Nucleolar phosphoprotein B23) (Nucleolar protein NO38) (Numatrin),DSKPSSTPR,KDSKPSSTPRSKGQE,P06748,NPM1,S(2): 0.2;S(5): 1.1;S(6): 9.5;T(7): 89.2,P06748,S5(Phospho),1
0,0.12,-3.35,-3.80,0.62,0.35,0.26,-0.05,K7(iTRAQ8plex);N-Term(iTRAQ8plex);S5(Phospho),Casein kinase II substrate motif;MAPKAPK2 kinase substrate motif;PKA kinase substrate motif;PKC kinase substrate motif,+,0.1002,2,1,1,25900000,0.002485,1.38,0,3.851209821,"Myristoylated alanine-rich C-kinase substrate (MARCKS) (Protein kinase C substrate, 80 kDa protein, light chain) (80K-L protein) (PKCSL)",LSGFSFK,FKKSFKLSGFSFKKN,P29966,MARCKS,S(2): 0.0;S(5): 100.0,P29966,S5(Phospho),1
0,0.04,-0.67,-0.71,-0.23,-0.12,-0.07,-0.03,K8(iTRAQ8plex);N-Term(iTRAQ8plex);S5(Phospho),"Casein kinase II substrate motif;Cdc2 kinase substrate motif;CDK kinase substrate motif;CDK1,2,4,6 kinase substrate motif;DNA dependent Protein kinase substrate motif;ERK1,2 kinase substrate motif;GSK-3, ERK1, ERK2, CDK5 substrate motif;WW domain binding motif",+,0.02944,10,1,1,24200000,0,2.87,0,3.503148559,Microtubule-associated protein 4 (MAP-4),ELPPSPEK,PNKELPPSPEKKTKP,P27816,MAP4,S(5): 100.0,P27816,S5(Phospho),1
0,0.11,0.55,0.33,-0.27,-0.33,0.39,0.47,K9(iTRAQ8plex);N-Term(iTRAQ8plex);S5(Phospho),G protein-coupled receptor kinase 1 substrate motif,+,0.1141,2,1,1,0,0.007171,3.18,0,2.391494457,MYCBP-associated protein (AMAM-1) (AMY-1-binding protein 1) (AMAP-1),LLEASENVK,PTRLLEASENVKEKK,Q8TBZ2,MYCBPAP,S(5): 100.0,Q8TBZ2,S5(Phospho),1
0,0.05,0.10,0.18,-0.32,-0.31,-0.15,-0.18,K9(iTRAQ8plex);N-Term(iTRAQ8plex);S5(Phospho),Casein kinase II substrate motif;G protein-coupled receptor kinase 1 substrate motif;GSK3 kinase substrate motif;PKA kinase substrate motif;PKC kinase substrate motif,+,0.1056,2,1,1,18600000,0.00444,2.26,0,3.138307226,Sodium-coupled neutral amino acid transporter 1 (Amino acid transporter A1) (N-system amino acid transporter 2) (Solute carrier family 38 member 1) (System A amino acid transporter 1) (System N amino acid transporter 1),SLTNSHLEK,SDRESRRSLTNSHLE,Q9H2H9,SLC38A1,S(1): 84.3;T(3): 13.3;S(5): 2.4,Q9H2H9,S5(Phospho),1
0,-0.05,-2.28,-2.58,-1.63,-2.14,-2.02,-2.16,K12(iTRAQ8plex);S5(Phospho),14-3-3 domain binding motif;Akt kinase substrate motif;Calmodulin-dependent protein kinase II substrate motif;MAPKAPK1 kinase substrate motif;PKA kinase substrate motif;PKC kinase substrate motif;ZIP kinase substrate motif,+,0.1288,4,1,1,0,0.005212,2.55,1,2.911249825,Homeobox protein MOX-1 (Mesenchyme homeobox 1),RRPNSGPAGGSK,DARRRPNSGPAGGSK,P50221,MEOX1,S(5): 100.0;S(11): 0.0,P50221,S5(Phospho),1
0,0.06,1.23,1.53,0.97,0.59,0.77,1.03,K20(iTRAQ8plex);S5(Phospho),,+,0.1632,2,1,1,783000000,0.005201,2.51,2,2.013899915,"Pyruvate dehydrogenase E1 component subunit beta, mitochondrial (PDHE1-B) (EC 1.2.4.1)",MAAVSGLVRRPLREVSGLLK,EEVMAAVSGLVRRPL,P11177,PDHB,S(5): 100.0;S(16): 0.0,P11177,S5(Phospho),1
0,-0.07,0.37,0.35,-0.18,-0.43,0.17,0.08,N-Term(iTRAQ8plex);S5(Phospho),14-3-3 domain binding motif;Akt kinase substrate motif;Calmodulin-dependent protein kinase II substrate motif;Casein kinase II substrate motif;DNA dependent Protein kinase substrate motif;MAPKAPK1 kinase substrate motif;MAPKAPK2 kinase substrate motif;PKA kinase substrate motif;PKC kinase substrate motif,+,0.06004,2,1,1,50800000,0.001183,3.61,1,2.018129742,Small glutamine-rich tetratricopeptide repeat-containing protein alpha (Alpha-SGT) (Vpu-binding protein) (UBP),SRTPSASNDDQQE,QIRSRTPSASNDDQQ,O43765,SGTA,S(1): 0.0;T(3): 0.0;S(5): 100.0;S(7): 0.0,O43765,S5(Phospho),1
0,0.02,0.64,0.67,0.25,0.21,0.46,0.55,N-Term(iTRAQ8plex);S5(Phospho),"Casein kinase II substrate motif;ERK1,2 kinase substrate motif;G protein-coupled receptor kinase 1 substrate motif;GSK-3, ERK1, ERK2, CDK5 substrate motif;WW domain binding motif",+,0.02067,15,1,1,11900000,0,3.75,0,3.686719449,Protein transport protein Sec31A (ABP125) (ABP130) (SEC31-like protein 1) (SEC31-related protein A) (Web1-like protein),EQTLSPTITSGLHNIAR,KLREQTLSPTITSGL,O94979,SEC31A,T(3): 2.7;S(5): 96.7;T(7): 0.5;T(9): 0.0;S(10): 0.0,O94979,S5(Phospho),1
0,0.14,0.32,0.18,-0.21,-0.31,0.25,0.16,N-Term(iTRAQ8plex);S5(Phospho),Casein kinase II substrate motif;G protein-coupled receptor kinase 1 substrate motif;Pyruvate dehydrogenase kinase substrate motif,+,0.0005645,61,2,1,414000000,0,4.59,0,1.891242635,"Pyruvate dehydrogenase E1 component subunit alpha, somatic form, mitochondrial (EC 1.2.4.1) (PDHE1-A type I)",YHGHSMSDPGVSYR,TYRYHGHSMSDPGVS,P08559,PDHA1,Y(1): 0.0;S(5): 100.0;S(7): 0.0;S(12): 0.0;Y(13): 0.0,P08559,S5(Phospho),1
0,0.23,-0.71,-0.76,1.13,1.23,1.04,0.98,N-Term(iTRAQ8plex);S5(Phospho),MAPKAPK2 kinase substrate motif,+,3.54E-05,103,1,1,154000000,0,4.59,0,4.003422477,Vimentin,SLYASSPGGVYATR,TSRSLYASSPGGVYA,P08670,VIM,S(1): 0.0;Y(3): 0.0;S(5): 99.7;S(6): 0.3;Y(11): 0.0;T(13): 0.0,P08670,S5(Phospho),1
0,0.04,0.61,0.53,0.34,0.38,0.53,0.45,N-Term(iTRAQ8plex);S5(Phospho),"b-Adrenergic Receptor kinase substrate motif;Casein kinase I substrate motif;ERK1,2 kinase substrate motif;G protein-coupled receptor kinase 1 substrate motif;GSK-3, ERK1, ERK2, CDK5 substrate motif;WW domain binding motif",+,0.03204,6,1,1,37400000,0.0006395,3.14,0,3.051164796,Pyruvate kinase PKM (EC 2.7.1.40) (Cytosolic thyroid hormone-binding protein) (CTHBP) (Opa-interacting protein 3) (OIP-3) (Pyruvate kinase 2/3) (Pyruvate kinase muscle isozyme) (Thyroid hormone-binding protein 1) (THBP1) (Tumor M2-PK) (p58),LDIDSPPITAR,MCRLDIDSPPITARN,P14618,PKM,S(5): 88.6;T(9): 11.4,P14618,S5(Phospho),1
0,0.06,-1.75,-1.61,-0.13,-0.29,-0.74,-0.72,N-Term(iTRAQ8plex);S5(Phospho),14-3-3 domain binding motif;Akt kinase substrate motif;Calmodulin-dependent protein kinase II substrate motif;Casein kinase II substrate motif;G protein-coupled receptor kinase 1 substrate motif;MAPKAPK1 kinase substrate motif;MAPKAPK2 kinase substrate motif;PKA kinase substrate motif;PKC kinase substrate motif,+,0.0001499,28,1,1,189000000,0,4.84,1,4.014925992,Eukaryotic translation initiation factor 4B (eIF-4B),SRTGSESSQTGTSTTSSR,RERSRTGSESSQTGT,P23588,EIF4B,S(1): 0.3;T(3): 11.9;S(5): 87.8;S(7): 0.0;S(8): 0.0;T(10): 0.0;T(12): 0.0;S(13): 0.0;T(14): 0.0;T(15): 0.0;S(16): 0.0;S(17): 0.0,P23588,S5(Phospho),1
0,-0.01,-0.81,-1.15,0.02,-0.12,0.06,-0.09,N-Term(iTRAQ8plex);S5(Phospho),"Casein kinase II substrate motif;ERK1,2 kinase substrate motif;Growth associated histone HI kinase substrate motif;GSK-3, ERK1, ERK2, CDK5 substrate motif;PKA kinase substrate motif;PKC kinase substrate motif;Pyruvate dehydrogenase kinase substrate motif;WW domain binding motif",+,0.3053,4,2,1,32300000,0.004,2.5,0,2.287574523,"RNA-binding motif protein, X chromosome (Glycoprotein p43) (Heterogeneous nuclear ribonucleoprotein G) (hnRNP G) [Cleaved into: RNA-binding motif protein, X chromosome, N-terminally processed]",DVYLSPR,SRRDVYLSPRDDGYS,P38159,RBMX,,P38159,S5(Phospho),1
0,0.39,-0.82,-0.60,1.26,0.64,0.75,1.00,N-Term(iTRAQ8plex);S5(Phospho),"Casein kinase II substrate motif;ERK1,2 kinase substrate motif;GSK-3, ERK1, ERK2, CDK5 substrate motif;WW domain binding motif",+,1.84E-07,4,1,1,178000,0,6.41,0,1.908714369,Tight junction protein ZO-1 (Tight junction protein 1) (Zona occludens protein 1) (Zonula occludens protein 1),AIPVSPSAVEEDEDEDGHTVVATAR,VPKAIPVSPSAVEED,Q07157,TJP1,S(5): 100.0;S(7): 0.0;T(19): 0.0;T(23): 0.0,Q07157,S5(Phospho),1
0,0.27,-0.76,-0.76,0.07,0.19,0.25,0.21,N-Term(iTRAQ8plex);S5(Phospho),"Casein kinase I substrate motif;Casein kinase II substrate motif;Cdc2 kinase substrate motif;CDK kinase substrate motif;CDK1,2,4,6 kinase substrate motif;ERK1,2 kinase substrate motif;GSK-3, ERK1, ERK2, CDK5 substrate motif;MAPKAPK2 kinase substrate motif;WW domain binding motif",+,0.02965,6,1,1,42200000,0,3.39,1,2.692645426,Myocyte-specific enhancer factor 2D,SEPVSPSRER,SIKSEPVSPSRERSP,Q14814,MEF2D,S(1): 0.0;S(5): 88.2;S(7): 11.8,Q14814,S5(Phospho),1
0,-0.02,-1.48,-1.41,-0.14,0.01,-0.51,-0.52,N-Term(iTRAQ8plex);S5(Phospho),"14-3-3 domain binding motif;Akt kinase substrate motif;Calmodulin-dependent protein kinase II substrate motif;Casein kinase II substrate motif;ERK1,2 kinase substrate motif;G protein-coupled receptor kinase 1 substrate motif;GSK3 kinase substrate motif;GSK-3, ERK1, ERK2, CDK5 substrate motif;MAPKAPK1 kinase substrate motif;PKA kinase substrate motif;PKC kinase substrate motif;WW domain binding motif",+,0.05488,5,1,1,10900000,0.001328,3.28,1,4.255367686,Pre-mRNA 3'-end-processing factor FIP1 (hFip1) (FIP1-like 1 protein) (Factor interacting with PAP) (Rearranged in hypereosinophilia),ERDHSPTPSVFNSDEER,RERERDHSPTPSVFN,Q6UN15,FIP1L1,S(5): 99.9;T(7): 0.1;S(9): 0.0;S(13): 0.0,Q6UN15,S5(Phospho),1
0,0.32,-1.17,-1.36,0.01,0.19,-0.14,-0.18,N-Term(iTRAQ8plex);S5(Phospho),"Casein kinase II substrate motif;ERK1,2 kinase substrate motif;Growth associated histone HI kinase substrate motif;GSK-3, ERK1, ERK2, CDK5 substrate motif;WW domain binding motif",+,0.0286,3,1,1,91800000,0,1.64,1,2.742426403,Putative RNA-binding protein 15 (One-twenty two protein 1) (RNA-binding motif protein 15),HLDRSPESDRPR,GGRHLDRSPESDRPR,Q96T37,RBM15,,Q96T37,S5(Phospho),1
0,0.07,-0.41,-0.29,0.27,0.30,0.08,0.02,N-Term(iTRAQ8plex);S5(Phospho),"Casein kinase II substrate motif;ERK1,2 kinase substrate motif;GSK-3, ERK1, ERK2, CDK5 substrate motif;MAPKAPK2 kinase substrate motif;WW domain binding motif",+,0.002436,6,1,1,11400000,0,4.75,0,2.804601292,Kinetochore-associated protein DSN1 homolog,SLHLSPQEQSASYQDR,QSKSLHLSPQEQSAS,Q9H410,DSN1,S(1): 0.0;S(5): 100.0;S(10): 0.0;S(12): 0.0;Y(13): 0.0,Q9H410,S5(Phospho),1
0,0.06,0.51,0.44,-0.06,-0.11,0.15,0.21,N-Term(iTRAQ8plex);S5(Phospho),b-Adrenergic Receptor kinase substrate motif;Casein kinase II substrate motif;Pyruvate dehydrogenase kinase substrate motif,+,0.04604,2,1,1,0,0.001645,3.2,0,3.171228046,Probable cation-transporting ATPase 13A3 (EC 3.6.3.-) (ATPase family homolog up-regulated in senescence cells 1),LVHDSLEDLQMTR,PVKLVHDSLEDLQMT,Q9H7F0,ATP13A3,S(5): 99.4;T(12): 0.6,Q9H7F0,S5(Phospho),1
0,-0.03,-0.43,-0.67,0.09,-0.01,-0.26,-0.22,N-Term(iTRAQ8plex);S5(Phospho),Casein kinase II substrate motif;MDC1 BRCT domain binding motif;Plk1 PBD domain binding motif,+,0.02095,6,1,1,27600000,0,2.74,0,1.965123115,Abl interactor 2 (Abelson interactor 2) (Abi-2) (Abl-binding protein 3) (AblBP3) (Arg-binding protein 1) (ArgBP1),TYSSSGSSGGSHPSSR,RNRTYSSSGSSGGSH,Q9NYB9,ABI2,T(1): 0.0;Y(2): 0.3;S(3): 0.3;S(4): 0.3;S(5): 99.1;S(7): 0.0;S(8): 0.0;S(11): 0.0;S(14): 0.0;S(15): 0.0,Q9NYB9,S5(Phospho),1
0,0.27,-1.31,-0.97,0.18,0.11,-0.66,-0.23,N-Term(iTRAQ8plex);S5(Phospho),"Casein kinase II substrate motif;ERK1,2 kinase substrate motif;GSK-3, ERK1, ERK2, CDK5 substrate motif;WW domain binding motif",+,0.02652,6,1,1,154000000,0.0007602,2.47,1,1.94516248,Bcl-2-associated transcription factor 1 (Btf),RIDISPSTLR,IHRRIDISPSTFRKH,Q9NYF8,BCLAF1,S(5): 95.5;S(7): 2.3;T(8): 2.3,Q9NYF8,S5(Phospho),1
0,-0.03,-0.86,-0.72,-0.03,-0.04,-0.30,-0.33,N-Term(iTRAQ8plex);S5(Phospho),MDC1 BRCT domain binding motif;PKA kinase substrate motif;PKC kinase substrate motif;Plk1 PBD domain binding motif,+,0.0474,11,1,1,424000000,0.0006395,2.93,1,3.506073894,Thyroid hormone receptor-associated protein 3 (Thyroid hormone receptor-associated protein complex 150 kDa component) (Trap150),RIDISPSTFR,RIDISPSTFRKHGLA,Q9Y2W1,THRAP3,S(5): 10.8;S(7): 10.8;T(8): 78.4,Q9Y2W1,S5(Phospho),1
0,0.39,-1.19,-1.20,-0.55,-0.37,-0.59,-0.68,C14(Carbamidomethyl);C3(Carbamidomethyl);N-Term(iTRAQ8plex);S6(Phospho),MAPKAPK2 kinase substrate motif;PKA kinase substrate motif;PKC kinase substrate motif,+,0.006471,43,1,1,392000000,0,4.43,1,2.397812568,"Keratin, type I cytoskeletal 17 (39.1) (Cytokeratin-17) (CK-17) (Keratin-17) (K17)",TSCRLSGGLGAGSCR,SRTSCRLSGGLGAGS,Q04695,KRT17,T(1): 0.1;S(2): 50.0;S(6): 50.0;S(13): 0.0,Q04695,S6(Phospho),1
0,0.13,-0.60,-0.67,0.21,0.23,0.23,0.08,C2(Carbamidomethyl);K12(iTRAQ8plex);N-Term(iTRAQ8plex);S6(Phospho),"ERK1,2 kinase substrate motif;GSK-3, ERK1, ERK2, CDK5 substrate motif;MDC1 BRCT domain binding motif;Plk1 PBD domain binding motif;WW domain binding motif",+,0.0262,38,1,1,45800000,0,4.05,0,2.972558645,Serine/arginine repetitive matrix protein 2 (300 kDa nuclear matrix antigen) (Serine/arginine-rich splicing factor-related nuclear matrix protein of 300 kDa) (SR-related nuclear matrix protein of 300 kDa) (Ser/Arg-related nuclear matrix protein of 300 kDa) (Splicing coactivator subunit SRm300) (Tax-responsive enhancer element-binding protein 803) (TaxREB803),SCFESSPDPELK,RRSCFESSPDPELKS,Q9UQ35,SRRM2,S(1): 0.0;S(5): 7.1;S(6): 92.9,Q9UQ35,S6(Phospho),1
0,-0.08,-3.26,-2.82,0.48,0.20,-1.00,-0.87,K12(iTRAQ8plex);K15(iTRAQ8plex);N-Term(iTRAQ8plex);S6(Phospho),b-Adrenergic Receptor kinase substrate motif;Casein kinase II substrate motif;G protein-coupled receptor kinase 1 substrate motif;MAPKAPK2 kinase substrate motif,+,0.1211,4,1,1,13300000,0.002391,2.83,1,3.669036994,Nuclear ubiquitous casein and cyclin-dependent kinase substrate 1 (P1),NSQEDSEDSEDKDVK,GKNSQEDSEDSEDKD,Q9H1E3,NUCKS1,S(2): 0.1;S(6): 50.0;S(9): 50.0,Q9H1E3,S6(Phospho),1
0,0.38,-1.46,-1.46,-0.13,0.30,-0.38,-0.63,K14(iTRAQ8plex);K16(iTRAQ8plex);N-Term(iTRAQ8plex);S6(Phospho),BARD1 BRCT domain binding motif;Casein kinase I substrate motif;Casein kinase II substrate motif,+,0.00546,17,2,1,472000000,0,4.35,1,2.265459205,Heat shock protein HSP 90-beta (HSP 90) (Heat shock 84 kDa) (HSP 84) (HSP84),IEDVGSDEEDDSGKDK,PKIEDVGSDEEDDSG,P08238,HSP90AB1,S(6): 100.0;S(12): 0.0,P08238,S6(Phospho),1
0,-0.03,1.04,1.18,1.15,0.75,0.64,0.81,C4(Carbamidomethyl);K17(iTRAQ8plex);N-Term(iTRAQ8plex);S6(Phospho),Casein kinase II substrate motif;G protein-coupled receptor kinase 1 substrate motif,+,0.009094,6,1,1,13500000,0,4.07,0,2.086920793,Sorting nexin-24,AESCGSFDETESEESSK,PKAESCGSFDETESE,Q9Y343,SNX24,S(3): 0.0;S(6): 100.0;T(10): 0.0;S(12): 0.0;S(15): 0.0;S(16): 0.0,Q9Y343,S6(Phospho),1
0,0.03,-1.07,-1.23,0.25,-0.03,-0.72,-0.50,K11(iTRAQ8plex);K9(iTRAQ8plex);N-Term(iTRAQ8plex);S6(Phospho),"AMP-activated protein kinase substrate motif;GSK-3, ERK1, ERK2, CDK5 substrate motif;PKA kinase substrate motif;WW domain binding motif",+,0.1059,6,1,1,91400000,0.002329,1.53,1,2.609914752,Nuclear ubiquitous casein and cyclin-dependent kinase substrate 1 (P1),ATVTPSPVKGK,PRLKATVTPSPVKGK,Q9H1E3,NUCKS1,T(2): 2.7;T(4): 48.7;S(6): 48.7,Q9H1E3,S6(Phospho),1
0,0.07,0.62,0.72,-0.13,-0.13,0.25,0.06,C9(Carbamidomethyl);N-Term(iTRAQ8plex);S6(Phospho),G protein-coupled receptor kinase 1 substrate motif;GSK3 kinase substrate motif,+,0.02795,36,2,1,106000000,0,2.79,0,2.650816155,Glycogen synthase kinase-3 beta (GSK-3 beta) (EC 2.7.11.26) (Serine/threonine-protein kinase GSK3B) (EC 2.7.11.1),GEPNVSYICSR,VRGEPNVSYICSRYY,P49841,GSK3B,S(6): 50.0;Y(7): 50.0;S(10): 0.0,P49841,S6(Phospho),1
0,0.18,-1.04,-0.97,-0.60,-0.53,-0.45,-0.55,K10(iTRAQ8plex);N-Term(iTRAQ8plex);S6(Phospho),"Casein kinase I substrate motif;Casein kinase II substrate motif;ERK1,2 kinase substrate motif;GSK-3, ERK1, ERK2, CDK5 substrate motif;MDC1 BRCT domain binding motif;Plk1 PBD domain binding motif;WW domain binding motif",+,0.01081,34,1,1,99500000,0,3.84,0,3.092754546,Neuroblast differentiation-associated protein AHNAK (Desmoyokin),DIDISSPEFK,AKDIDISSPEFKIKI,Q09666,AHNAK,S(5): 8.0;S(6): 92.0,Q09666,S6(Phospho),1
0,0.27,-2.63,-2.39,-0.10,-0.53,-1.09,-0.98,K10(iTRAQ8plex);N-Term(iTRAQ8plex);S6(Phospho),"14-3-3 domain binding motif;Calmodulin-dependent protein kinase II substrate motif;Casein kinase II substrate motif;ERK1,2 kinase substrate motif;GSK-3, ERK1, ERK2, CDK5 substrate motif;PKA kinase substrate motif;PKC kinase substrate motif;WW domain binding motif",+,0.1055,2,1,1,377000000,0.002329,1.81,1,3.11280525,Peptidyl-prolyl cis-trans isomerase G (PPIase G) (Peptidyl-prolyl isomerase G) (EC 5.2.1.8) (CASP10) (Clk-associating RS-cyclophilin) (CARS-Cyp) (CARS-cyclophilin) (SR-cyclophilin) (SR-cyp) (SRcyp) (Cyclophilin G) (Rotamase G),ADRDQSPFSK,KKADRDQSPFSKIKQ,Q13427,PPIG,S(6): 97.9;S(9): 2.1,Q13427,S6(Phospho),1
0,0.09,0.41,0.48,-0.19,-0.40,-0.12,-0.21,K10(iTRAQ8plex);N-Term(iTRAQ8plex);S6(Phospho),"Casein kinase II substrate motif;ERK1,2 kinase substrate motif;GSK-3, ERK1, ERK2, CDK5 substrate motif;WW domain binding motif",+,0.01785,10,1,1,94400000,0,3.18,0,2.342531113,Epidermal growth factor receptor kinase substrate 8-like protein 2 (EPS8-like protein 2) (Epidermal growth factor receptor pathway substrate 8-related protein 2) (EPS8-related protein 2),YWGPASPTHK,QKYWGPASPTHKLPP,Q9H6S3,EPS8L2,Y(1): 0.0;S(6): 100.0;T(8): 0.0,Q9H6S3,S6(Phospho),1
0,0.09,-1.87,-2.49,0.41,0.23,-0.71,-0.64,K10(iTRAQ8plex);N-Term(iTRAQ8plex);S6(Phospho),Casein kinase II substrate motif;G protein-coupled receptor kinase 1 substrate motif;MAPKAPK2 kinase substrate motif,+,0.1004,16,1,1,562000000,0.00315,2.43,0,2.858358116,Serine/arginine repetitive matrix protein 2 (300 kDa nuclear matrix antigen) (Serine/arginine-rich splicing factor-related nuclear matrix protein of 300 kDa) (SR-related nuclear matrix protein of 300 kDa) (Ser/Arg-related nuclear matrix protein of 300 kDa) (Splicing coactivator subunit SRm300) (Tax-responsive enhancer element-binding protein 803) (TaxREB803),SGAGSSPETK,RERSGAGSSPETKEQ,Q9UQ35,SRRM2,S(1): 0.3;S(5): 11.7;S(6): 86.1;T(9): 1.8,Q9UQ35,S6(Phospho),1
0,0.12,-1.05,-0.89,-0.46,-0.25,-0.19,-0.06,K11(iTRAQ8plex);N-Term(iTRAQ8plex);S6(Phospho),Casein kinase II substrate motif;Pyruvate dehydrogenase kinase substrate motif,+,0.008299,10,1,1,29200000,0,4.09,0,2.519214243,Microtubule-associated protein 4 (MAP-4),LATNTSAPDLK,SRLATNTSAPDLKNV,P27816,MAP4,T(3): 0.1;T(5): 9.5;S(6): 90.4,P27816,S6(Phospho),1
0,0.09,-1.31,-1.01,0.35,0.05,-0.46,-0.34,K11(iTRAQ8plex);N-Term(iTRAQ8plex);S6(Phospho),"ERK1,2 kinase substrate motif;GSK-3, ERK1, ERK2, CDK5 substrate motif;WW domain binding motif",+,0.02717,36,1,1,42000000,0,2.59,0,2.469494542,Bcl-2-associated transcription factor 1 (Btf),DLFDYSPPLHK,LKDLFDYSPPLHKNL,Q9NYF8,BCLAF1,Y(5): 50.0;S(6): 50.0,Q9NYF8,S6(Phospho),1
0,-0.17,-0.08,0.09,0.46,0.37,0.99,1.10,K12(iTRAQ8plex);N-Term(iTRAQ8plex);S6(Phospho),"ERK1,2 kinase substrate motif;G protein-coupled receptor kinase 1 substrate motif;GSK-3, ERK1, ERK2, CDK5 substrate motif;MDC1 BRCT domain binding motif;Plk1 PBD domain binding motif;WW domain binding motif",+,0.005938,206,1,1,1140000000,0,3.19,0,3.008699638,Zyxin (Zyxin-2),GPPASSPAPAPK,PRGPPASSPAPAPKF,Q15942,ZYX,S(5): 7.2;S(6): 92.8,Q15942,S6(Phospho),1
0,0.27,-1.65,-1.56,1.18,1.12,0.78,0.56,K13(iTRAQ8plex);N-Term(iTRAQ8plex);S6(Phospho),"b-Adrenergic Receptor kinase substrate motif;Casein kinase I substrate motif;Casein kinase II substrate motif;ERK1,2 kinase substrate motif;GSK-3, ERK1, ERK2, CDK5 substrate motif;WW domain binding motif",+,0.01406,6,1,1,967000,0,2.29,0,3.945826789,Signal-induced proliferation-associated 1-like protein 1 (SIPA1-like protein 1) (High-risk human papilloma viruses E6 oncoproteins targeted protein 1) (E6-targeted protein 1),LIDLESPTPESQK,KKLIDLESPTPESQK,O43166,SIPA1L1,S(6): 88.8;T(8): 11.0;S(11): 0.2,O43166,S6(Phospho),1
0,0.26,-2.29,-1.37,0.63,0.26,-0.66,-0.35,K13(iTRAQ8plex);N-Term(iTRAQ8plex);S6(Phospho),BARD1 BRCT domain binding motif;Casein kinase II substrate motif;G protein-coupled receptor kinase 1 substrate motif,+,0.005365,2,1,1,21800000,0,2.69,0,1.871786726,Eukaryotic translation initiation factor 3 subunit C (eIF3c) (Eukaryotic translation initiation factor 3 subunit 8) (eIF3 p110),QPLLLSEDEEDTK,GKQPLLLSEDEEDTK,Q99613,EIF3C,S(6): 100.0;T(12): 0.0,Q99613,S6(Phospho),1
0,0.30,-0.81,-0.67,0.06,0.20,-0.05,-0.10,K14(iTRAQ8plex);N-Term(iTRAQ8plex);S6(Phospho),"ERK1,2 kinase substrate motif;G protein-coupled receptor kinase 1 substrate motif;GSK-3, ERK1, ERK2, CDK5 substrate motif;WW domain binding motif",+,0.002343,5,1,1,16600000,0,3.4,0,2.191484644,RNA-binding protein 25 (Arg/Glu/Asp-rich protein of 120 kDa) (RED120) (Protein S164) (RNA-binding motif protein 25) (RNA-binding region-containing protein 7),LGASNSPGQPNSVK,LKLGASNSPGQPNSV,P49756,RBM25,S(4): 14.5;S(6): 85.5;S(12): 0.0,P49756,S6(Phospho),1
0,-0.03,-0.14,-0.10,0.72,0.62,2.27,2.39,K15(iTRAQ8plex);N-Term(iTRAQ8plex);S6(Phospho),b-Adrenergic Receptor kinase substrate motif,+,2.51E-05,76,1,1,321000000,0,5.34,0,5.227871205,Vimentin,ETNLDSLPLVDTHSK,LRETNLDSLPLVDTH,P08670,VIM,T(2): 0.6;S(6): 99.4;T(12): 0.0;S(14): 0.0,P08670,S6(Phospho),1
0,-0.04,-0.79,-0.72,-0.48,-0.55,-0.25,-0.22,K15(iTRAQ8plex);N-Term(iTRAQ8plex);S6(Phospho),"Casein kinase II substrate motif;ERK1,2 kinase substrate motif;G protein-coupled receptor kinase 1 substrate motif;GSK3 kinase substrate motif;GSK-3, ERK1, ERK2, CDK5 substrate motif;WW domain binding motif",+,0.001238,37,1,1,298000000,0,4.97,0,3.803075309,Neuroblast differentiation-associated protein AHNAK (Desmoyokin),GGVTGSPEASISGSK,GKGGVTGSPEASISG,Q09666,AHNAK,T(4): 0.0;S(6): 100.0;S(10): 0.0;S(12): 0.0;S(14): 0.0,Q09666,S6(Phospho),1
0,0.01,-0.30,-0.15,-0.07,0.01,0.34,0.29,K16(iTRAQ8plex);N-Term(iTRAQ8plex);S6(Phospho),BARD1 BRCT domain binding motif;Casein kinase II substrate motif;G protein-coupled receptor kinase 1 substrate motif;GSK3 kinase substrate motif,+,0.01479,23,1,1,11000000,0,4.04,0,2.353808707,Vigilin (High density lipoprotein-binding protein) (HDL-binding protein),VATLNSEEESDPPTYK,IKVATLNSEEESDPP,Q00341,HDLBP,T(3): 0.1;S(6): 99.8;S(10): 0.0;T(14): 0.0;Y(15): 0.0,Q00341,S6(Phospho),1
0,0.03,0.19,0.23,-0.37,-0.40,-0.13,-0.13,K17(iTRAQ8plex);N-Term(iTRAQ8plex);S6(Phospho),b-Adrenergic Receptor kinase substrate motif;BARD1 BRCT domain binding motif;Casein kinase II substrate motif,+,0.005722,2,1,1,99200000,0,4.69,1,4.503626996,DNA replication licensing factor MCM2 (EC 3.6.4.12) (Minichromosome maintenance protein 2 homolog) (Nuclear protein BM28),GLLYDSDEEDEERPARK,RRGLLYDSDEEDEER,P49736,MCM2,Y(4): 0.2;S(6): 99.8,P49736,S6(Phospho),1
0,0.06,-1.46,-1.35,-0.33,-0.21,-0.54,-0.54,K2(iTRAQ8plex);N-Term(iTRAQ8plex);S6(Phospho),Casein kinase I substrate motif;Casein kinase II substrate motif;PKA kinase substrate motif,+,0.2658,6,1,1,58600000,0.002,3.16,1,4.123702132,STE20-like serine/threonine-protein kinase (STE20-like kinase) (hSLK) (EC 2.7.11.1) (CTCL tumor antigen se20-9) (STE20-related serine/threonine-protein kinase) (STE20-related kinase) (Serine/threonine-protein kinase 2),TKDSGSISLQETR,SKTKDSGSISLQETR,Q9H2G2,SLK,,Q9H2G2,S6(Phospho),1
0,0.24,0.55,0.47,0.94,0.99,1.47,1.67,K5(iTRAQ8plex);N-Term(iTRAQ8plex);S6(Phospho),"ERK1, ERK2, SAPK, CDK5 and GSK3 kinase substrate motif;ERK1,2 kinase substrate motif;G protein-coupled receptor kinase 1 substrate motif;Growth associated histone HI kinase substrate motif;GSK-3, ERK1, ERK2, CDK5 substrate motif;WW domain binding motif",+,0.2283,2,1,1,17800000,0.006394,2.93,1,3.040323399,Myocyte-specific enhancer factor 2D,VIPAKSPPPPTHSTQLGAPSR,NKVIPAKSPPPPTHS,Q14814,MEF2D,S(6): 99.8;T(11): 0.0;S(13): 0.1;T(14): 0.0;S(20): 0.0,Q14814,S6(Phospho),1
0,-0.11,1.42,1.57,0.80,0.51,0.59,0.53,K7(iTRAQ8plex);N-Term(iTRAQ8plex);S6(Phospho),,+,0.1996,2,1,1,1290000,0.006134,1.59,0,2.940488983,Phorbol-12-myristate-13-acetate-induced protein 1 (PMA-induced protein 1) (Immediate-early-response protein APR) (Protein Noxa),LLNLISK,KLLNLISKLFCSGT_,Q13794,PMAIP1,S(6): 100.0,Q13794,S6(Phospho),1
0,-0.03,-0.04,-0.04,0.30,0.23,0.10,0.15,K8(iTRAQ8plex);N-Term(iTRAQ8plex);S6(Phospho),14-3-3 domain binding motif;b-Adrenergic Receptor kinase substrate motif;Calmodulin-dependent protein kinase II alpha substrate motif;Calmodulin-dependent protein kinase II substrate motif;Calmodulin-dependent protein kinase IV substrate motif;Casein kinase II substrate motif;Chk1 kinase substrate motif;G protein-coupled receptor kinase 1 substrate motif;MAPKAPK2 kinase substrate motif;Phosphorylase kinase substrate motif;PKA kinase substrate motif;PKC kinase substrate motif,+,0.05958,2,1,1,10900000,0.004,3.03,2,2.629223539,Palmitoyltransferase ZDHHC5 (EC 2.3.1.225) (Zinc finger DHHC domain-containing protein 5) (DHHC-5) (Zinc finger protein 375),LSRGDSLKEPTSIAESSR,AKLSRGDSLKEPTSI,Q9C0B5,ZDHHC5,S(2): 4.5;S(6): 94.0;T(11): 1.1;S(12): 0.3;S(16): 0.0;S(17): 0.0,Q9C0B5,S6(Phospho),1
0,0.02,-1.33,-1.58,-0.36,-0.33,-0.18,-0.24,K9(iTRAQ8plex);N-Term(iTRAQ8plex);S6(Phospho),"Casein kinase I substrate motif;Cdc2 kinase substrate motif;CDK kinase substrate motif;CDK1,2,4,6 kinase substrate motif;ERK1,2 kinase substrate motif;GSK-3, ERK1, ERK2, CDK5 substrate motif;PKA kinase substrate motif;PKC kinase substrate motif;WW domain binding motif",+,0.1101,2,1,1,772000000,0.004872,2.53,1,3.477807254,Microtubule-associated protein 4 (MAP-4),ETERASPIK,LKETERASPIKMDLA,P27816,MAP4,T(2): 0.0;S(6): 100.0,P27816,S6(Phospho),1
0,-0.38,-2.95,-2.52,0.42,0.11,-0.89,0.13,K9(iTRAQ8plex);N-Term(iTRAQ8plex);S6(Phospho),Casein kinase II substrate motif;G protein-coupled receptor kinase 1 substrate motif;GSK3 kinase substrate motif;PKA kinase substrate motif;PKC kinase substrate motif,+,0.1149,16,1,1,263000000,0.00315,1.88,0,2.133098785,Methyl-CpG-binding protein 2 (MeCp-2 protein) (MeCp2),SSSASSPPK,ESSPKGRSSSASSPP,P51608,MECP2,S(1): 84.6;S(2): 10.8;S(3): 1.5;S(5): 1.5;S(6): 1.5,P51608,S6(Phospho),1
0,0.26,-1.86,-1.81,-1.21,-1.03,-1.56,-1.65,K9(iTRAQ8plex);N-Term(iTRAQ8plex);S6(Phospho),MDC1 BRCT domain binding motif;Plk1 PBD domain binding motif,+,0.01347,120,1,1,649000000,0,4.06,0,3.593867629,"Keratin, type I cytoskeletal 17 (39.1) (Cytokeratin-17) (CK-17) (Keratin-17) (K17)",QFTSSSSIK,IRQFTSSSSIKGSSG,Q04695,KRT17,T(3): 0.0;S(4): 0.6;S(5): 0.6;S(6): 98.3;S(7): 0.6,Q04695,S6(Phospho),1
0,0.07,-0.67,-0.51,-2.02,-2.16,NaN,-3.02,K9(iTRAQ8plex);N-Term(iTRAQ8plex);S6(Phospho),MAPKAPK2 kinase substrate motif,+,0.05255,4,1,1,48200000,0.0008035,1.54,0,3.446860369,Desmoglein-2 (Cadherin family member 5) (HDGC),GSSSASIVK,MKGSSSASIVKGQHE,Q14126,DSG2,S(2): 0.0;S(3): 0.2;S(4): 0.2;S(6): 99.6,Q14126,S6(Phospho),1
0,0.14,-0.08,-0.14,0.38,0.41,0.11,0.02,K9(iTRAQ8plex);N-Term(iTRAQ8plex);S6(Phospho),DNA dependent Protein kinase substrate motif;PKA kinase substrate motif;PKC kinase substrate motif,+,0.06096,2,1,1,0,0.001183,2.59,0,2.250992469,Methylthioribulose-1-phosphate dehydratase (MTRu-1-P dehydratase) (EC 4.2.1.109) (APAF1-interacting protein) (hAPIP),DISGPSPSK,DISGPSPSKKLKKSQ,Q96GX9,APIP,S(3): 0.0;S(6): 98.1;S(8): 1.9,Q96GX9,S6(Phospho),1
0,-0.23,-1.39,-1.35,-0.38,-0.52,-0.45,-0.41,K9(iTRAQ8plex);N-Term(iTRAQ8plex);S6(Phospho),"Cdc2 kinase substrate motif;CDK kinase substrate motif;CDK1,2,4,6 kinase substrate motif;DNA dependent Protein kinase substrate motif;ERK1,2 kinase substrate motif;GSK-3, ERK1, ERK2, CDK5 substrate motif;WW domain binding motif",+,0.03435,34,1,1,299000000,0,3.59,0,3.074896852,Nuclear ubiquitous casein and cyclin-dependent kinase substrate 1 (P1),ATVTPSPVK,LKATVTPSPVKGKGK,Q9H1E3,NUCKS1,T(2): 0.0;T(4): 0.0;S(6): 100.0,Q9H1E3,S6(Phospho),1
0,0.08,-0.83,-0.78,-0.35,-0.55,-0.64,-0.58,N-Term(iTRAQ8plex);S6(Phospho),b-Adrenergic Receptor kinase substrate motif;MAPKAPK2 kinase substrate motif,+,0.009181,8,1,1,8740000,0,3.15,0,2.736023299,Catenin delta-1 (Cadherin-associated Src substrate) (CAS) (p120 catenin) (p120(ctn)) (p120(cas)),SQSSHSYDDSTLPLIDR,SSHSYDDSTLPLIDR,O60716,CTNND1,S(1): 1.8;S(3): 8.0;S(4): 8.0;S(6): 39.9;Y(7): 39.9;S(10): 1.8;T(11): 0.5,O60716,S6(Phospho),1
0,0.01,-0.10,0.37,1.68,1.50,1.61,1.76,N-Term(iTRAQ8plex);S6(Phospho),b-Adrenergic Receptor kinase substrate motif;Casein kinase II substrate motif;G protein-coupled receptor kinase 1 substrate motif;GSK3 kinase substrate motif,+,0.1543,6,1,1,549000000,0.006545,3.23,0,2.861833871,"Ferritin heavy chain (Ferritin H subunit) (EC 1.16.3.1) (Cell proliferation-inducing gene 15 protein) [Cleaved into: Ferritin heavy chain, N-terminally processed]",HTLGDSDNES,DKHTLGDSDNES___,P02794,FTH1,T(2): 0.0;S(6): 100.0;S(10): 0.0,P02794,S6(Phospho),1
0,0.08,0.19,-0.01,-0.33,-0.38,0.33,0.25,N-Term(iTRAQ8plex);S6(Phospho),Casein kinase II substrate motif;G protein-coupled receptor kinase 1 substrate motif,+,0.3089,2,1,1,0,0.004,2.65,0,2.202210344,"Pyruvate dehydrogenase E1 component subunit alpha, somatic form, mitochondrial (EC 1.2.4.1) (PDHE1-A type I)",YGMGTSVER,NRYGMGTSVERAAAS,P08559,PDHA1,,P08559,S6(Phospho),1
0,-0.12,-0.75,-0.72,0.77,0.76,0.55,0.49,N-Term(iTRAQ8plex);S6(Phospho),MDC1 BRCT domain binding motif;PKA kinase substrate motif;PKC kinase substrate motif;Plk1 PBD domain binding motif,+,0.1445,2,1,1,116000000,0.008873,2.82,1,4.598178802,Vimentin,SVSSSSYRR,TRSVSSSSYRRMFGG,P08670,VIM,S(1): 0.3;S(3): 9.9;S(4): 0.3;S(5): 9.9;S(6): 69.6;Y(7): 9.9,P08670,S6(Phospho),1
0,0.12,-1.11,-1.08,-1.02,-1.07,-0.85,-0.92,N-Term(iTRAQ8plex);S6(Phospho),"G protein-coupled receptor kinase 1 substrate motif;GSK-3, ERK1, ERK2, CDK5 substrate motif;RAF1 kinase substrate motif;WW domain binding motif",+,0.005974,295,1,1,1860000000,0,4.8,0,4.153666329,"Keratin, type II cytoskeletal 5 (58 kDa cytokeratin) (Cytokeratin-5) (CK-5) (Keratin-5) (K5) (Type-II keratin Kb5)",SFSTASAITPSVSR,FSTASAITPSVSRTS,P13647,KRT5,S(1): 0.0;S(3): 0.1;T(4): 0.1;S(6): 99.7;T(9): 0.0;S(11): 0.0;S(13): 0.0,P13647,S6(Phospho),1
0,0.04,0.49,0.54,0.33,0.31,0.75,0.84,N-Term(iTRAQ8plex);S6(Phospho),"ERK1,2 kinase substrate motif;GSK-3, ERK1, ERK2, CDK5 substrate motif;WW domain binding motif",+,0.01255,18,1,1,298000000,0,3.62,0,3.75297033,Arf-GAP domain and FG repeat-containing protein 1 (HIV-1 Rev-binding protein) (Nucleoporin-like protein RIP) (Rev-interacting protein) (Rev/Rex activation domain-binding protein),GTPSQSPVVGR,NKGTPSQSPVVGRSQ,P52594,AGFG1,T(2): 0.0;S(4): 0.0;S(6): 100.0,P52594,S6(Phospho),1
0,0.16,0.71,0.61,-0.80,-0.85,1.01,0.96,N-Term(iTRAQ8plex);S6(Phospho),"Casein kinase I substrate motif;Cdc2 kinase substrate motif;CDK kinase substrate motif;CDK1,2,4,6 kinase substrate motif;ERK1,2 kinase substrate motif;Growth associated histone HI kinase substrate motif;GSK-3, ERK1, ERK2, CDK5 substrate motif;PKA kinase substrate motif;PKC kinase substrate motif;WW domain binding motif",+,0.06716,12,1,1,1170000000,0.004,2.8,0,4.254732908,Heterogeneous nuclear ribonucleoprotein K (hnRNP K) (Transformation up-regulated nuclear protein) (TUNP),DYDDMSPR,RRDYDDMSPRRGPPP,P61978,HNRNPK,Y(2): 0.0;S(6): 100.0,P61978,S6(Phospho),1
0,0.04,-0.34,-0.44,0.04,0.07,0.05,0.17,N-Term(iTRAQ8plex);S6(Phospho),Casein kinase II substrate motif;G protein-coupled receptor kinase 1 substrate motif;PKA kinase substrate motif;PKC kinase substrate motif,+,0.1309,2,1,1,13100000,0.007411,2.73,0,2.568200023,RNA-binding protein 6 (Lung cancer antigen NY-LU-12) (Protein G16) (RNA-binding motif protein 6) (RNA-binding protein DEF-3),LQSFDSPER,DRREKLQSFDSPERK,P78332,RBM6,S(3): 91.1;S(6): 8.9,P78332,S6(Phospho),1
0,0.15,-1.05,-0.99,0.01,-0.02,-0.21,-0.32,N-Term(iTRAQ8plex);S6(Phospho),"Casein kinase II substrate motif;ERK1,2 kinase substrate motif;Growth associated histone HI kinase substrate motif;GSK-3, ERK1, ERK2, CDK5 substrate motif;WW domain binding motif",+,0.04398,21,1,1,1060000000,0.001217,3.35,1,3.472204928,"Serine/arginine-rich splicing factor 1 (Alternative-splicing factor 1) (ASF-1) (Splicing factor, arginine/serine-rich 1) (pre-mRNA-splicing factor SF2, P33 subunit)",VDGPRSPSYGR,VKVDGPRSPSYGRSR,Q07955,SRSF1,S(6): 97.6;S(8): 1.2;Y(9): 1.2,Q07955,S6(Phospho),1
0,0.03,-1.34,-1.25,0.01,-0.24,-0.72,-0.48,N-Term(iTRAQ8plex);S6(Phospho),14-3-3 domain binding motif;b-Adrenergic Receptor kinase substrate motif;Calmodulin-dependent protein kinase II substrate motif;G protein-coupled receptor kinase 1 substrate motif;PKA kinase substrate motif;PKC kinase substrate motif,+,0.001677,10,1,1,94000000,0,4.65,1,2.781551011,"Serine/arginine-rich splicing factor 4 (Pre-mRNA-splicing factor SRP75) (SRP001LB) (Splicing factor, arginine/serine-rich 4)",EGRGESENAGTNQETR,QREGRGESENAGTNQ,Q08170,SRSF4,S(6): 100.0;T(11): 0.0;T(15): 0.0,Q08170,S6(Phospho),1
0,-0.20,-0.81,-0.62,-0.15,-0.21,0.02,0.18,N-Term(iTRAQ8plex);S6(Phospho),b-Adrenergic Receptor kinase substrate motif;Casein kinase I substrate motif;Casein kinase II substrate motif;G protein-coupled receptor kinase 1 substrate motif,+,0.03055,2,1,1,56900000,0,4.02,1,2.091455515,U4/U6.U5 tri-snRNP-associated protein 2 (Inactive ubiquitin-specific peptidase 39) (SAD1 homolog) (U4/U6.U5 tri-snRNP-associated 65 kDa protein) (65K),EVDEDSEPEREVR,EREVDEDSEPEREVR,Q53GS9,USP39,S(6): 100.0,Q53GS9,S6(Phospho),1
0,0.06,0.02,-0.12,0.73,0.70,0.80,0.77,N-Term(iTRAQ8plex);S6(Phospho),"Casein kinase II substrate motif;ERK1,2 kinase substrate motif;G protein-coupled receptor kinase 1 substrate motif;GSK3 kinase substrate motif;GSK-3, ERK1, ERK2, CDK5 substrate motif;WW domain binding motif",+,0.0433,7,1,1,52400000,0,3.34,0,3.652051733,Pleckstrin homology-like domain family B member 1 (Protein LL5-alpha),ELPPLSPSLSR,MRELPPLSPSLSRRA,Q86UU1,PHLDB1,S(6): 99.2;S(8): 0.7;S(10): 0.1,Q86UU1,S6(Phospho),1
0,-0.21,-1.52,-1.41,-0.60,-0.78,-0.58,-0.56,N-Term(iTRAQ8plex);S6(Phospho),"Casein kinase II substrate motif;ERK1,2 kinase substrate motif;G protein-coupled receptor kinase 1 substrate motif;GSK-3, ERK1, ERK2, CDK5 substrate motif;WW domain binding motif",+,2.13E-06,64,1,1,289000000,0,7.68,0,3.030793835,Protein AHNAK2,DAHDVSPTSTDTEAQLTVER,PRDAHDVSPTSTDTE,Q8IVF2,AHNAK2,S(6): 100.0;T(8): 0.0;S(9): 0.0;T(10): 0.0;T(12): 0.0;T(17): 0.0,Q8IVF2,S6(Phospho),1
0,0.18,0.81,1.00,0.05,0.14,-0.45,-0.24,N-Term(iTRAQ8plex);S6(Phospho),"Cdc2 kinase substrate motif;CDK kinase substrate motif;CDK1,2,4,6 kinase substrate motif;ERK1,2 kinase substrate motif;G protein-coupled receptor kinase 1 substrate motif;GSK-3, ERK1, ERK2, CDK5 substrate motif;WW domain binding motif",+,0.05546,20,1,1,2200000000,0.001202,1.9,0,2.648863391,Abl interactor 1 (Abelson interactor 1) (Abi-1) (Abl-binding protein 4) (AblBP4) (Eps8 SH3 domain-binding protein) (Eps8-binding protein) (Nap1-binding protein) (Nap1BP) (Spectrin SH3 domain-binding protein 1) (e3B1),LGSQHSPGR,ARLGSQHSPGRTASL,Q8IZP0,ABI1,S(3): 0.0;S(6): 100.0,Q8IZP0,S6(Phospho),1
0,-0.15,0.52,0.78,0.23,-0.01,-0.38,-0.17,N-Term(iTRAQ8plex);S6(Phospho),Casein kinase II substrate motif;DNA dependent Protein kinase substrate motif,+,0.03152,6,1,1,35400000,0.0006395,3,0,1.816798692,Nuclear pore complex protein Nup93 (93 kDa nucleoporin) (Nucleoporin Nup93),GTSPSSSSRPQR,RLKGTSPSSSSRPQR,Q8N1F7,NUP93,T(2): 0.0;S(3): 0.1;S(5): 3.9;S(6): 32.0;S(7): 32.0;S(8): 32.0,Q8N1F7,S6(Phospho),1
0,-0.01,-0.76,-0.57,0.15,0.14,0.07,0.00,N-Term(iTRAQ8plex);S6(Phospho),"Casein kinase II substrate motif;ERK1,2 kinase substrate motif;G protein-coupled receptor kinase 1 substrate motif;GSK3 kinase substrate motif;GSK-3, ERK1, ERK2, CDK5 substrate motif;WW domain binding motif",+,0.02025,28,1,1,57100000,0,3.55,0,2.928842112,Protein phosphatase 1 regulatory subunit 14C (Kinase-enhanced PP1 inhibitor) (PKC-potentiated PP1 inhibitory protein) (Serologically defined breast cancer antigen NY-BR-81),GGAGGSPGSSSGSGSSR,PRGGAGGSPGSSSGS,Q8TAE6,PPP1R14C,S(6): 100.0;S(9): 0.0;S(10): 0.0;S(11): 0.0;S(13): 0.0;S(15): 0.0;S(16): 0.0,Q8TAE6,S6(Phospho),1
0,0.14,-0.59,-0.58,-0.06,0.03,-0.03,-0.20,N-Term(iTRAQ8plex);S6(Phospho),b-Adrenergic Receptor kinase substrate motif;BARD1 BRCT domain binding motif;Casein kinase I substrate motif;Casein kinase II substrate motif;PKA kinase substrate motif;PKC kinase substrate motif,+,0.006339,4,1,1,81000000,0,3.91,1,2.307303655,ATP-dependent RNA helicase DDX54 (EC 3.6.4.13) (ATP-dependent RNA helicase DP97) (DEAD box RNA helicase 97 kDa) (DEAD box protein 54),IDDRDSDEEGASDR,QKIDDRDSDEEGASD,Q8TDD1,DDX54,S(6): 99.7;S(12): 0.3,Q8TDD1,S6(Phospho),1
0,-0.08,0.76,0.89,-0.43,-0.60,0.46,0.49,N-Term(iTRAQ8plex);S6(Phospho),"ERK1,2 kinase substrate motif;G protein-coupled receptor kinase 1 substrate motif;GSK-3, ERK1, ERK2, CDK5 substrate motif;WW domain binding motif",+,0.04763,24,1,1,145000000,0,3.29,0,3.528796776,RelA-associated inhibitor (Inhibitor of ASPP protein) (Protein iASPP) (NFkB-interacting protein 1) (PPP1R13B-like protein),AMLPGSPLFTR,SRAMLPGSPLFTRAP,Q8WUF5,PPP1R13L,S(6): 87.9;T(10): 12.1,Q8WUF5,S6(Phospho),1
0,0.08,-1.23,-0.89,0.00,-0.05,-0.36,-0.35,N-Term(iTRAQ8plex);S6(Phospho),b-Adrenergic Receptor kinase substrate motif;Casein kinase I substrate motif;Casein kinase II substrate motif;Pyruvate dehydrogenase kinase substrate motif,+,0.005537,32,1,1,68900000,0,5.03,1,2.565831557,Splicing factor 45 (45 kDa-splicing factor) (RNA-binding motif protein 17),RPDPDSDEDEDYERER,ARRPDPDSDEDEDYE,Q96I25,RBM17,S(6): 100.0;Y(12): 0.0,Q96I25,S6(Phospho),1
0,0.04,-1.13,-1.06,-0.28,-0.14,-0.26,-0.29,N-Term(iTRAQ8plex);S6(Phospho),"Casein kinase II substrate motif;ERK1,2 kinase substrate motif;GSK-3, ERK1, ERK2, CDK5 substrate motif;WW domain binding motif",+,0.3239,4,1,1,0,0.008,2.71,0,3.76100375,Chromosome alignment-maintaining phosphoprotein 1 (Zinc finger protein 828),TAPPASPEAR,AKTAPPASPEARKRA,Q96JM3,CHAMP1,,Q96JM3,S6(Phospho),1
0,0.26,-0.81,-0.68,0.10,0.09,0.20,0.05,N-Term(iTRAQ8plex);S6(Phospho),"Cdc2 kinase substrate motif;CDK kinase substrate motif;CDK1,2,4,6 kinase substrate motif;DNA dependent Protein kinase substrate motif;ERK1,2 kinase substrate motif;GSK-3, ERK1, ERK2, CDK5 substrate motif;WW domain binding motif",+,0.09322,5,1,1,9490000,0.004228,2.15,0,2.385592568,Apoptotic chromatin condensation inducer in the nucleus (Acinus),TAQVPSPPR,VRTAQVPSPPRGKIS,Q9UKV3,ACIN1,T(1): 0.9;S(6): 99.1,Q9UKV3,S6(Phospho),1
0,-0.04,-2.66,-2.50,0.40,0.12,-0.21,-0.40,K11(iTRAQ8plex);K12(iTRAQ8plex);N-Term(iTRAQ8plex);S7(Phospho),MDC1 BRCT domain binding motif;Plk1 PBD domain binding motif,+,0.1788,4,1,1,97100000,0.0081,1.44,1,4.063942353,Heterogeneous nuclear ribonucleoproteins C1/C2 (hnRNP C1/C2),SEEEQSSSSVKK,SEEEQSSSSVKKDET,P07910,HNRNPC,S(1): 0.0;S(6): 43.6;S(7): 43.6;S(8): 6.4;S(9): 6.4,P07910,S7(Phospho),1
0,0.22,-1.44,-1.64,0.70,0.93,0.04,0.00,K1(iTRAQ8plex);K14(iTRAQ8plex);N-Term(iTRAQ8plex);S7(Phospho),BARD1 BRCT domain binding motif;Casein kinase II substrate motif,+,0.005585,73,1,1,12900000000,0,5.36,1,3.561848797,"Myosin-9 (Cellular myosin heavy chain, type A) (Myosin heavy chain 9) (Myosin heavy chain, non-muscle IIa) (Non-muscle myosin heavy chain A) (NMMHC-A) (Non-muscle myosin heavy chain IIa) (NMMHC II-a) (NMMHC-IIA)",KGAGDGSDEEVDGK,RKGAGDGSDEEVDGK,P35579,MYH9,S(7): 100.0,P35579,S7(Phospho),1
0,-0.13,0.71,0.85,-0.24,-0.38,0.41,0.36,C9(Carbamidomethyl);K18(iTRAQ8plex);N-Term(iTRAQ8plex);S7(Phospho),"ERK1,2 kinase substrate motif;GSK-3, ERK1, ERK2, CDK5 substrate motif;MDC1 BRCT domain binding motif;Plk1 PBD domain binding motif;WW domain binding motif",+,0.004627,4,1,1,0,0,3.9,0,3.088273767,60S ribosomal protein L17 (60S ribosomal protein L23) (PD-1),INPYMSSPCHIEMILTEK,RINPYMSSPCHIEMI,P18621,RPL17,Y(4): 2.8;S(6): 14.7;S(7): 82.5;T(16): 0.0,P18621,S7(Phospho),1
0,0.18,-0.31,-0.45,-0.42,-0.35,-0.28,-0.28,K10(iTRAQ8plex);K18(iTRAQ8plex);N-Term(iTRAQ8plex);S7(Phospho),"Casein kinase II substrate motif;Cdc2 kinase substrate motif;CDK kinase substrate motif;CDK1,2,4,6 kinase substrate motif;ERK1,2 kinase substrate motif;G protein-coupled receptor kinase 1 substrate motif;GSK3 kinase substrate motif;GSK-3, ERK1, ERK2, CDK5 substrate motif;WW domain binding motif",+,0.01431,18,1,1,238000000,0,4.16,1,1.845725605,E3 ubiquitin-protein ligase CHIP (EC 6.3.2.-) (Antigen NY-CO-7) (CLL-associated antigen KW-8) (Carboxy terminus of Hsp70-interacting protein) (STIP1 homology and U box-containing protein 1),LGAGGGSPEKSPSAQELK,RLGAGGGSPEKSPSA,Q9UNE7,STUB1,S(7): 100.0;S(11): 0.0;S(13): 0.0,Q9UNE7,S7(Phospho),1
0,0.41,-1.29,-1.29,-0.49,-0.21,-0.35,-0.41,K1(iTRAQ8plex);K9(iTRAQ8plex);N-Term(iTRAQ8plex);S7(Phospho),"Casein kinase I substrate motif;Casein kinase II substrate motif;ERK1,2 kinase substrate motif;Growth associated histone HI kinase substrate motif;GSK-3, ERK1, ERK2, CDK5 substrate motif;PKA kinase substrate motif;PKC kinase substrate motif;WW domain binding motif",+,0.04994,28,1,1,1070000000,0,3.71,0,2.316265503,"Serine/arginine-rich splicing factor 11 (Arginine-rich 54 kDa nuclear protein) (p54) (Splicing factor, arginine/serine-rich 11)",KPIETGSPK,KKPIETGSPKTKECS,Q05519,SRSF11,T(5): 0.0;S(7): 100.0,Q05519,S7(Phospho),1
0,-0.01,1.51,1.54,0.66,0.41,0.90,1.08,K17(iTRAQ8plex);K9(iTRAQ8plex);N-Term(iTRAQ8plex);S7(Phospho),Casein kinase I substrate motif;G protein-coupled receptor kinase 1 substrate motif;PKA kinase substrate motif;PKC kinase substrate motif,+,0.01569,4,1,1,274000000,0,2.87,1,3.199998883,Caveolin-1,AMADELSEKQVYDAHTK,KAMADELSEKQVYDA,Q03135,CAV1,S(7): 98.0;Y(12): 1.5;T(16): 0.5,Q03135,S7(Phospho),1
0,0.39,-1.12,-1.20,0.01,0.19,-0.32,-0.39,C3(Carbamidomethyl);N-Term(iTRAQ8plex);S7(Phospho),"Cdc2 kinase substrate motif;CDK kinase substrate motif;CDK1,2,4,6 kinase substrate motif;ERK1,2 kinase substrate motif;Growth associated histone HI kinase substrate motif;GSK-3, ERK1, ERK2, CDK5 substrate motif;MDC1 BRCT domain binding motif;Plk1 PBD domain binding motif;WW domain binding motif",+,0.06503,18,1,1,243000000,0,3.01,0,2.503353346,Serine/arginine repetitive matrix protein 2 (300 kDa nuclear matrix antigen) (Serine/arginine-rich splicing factor-related nuclear matrix protein of 300 kDa) (SR-related nuclear matrix protein of 300 kDa) (Ser/Arg-related nuclear matrix protein of 300 kDa) (Splicing coactivator subunit SRm300) (Tax-responsive enhancer element-binding protein 803) (TaxREB803),HSCSGSSPPR,RHSCSGSSPPRVKSS,Q9UQ35,SRRM2,S(2): 0.0;S(4): 0.1;S(6): 9.5;S(7): 90.3,Q9UQ35,S7(Phospho),1
0,0.16,-0.27,-0.39,-0.25,-0.25,0.09,0.04,C5(Carbamidomethyl);N-Term(iTRAQ8plex);S7(Phospho),b-Adrenergic Receptor kinase substrate motif;Casein kinase II substrate motif;G protein-coupled receptor kinase 1 substrate motif,+,0.01547,7,1,1,120000000,0,4.03,0,1.976978444,DnaJ homolog subfamily B member 6 (HHDJ1) (Heat shock protein J2) (HSJ-2) (MRJ) (MSJ-1),HAPHCLSEEEGEQDRPR,DRGYTSDSEVYTDHG,O75190,DNAJB6,S(7): 100.0,O75190,S7(Phospho),1
0,0.02,0.35,0.40,-0.22,-0.45,0.91,0.84,K1(iTRAQ8plex);N-Term(iTRAQ8plex);S7(Phospho),"ERK1,2 kinase substrate motif;G protein-coupled receptor kinase 1 substrate motif;GSK-3, ERK1, ERK2, CDK5 substrate motif;WW domain binding motif",+,0.0392,2,1,1,12700000,0.0006395,3.87,1,3.230385284,Cyclic AMP-dependent transcription factor ATF-2 (cAMP-dependent transcription factor ATF-2) (EC 2.3.1.48) (Activating transcription factor 2) (Cyclic AMP-responsive element-binding protein 2) (CREB-2) (cAMP-responsive element-binding protein 2) (HB16) (Histone acetyltransferase ATF2) (cAMP response element-binding protein CRE-BP1),KMPLDLSPLATPIIR,KKMPLDLSPLATPII,P15336,ATF2,S(7): 100.0;T(11): 0.0,P15336,S7(Phospho),1
0,0.18,-0.40,-0.31,-1.85,-1.91,-1.29,-1.50,K10(iTRAQ8plex);N-Term(iTRAQ8plex);S7(Phospho),"Casein kinase II substrate motif;Cdc2 kinase substrate motif;CDK kinase substrate motif;CDK1,2,4,6 kinase substrate motif;ERK1,2 kinase substrate motif;G protein-coupled receptor kinase 1 substrate motif;GSK3 kinase substrate motif;GSK-3, ERK1, ERK2, CDK5 substrate motif;WW domain binding motif",+,0.118,2,1,1,16300000,0.004853,1.17,0,3.859863383,E3 ubiquitin-protein ligase CHIP (EC 6.3.2.-) (Antigen NY-CO-7) (CLL-associated antigen KW-8) (Carboxy terminus of Hsp70-interacting protein) (STIP1 homology and U box-containing protein 1),LGAGGGSPEK,RLGAGGGSPEKSPSA,Q9UNE7,STUB1,S(7): 100.0,Q9UNE7,S7(Phospho),1
0,-0.02,-0.88,-1.16,-0.27,-0.11,-0.26,-0.23,K11(iTRAQ8plex);N-Term(iTRAQ8plex);S7(Phospho),"Casein kinase II substrate motif;ERK1,2 kinase substrate motif;GSK-3, ERK1, ERK2, CDK5 substrate motif;WW domain binding motif",+,0.08019,2,1,1,0,0.002,3.25,0,2.491392336,182 kDa tankyrase-1-binding protein,VSGAGFSPSSK,RVSGAGFSPSSKMEG,Q9C0C2,TNKS1BP1,,Q9C0C2,S7(Phospho),1
0,0.17,-1.34,-1.27,-0.42,-0.08,-0.53,-0.86,K11(iTRAQ8plex);N-Term(iTRAQ8plex);S7(Phospho),b-Adrenergic Receptor kinase substrate motif;MAPKAPK2 kinase substrate motif,+,0.000518,93,1,1,311000000,0,4.21,0,2.242053891,LIM domain and actin-binding protein 1 (Epithelial protein lost in neoplasm),ASSLSESSPPK,RASSLSESSPPKAMK,Q9UHB6,LIMA1,S(2): 0.4;S(3): 4.2;S(5): 0.4;S(7): 47.5;S(8): 47.5,Q9UHB6,S7(Phospho),1
0,-0.18,-1.00,-0.90,0.01,-0.23,-0.37,-0.24,K11(iTRAQ8plex);N-Term(iTRAQ8plex);S7(Phospho),G protein-coupled receptor kinase 1 substrate motif;MAPKAPK2 kinase substrate motif;MDC1 BRCT domain binding motif;Plk1 PBD domain binding motif,+,0.01471,2,1,1,34200000,0,3.83,0,2.188993084,Serine/arginine repetitive matrix protein 2 (300 kDa nuclear matrix antigen) (Serine/arginine-rich splicing factor-related nuclear matrix protein of 300 kDa) (SR-related nuclear matrix protein of 300 kDa) (Ser/Arg-related nuclear matrix protein of 300 kDa) (Splicing coactivator subunit SRm300) (Tax-responsive enhancer element-binding protein 803) (TaxREB803),QSHSSSSPHPK,SRQSHSSSSPHPKVK,Q9UQ35,SRRM2,S(2): 0.0;S(4): 0.1;S(5): 4.6;S(6): 47.7;S(7): 47.7,Q9UQ35,S7(Phospho),1
0,0.00,0.80,0.92,0.04,0.03,0.67,0.65,K13(iTRAQ8plex);N-Term(iTRAQ8plex);S7(Phospho),14-3-3 domain binding motif;AMP-activated protein kinase substrate motif;BARD1 BRCT domain binding motif;Calmodulin-dependent protein kinase I substrate motif;Calmodulin-dependent protein kinase II substrate motif;Calmodulin-dependent protein kinase IV substrate motif;Casein kinase II substrate motif;Chk1 kinase substrate motif;DNA dependent Protein kinase substrate motif;G protein-coupled receptor kinase 1 substrate motif;HMGCoA Reductase kinase substrate motif;PKA kinase substrate motif;PKC kinase substrate motif,+,0.008502,39,1,1,260000000,0,4.4,1,4.148033502,Astrocytic phosphoprotein PEA-15 (15 kDa phosphoprotein enriched in astrocytes) (Phosphoprotein enriched in diabetes) (PED),DIIRQPSEEEIIK,KDIIRQPSEEEIIKL,Q15121,PEA15,S(7): 100.0,Q15121,S7(Phospho),1
0,0.17,-2.69,-2.96,-0.01,-0.20,-0.73,-0.57,K17(iTRAQ8plex);N-Term(iTRAQ8plex);S7(Phospho),b-Adrenergic Receptor kinase substrate motif;BARD1 BRCT domain binding motif;Casein kinase II substrate motif;G protein-coupled receptor kinase 1 substrate motif,+,0.005427,2,1,1,5550000,0,3.5,0,3.957955862,28 kDa heat- and acid-stable phosphoprotein (PDGF-associated protein) (PAP) (PDGFA-associated protein 1) (PAP1),SLDSDESEDEEDDYQQK,KSLDSDESEDEEDDY,Q13442,PDAP1,S(1): 0.2;S(4): 11.0;S(7): 88.8;Y(14): 0.0,Q13442,S7(Phospho),1
0,0.25,1.70,1.70,0.88,0.69,0.48,0.13,K4(iTRAQ8plex);N-Term(iTRAQ8plex);S7(Phospho),b-Adrenergic Receptor kinase substrate motif;Casein kinase II substrate motif;G protein-coupled receptor kinase 1 substrate motif;PKA kinase substrate motif;PKC kinase substrate motif,+,0.01787,2,2,1,148000,0,4.07,1,2.629329134,60S acidic ribosomal protein P0 (60S ribosomal protein L10E),VEAKEESEESDEDMGFGLFD,KVEAKEESEESDEDM,P05388,RPLP0,S(7): 100.0;S(10): 0.0,P05388,S7(Phospho),1
0,-0.04,1.12,1.13,-1.41,-2.06,-2.26,-2.19,K6(iTRAQ8plex);N-Term(iTRAQ8plex);S7(Phospho),Casein kinase II substrate motif;Pyruvate dehydrogenase kinase substrate motif,+,0.04613,14,1,1,764000000,0.0006143,2.9,1,3.383690355,Tumor protein D54 (hD54) (Tumor protein D52-like 2),NSATFKSFEDR,RNSATFKSFEDRVGT,O43399,TPD52L2,S(2): 0.1;T(4): 0.4;S(7): 99.5,O43399,S7(Phospho),1
0,-0.13,0.44,0.65,0.28,0.06,0.66,0.75,K6(iTRAQ8plex);N-Term(iTRAQ8plex);S7(Phospho),"Casein kinase II substrate motif;Cdc2 kinase substrate motif;CDK kinase substrate motif;CDK1,2,4,6 kinase substrate motif;ERK1,2 kinase substrate motif;Growth associated histone HI kinase substrate motif;GSK-3, ERK1, ERK2, CDK5 substrate motif;WW domain binding motif",+,0.133,2,1,1,51600000,0.007716,2.95,1,2.000765596,Mitotic-spindle organizing protein 2B (Mitotic-spindle organizing protein associated with a ring of gamma-tubulin 2B),GGGPGKSPTR,KGGGPGKSPTRGST_,Q6NZ67,MZT2B,S(7): 88.5;T(9): 11.5,Q6NZ67,S7(Phospho),1
0,-0.01,0.35,0.40,-0.16,-0.02,0.67,0.65,K9(iTRAQ8plex);N-Term(iTRAQ8plex);S7(Phospho),Casein kinase I substrate motif;G protein-coupled receptor kinase 1 substrate motif;PKA kinase substrate motif;PKC kinase substrate motif,+,0.06312,3,1,1,85100000,0.001183,3.3,0,3.315889406,Caveolin-1,AMADELSEK,KAMADELSEKQVYDA,Q03135,CAV1,S(7): 100.0,Q03135,S7(Phospho),1
0,0.18,-1.14,-1.08,-0.56,-0.47,-0.44,-0.46,K9(iTRAQ8plex);N-Term(iTRAQ8plex);S7(Phospho),"DNA dependent Protein kinase substrate motif;ERK1,2 kinase substrate motif;Growth associated histone HI kinase substrate motif;GSK-3, ERK1, ERK2, CDK5 substrate motif;PKA kinase substrate motif;PKC kinase substrate motif;WW domain binding motif",+,0.01119,49,1,1,358000000,0,3.53,0,3.371803327,Neuroblast differentiation-associated protein AHNAK (Desmoyokin),AEAPLPSPK,KAEAPLPSPKLEGEL,Q09666,AHNAK,S(7): 100.0,Q09666,S7(Phospho),1
0,0.30,-1.42,-1.46,-1.05,-1.10,-1.00,-1.07,N-Term(iTRAQ8plex);S7(Phospho),Casein kinase II substrate motif;G protein-coupled receptor kinase 1 substrate motif;GSK3 kinase substrate motif,+,0.01892,15,1,1,59100000,0,2.71,0,3.241892993,"Keratin, type II cytoskeletal 6A (Cytokeratin-6A) (CK-6A) (Cytokeratin-6D) (CK-6D) (Keratin-6A) (K6A) (Type-II keratin Kb6) (allergen Hom s 5)",SGFSSVSVSR,RSGFSSVSVSRSRGS,P02538,KRT6A,S(1): 0.0;S(4): 0.3;S(5): 2.0;S(7): 95.8;S(9): 2.0,P02538,S7(Phospho),1
0,0.15,1.05,1.10,0.55,0.13,0.11,0.30,N-Term(iTRAQ8plex);S7(Phospho),Casein kinase II substrate motif,+,0.09436,8,1,1,981000000,0.001958,2.46,1,1.835489493,Nuclear factor 1 C-type (NF1-C) (Nuclear factor 1/C) (CCAAT-box-binding transcription factor) (CTF) (Nuclear factor I/C) (NF-I/C) (NFI-C) (TGGCA-binding protein),ERDAEQSGSPR,RERDAEQSGSPRTGM,P08651,NFIC,S(7): 50.0;S(9): 50.0,P08651,S7(Phospho),1
0,0.17,1.32,1.55,0.66,0.24,-0.33,-0.19,N-Term(iTRAQ8plex);S7(Phospho),G protein-coupled receptor kinase 1 substrate motif,+,0.06692,4,1,1,1240000000,0.001547,3.09,1,2.477731472,DNA replication licensing factor MCM4 (EC 3.6.4.12) (CDC21 homolog) (P1-CDC21),SEDARSSPSQR,TPAQTPRSEDARSSP,P33991,MCM4,S(1): 80.2;S(6): 3.4;S(7): 15.5;S(9): 0.8,P33991,S7(Phospho),1
0,0.05,0.63,0.94,-0.15,-0.17,0.33,0.36,N-Term(iTRAQ8plex);S7(Phospho),"Casein kinase I substrate motif;Cdc2 kinase substrate motif;CDK kinase substrate motif;CDK1,2,4,6 kinase substrate motif;ERK1,2 kinase substrate motif;Growth associated histone HI kinase substrate motif;GSK-3, ERK1, ERK2, CDK5 substrate motif;PKA kinase substrate motif;PKC kinase substrate motif;WW domain binding motif",+,0.02589,38,1,1,6340000000,0,3.58,1,2.433641486,Heterogeneous nuclear ribonucleoprotein K (hnRNP K) (Transformation up-regulated nuclear protein) (TUNP),RDYDDMSPR,RRDYDDMSPRRGPPP,P61978,HNRNPK,Y(3): 0.0;S(7): 100.0,P61978,S7(Phospho),1
0,0.02,-0.51,-0.48,-0.04,0.02,-0.33,-0.38,N-Term(iTRAQ8plex);S7(Phospho),,+,0.08768,8,1,1,139000000,0.001958,3.18,0,3.940052305,Liprin-alpha-1 (LAR-interacting protein 1) (LIP-1) (Protein tyrosine phosphatase receptor type f polypeptide-interacting protein alpha-1) (PTPRF-interacting protein alpha-1),GALHTVSHEDIR,LHKGALHTVSHEDIR,Q13136,PPFIA1,T(5): 97.7;S(7): 2.3,Q13136,S7(Phospho),1
0,0.01,-0.86,-0.88,0.13,0.07,-0.19,-0.23,N-Term(iTRAQ8plex);S7(Phospho),14-3-3 domain binding motif;b-Adrenergic Receptor kinase substrate motif;Calmodulin-dependent protein kinase II substrate motif;Casein kinase II substrate motif;G protein-coupled receptor kinase 1 substrate motif;GSK3 kinase substrate motif;Phosphorylase kinase substrate motif;PKA kinase substrate motif;PKC kinase substrate motif;Pyruvate dehydrogenase kinase substrate motif,+,0.0214,4,1,1,46600000,0,4.04,1,4.975917776,Programmed cell death protein 4 (Neoplastic transformation inhibitor protein) (Nuclear antigen H731-like) (Protein 197/15a),DSGRGDSVSDSGSDALR,RDSGRGDSVSDSGSD,Q53EL6,PDCD4,S(2): 1.3;S(7): 98.6;S(9): 0.0;S(11): 0.0;S(13): 0.0,Q53EL6,S7(Phospho),1
0,0.16,-0.97,-1.19,0.87,0.73,0.17,0.26,N-Term(iTRAQ8plex);S7(Phospho),Casein kinase II substrate motif,+,1.26E-07,28,1,1,312000000,0,6.81,0,3.494602921,Centrosomal protein of 170 kDa (Cep170) (KARP-1-binding protein) (KARP1-binding protein),HDDGTQSDSENAGAHR,KHDDGTQSDSENAGA,Q5SW79,CEP170,T(5): 0.0;S(7): 100.0;S(9): 0.0,Q5SW79,S7(Phospho),1
0,-0.14,-1.26,-1.74,0.77,0.96,0.37,0.17,N-Term(iTRAQ8plex);S7(Phospho),Casein kinase II substrate motif,+,0.009021,16,1,1,363000000,0,4.92,1,2.903494173,Centrosomal protein of 170 kDa (Cep170) (KARP-1-binding protein) (KARP1-binding protein),HDDGTQSDSENAGAHRR,KHDDGTQSDSENAGA,Q5SW79,CEP170,T(5): 14.5;S(7): 82.8;S(9): 2.7,Q5SW79,S7(Phospho),1
0,0.09,-0.83,-0.58,0.50,0.47,0.30,0.33,N-Term(iTRAQ8plex);S7(Phospho),Casein kinase I substrate motif;MAPKAPK2 kinase substrate motif,+,0.002692,20,1,1,39000000,0,4.45,0,3.022423336,SH3 domain-binding protein 5-like (SH3BP-5-like),GLSDHVSLDGQELGTR,RGLSDHVSLDGQELG,Q7L8J4,SH3BP5L,S(3): 0.0;S(7): 100.0;T(15): 0.0,Q7L8J4,S7(Phospho),1
0,0.10,0.20,0.16,0.29,0.29,0.40,0.35,N-Term(iTRAQ8plex);S7(Phospho),"ERK1,2 kinase substrate motif;G protein-coupled receptor kinase 1 substrate motif;GSK-3, ERK1, ERK2, CDK5 substrate motif;WW domain binding motif",+,0.01149,8,1,1,57100000,0,3.65,0,2.237148865,Formin-binding protein 4 (Formin-binding protein 30),RPILQLSPPGPR,RRPILQLSPPGPRGS,Q8N3X1,FNBP4,S(7): 100.0,Q8N3X1,S7(Phospho),1
0,-0.19,-0.56,-0.64,0.39,0.35,0.53,0.52,N-Term(iTRAQ8plex);S7(Phospho),"Casein kinase II substrate motif;ERK1,2 kinase substrate motif;GSK-3, ERK1, ERK2, CDK5 substrate motif;WW domain binding motif",+,0.02966,10,1,1,52000000,0,3.1,0,3.462038056,Tensin-1,VATTPGSPSLGR,KVATTPGSPSLGRHP,Q9HBL0,TNS1,T(3): 0.0;T(4): 0.0;S(7): 50.0;S(9): 50.0,Q9HBL0,S7(Phospho),1
0,-0.02,-1.79,-1.44,0.30,0.10,-0.52,-0.75,N-Term(iTRAQ8plex);S7(Phospho),"14-3-3 domain binding motif;AMP-activated protein kinase substrate motif;b-Adrenergic Receptor kinase substrate motif;Calmodulin-dependent protein kinase II substrate motif;Cdc2 kinase substrate motif;CDK kinase substrate motif;CDK1,2,4,6 kinase substrate motif;CLK1 kinase substrate motif;ERK1,2 kinase substrate motif;GSK-3, ERK1, ERK2, CDK5 substrate motif;HMGCoA Reductase kinase substrate motif;PKA kinase substrate motif;PKC epsilon kinase substrate motif;PKC kinase substrate motif;WW domain binding motif",+,0.1024,12,1,1,273000000,0.00608,2.47,1,2.869541988,Bcl-2-associated transcription factor 1 (Btf),STFREESPLR,KSTFREESPLRIKMI,Q9NYF8,BCLAF1,S(1): 0.0;T(2): 0.1;S(7): 99.9,Q9NYF8,S7(Phospho),1
0,0.17,-2.14,-3.33,-0.71,-1.08,-1.29,-1.58,C1(Carbamidomethyl);C17(Carbamidomethyl);N-Term(iTRAQ8plex);S8(Phospho),"b-Adrenergic Receptor kinase substrate motif;Casein kinase I substrate motif;Casein kinase II substrate motif;ERK1,2 kinase substrate motif;GSK-3, ERK1, ERK2, CDK5 substrate motif;WW domain binding motif",+,0.002778,4,1,1,0,0,5.56,0,1.817796239,Leucine-rich repeat flightless-interacting protein 1 (LRR FLII-interacting protein 1) (GC-binding factor 2) (TAR RNA-interacting protein),CTLPEHESPSQDISDACEAESTER,CTLPEHESPSQDISD,Q32MZ4,LRRFIP1,T(2): 0.1;S(8): 97.3;S(10): 2.6;S(14): 0.0;S(21): 0.0;T(22): 0.0,Q32MZ4,S8(Phospho),1
0,0.06,0.54,1.04,-0.13,-0.40,-0.90,-0.67,K11(iTRAQ8plex);K12(iTRAQ8plex);N-Term(iTRAQ8plex);S8(Phospho),"Casein kinase II substrate motif;Cdc2 kinase substrate motif;CDK kinase substrate motif;CDK1,2,4,6 kinase substrate motif;ERK1,2 kinase substrate motif;GSK-3, ERK1, ERK2, CDK5 substrate motif;MAPKAPK2 kinase substrate motif;WW domain binding motif",+,0.1447,6,1,1,76700000,0.004142,1.59,1,2.074473327,Histone H1x,AGGSAALSPSKK,AGGSAALSPSKKRKN,Q92522,H1FX,S(4): 49.9;S(8): 49.9;S(10): 0.1,Q92522,S8(Phospho),1
0,0.02,-2.72,-2.37,0.22,-0.35,-0.35,-0.81,K1(iTRAQ8plex);K13(iTRAQ8plex);N-Term(iTRAQ8plex);S8(Phospho),BARD1 BRCT domain binding motif;Casein kinase I substrate motif;Casein kinase II substrate motif;MDC1 BRCT domain binding motif;Plk1 PBD domain binding motif,+,0.1005,10,1,1,109000000,0.002391,3.59,1,2.606740954,Hepatoma-derived growth factor (HDGF) (High mobility group protein 1-like 2) (HMG-1L2),KGNAEGSSDEEGK,KGNAEGSSDEEGKLV,P51858,HDGF,S(7): 11.0;S(8): 89.0,P51858,S8(Phospho),1
0,0.17,-2.33,-2.49,-0.25,-0.12,-0.01,-0.05,K10(iTRAQ8plex);K13(iTRAQ8plex);N-Term(iTRAQ8plex);S8(Phospho),"b-Adrenergic Receptor kinase substrate motif;Cdc2 kinase substrate motif;CDK kinase substrate motif;CDK1,2,4,6 kinase substrate motif;ERK1,2 kinase substrate motif;G protein-coupled receptor kinase 1 substrate motif;Growth associated histone HI kinase substrate motif;GSK-3, ERK1, ERK2, CDK5 substrate motif;PKA kinase substrate motif;PKC kinase substrate motif;WW domain binding motif",+,0.002869,137,1,1,2840000000,0,4.41,1,4.449273385,Hepatoma-derived growth factor (HDGF) (High mobility group protein 1-like 2) (HMG-1L2),AGDLLEDSPKRPK,AGDLLEDSPKRPKEA,P51858,HDGF,S(8): 100.0,P51858,S8(Phospho),1
0,-0.41,1.37,1.68,0.54,0.11,0.14,0.56,K13(iTRAQ8plex);K14(iTRAQ8plex);N-Term(iTRAQ8plex);S8(Phospho),"Casein kinase II substrate motif;ERK1,2 kinase substrate motif;GSK-3, ERK1, ERK2, CDK5 substrate motif;WW domain binding motif",+,0.07606,2,1,1,24000000,0.001547,2.17,1,1.833922028,Voltage-dependent anion-selective channel protein 1 (VDAC-1) (hVDAC1) (Outer mitochondrial membrane protein porin 1) (Plasmalemmal porin) (Porin 31HL) (Porin 31HM),LTFDSSFSPNTGKK,LTFDSSFSPNTGKKN,P21796,VDAC1,T(2): 0.8;S(5): 3.3;S(6): 15.3;S(8): 79.9;T(11): 0.8,P21796,S8(Phospho),1
0,-0.15,-0.92,-0.72,-1.34,-1.48,-2.10,-2.00,K20(iTRAQ8plex);K21(iTRAQ8plex);N-Term(iTRAQ8plex);S8(Phospho),b-Adrenergic Receptor kinase substrate motif;PKA kinase substrate motif;PKC kinase substrate motif,+,0.1647,2,1,1,14500000,0.005201,2.13,1,3.622955361,Collagen alpha-1(XVII) chain (180 kDa bullous pemphigoid antigen 2) (Bullous pemphigoid antigen 2) [Cleaved into: 120 kDa linear IgA disease antigen (120 kDa linear IgA dermatosis antigen) (Linear IgA disease antigen 1) (LAD-1);97 kDa linear IgA disease antigen (97 kDa linear IgA bullous dermatosis antigen) (97 kDa LAD antigen) (97-LAD) (Linear IgA bullous disease antigen of 97 kDa) (LABD97)],VFTASPASIAATSFSEDTLKK,ATSFSEDTLKKEKQA,Q9UMD9,COL17A1,T(3): 0.5;S(5): 4.1;S(8): 13.7;T(12): 4.1;S(13): 13.7;S(15): 13.7;T(18): 50.3,Q9UMD9,S8(Phospho),1
0,-0.07,0.27,0.21,0.03,-0.06,0.27,0.26,K12(iTRAQ8plex);K7(iTRAQ8plex);N-Term(iTRAQ8plex);S8(Phospho),b-Adrenergic Receptor kinase substrate motif;Casein kinase II substrate motif;G protein-coupled receptor kinase 1 substrate motif;MAPKAPK2 kinase substrate motif,+,0.04967,25,1,1,122000000,0.0006143,3.3,1,2.385824853,Regulation of nuclear pre-mRNA domain-containing protein 1B (Cell cycle-related and expression-elevated protein in tumor),LSMEDSKSPPPK,LKLSMEDSKSPPPKA,Q9NQG5,RPRD1B,S(2): 0.1;S(6): 49.9;S(8): 49.9,Q9NQG5,S8(Phospho),1
0,-0.14,-0.69,-0.53,-0.76,-0.79,-0.62,-0.55,K11(iTRAQ8plex);N-Term(iTRAQ8plex);S8(Phospho),b-Adrenergic Receptor kinase substrate motif;PKA kinase substrate motif;PKC kinase substrate motif,+,0.09147,2,1,1,36700000,0.003607,3.01,1,2.445194871,Catenin delta-1 (Cadherin-associated Src substrate) (CAS) (p120 catenin) (p120(ctn)) (p120(cas)),GSLASLDSLRK,GSLASLDSLRKGGPP,O60716,CTNND1,S(2): 0.0;S(5): 0.0;S(8): 100.0,O60716,S8(Phospho),1
0,0.42,1.33,1.70,0.91,0.78,0.68,0.69,K11(iTRAQ8plex);N-Term(iTRAQ8plex);S8(Phospho),"Casein kinase II substrate motif;Cdc2 kinase substrate motif;CDK kinase substrate motif;CDK1,2,4,6 kinase substrate motif;ERK1,2 kinase substrate motif;G protein-coupled receptor kinase 1 substrate motif;GSK3 kinase substrate motif;GSK-3, ERK1, ERK2, CDK5 substrate motif;WW domain binding motif",+,0.01807,4,1,1,263000000,0,3.59,0,1.860534457,Adenylyl cyclase-associated protein 2 (CAP 2),AQGGQTQSPTK,AQGGQTQSPTKSHTP,P40123,CAP2,T(6): 10.9;S(8): 88.9;T(10): 0.2,P40123,S8(Phospho),1
0,0.21,-0.70,-0.65,-0.08,0.12,-0.04,-0.12,K11(iTRAQ8plex);N-Term(iTRAQ8plex);S8(Phospho),"Cdc2 kinase substrate motif;CDK kinase substrate motif;CDK1,2,4,6 kinase substrate motif;ERK1,2 kinase substrate motif;GSK-3, ERK1, ERK2, CDK5 substrate motif;WW domain binding motif",+,0.0004014,18,1,1,46400000,0,4.11,0,2.174990171,Plectin (PCN) (PLTN) (Hemidesmosomal protein 1) (HD1) (Plectin-1),AQLEPVASPAK,AQLEPVASPAKKPKV,Q15149,PLEC,S(8): 100.0,Q15149,S8(Phospho),1
0,0.03,-0.94,-0.71,-0.13,-0.20,-0.41,-0.40,K11(iTRAQ8plex);N-Term(iTRAQ8plex);S8(Phospho),"Casein kinase II substrate motif;Cdc2 kinase substrate motif;CDK kinase substrate motif;CDK1,2,4,6 kinase substrate motif;ERK1,2 kinase substrate motif;GSK-3, ERK1, ERK2, CDK5 substrate motif;MAPKAPK2 kinase substrate motif;WW domain binding motif",+,0.0354,24,1,1,202000000,0,3.49,0,2.599936077,Histone H1x,AGGSAALSPSK,AGGSAALSPSKKRKN,Q92522,H1FX,S(4): 0.1;S(8): 99.9;S(10): 0.0,Q92522,S8(Phospho),1
0,0.18,-0.63,-0.54,-0.29,-0.16,-0.47,-0.52,K13(iTRAQ8plex);N-Term(iTRAQ8plex);S8(Phospho),Casein kinase I substrate motif;Casein kinase II substrate motif;G protein-coupled receptor kinase 1 substrate motif,+,0.04043,24,1,1,32000000,0,3.62,0,2.29430716,Leucine-rich repeat flightless-interacting protein 1 (LRR FLII-interacting protein 1) (GC-binding factor 2) (TAR RNA-interacting protein),IDGATQSSPAEPK,NAKIDGATQSSPAEP,Q32MZ4,LRRFIP1,T(5): 83.7;S(7): 2.5;S(8): 13.8,Q32MZ4,S8(Phospho),1
0,0.00,-0.96,-0.88,-0.20,-0.17,-0.21,-0.12,K14(iTRAQ8plex);N-Term(iTRAQ8plex);S8(Phospho),BARD1 BRCT domain binding motif;Casein kinase II substrate motif;G protein-coupled receptor kinase 1 substrate motif,+,0.0007288,212,1,1,871000000,0,5.43,0,4.010004197,Neuroblast differentiation-associated protein AHNAK (Desmoyokin),GHYEVTGSDDETGK,GHYEVTGSDDETGKL,Q09666,AHNAK,Y(3): 0.0;T(6): 7.7;S(8): 92.3;T(12): 0.0,Q09666,S8(Phospho),1
0,0.07,-1.52,-0.97,0.33,0.03,-0.24,-0.02,K19(iTRAQ8plex);N-Term(iTRAQ8plex);S8(Phospho),Casein kinase II substrate motif;G protein-coupled receptor kinase 1 substrate motif,+,0.00327,4,1,1,9410000,0,4,0,1.944283818,Splicing factor 3B subunit 2 (Pre-mRNA-splicing factor SF3b 145 kDa subunit) (SF3b145) (SF3b150) (Spliceosome-associated protein 145) (SAP 145),SSLGQSASETEEDTVSVSK,SSLGQSASETEEDTV,Q13435,SF3B2,S(1): 0.2;S(2): 0.2;S(6): 49.6;S(8): 49.6;T(10): 0.2;T(14): 0.0;S(16): 0.0;S(18): 0.0,Q13435,S8(Phospho),1
0,-0.16,-2.40,-1.55,-0.64,-0.35,-1.03,-1.23,K19(iTRAQ8plex);N-Term(iTRAQ8plex);S8(Phospho),b-Adrenergic Receptor kinase substrate motif;Casein kinase I substrate motif;Casein kinase II substrate motif,+,0.0005133,4,1,1,0,0,2.64,0,1.768355265,Cdc42 effector protein 4 (Binder of Rho GTPases 4),AGEPDGESLDEQPSSSSSK,AGEPDGESLDEQPSS,Q9H3Q1,CDC42EP4,S(8): 100.0;S(14): 0.0;S(15): 0.0;S(16): 0.0;S(17): 0.0;S(18): 0.0,Q9H3Q1,S8(Phospho),1
0,0.11,1.25,1.29,0.57,0.67,0.69,0.46,K20(iTRAQ8plex);N-Term(iTRAQ8plex);S8(Phospho),b-Adrenergic Receptor kinase substrate motif;Casein kinase II substrate motif,+,0.004675,4,5,1,382000,0,3.05,0,2.929263617,Tubulin alpha-1C chain (Alpha-tubulin 6) (Tubulin alpha-6 chain),TIGGGDDSFNTFFSETGAGK,TIGGGDDSFNTFFSE,Q9BQE3,TUBA1C,T(1): 0.2;S(8): 99.5;T(11): 0.2;S(14): 0.0;T(16): 0.0,Q9BQE3,S8(Phospho),1
0,0.24,-2.86,-2.58,0.20,0.03,-0.99,-0.69,K25(iTRAQ8plex);N-Term(iTRAQ8plex);S8(Phospho),14-3-3 domain binding motif;Calmodulin-dependent protein kinase II substrate motif;G protein-coupled receptor kinase 1 substrate motif;GSK3 kinase substrate motif;PKA kinase substrate motif;PKC kinase substrate motif,+,0.001643,6,1,1,1800000,0,5.24,0,3.579679312,182 kDa tankyrase-1-binding protein,SFGTRPLSSGFSPEEAQQQDEEFEK,SFGTRPLSSGFSPEE,Q9C0C2,TNKS1BP1,S(1): 2.1;T(4): 44.1;S(8): 44.1;S(9): 9.3;S(12): 0.5,Q9C0C2,S8(Phospho),1
0,-0.16,-1.10,-1.30,-0.91,-1.03,-0.21,0.02,K28(iTRAQ8plex);N-Term(iTRAQ8plex);S8(Phospho),b-Adrenergic Receptor kinase substrate motif;BARD1 BRCT domain binding motif;Casein kinase II substrate motif,+,0.0006067,4,1,1,489000,0,5.89,0,2.723374198,Probable ATP-dependent RNA helicase DDX46 (EC 3.6.4.13) (DEAD box protein 46) (PRP5 homolog),AALGLQDSDDEDAAVDIDEQIESMFNSK,AALGLQDSDDEDAAV,Q7L014,DDX46,S(8): 100.0;S(23): 0.0;S(27): 0.0,Q7L014,S8(Phospho),1
0,-0.10,0.99,1.40,0.72,0.72,0.95,1.05,K7(iTRAQ8plex);N-Term(iTRAQ8plex);S8(Phospho),"ERK1,2 kinase substrate motif;Growth associated histone HI kinase substrate motif;GSK-3, ERK1, ERK2, CDK5 substrate motif;WW domain binding motif",+,0.01833,28,1,1,849000000,0,3.86,1,2.326504827,La-related protein 4B (La ribonucleoprotein domain family member 4B) (La ribonucleoprotein domain family member 5) (La-related protein 5),EQSTPPKSPQ,EQSTPPKSPQ_____,Q92615,LARP4B,S(3): 0.0;T(4): 0.0;S(8): 100.0,Q92615,S8(Phospho),1
0,0.12,-0.46,-0.53,0.11,0.01,-0.08,-0.09,N-Term(iTRAQ8plex);S8(Phospho),"DNA dependent Protein kinase substrate motif;ERK1,2 kinase substrate motif;GSK-3, ERK1, ERK2, CDK5 substrate motif;WW domain binding motif",+,0.01149,11,1,1,185000000,0,3.61,0,2.630148236,U1 small nuclear ribonucleoprotein 70 kDa (U1 snRNP 70 kDa) (U1-70K) (snRNP70),YDERPGPSPLPHR,YDERPGPSPLPHRDR,P08621,SNRNP70,,P08621,S8(Phospho),1
0,-0.10,0.46,0.47,0.37,0.39,0.48,0.61,N-Term(iTRAQ8plex);S8(Phospho),AMP-activated protein kinase substrate motif;b-Adrenergic Receptor kinase substrate motif;Casein kinase II substrate motif;HMGCoA Reductase kinase substrate motif;Pyruvate dehydrogenase kinase substrate motif,+,0.04097,2,1,1,59100000,0.0006798,3.23,0,2.67323854,Cation-independent mannose-6-phosphate receptor (CI Man-6-P receptor) (CI-MPR) (M6PR) (300 kDa mannose 6-phosphate receptor) (MPR 300) (Insulin-like growth factor 2 receptor) (Insulin-like growth factor II receptor) (IGF-II receptor) (M6P/IGF2 receptor) (M6P/IGF2R) (CD antigen CD222),LVSFHDDSDEDLLHI,LVSFHDDSDEDLLHI,P11717,IGF2R,S(3): 0.0;S(8): 100.0,P11717,S8(Phospho),1
0,-0.02,0.01,-0.03,-0.10,-0.07,0.39,0.35,N-Term(iTRAQ8plex);S8(Phospho),"Casein kinase I substrate motif;ERK1,2 kinase substrate motif;G protein-coupled receptor kinase 1 substrate motif;Growth associated histone HI kinase substrate motif;GSK-3, ERK1, ERK2, CDK5 substrate motif;PKA kinase substrate motif;PKC kinase substrate motif;WW domain binding motif",+,0.01439,2,1,1,65100000,0,3.82,2,3.782365138,Fos-related antigen 2 (FRA-2),ISPEERRSPPAPGLQPMR,ISPEERRSPPAPGLQ,P15408,FOSL2,S(2): 4.9;S(8): 95.1,P15408,S8(Phospho),1
0,-0.07,0.81,0.76,0.02,-0.18,0.67,0.62,N-Term(iTRAQ8plex);S8(Phospho),b-Adrenergic Receptor kinase substrate motif;Casein kinase II substrate motif;G protein-coupled receptor kinase 1 substrate motif,+,0.000416,13,1,1,23300000,0,5.48,0,3.138530422,Catenin alpha-1 (Alpha E-catenin) (Cadherin-associated protein) (Renal carcinoma antigen NY-REN-13),TPEELDDSDFETEDFDVR,TPEELDDSDFETEDF,P35221,CTNNA1,T(1): 0.0;S(8): 99.9;T(12): 0.1,P35221,S8(Phospho),1
0,0.13,-0.50,-0.42,0.23,0.10,-0.05,-0.12,N-Term(iTRAQ8plex);S8(Phospho),"Casein kinase I substrate motif;Cdc2 kinase substrate motif;CDK kinase substrate motif;CDK1,2,4,6 kinase substrate motif;DNA dependent Protein kinase substrate motif;ERK1,2 kinase substrate motif;GSK-3, ERK1, ERK2, CDK5 substrate motif;PKA kinase substrate motif;PKC kinase substrate motif;WW domain binding motif",+,0.01249,12,1,1,132000000,0,3.48,0,2.419309783,RNA-binding protein 10 (G patch domain-containing protein 9) (RNA-binding motif protein 10) (RNA-binding protein S1-1) (S1-1),LASDDRPSPPR,LASDDRPSPPRGLVA,P98175,RBM10,S(3): 0.0;S(8): 100.0,P98175,S8(Phospho),1
0,-0.11,-1.81,-1.46,-1.36,-1.55,-1.35,-1.35,N-Term(iTRAQ8plex);S8(Phospho),Casein kinase II substrate motif;G protein-coupled receptor kinase 1 substrate motif;GSK3 kinase substrate motif;MDC1 BRCT domain binding motif;Plk1 PBD domain binding motif,+,0.1767,30,1,1,20000000,0,3.42,0,2.87664689,Lamin-B2,ATSSSSGSLSATGR,SRATSSSSGSLSATG,Q03252,LMNB2,,Q03252,S8(Phospho),1
0,0.16,-1.76,-1.21,0.05,-0.15,-0.35,-0.66,N-Term(iTRAQ8plex);S8(Phospho),BARD1 BRCT domain binding motif;Casein kinase II substrate motif,+,6.79E-06,4,1,1,332000,0,4.6,0,2.031043784,Periodic tryptophan protein 1 homolog (Keratinocyte protein IEF SSP 9502),LQEEGGGSDEEETGSPSEDGMQSAR,LQEEGGGSDEEETGS,Q13610,PWP1,S(8): 100.0;T(13): 0.0;S(15): 0.0;S(17): 0.0;S(23): 0.0,Q13610,S8(Phospho),1
0,-0.40,0.69,0.80,1.80,1.80,1.39,1.69,N-Term(iTRAQ8plex);S8(Phospho),Casein kinase II substrate motif;G protein-coupled receptor kinase 1 substrate motif,+,0.0007839,4,1,1,125000,0,3.67,0,2.899227214,Dihydropyrimidinase-related protein 2 (DRP-2) (Collapsin response mediator protein 2) (CRMP-2) (N2A3) (Unc-33-like phosphoprotein 2) (ULIP-2),NLHQSGFSLSGAQIDDNIPR,NLHQSGFSLSGAQID,Q16555,DPYSL2,S(5): 0.3;S(8): 99.4;S(10): 0.3,Q16555,S8(Phospho),1
0,0.01,-1.15,-1.03,-0.15,-0.18,-0.60,-0.62,N-Term(iTRAQ8plex);S8(Phospho),b-Adrenergic Receptor kinase substrate motif;Casein kinase I substrate motif;G protein-coupled receptor kinase 1 substrate motif;GSK3 kinase substrate motif;PKA kinase substrate motif,+,0.06498,6,1,1,46400000,0.001183,2.91,0,4.139663797,La-related protein 1 (La ribonucleoprotein domain family member 1),ETESAPGSPR,HYQKETESAPGSPRA,Q6PKG0,LARP1,T(2): 0.0;S(4): 0.3;S(8): 99.7,Q6PKG0,S8(Phospho),1
0,0.01,0.54,0.43,0.32,0.33,0.69,0.67,N-Term(iTRAQ8plex);S8(Phospho),,+,0.0174,6,1,1,27400000,0,3.65,0,3.615989419,CREB-regulated transcription coactivator 3 (Transducer of regulated cAMP response element-binding protein 3) (TORC-3) (Transducer of CREB protein 3),LTQYHGGSLPNVSQLR,LTQYHGGSLPNVSQL,Q6UUV7,CRTC3,T(2): 0.0;Y(4): 0.0;S(8): 100.0;S(13): 0.0,Q6UUV7,S8(Phospho),1
0,0.07,0.00,0.08,-0.05,-0.05,0.70,0.64,N-Term(iTRAQ8plex);S8(Phospho),"Casein kinase I substrate motif;Casein kinase II substrate motif;ERK1,2 kinase substrate motif;G protein-coupled receptor kinase 1 substrate motif;GSK-3, ERK1, ERK2, CDK5 substrate motif;WW domain binding motif",+,0.02732,40,1,1,11700000,0,4.48,0,3.593769282,Proline and serine-rich protein 2,MAGNEALSPTSPFR,MAGNEALSPTSPFRE,Q86WR7,PROSER2,S(8): 100.0;T(10): 0.0;S(11): 0.0,Q86WR7,S8(Phospho),1
0,0.14,-0.29,-0.38,-0.20,-0.13,0.11,0.02,N-Term(iTRAQ8plex);S8(Phospho),"ERK1,2 kinase substrate motif;G protein-coupled receptor kinase 1 substrate motif;GSK-3, ERK1, ERK2, CDK5 substrate motif;WW domain binding motif",+,0.01238,10,1,1,43100000,0,4.29,0,1.926599486,MICAL-like protein 1 (Molecule interacting with Rab13) (MIRab13),VEQMPQASPGLAPR,VEQMPQASPGLAPRT,Q8N3F8,MICALL1,S(8): 100.0,Q8N3F8,S8(Phospho),1
0,-0.07,-0.99,-1.06,-0.05,-0.25,-0.26,-0.41,N-Term(iTRAQ8plex);S8(Phospho),"Casein kinase I substrate motif;Casein kinase II substrate motif;ERK1,2 kinase substrate motif;GSK-3, ERK1, ERK2, CDK5 substrate motif;WW domain binding motif",+,0.06544,8,1,1,24800000,0.001217,3.68,1,2.81391719,SWI/SNF complex subunit SMARCC2 (BRG1-associated factor 170) (BAF170) (SWI/SNF complex 170 kDa subunit) (SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily C member 2),TLTDEVNSPDSDRR,TLTDEVNSPDSDRRD,Q8TAQ2,SMARCC2,T(1): 0.0;T(3): 0.1;S(8): 88.0;S(11): 11.9,Q8TAQ2,S8(Phospho),1
0,0.14,0.61,0.52,0.22,0.41,0.60,0.59,N-Term(iTRAQ8plex);S8(Phospho),"Cdc2 kinase substrate motif;CDK kinase substrate motif;CDK1,2,4,6 kinase substrate motif;ERK1,2 kinase substrate motif;GSK-3, ERK1, ERK2, CDK5 substrate motif;WW domain binding motif",+,0.0322,28,1,1,152000000,0,3.79,0,1.929615435,Protein FAM122A,HGLLLPASPVR,HGLLLPASPVRMHSS,Q96E09,FAM122A,S(8): 100.0,Q96E09,S8(Phospho),1
0,0.05,-0.45,-0.49,0.19,0.16,-0.04,-0.03,N-Term(iTRAQ8plex);S8(Phospho),"b-Adrenergic Receptor kinase substrate motif;ERK1,2 kinase substrate motif;Growth associated histone HI kinase substrate motif;GSK-3, ERK1, ERK2, CDK5 substrate motif;PKA kinase substrate motif;PKC kinase substrate motif;WW domain binding motif",+,0.05368,4,1,1,21700000,0.0006395,3,0,4.22039203,Coiled-coil domain-containing protein 86 (Cytokine-induced protein with coiled-coil domain),QPEYSPESPR,QPEYSPESPRCQPKP,Q9H6F5,CCDC86,Y(4): 0.2;S(5): 0.0;S(8): 99.8,Q9H6F5,S8(Phospho),1
0,-0.05,-0.89,-0.95,-0.08,-0.16,-0.11,-0.10,N-Term(iTRAQ8plex);S8(Phospho),"Casein kinase II substrate motif;ERK1,2 kinase substrate motif;Growth associated histone HI kinase substrate motif;GSK-3, ERK1, ERK2, CDK5 substrate motif;PKA kinase substrate motif;PKC kinase substrate motif;WW domain binding motif",+,0.04616,10,1,1,624000000,0.0006395,3.44,0,4.092739469,Thyroid hormone receptor-associated protein 3 (Thyroid hormone receptor-associated protein complex 150 kDa component) (Trap150),ASAVSELSPR,ASAVSELSPRERSPA,Q9Y2W1,THRAP3,S(2): 0.0;S(5): 0.6;S(8): 99.4,Q9Y2W1,S8(Phospho),1
0,0.45,NaN,-0.03,2.88,2.68,2.39,2.18,C2(Carbamidomethyl);C5(Carbamidomethyl);K11(iTRAQ8plex);N-Term(iTRAQ8plex);S9(Phospho),"ERK1,2 kinase substrate motif;G protein-coupled receptor kinase 1 substrate motif;Growth associated histone HI kinase substrate motif;GSK-3, ERK1, ERK2, CDK5 substrate motif;MDC1 BRCT domain binding motif;PKA kinase substrate motif;PKC kinase substrate motif;Plk1 PBD domain binding motif;WW domain binding motif",+,0.08659,2,1,1,15800000,0.002183,1.89,0,2.584013865,Insulin receptor substrate 2 (IRS-2),LCPSCPASSPK,CPSCPASSPKVAYHP,Q9Y4H2,IRS2,S(4): 0.8;S(8): 15.6;S(9): 83.7,Q9Y4H2,S9(Phospho),1
0,-0.02,-1.96,-2.24,-0.64,-0.92,-1.26,-1.43,K12(iTRAQ8plex);K2(iTRAQ8plex);N-Term(iTRAQ8plex);S9(Phospho),"Casein kinase II substrate motif;Cdc2 kinase substrate motif;CDK kinase substrate motif;CDK1,2,4,6 kinase substrate motif;ERK1,2 kinase substrate motif;GSK-3, ERK1, ERK2, CDK5 substrate motif;MAPKAPK2 kinase substrate motif;WW domain binding motif",+,0.06452,4,1,1,48100000,0.001547,2.12,1,3.129869318,Protein AHNAK2,FKIPSLGWSPSK,KIPSLGWSPSKHTKT,Q8IVF2,AHNAK2,S(5): 11.1;S(9): 88.6;S(11): 0.3,Q8IVF2,S9(Phospho),1
0,-0.11,1.25,1.48,-0.17,-0.50,-0.36,-0.66,K4(iTRAQ8plex);M14(Oxidation);N-Term(iTRAQ8plex);S9(Phospho),b-Adrenergic Receptor kinase substrate motif;Casein kinase I substrate motif;Casein kinase II substrate motif;Pyruvate dehydrogenase kinase substrate motif,+,0.05153,2,1,1,15300000,0.0006606,4.29,1,2.792798674,Proteasome subunit alpha type-3 (EC 3.4.25.1) (Macropain subunit C8) (Multicatalytic endopeptidase complex subunit C8) (Proteasome component C8),ESLKEEDESDDDNM,SLKEEDESDDDNM__,P25788,PSMA3,S(2): 0.0;S(9): 100.0,P25788,S9(Phospho),1
0,0.26,-1.43,-1.45,-1.00,-0.79,-0.94,-1.01,C10(Carbamidomethyl);N-Term(iTRAQ8plex);S9(Phospho),PKA kinase substrate motif;PKC kinase substrate motif,+,0.01505,25,1,1,334000000,0,3.71,0,3.050615341,"Keratin, type I cytoskeletal 17 (39.1) (Cytokeratin-17) (CK-17) (Keratin-17) (K17)",LSGGLGAGSCR,SGGLGAGSCRLGSAG,Q04695,KRT17,S(2): 0.0;S(9): 100.0,Q04695,S9(Phospho),1
0,0.30,-2.17,-1.62,-0.02,-0.15,-0.89,-0.60,K1(iTRAQ8plex);N-Term(iTRAQ8plex);S9(Phospho),"ERK1,2 kinase substrate motif;G protein-coupled receptor kinase 1 substrate motif;Growth associated histone HI kinase substrate motif;GSK3 kinase substrate motif;GSK-3, ERK1, ERK2, CDK5 substrate motif;PKA kinase substrate motif;PKC kinase substrate motif;WW domain binding motif",+,0.1627,4,1,1,415000000,0.005201,2.17,1,2.394718169,Arginine/serine-rich coiled-coil protein 2,KEQSEVSVSPR,EQSEVSVSPRASKHH,Q7L4I2,RSRC2,S(4): 33.3;S(7): 33.3;S(9): 33.3,Q7L4I2,S9(Phospho),1
0,-0.06,-1.30,-1.17,0.56,0.43,-0.45,-0.56,K11(iTRAQ8plex);N-Term(iTRAQ8plex);S9(Phospho),"Cdc2 kinase substrate motif;CDK kinase substrate motif;CDK1,2,4,6 kinase substrate motif;ERK1,2 kinase substrate motif;Growth associated histone HI kinase substrate motif;GSK-3, ERK1, ERK2, CDK5 substrate motif;MAPKAPK2 kinase substrate motif;PKA kinase substrate motif;PKC kinase substrate motif;WW domain binding motif",+,0.04034,5,1,1,91900000,0.0006395,3.54,0,3.966695631,Zinc finger CCHC domain-containing protein 8 (TRAMP-like complex RNA-binding factor ZCCHC8),SSSHSSPGSPK,SSHSSPGSPKKQKNE,Q6NZY4,ZCCHC8,S(1): 0.0;S(2): 0.0;S(3): 0.0;S(5): 0.0;S(6): 0.0;S(9): 100.0,Q6NZY4,S9(Phospho),1
0,0.12,-0.42,-0.33,0.46,0.63,0.29,0.16,K12(iTRAQ8plex);N-Term(iTRAQ8plex);S9(Phospho),"Cdc2 kinase substrate motif;CDK kinase substrate motif;CDK1,2,4,6 kinase substrate motif;CDK4 kinase substrate motif;ERK1,2 kinase substrate motif;GSK-3, ERK1, ERK2, CDK5 substrate motif;WW domain binding motif",+,0.0002919,60,1,1,196000000,0,4.83,0,2.574827563,Stathmin (Leukemia-associated phosphoprotein p18) (Metablastin) (Oncoprotein 18) (Op18) (Phosphoprotein p19) (pp19) (Prosolin) (Protein Pr22) (pp17),ESVPEFPLSPPK,SVPEFPLSPPKKKDL,P16949,STMN1,S(2): 0.0;S(9): 100.0,P16949,S9(Phospho),1
0,0.02,0.14,0.12,0.09,0.10,0.44,0.35,K12(iTRAQ8plex);N-Term(iTRAQ8plex);S9(Phospho),"Cdc2 kinase substrate motif;CDK kinase substrate motif;CDK1,2,4,6 kinase substrate motif;ERK1,2 kinase substrate motif;G protein-coupled receptor kinase 1 substrate motif;GSK-3, ERK1, ERK2, CDK5 substrate motif;WW domain binding motif",+,0.09154,2,1,1,19200000,0.00264,3.43,1,2.809405808,Eukaryotic translation initiation factor 4 gamma 1 (eIF-4-gamma 1) (eIF-4G 1) (eIF-4G1) (p220),REAALPPVSPLK,EAALPPVSPLKAALS,Q04637,EIF4G1,S(9): 100.0,Q04637,S9(Phospho),1
0,0.16,-0.67,-0.53,-0.05,-0.15,-0.40,-0.40,K12(iTRAQ8plex);N-Term(iTRAQ8plex);S9(Phospho),"Cdc2 kinase substrate motif;CDK kinase substrate motif;CDK1,2,4,6 kinase substrate motif;ERK1,2 kinase substrate motif;Growth associated histone HI kinase substrate motif;GSK-3, ERK1, ERK2, CDK5 substrate motif;MAPKAPK2 kinase substrate motif;MDC1 BRCT domain binding motif;Plk1 PBD domain binding motif;WW domain binding motif",+,0.003449,27,1,1,168000000,0,4.43,1,2.395382656,Ubiquitin-associated protein 2-like (Protein NICE-4),RYPSSISSSPQK,YPSSISSSPQKDLTQ,Q14157,UBAP2L,Y(2): 0.0;S(4): 0.0;S(5): 0.0;S(7): 0.7;S(8): 8.0;S(9): 91.3,Q14157,S9(Phospho),1
0,0.22,0.71,0.77,0.84,0.81,0.81,0.84,K13(iTRAQ8plex);N-Term(iTRAQ8plex);S9(Phospho),G protein-coupled receptor kinase 1 substrate motif,+,0.02386,24,1,1,36900000,0,3.55,0,2.641078704,Ragulator complex protein LAMTOR1 (Late endosomal/lysosomal adaptor and MAPK and MTOR activator 1) (Lipid raft adaptor protein p18) (Protein associated with DRMs and endosomes) (p27Kip1-releasing factor from RhoA) (p27RF-Rho),TDEQALLSSILAK,TDEQALLSSILAKTA,Q6IAA8,LAMTOR1,T(1): 0.0;S(8): 11.6;S(9): 88.4,Q6IAA8,S9(Phospho),1
0,0.15,-1.72,-1.76,0.18,-0.17,-1.04,-0.65,K14(iTRAQ8plex);N-Term(iTRAQ8plex);S9(Phospho),Casein kinase II substrate motif;G protein-coupled receptor kinase 1 substrate motif,+,0.0002162,36,1,1,219000000,0,5.98,0,2.695855463,Nuclease-sensitive element-binding protein 1 (CCAAT-binding transcription factor I subunit A) (CBF-A) (DNA-binding protein B) (DBPB) (Enhancer factor I subunit A) (EFI-A) (Y-box transcription factor) (Y-box-binding protein 1) (YB-1),NYQQNYQNSESGEK,YQQNYQNSESGEKNE,P67809,YBX1,Y(2): 0.0;Y(6): 0.0;S(9): 91.6;S(11): 8.4,P67809,S9(Phospho),1
0,0.11,0.28,0.33,0.27,0.34,0.63,0.60,K22(iTRAQ8plex);N-Term(iTRAQ8plex);S9(Phospho),Casein kinase II substrate motif,+,0.001864,6,1,1,4060000,0,4.24,0,2.747657498,Anaphase-promoting complex subunit CDC26 (Anaphase-promoting complex subunit 12) (APC12) (Cell division cycle protein 26 homolog),EDVEVVGGSDGEGAIGLSSDPK,DVEVVGGSDGEGAIG,Q8NHZ8,CDC26,S(9): 100.0;S(18): 0.0;S(19): 0.0,Q8NHZ8,S9(Phospho),1
0,0.33,1.82,2.05,0.45,0.05,0.65,0.54,K4(iTRAQ8plex);N-Term(iTRAQ8plex);S9(Phospho),b-Adrenergic Receptor kinase substrate motif;Casein kinase I substrate motif;Casein kinase II substrate motif;Pyruvate dehydrogenase kinase substrate motif,+,0.03631,74,1,1,587000000,0,4.66,1,2.55091589,Proteasome subunit alpha type-3 (EC 3.4.25.1) (Macropain subunit C8) (Multicatalytic endopeptidase complex subunit C8) (Proteasome component C8),ESLKEEDESDDDNM,SLKEEDESDDDNM__,P25788,PSMA3,S(2): 0.0;S(9): 100.0,P25788,S9(Phospho),1
0,0.14,0.70,0.78,0.89,1.00,1.49,1.27,N-Term(iTRAQ8plex);S9(Phospho),Casein kinase II substrate motif;G protein-coupled receptor kinase 1 substrate motif,+,0.01227,12,1,1,10600000,0,3.36,1,2.97908949,Target of Myb protein 1,AADRLPNLSSPSAEGPPGPPSGPAPR,ADRLPNLSSPSAEGP,O60784,TOM1,S(9): 33.3;S(10): 33.3;S(12): 33.3;S(21): 0.0,O60784,S9(Phospho),1
0,0.18,-0.39,-0.35,0.48,0.51,0.28,0.29,N-Term(iTRAQ8plex);S9(Phospho),ATM kinase substrate motif;DNA dependent Protein kinase substrate motif,+,0.03038,11,1,1,66200000,0.001,3.27,0,3.039726982,Vimentin,DGQVINETSQHHDDLE,GQVINETSQHHDDLE,P08670,VIM,T(8): 2.5;S(9): 97.5,P08670,S9(Phospho),1
0,0.01,-0.54,-0.41,-0.58,-0.51,-0.42,-0.50,N-Term(iTRAQ8plex);S9(Phospho),b-Adrenergic Receptor kinase substrate motif;Casein kinase I substrate motif,+,0.02576,8,1,1,11300000,0,4,0,2.614660607,Integrin beta-4 (GP150) (CD antigen CD104),LLELQEVDSLLR,LELQEVDSLLRGRQV,P16144,ITGB4,S(9): 100.0,P16144,S9(Phospho),1
0,0.12,-1.52,-1.08,-0.11,-0.38,-1.23,-1.22,N-Term(iTRAQ8plex);S9(Phospho),"ERK1,2 kinase substrate motif;GSK-3, ERK1, ERK2, CDK5 substrate motif;PKA kinase substrate motif;PKC kinase substrate motif;WW domain binding motif",+,0.02335,10,1,1,173000000,0.0007602,2.78,1,2.391570146,Nucleolin (Protein C23),LELQGPRGSPNAR,ELQGPRGSPNARSQP,P19338,NCL,S(9): 100.0,P19338,S9(Phospho),1
0,-0.04,-0.95,-0.96,-0.13,-0.18,0.11,0.09,N-Term(iTRAQ8plex);S9(Phospho),"Cdc2 kinase substrate motif;ERK1,2 kinase substrate motif;Growth associated histone HI kinase substrate motif;GSK-3, ERK1, ERK2, CDK5 substrate motif;PKA kinase substrate motif;PKC kinase substrate motif;WW domain binding motif",+,0.01627,80,1,1,8060000000,0,4.67,1,5.176606085,Splicing factor U2AF 65 kDa subunit (U2 auxiliary factor 65 kDa subunit) (hU2AF(65)) (hU2AF65) (U2 snRNP auxiliary factor large subunit),EEHGGLIRSPR,EHGGLIRSPRHEKKK,P26368,U2AF2,S(9): 100.0,P26368,S9(Phospho),1
0,0.29,-1.75,-1.40,0.41,0.26,-0.26,-0.42,N-Term(iTRAQ8plex);S9(Phospho),"AMP-activated protein kinase substrate motif;Casein kinase II substrate motif;ERK1,2 kinase substrate motif;GSK-3, ERK1, ERK2, CDK5 substrate motif;PKA kinase substrate motif;PKC kinase substrate motif;WW domain binding motif",+,0.04327,8,1,1,20800000,0,3.07,1,2.841665513,"Serine/arginine-rich splicing factor 2 (Protein PR264) (Splicing component, 35 kDa) (Splicing factor SC35) (SC-35) (Splicing factor, arginine/serine-rich 2)",VDNLTYRTSPDTLR,DNLTYRTSPDTLRRV,Q01130,SRSF2,T(5): 23.7;Y(6): 23.7;T(8): 23.7;S(9): 23.7;T(12): 5.3,Q01130,S9(Phospho),1
0,-0.05,-1.39,-1.29,-0.92,-1.08,-1.04,-1.02,N-Term(iTRAQ8plex);S9(Phospho),Casein kinase II substrate motif;G protein-coupled receptor kinase 1 substrate motif;GSK3 kinase substrate motif;PKA kinase substrate motif;PKC kinase substrate motif,+,0.1412,5,1,1,327000000,0.005792,3.32,0,3.703492575,"Keratin, type I cytoskeletal 17 (39.1) (Cytokeratin-17) (CK-17) (Keratin-17) (K17)",GSSGLGGGSSR,SSGLGGGSSRTSCRL,Q04695,KRT17,S(2): 0.0;S(3): 0.0;S(9): 98.2;S(10): 1.7,Q04695,S9(Phospho),1
0,-0.01,-1.00,-0.81,-0.59,-0.56,-0.30,-0.29,N-Term(iTRAQ8plex);S9(Phospho),14-3-3 domain binding motif;Calmodulin-dependent protein kinase II substrate motif;Calmodulin-dependent protein kinase IV substrate motif;Casein kinase II substrate motif;Chk1 kinase substrate motif;DNA dependent Protein kinase substrate motif;G protein-coupled receptor kinase 1 substrate motif;PKA kinase substrate motif;PKC kinase substrate motif,+,0.0003005,101,1,1,260000000,0,5.53,0,3.031688023,Neuroblast differentiation-associated protein AHNAK (Desmoyokin),LPSGSGAASPTGSAVDIR,KTVIRLPSGSGAASP,Q09666,AHNAK,S(3): 0.0;S(5): 0.0;S(9): 99.6;T(11): 0.3;S(13): 0.1,Q09666,S9(Phospho),1
0,0.15,1.01,1.09,0.80,0.79,1.06,0.93,N-Term(iTRAQ8plex);S9(Phospho),"14-3-3 domain binding motif;Calmodulin-dependent protein kinase II substrate motif;Calmodulin-dependent protein kinase IV substrate motif;Casein kinase II substrate motif;ERK1,2 kinase substrate motif;GSK-3, ERK1, ERK2, CDK5 substrate motif;PKA kinase substrate motif;PKC kinase substrate motif;WW domain binding motif",+,0.02036,4,1,1,12200000,0,3.65,0,3.177919404,RelA-associated inhibitor (Inhibitor of ASPP protein) (Protein iASPP) (NFkB-interacting protein 1) (PPP1R13B-like protein),LDVFARPASPSLQLLPWR,DVFARPASPSLQLLP,Q8WUF5,PPP1R13L,S(9): 95.8;S(11): 4.2,Q8WUF5,S9(Phospho),1
0,-0.30,-0.56,-0.51,0.85,0.43,-0.83,-0.84,C14(Carbamidomethyl);K15(iTRAQ8plex);N-Term(iTRAQ8plex);T10(Phospho),b-Adrenergic Receptor kinase substrate motif;Casein kinase II substrate motif;G protein-coupled receptor kinase 1 substrate motif,+,0.1039,2,1,1,1060000,0.002485,1.4,0,2.295527401,Coilin (p80-coilin),AFQLEEGEETEPDCK,QLEEGEETEPDCKYS,P38432,COIL,T(10): 100.0,P38432,T10(Phospho),1
0,-0.14,0.50,0.35,0.64,1.21,1.43,1.63,K11(iTRAQ8plex);K5(iTRAQ8plex);T10(Phospho),b-Adrenergic Receptor kinase substrate motif;G protein-coupled receptor kinase 1 substrate motif,+,0.02668,2,1,1,0,0,1.95,1,2.087275242,LisH domain-containing protein ARMC9 (Melanoma/melanocyte-specific tumor antigen KU-MEL-1) (NS21),ISYFKTYLETK,YFKTYLETKGAALSQ,Q7Z3E5,ARMC9,S(2): 0.1;Y(3): 0.4;T(6): 0.1;Y(7): 0.1;T(10): 99.3,Q7Z3E5,T10(Phospho),1
0,0.06,0.07,0.13,0.37,0.45,0.94,0.96,C2(Carbamidomethyl);N-Term(iTRAQ8plex);T10(Phospho),DNA dependent Protein kinase substrate motif,+,0.0159,44,1,1,99900000,0,4.58,0,4.060198182,Vinexin (SH3-containing adapter molecule 1) (SCAM-1) (Sorbin and SH3 domain-containing protein 3),LCDDGPQLPTSPR,DDGPQLPTSPRLTAA,O60504,SORBS3,T(10): 90.0;S(11): 10.0,O60504,T10(Phospho),1
0,0.28,-0.33,-0.44,0.31,0.22,-0.31,-0.26,N-Term(iTRAQ8plex);T10(Phospho),"Casein kinase II substrate motif;G protein-coupled receptor kinase 1 substrate motif;GSK-3, ERK1, ERK2, CDK5 substrate motif;MAPKAPK2 kinase substrate motif;MDC1 BRCT domain binding motif;Plk1 PBD domain binding motif;WW domain binding motif",+,0.0001548,43,1,1,156000000,0,4.42,0,1.956514239,"Spectrin beta chain, non-erythrocytic 1 (Beta-II spectrin) (Fodrin beta chain) (Spectrin, non-erythroid beta chain 1)",HEVSASTQSTPASSR,VSASTQSTPASSRAQ,Q01082,SPTBN1,S(4): 0.1;S(6): 1.9;T(7): 1.9;S(9): 12.2;T(10): 83.3;S(13): 0.3;S(14): 0.3,Q01082,T10(Phospho),1
0,0.12,0.29,0.31,0.36,0.49,0.57,0.48,N-Term(iTRAQ8plex);T10(Phospho),G protein-coupled receptor kinase 1 substrate motif,+,0.01391,19,1,1,99700000,0,3.82,0,2.059331864,RelA-associated inhibitor (Inhibitor of ASPP protein) (Protein iASPP) (NFkB-interacting protein 1) (PPP1R13B-like protein),SLGSAGPSGTLPR,GSAGPSGTLPRSWQP,Q8WUF5,PPP1R13L,S(1): 0.0;S(4): 0.0;S(8): 50.0;T(10): 50.0,Q8WUF5,T10(Phospho),1
0,0.17,0.66,0.62,0.47,0.59,0.54,0.45,N-Term(iTRAQ8plex);T10(Phospho),PKA kinase substrate motif;PKC kinase substrate motif,+,0.1045,2,1,1,0,0.006349,3.24,0,2.063748993,Leucine-rich repeat and calponin homology domain-containing protein 1 (Calponin homology domain-containing protein 1) (Neuronal protein 81) (NP81),NLESIDPQFTIR,ESIDPQFTIRRKMEQ,Q9Y2L9,LRCH1,S(4): 0.0;T(10): 100.0,Q9Y2L9,T10(Phospho),1
0,0.41,NaN,-1.87,-0.07,-0.07,-1.45,-2.17,N-Term(iTRAQ8plex);T11(Phospho),"Casein kinase II substrate motif;GSK-3, ERK1, ERK2, CDK5 substrate motif;PKA kinase substrate motif;PKC kinase substrate motif;WW domain binding motif",+,0.08661,2,1,1,1280000,0.003825,2.2,1,1.762824155,Cleavage and polyadenylation specificity factor subunit 7 (Cleavage and polyadenylation specificity factor 59 kDa subunit) (CFIm59) (CPSF 59 kDa subunit) (Pre-mRNA cleavage factor Im 59 kDa subunit),DSSDSADGRATPSENLVPSSAR,DSADGRATPSENLVP,Q8N684,CPSF7,S(2): 0.9;S(3): 0.9;S(5): 3.8;T(11): 90.7;S(13): 3.8;S(19): 0.0;S(20): 0.0,Q8N684,T11(Phospho),1
0,-0.25,-0.69,-0.72,-0.17,-0.27,-0.20,-0.19,K14(iTRAQ8plex);N-Term(iTRAQ8plex);T12(Phospho),"Growth associated histone HI kinase substrate motif;GSK-3, ERK1, ERK2, CDK5 substrate motif;MDC1 BRCT domain binding motif;PKA kinase substrate motif;PKC kinase substrate motif;Plk1 PBD domain binding motif;WW domain binding motif",+,0.01964,6,1,1,36000000,0,3.32,0,1.956748463,Brain acid soluble protein 1 (22 kDa neuronal tissue-enriched acidic protein) (Neuronal axonal membrane protein NAP-22),ETPAATEAPSSTPK,ATEAPSSTPKAQGPA,P80723,BASP1,T(2): 0.0;T(6): 0.2;S(10): 3.3;S(11): 3.3;T(12): 93.3,P80723,T12(Phospho),1
0,0.12,-1.25,-1.28,-0.36,-0.20,-0.12,-0.16,K15(iTRAQ8plex);K16(iTRAQ8plex);K17(iTRAQ8plex);N-Term(iTRAQ8plex);T13(Phospho),"Casein kinase II substrate motif;DNA dependent Protein kinase substrate motif;ERK1,2 kinase substrate motif;GSK-3, ERK1, ERK2, CDK5 substrate motif;WW domain binding motif",+,0.08606,2,1,1,37500000,0.008,3.13,2,3.758904734,"Myristoylated alanine-rich C-kinase substrate (MARCKS) (Protein kinase C substrate, 80 kDa protein, light chain) (80K-L protein) (PKCSL)",AEDGATPSPSNETPKKK,AEDGATPSPSNETPK,P29966,MARCKS,T(6): 18.0;S(8): 57.8;S(10): 6.2;T(13): 18.0,P29966,T13(Phospho),1
0,0.13,0.39,0.28,0.27,0.39,0.89,0.75,C8(Carbamidomethyl);K15(iTRAQ8plex);N-Term(iTRAQ8plex);T13(Phospho),"Growth associated histone HI kinase substrate motif;GSK-3, ERK1, ERK2, CDK5 substrate motif;PKA kinase substrate motif;PKC kinase substrate motif;WW domain binding motif",+,0.01462,38,1,1,72700000,0,4.71,0,2.334939409,Dihydropyrimidinase-related protein 2 (DRP-2) (Collapsin response mediator protein 2) (CRMP-2) (N2A3) (Unc-33-like phosphoprotein 2) (ULIP-2),GLYDGPVCEVSVTPK,PVCEVSVTPKTVTPA,Q16555,DPYSL2,Y(3): 0.0;S(11): 0.1;T(13): 99.9,Q16555,T13(Phospho),1
0,0.10,-1.11,-0.83,-0.09,-0.04,-0.15,-0.14,K15(iTRAQ8plex);N-Term(iTRAQ8plex);T13(Phospho),"b-Adrenergic Receptor kinase substrate motif;Cdc2 kinase substrate motif;CDK1,2,4,6 kinase substrate motif;CDK5 kinase substrate motif;Growth associated histone HI kinase substrate motif;GSK-3, ERK1, ERK2, CDK5 substrate motif;PKA kinase substrate motif;PKC kinase substrate motif;WW domain binding motif",+,0.003546,43,1,1,164000000,0,5.04,0,2.684979029,"Myristoylated alanine-rich C-kinase substrate (MARCKS) (Protein kinase C substrate, 80 kDa protein, light chain) (80K-L protein) (PKCSL)",AEDGATPSPSNETPK,TPSPSNETPKKKKKR,P29966,MARCKS,T(6): 0.0;S(8): 0.0;S(10): 0.0;T(13): 100.0,P29966,T13(Phospho),1
0,0.07,0.48,0.49,0.06,-0.08,0.62,0.64,N-Term(iTRAQ8plex);T13(Phospho),Casein kinase II substrate motif;DNA dependent Protein kinase substrate motif,+,0.02338,10,1,1,19900000,0,4.09,0,3.095128649,General transcription factor 3C polypeptide 2 (TF3C-beta) (Transcription factor IIIC 110 kDa subunit) (TFIIIC 110 kDa subunit) (TFIIIC110) (Transcription factor IIIC subunit beta),AHFNAMFQPSSPTR,FNAMFQPSSPTRRPG,Q8WUA4,GTF3C2,S(10): 10.2;S(11): 79.6;T(13): 10.2,Q8WUA4,T13(Phospho),1
0,-0.19,0.71,1.00,0.15,0.05,0.82,0.77,C2(Carbamidomethyl);K23(iTRAQ8plex);M12(Oxidation);T14(Phospho),Casein kinase I substrate motif;Casein kinase II substrate motif;G protein-coupled receptor kinase 1 substrate motif,+,0.01259,4,3,1,210000,0,3.48,0,2.425957508,"Actin, cytoplasmic 1 (Beta-actin) [Cleaved into: Actin, cytoplasmic 1, N-terminally processed]",LCYVALDFEQEMATAASSSSLEK,DFEQEMATAASSSSL,P60709,ACTB,Y(3): 10.6;T(14): 89.1;S(17): 0.2;S(18): 0.0;S(19): 0.0;S(20): 0.0,P60709,T14(Phospho),1
0,-0.27,0.66,0.90,0.41,0.23,1.14,1.09,C2(Carbamidomethyl);K23(iTRAQ8plex);M12(Oxidation);T14(Phospho),Casein kinase I substrate motif;Casein kinase II substrate motif;G protein-coupled receptor kinase 1 substrate motif,+,0.08804,4,4,1,12700,0,3.63,0,2.436627666,"Actin, alpha cardiac muscle 1 (Alpha-cardiac actin)",LCYVALDFENEMATAASSSSLEK,DFENEMATAASSSSL,P68032,ACTC1,Y(3): 15.8;T(14): 83.2;S(17): 0.7;S(18): 0.2;S(19): 0.0;S(20): 0.0,P68032,T14(Phospho),1
0,0.11,-1.12,-1.02,-1.31,-1.77,-1.92,-2.20,K15(iTRAQ8plex);N-Term(iTRAQ8plex);T14(Phospho),,+,0.06328,2,1,1,0,0.001537,3.09,1,2.75090432,Neuroendocrine convertase 2 (NEC 2) (EC 3.4.21.94) (KEX2-like endoprotease 2) (Prohormone convertase 2) (Proprotein convertase 2) (PC2),RGDLNINMTSPMGTK,GDLNINMTSPMGTKS,P16519,PCSK2,T(9): 33.3;S(10): 33.3;T(14): 33.3,P16519,T14(Phospho),1
0,0.00,0.90,0.93,0.13,-0.06,1.17,1.24,C29(Carbamidomethyl);K36(iTRAQ8plex);N-Term(iTRAQ8plex);T15(Phospho),Casein kinase II substrate motif;DNA dependent Protein kinase substrate motif;PKA kinase substrate motif,+,2.15E-05,51,1,1,14900000,0,7.42,0,3.800065947,Heterogeneous nuclear ribonucleoprotein K (hnRNP K) (Transformation up-regulated nuclear protein) (TUNP),IIPTLEEGLQLPSPTATSQLPLESDAVECLNYQHYK,ILKKIIPTLEEGLQL,P61978,HNRNPK,T(4): 55.7;S(13): 13.6;T(15): 13.6;T(17): 13.6;S(18): 3.4;S(24): 0.1;Y(32): 0.0;Y(35): 0.0,P61978,T15(Phospho),1
0,-0.25,0.59,0.74,0.99,0.92,0.29,0.46,K23(iTRAQ8plex);M10(Oxidation);T17(Phospho),G protein-coupled receptor kinase 1 substrate motif,+,0.1076,2,1,1,0,0.006349,2.83,0,2.434407374,Transmembrane protein 132C,DLVGIVPLAMDTEILNTAVLTGK,MDTEILNTAVLTGKT,Q8N3T6,TMEM132C,T(12): 1.1;T(17): 49.5;T(21): 49.5,Q8N3T6,T17(Phospho),1
0,0.41,1.07,1.01,-0.36,-0.72,-1.14,-0.75,K21(iTRAQ8plex);N-Term(iTRAQ8plex);T17(Phospho),"GSK-3, ERK1, ERK2, CDK5 substrate motif;WW domain binding motif",+,0.000401,2,1,1,1990000,0,3.92,0,2.395095294,Casein kinase I isoform alpha (CKI-alpha) (EC 2.7.11.1) (CK1),AAQQAASSSGQGQQAQTPTGK,GQGQQAQTPTGKQTD,P48729,CSNK1A1,S(7): 0.0;S(8): 0.0;S(9): 0.0;T(17): 99.9;T(19): 0.0,P48729,T17(Phospho),1
0,-0.15,-1.37,-1.54,-0.64,-0.58,-0.50,-0.53,K6(iTRAQ8plex);N-Term(iTRAQ8plex);T2(Phospho),PKA kinase substrate motif;PKC kinase substrate motif,+,0.3057,2,1,1,0,0.004,2.11,0,3.422444254,Complexin-4 (Complexin IV) (CPX IV),QTAEQK,TFTEIKQTAEQKCSV,Q7Z7G2,CPLX4,,Q7Z7G2,T2(Phospho),1
0,-0.34,2.29,2.12,1.72,1.69,0.60,0.20,K7(iTRAQ8plex);T2(Phospho),G protein-coupled receptor kinase 1 substrate motif;PKA kinase substrate motif;PKC kinase substrate motif,+,0.07981,4,1,1,24000000,0.001788,1.48,0,3.119470386,Mucin-16 (MUC-16) (Ovarian cancer-related tumor marker CA125) (CA-125) (Ovarian carcinoma antigen CA125),LTLLRPK,LYSGCRLTLLRPKKD,Q8WXI7,MUC16,T(2): 100.0,Q8WXI7,T2(Phospho),1
0,0.04,-1.81,-1.74,0.28,-0.06,-0.48,-0.53,N-Term(iTRAQ8plex);T2(Phospho),Calmodulin-dependent protein kinase II substrate motif;G protein-coupled receptor kinase 1 substrate motif;PKA kinase substrate motif;PKC kinase substrate motif,+,0.02744,4,1,1,583000000,0,4.18,2,3.473750966,Luc7-like protein 3 (Cisplatin resistance-associated-overexpressed protein) (Luc7A) (Okadaic acid-inducible phosphoprotein OA48-18) (cAMP regulatory element-associated protein 1) (CRE-associated protein 1) (CREAP-1),RTEEPDRDER,KEKLRKRTEEPDRDE,O95232,LUC7L3,T(2): 100.0,O95232,T2(Phospho),1
0,0.16,0.69,0.44,-1.47,-1.56,-1.55,-1.58,K13(iTRAQ8plex);N-Term(iTRAQ8plex);T20(Phospho),"GSK-3, ERK1, ERK2, CDK5 substrate motif;WW domain binding motif",+,0.00863,59,1,1,3440000000,0,5.55,0,4.075357673,Protein S100-A9 (Calgranulin-B) (Calprotectin L1H subunit) (Leukocyte L1 complex heavy chain) (Migration inhibitory factor-related protein 14) (MRP-14) (p14) (S100 calcium-binding protein A9),MHEGDEGPGHHHKPGLGEGTP,KPGLGEGTP______,P06702,S100A9,T(20): 100.0,P06702,T20(Phospho),1
0,0.02,-1.17,-1.44,0.43,-0.13,-0.45,-0.63,K12(iTRAQ8plex);K2(iTRAQ8plex);N-Term(iTRAQ8plex);T3(Phospho),"G protein-coupled receptor kinase 1 substrate motif;Growth associated histone HI kinase substrate motif;GSK-3, ERK1, ERK2, CDK5 substrate motif;PKA kinase substrate motif;PKC kinase substrate motif;WW domain binding motif",+,0.05932,2,1,1,115000000,0.001547,2.25,1,2.010953786,Serine/arginine repetitive matrix protein 1 (SR-related nuclear matrix protein of 160 kDa) (SRm160) (Ser/Arg-related nuclear matrix protein),EKTPELPEPSVK,APEKKEKTPELPEPS,Q8IYB3,SRRM1,T(3): 100.0;S(10): 0.0,Q8IYB3,T3(Phospho),1
0,-0.24,1.56,1.97,0.34,0.22,-0.14,0.67,K4(iTRAQ8plex);K6(iTRAQ8plex);N-Term(iTRAQ8plex);T3(Phospho),Calmodulin-dependent protein kinase II substrate motif;Calmodulin-dependent protein kinase IV substrate motif;Chk1 kinase substrate motif;PKC kinase substrate motif,+,0.1149,12,1,1,925000,0.00315,1.11,0,1.76396807,Developmentally-regulated GTP-binding protein 1 (DRG-1) (Neural precursor cell expressed developmentally down-regulated protein 3) (NEDD-3),IYTKPK,LKLVRIYTKPKGQLP,Q9Y295,DRG1,Y(2): 0.3;T(3): 99.7,Q9Y295,T3(Phospho),1
0,0.54,-0.35,-0.40,0.88,1.29,1.04,0.88,K10(iTRAQ8plex);N-Term(iTRAQ8plex);T3(Phospho),AMP-activated protein kinase substrate motif;PKA kinase substrate motif;PKC kinase substrate motif,+,0.01532,26,1,1,152000000,0,3.27,0,1.920405661,Neuroblast differentiation-associated protein AHNAK (Desmoyokin),FGTFGGLGSK,HGKLKFGTFGGLGSK,Q09666,AHNAK,T(3): 100.0;S(9): 0.0,Q09666,T3(Phospho),1
0,0.20,0.95,1.54,1.42,1.24,1.53,1.59,K14(iTRAQ8plex);N-Term(iTRAQ8plex);T3(Phospho),Casein kinase II substrate motif,+,0.0206,7,1,1,14000000,0,4.39,0,1.961313261,TSC22 domain family protein 4 (TSC22-related-inducible leucine zipper protein 2) (Tsc-22-like protein THG-1),SFTGGLGQLVVPSK,SPGPQARSFTGGLGQ,Q9Y3Q8,TSC22D4,S(1): 50.0;T(3): 50.0;S(13): 0.0,Q9Y3Q8,T3(Phospho),1
0,-0.01,0.93,1.15,0.62,0.60,1.11,1.15,K9(iTRAQ8plex);N-Term(iTRAQ8plex);T3(Phospho),"Casein kinase II substrate motif;G protein-coupled receptor kinase 1 substrate motif;GSK-3, ERK1, ERK2, CDK5 substrate motif;PKA kinase substrate motif;PKC kinase substrate motif;WW domain binding motif",+,0.01713,55,1,1,1250000000,0,3.47,0,3.368377387,Dihydropyrimidinase-related protein 2 (DRP-2) (Collapsin response mediator protein 2) (CRMP-2) (N2A3) (Unc-33-like phosphoprotein 2) (ULIP-2),TVTPASSAK,SVTPKTVTPASSAKT,Q16555,DPYSL2,T(1): 0.0;T(3): 100.0;S(6): 0.0;S(7): 0.0,Q16555,T3(Phospho),1
0,0.01,-0.64,-0.65,0.19,0.17,0.18,0.07,N-Term(iTRAQ8plex);T3(Phospho),"Calmodulin-dependent protein kinase II substrate motif;G protein-coupled receptor kinase 1 substrate motif;GSK-3, ERK1, ERK2, CDK5 substrate motif;MAPKAPK2 kinase substrate motif;MDC1 BRCT domain binding motif;PKC kinase substrate motif;Plk1 PBD domain binding motif;WW domain binding motif",+,0.02868,55,2,1,141000000,0,3.76,0,3.939615548,"Lamina-associated polypeptide 2, isoform alpha (Thymopoietin isoform alpha) (TP alpha) (Thymopoietin-related peptide isoform alpha) (TPRP isoform alpha) [Cleaved into: Thymopoietin (TP) (Splenin);Thymopentin (TP5)]",SSTPLPTISSSAENTR,GTESRSSTPLPTISS,P42166,TMPO,S(1): 0.0;S(2): 1.7;T(3): 82.9;T(7): 11.6;S(9): 1.7;S(10): 1.7;S(11): 0.3;T(15): 0.0,P42166,T3(Phospho),1
0,0.15,-1.06,-0.63,0.56,0.48,0.04,0.22,N-Term(iTRAQ8plex);T3(Phospho),"Growth associated histone HI kinase substrate motif;GSK-3, ERK1, ERK2, CDK5 substrate motif;PKA kinase substrate motif;PKC kinase substrate motif;WW domain binding motif",+,0.0933,2,1,1,17400000,0.009,2.12,1,2.217427307,Microtubule-associated protein 1B (MAP-1B) [Cleaved into: MAP1B heavy chain;MAP1 light chain LC1],SRTPVQDHR,PKTAKSRTPVQDHRS,P46821,MAP1B,S(1): 12.1;T(3): 87.9,P46821,T3(Phospho),1
0,-0.07,-0.50,-0.55,0.45,0.63,0.34,0.38,N-Term(iTRAQ8plex);T3(Phospho),"G protein-coupled receptor kinase 1 substrate motif;GSK-3, ERK1, ERK2, CDK5 substrate motif;PKA kinase substrate motif;PKC kinase substrate motif;WW domain binding motif",+,7.58E-05,12,1,1,33600000,0,4.89,0,3.364619834,Src substrate cortactin (Amplaxin) (Oncogene EMS1),TQTPPVSPAPQPTEER,QARAKTQTPPVSPAP,Q14247,CTTN,T(1): 0.0;T(3): 100.0;S(7): 0.0;T(13): 0.0,Q14247,T3(Phospho),1
0,0.01,-0.50,-0.39,-0.02,-0.22,0.03,-0.04,N-Term(iTRAQ8plex);T3(Phospho),Casein kinase II substrate motif;PKA kinase substrate motif;PKC kinase substrate motif,+,0.0349,12,1,1,21300000,0,2.89,0,1.817175346,Polymerase I and transcript release factor (Cavin-1),SFTPDHVVYAR,SRDKLRKSFTPDHVV,Q6NZI2,PTRF,S(1): 92.7;T(3): 7.3;Y(9): 0.0,Q6NZI2,T3(Phospho),1
0,0.35,-1.32,-1.08,-0.47,-0.23,-0.39,-0.30,N-Term(iTRAQ8plex);T3(Phospho),Akt kinase substrate motif;Calmodulin-dependent protein kinase II substrate motif;G protein-coupled receptor kinase 1 substrate motif;MAPKAPK2 kinase substrate motif;PKC kinase substrate motif,+,0.0772,5,1,1,14400000,0.008,1.86,0,2.172786438,Protein NDRG1 (Differentiation-related gene 1 protein) (DRG-1) (N-myc downstream-regulated gene 1 protein) (Nickel-specific induction protein Cap43) (Reducing agents and tunicamycin-responsive protein) (RTP) (Rit42),SHTSEGTR,GTRSRSHTSEGTRSR,Q92597,NDRG1,S(1): 15.8;T(3): 76.5;S(4): 3.9;T(7): 3.9,Q92597,T3(Phospho),1
0,0.01,0.84,0.78,-0.78,-1.64,0.81,0.58,N-Term(iTRAQ8plex);T3(Phospho),"Calmodulin-dependent protein kinase II substrate motif;DNA dependent Protein kinase substrate motif;GSK-3, ERK1, ERK2, CDK5 substrate motif;PKC kinase substrate motif;WW domain binding motif",+,0.1382,2,1,1,41800000,0.005792,1.13,0,2.012810211,RNA-binding protein 14 (Paraspeckle protein 2) (PSP2) (RNA-binding motif protein 14) (RRM-containing coactivator activator/modulator) (Synaptotagmin-interacting protein) (SYT-interacting protein),QPTPPFFGR,DGQARQPTPPFFGRD,Q96PK6,RBM14,T(3): 100.0,Q96PK6,T3(Phospho),1
0,0.11,-0.40,-0.38,0.34,0.36,-0.01,0.06,N-Term(iTRAQ8plex);T3(Phospho),"14-3-3 domain binding motif;Akt kinase substrate motif;Calmodulin-dependent protein kinase II substrate motif;Casein kinase II substrate motif;G protein-coupled receptor kinase 1 substrate motif;Growth associated histone HI kinase substrate motif;GSK-3, ERK1, ERK2, CDK5 substrate motif;PKC kinase substrate motif;WW domain binding motif",+,0.09572,8,1,1,304000000,0.001958,2.4,1,3.288990757,Serine/arginine repetitive matrix protein 2 (300 kDa nuclear matrix antigen) (Serine/arginine-rich splicing factor-related nuclear matrix protein of 300 kDa) (SR-related nuclear matrix protein of 300 kDa) (Ser/Arg-related nuclear matrix protein of 300 kDa) (Splicing coactivator subunit SRm300) (Tax-responsive enhancer element-binding protein 803) (TaxREB803),SRTPPSAPSQSR,LDRARSRTPPSAPSQ,Q9UQ35,SRRM2,S(1): 14.2;T(3): 85.8;S(6): 0.0;S(9): 0.0;S(11): 0.0,Q9UQ35,T3(Phospho),1
0,0.11,0.78,0.85,-2.81,-2.93,-2.86,-3.86,K11(iTRAQ8plex);K6(iTRAQ8plex);N-Term(iTRAQ8plex);T4(Phospho),Casein kinase II substrate motif,+,0.1764,2,1,1,40800000,0.005886,1.7,1,3.158965112,Tumor protein D52 (Protein N8),NSPTFKSFEEK,KNSPTFKSFEEKVEN,P55327,TPD52,S(2): 0.4;T(4): 13.1;S(7): 86.5,P55327,T4(Phospho),1
0,0.30,NaN,-1.91,-1.56,-0.97,-3.05,-2.67,K7(iTRAQ8plex);N-Term(iTRAQ8plex);T4(Phospho),"Cdc2 kinase substrate motif;CDK1,2,4,6 kinase substrate motif;CDK5 kinase substrate motif;GSK-3, ERK1, ERK2, CDK5 substrate motif;PKA kinase substrate motif;WW domain binding motif",+,0.02563,12,1,1,103000000,0,1.79,0,2.268630241,Nucleolin (Protein C23),AAVTPGK,PAKKAAVTPGKKAAA,P19338,NCL,T(4): 100.0,P19338,T4(Phospho),1
0,0.03,NaN,-1.73,-1.26,-1.02,-2.10,-2.05,K7(iTRAQ8plex);N-Term(iTRAQ8plex);T4(Phospho),"Cdc2 kinase substrate motif;CDK1,2,4,6 kinase substrate motif;CDK5 kinase substrate motif;Growth associated histone HI kinase substrate motif;GSK-3, ERK1, ERK2, CDK5 substrate motif;WW domain binding motif",+,0.04754,12,1,1,121000000,0.0002738,1.49,0,3.232922776,Nucleolin (Protein C23),AAAtPAK,SGRAAATTPTKVYSE,P19338,NCL,T(4): 100.0,P19338,T4(Phospho),1
0,0.13,0.56,0.77,1.55,1.36,1.53,1.49,K22(iTRAQ8plex);T4(Phospho),Casein kinase I substrate motif;PKA kinase substrate motif,+,0.0327,4,1,1,598000,0.001,2.71,0,3.226080017,Periostin (PN) (Osteoblast-specific factor 2) (OSF-2),DIVTNNGVIHLIDQVLIPDSAK,VNKKDIVTNNGVIHL,Q15063,POSTN,T(4): 100.0;S(20): 0.0,Q15063,T4(Phospho),1
0,0.13,0.91,1.31,0.57,0.42,1.06,1.12,K23(iTRAQ8plex);T4(Phospho),PKA kinase substrate motif;PKC kinase substrate motif,+,0.2387,2,1,1,0,0.006394,2.05,1,2.18729311,Zinc finger protein 62 homolog (Zfp-62),RTHTGEESLNVIYVGSYSGTSQK,NLTKHKRTHTGEESL,Q8NB50,ZFP62,T(2): 82.3;T(4): 14.7;S(8): 2.8;Y(13): 0.1;S(16): 0.0;Y(17): 0.0;S(18): 0.0;T(20): 0.0;S(21): 0.0,Q8NB50,T4(Phospho),1
0,-0.09,-0.47,-0.46,0.04,-0.01,0.06,0.00,K8(iTRAQ8plex);T4(Phospho),Casein kinase II substrate motif;MAPKAPK2 kinase substrate motif;PKA kinase substrate motif;PKC kinase substrate motif,+,0.06412,2,1,1,0,0.008,2.29,0,3.099648801,Microtubule-associated protein 4 (MAP-4),VGSTENIK,NVRSKVGSTENIKHQ,P27816,MAP4,,P27816,T4(Phospho),1
0,0.20,-1.50,-1.46,0.39,0.29,-0.72,-1.00,N-Term(iTRAQ8plex);T4(Phospho),PKA kinase substrate motif,+,0.1852,4,1,1,2170000000,0.00691,2.58,1,3.368913008,STE20-like serine/threonine-protein kinase (STE20-like kinase) (hSLK) (EC 2.7.11.1) (CTCL tumor antigen se20-9) (STE20-related serine/threonine-protein kinase) (STE20-related kinase) (Serine/threonine-protein kinase 2),NTRTIQR,VSAKNTRTIQRRDSF,Q9H2G2,SLK,T(2): 2.3;T(4): 97.7,Q9H2G2,T4(Phospho),1
0,0.23,-0.61,-0.39,0.74,0.46,0.02,0.11,K1(iTRAQ8plex);K10(iTRAQ8plex);N-Term(iTRAQ8plex);T5(Phospho),"GSK-3, ERK1, ERK2, CDK5 substrate motif;PKA kinase substrate motif;WW domain binding motif",+,0.1789,2,1,1,158000000,0.0081,1.25,1,2.031368663,Ribosome-binding protein 1 (180 kDa ribosome receptor homolog) (RRp) (ES/130-related protein) (Ribosome receptor protein),KAEGTPNQGK,QGRKAEGTPNQGKKT,Q9P2E9,RRBP1,T(5): 100.0,Q9P2E9,T5(Phospho),1
0,0.18,0.93,1.01,0.33,0.16,0.10,0.12,K11(iTRAQ8plex);N-Term(iTRAQ8plex);T5(Phospho),,+,0.01039,34,3,1,31600000,0,3.98,0,2.741177523,Cyclin-dependent kinase 1 (CDK1) (EC 2.7.11.22) (EC 2.7.11.23) (Cell division control protein 2 homolog) (Cell division protein kinase 1) (p34 protein kinase),IGEGTYGVVYK,VEKIGEGTYGVVYKA,P06493,CDK1,T(5): 91.6;Y(6): 8.4;Y(10): 0.0,P06493,T5(Phospho),1
0,-0.19,-2.99,-2.63,0.00,-0.18,-1.17,-0.58,K11(iTRAQ8plex);N-Term(iTRAQ8plex);T5(Phospho),b-Adrenergic Receptor kinase substrate motif,+,0.04443,4,1,1,18000000,0,1.89,0,2.862337645,Exosome complex component RRP45 (Autoantigen PM/Scl 1) (Exosome component 9) (P75 polymyositis-scleroderma overlap syndrome-associated autoantigen) (Polymyositis/scleroderma autoantigen 1) (Polymyositis/scleroderma autoantigen 75 kDa) (PM/Scl-75),APIDTSDVEEK,MEKAPIDTSDVEEKA,Q06265,EXOSC9,T(5): 50.0;S(6): 50.0,Q06265,T5(Phospho),1
0,0.08,-0.79,-0.69,-0.38,-0.33,-0.01,-0.07,K16(iTRAQ8plex);N-Term(iTRAQ8plex);T5(Phospho),"b-Adrenergic Receptor kinase substrate motif;Casein kinase I substrate motif;GSK-3, ERK1, ERK2, CDK5 substrate motif;WW domain binding motif",+,0.000836,28,1,1,92600000,0,6.1,0,3.433492109,Neuroblast differentiation-associated protein AHNAK (Desmoyokin),VDIDTPDIDIHGPEGK,GPKVDIDTPDIDIHG,Q09666,AHNAK,T(5): 100.0,Q09666,T5(Phospho),1
0,0.04,-0.25,-0.35,-0.34,-0.20,0.00,-0.05,K16(iTRAQ8plex);N-Term(iTRAQ8plex);T5(Phospho),"b-Adrenergic Receptor kinase substrate motif;Casein kinase I substrate motif;GSK-3, ERK1, ERK2, CDK5 substrate motif;WW domain binding motif",+,0.0006192,20,1,1,77100000,0,5.85,0,1.770034498,Neuroblast differentiation-associated protein AHNAK (Desmoyokin),VDIDTPDINIEGSEGK,GPKVDIDTPDIDIHG,Q09666,AHNAK,T(5): 100.0;S(13): 0.0,Q09666,T5(Phospho),1
0,0.07,-0.63,-0.57,-0.42,-0.16,-0.07,0.00,K16(iTRAQ8plex);N-Term(iTRAQ8plex);T5(Phospho),"b-Adrenergic Receptor kinase substrate motif;GSK-3, ERK1, ERK2, CDK5 substrate motif;WW domain binding motif",+,0.00127,10,1,1,16400000,0,4.79,0,2.010635518,Neuroblast differentiation-associated protein AHNAK (Desmoyokin),VGIDTPDIDIHGPEGK,GPKVGIDTPDIDIHG,Q09666,AHNAK,T(5): 100.0,Q09666,T5(Phospho),1
0,0.01,-1.20,-0.82,0.20,-0.21,0.13,0.10,K18(iTRAQ8plex);N-Term(iTRAQ8plex);T5(Phospho),"Casein kinase I substrate motif;GSK-3, ERK1, ERK2, CDK5 substrate motif;WW domain binding motif",+,0.01819,6,1,1,22400000,0,3.1,0,1.869195737,Neuroblast differentiation-associated protein AHNAK (Desmoyokin),VDINTPDVDVHGPDWHLK,GPKVDINTPDVDVHG,Q09666,AHNAK,T(5): 100.0,Q09666,T5(Phospho),1
0,0.11,-2.85,-3.20,-0.20,-0.38,-1.41,-1.45,K8(iTRAQ8plex);N-Term(iTRAQ8plex);T5(Phospho),"b-Adrenergic Receptor kinase substrate motif;Cdc2 kinase substrate motif;CDK1,2,4,6 kinase substrate motif;CDK5 kinase substrate motif;GSK-3, ERK1, ERK2, CDK5 substrate motif;MAPKAPK2 kinase substrate motif;PKA kinase substrate motif;PKC kinase substrate motif;WW domain binding motif",+,0.1273,12,1,1,2110000000,0.003056,2.41,1,3.999141225,Nucleophosmin (NPM) (Nucleolar phosphoprotein B23) (Nucleolar protein NO38) (Numatrin),SIRDTPAK,VKKSIRDTPAKNAQK,P06748,NPM1,S(1): 0.1;T(5): 99.9,P06748,T5(Phospho),1
0,0.17,-0.17,-0.20,-0.38,-0.43,-0.19,-0.33,K8(iTRAQ8plex);N-Term(iTRAQ8plex);T5(Phospho),"Cdc2 kinase substrate motif;CDK1,2,4,6 kinase substrate motif;CDK5 kinase substrate motif;GSK-3, ERK1, ERK2, CDK5 substrate motif;WW domain binding motif",+,0.06072,5,1,1,76500000,0.001645,2.36,0,1.802282413,Nucleolin (Protein C23),VAVATPAK,TKKVAVATPAKKAAV,P19338,NCL,T(5): 100.0,P19338,T5(Phospho),1
0,0.17,0.47,0.99,3.55,3.39,3.97,4.16,K8(iTRAQ8plex);N-Term(iTRAQ8plex);T5(Phospho),,+,0.07591,58,1,1,665000000,0.002392,2.59,0,3.936033839,Synaptopodin,AAATTPTK,MSGRAAATTPTKVYS,Q8N3V7,SYNPO,T(4): 99.6;T(5): 0.4;T(7): 0.0,Q8N3V7,T5(Phospho),1
0,0.11,1.38,1.32,0.97,0.59,0.36,0.40,N-Term(iTRAQ8plex);T5(Phospho),14-3-3 domain binding motif;Akt kinase substrate motif;Calmodulin-dependent protein kinase II substrate motif;Casein kinase II substrate motif;MAPKAPK1 kinase substrate motif;Pim1 kinase substrate sequence;PKA kinase substrate motif;PKC epsilon kinase substrate motif;PKC kinase substrate motif,+,0.01889,6,1,1,761000,0,4.44,1,2.470814398,Nuclear inhibitor of protein phosphatase 1 (NIPP-1) (Protein phosphatase 1 regulatory inhibitor subunit 8) [Includes: Activator of RNA decay (EC 3.1.4.-) (ARD-1)],NSRVTFSEDDEIINPEDVDPSVGR,PKRKRKNSRVTFSED,Q12972,PPP1R8,S(2): 45.0;T(5): 45.0;S(7): 9.9;S(21): 0.0,Q12972,T5(Phospho),1
0,0.13,0.22,0.20,-0.03,0.05,0.37,0.40,N-Term(iTRAQ8plex);T5(Phospho),Casein kinase II substrate motif,+,0.03871,7,1,1,24800000,0,3.44,0,2.061175535,Abl interactor 2 (Abelson interactor 2) (Abi-2) (Abl-binding protein 3) (AblBP3) (Arg-binding protein 1) (ArgBP1),HTPPTIGGSLPYR,TPPTIGGSLPYRRPP,Q9NYB9,ABI2,T(2): 0.0;T(5): 1.6;S(9): 86.9;Y(12): 11.4,Q9NYB9,T5(Phospho),1
0,0.02,-0.39,-0.48,-0.01,0.01,0.03,-0.06,N-Term(iTRAQ8plex);T5(Phospho),"ERK1,2 kinase substrate motif;Growth associated histone HI kinase substrate motif;GSK3, Erk1, Erk2 and CDK5 kinase motif;GSK-3, ERK1, ERK2, CDK5 substrate motif;PKA kinase substrate motif;PKC kinase substrate motif;WW domain binding motif",+,0.1254,2,1,1,264000000,0.006093,2.07,0,2.768373192,Serine/arginine repetitive matrix protein 2 (300 kDa nuclear matrix antigen) (Serine/arginine-rich splicing factor-related nuclear matrix protein of 300 kDa) (SR-related nuclear matrix protein of 300 kDa) (Ser/Arg-related nuclear matrix protein of 300 kDa) (Splicing coactivator subunit SRm300) (Tax-responsive enhancer element-binding protein 803) (TaxREB803),ALPQTPRPR,EPKALPQTPRPRSRS,Q9UQ35,SRRM2,T(5): 100.0,Q9UQ35,T5(Phospho),1
0,-0.24,-0.47,-0.46,1.21,0.99,0.62,0.74,C7(Carbamidomethyl);K13(iTRAQ8plex);N-Term(iTRAQ8plex);T6(Phospho),Casein kinase II substrate motif,+,0.07297,4,1,1,6680000,0.00339,1.62,0,3.158616268,Vimentin,QVQSLTCEVDALK,EYRRQVQSLTCEVDA,P08670,VIM,S(4): 50.0;T(6): 50.0,P08670,T6(Phospho),1
0,0.10,-0.25,-0.75,-1.11,-0.94,0.97,1.02,K14(iTRAQ8plex);K25(iTRAQ8plex);N-Term(iTRAQ8plex);T6(Phospho),Casein kinase II substrate motif,+,0.03757,8,1,1,0,0.002,2.56,1,2.734050425,Neuroblast differentiation-associated protein AHNAK (Desmoyokin),GHYEVTGSDDETGKLQGSGVSLASK,KLQGSGVSLASKKSR,Q09666,AHNAK,Y(3): 0.0;T(6): 4.9;S(8): 1.3;T(12): 1.3;S(18): 0.1;S(21): 87.5;S(24): 4.9,Q09666,T6(Phospho),1
0,0.02,-1.00,-0.93,-0.12,-0.10,-0.39,-0.28,K1(iTRAQ8plex);K8(iTRAQ8plex);N-Term(iTRAQ8plex);T6(Phospho),"Cdc2 kinase substrate motif;CDK1,2,4,6 kinase substrate motif;CDK5 kinase substrate motif;G protein-coupled receptor kinase 1 substrate motif;Growth associated histone HI kinase substrate motif;GSK-3, ERK1, ERK2, CDK5 substrate motif;PKA kinase substrate motif;PKC kinase substrate motif;WW domain binding motif",+,0.2831,2,1,1,0,0.003,2.49,0,3.944831813,Histone H1.5 (Histone H1a) (Histone H1b) (Histone H1s-3),KPAGATPK,AKKPAGATPKKAKKA,P16401,HIST1H1B,,P16401,T6(Phospho),1
0,0.14,-1.26,-0.91,0.55,0.13,0.00,-0.21,K13(iTRAQ8plex);K8(iTRAQ8plex);N-Term(iTRAQ8plex);T6(Phospho),"Casein kinase II substrate motif;ERK1,2 kinase substrate motif;Growth associated histone HI kinase substrate motif;GSK-3, ERK1, ERK2, CDK5 substrate motif;Pyruvate dehydrogenase kinase substrate motif;WW domain binding motif",+,0.03919,6,1,1,82400000,0,2.23,1,2.027891748,Nuclear autoantigenic sperm protein (NASP),VAQGATEKSPEDK,AQGATEKSPEDKVQI,P49321,NASP,T(6): 0.2;S(9): 99.8,P49321,T6(Phospho),1
0,0.04,0.82,0.86,0.36,0.42,0.59,0.68,K17(iTRAQ8plex);N-Term(iTRAQ8plex);T6(Phospho),14-3-3 domain binding motif;Calmodulin-dependent protein kinase II substrate motif;Casein kinase II substrate motif;PKA kinase substrate motif;PKC kinase substrate motif;ZIP kinase substrate motif,+,0.03534,6,1,1,8140000,0,3.88,0,3.718818365,AP2-associated protein kinase 1 (EC 2.7.11.1) (Adaptor-associated kinase 1),ILSDVTHSAVFGVPASK,AGHRRILSDVTHSAV,Q2M2I8,AAK1,S(3): 87.4;T(6): 12.4;S(8): 0.3;S(16): 0.0,Q2M2I8,T6(Phospho),1
0,0.02,-0.90,-0.98,0.59,0.43,-0.17,-0.19,K8(iTRAQ8plex);N-Term(iTRAQ8plex);T6(Phospho),"Cdc2 kinase substrate motif;CDK1,2,4,6 kinase substrate motif;CDK5 kinase substrate motif;G protein-coupled receptor kinase 1 substrate motif;Growth associated histone HI kinase substrate motif;GSK-3, ERK1, ERK2, CDK5 substrate motif;PKA kinase substrate motif;PKC kinase substrate motif;WW domain binding motif",+,0.03776,78,1,1,1980000000,0,3.1,0,4.029206418,Histone H1.4 (Histone H1b) (Histone H1s-4),ATGAATPK,KKATGAATPKKSAKK,P10412,HIST1H1E,T(2): 0.0;T(6): 100.0,P10412,T6(Phospho),1
0,0.07,-1.33,-0.77,0.41,0.18,-0.15,-0.34,K8(iTRAQ8plex);N-Term(iTRAQ8plex);T6(Phospho),"Cdc2 kinase substrate motif;CDK1,2,4,6 kinase substrate motif;CDK5 kinase substrate motif;G protein-coupled receptor kinase 1 substrate motif;Growth associated histone HI kinase substrate motif;GSK-3, ERK1, ERK2, CDK5 substrate motif;PKA kinase substrate motif;PKC kinase substrate motif;WW domain binding motif",+,0.01097,46,1,1,769000000,0,3.36,0,1.830307572,Histone H1.3 (Histone H1c) (Histone H1s-2),VAGAATPK,KKVAGAATPKKSIKK,P16402,HIST1H1D,T(6): 100.0,P16402,T6(Phospho),1
0,0.13,-0.67,-0.51,0.35,0.25,0.21,0.22,K8(iTRAQ8plex);N-Term(iTRAQ8plex);T6(Phospho),"Cdc2 kinase substrate motif;CDK1,2,4,6 kinase substrate motif;CDK5 kinase substrate motif;G protein-coupled receptor kinase 1 substrate motif;Growth associated histone HI kinase substrate motif;GSK-3, ERK1, ERK2, CDK5 substrate motif;PKA kinase substrate motif;PKC kinase substrate motif;WW domain binding motif",+,0.02932,33,1,1,1590000000,0,3.38,0,2.860806345,Histone H1.2 (Histone H1c) (Histone H1d) (Histone H1s-1),AAGGATPK,KKAAGGATPKKSAKK,P16403,HIST1H1C,T(6): 100.0,P16403,T6(Phospho),1
0,-0.25,0.71,1.08,0.16,-0.07,0.73,0.94,K17(iTRAQ8plex);T6(Phospho),,+,0.1374,2,1,1,16000000,0.007716,3.45,0,1.926986622,AP2-associated protein kinase 1 (EC 2.7.11.1) (Adaptor-associated kinase 1),ILSDVTHSAVFGVPASK,ILSDVTHSAVFGVPA,Q2M2I8,AAK1,S(3): 12.8;T(6): 2.0;S(8): 85.2;S(16): 0.0,Q2M2I8,T6(Phospho),1
0,-0.16,-2.12,-2.03,-0.48,-0.57,-0.50,-0.42,N-Term(iTRAQ8plex);T6(Phospho),Casein kinase II substrate motif;G protein-coupled receptor kinase 1 substrate motif;PKA kinase substrate motif;PKC kinase substrate motif,+,0.05133,23,1,1,112000000,0.001,3.41,0,4.31150786,Protein enabled homolog,ASSTSTPEPTR,EPVTSKASSTSTPEP,Q8N8S7,ENAH,S(2): 91.9;S(3): 2.5;T(4): 2.5;S(5): 0.5;T(6): 0.1;T(10): 2.5,Q8N8S7,T6(Phospho),1
0,0.16,-0.17,-0.43,0.60,0.74,0.85,0.74,N-Term(iTRAQ8plex);T6(Phospho),DNA dependent Protein kinase substrate motif;G protein-coupled receptor kinase 1 substrate motif,+,0.02138,10,1,1,80500000,0,3.15,0,2.581612205,Ataxin-2-like protein (Ataxin-2 domain protein) (Ataxin-2-related protein),STSTPTSPGPR,NKSTSTPTSPGPRTH,Q8WWM7,ATXN2L,S(1): 0.0;T(2): 0.0;S(3): 0.3;T(4): 0.3;T(6): 49.7;S(7): 49.7,Q8WWM7,T6(Phospho),1
0,0.17,-0.63,-0.31,-0.81,-0.85,-0.62,-0.59,K1(iTRAQ8plex);K8(iTRAQ8plex);K9(iTRAQ8plex);N-Term(iTRAQ8plex);T7(Phospho),"Casein kinase II substrate motif;Cdc2 kinase substrate motif;CDK kinase substrate motif;CDK1,2,4,6 kinase substrate motif;ERK1,2 kinase substrate motif;GSK-3, ERK1, ERK2, CDK5 substrate motif;PKA kinase substrate motif;WW domain binding motif",+,0.4689,2,1,1,0,0.005,0.73,2,2.063580514,Nucleolin (Protein C23),KVVVSPTKK,SAKKVVVSPTKKVAV,P19338,NCL,,P19338,T7(Phospho),1
0,-0.06,-0.75,-1.00,0.43,0.05,-0.48,-0.46,K1(iTRAQ8plex);K9(iTRAQ8plex);N-Term(iTRAQ8plex);T7(Phospho),"Cdc2 kinase substrate motif;CDK1,2,4,6 kinase substrate motif;CDK5 kinase substrate motif;ERK1,2 kinase substrate motif;Growth associated histone HI kinase substrate motif;GSK3, Erk1, Erk2 and CDK5 kinase motif;GSK-3, ERK1, ERK2, CDK5 substrate motif;PKA kinase substrate motif;PKC kinase substrate motif;WW domain binding motif",+,0.05158,2,1,1,202000000,0,2.1,1,2.063482871,Translocation protein SEC62 (Translocation protein 1) (TP-1) (hTP-1),KEETPGTPK,KKEETPGTPKKKETK,Q99442,SEC62,T(4): 0.0;T(7): 100.0,Q99442,T7(Phospho),1
0,0.18,0.87,0.87,0.65,0.74,0.88,0.79,K13(iTRAQ8plex);N-Term(iTRAQ8plex);T7(Phospho),"Casein kinase II substrate motif;ERK1,2 kinase substrate motif;GSK3, Erk1, Erk2 and CDK5 kinase motif;GSK-3, ERK1, ERK2, CDK5 substrate motif;WW domain binding motif",+,0.03119,69,1,1,104000000,0,3.96,0,2.806146349,40S ribosomal protein S3 (EC 4.2.99.18),DEILPTTPISEQK,KDEILPTTPISEQKG,P23396,RPS3,T(6): 7.5;T(7): 92.5;S(10): 0.0,P23396,T7(Phospho),1
0,0.20,-0.14,-0.26,0.33,0.45,0.47,0.46,N-Term(iTRAQ8plex);T7(Phospho),,+,0.04199,7,1,1,101000000,0,3.3,0,2.201108299,RelA-associated inhibitor (Inhibitor of ASPP protein) (Protein iASPP) (NFkB-interacting protein 1) (PPP1R13B-like protein),DNLTSATLPR,KDNLTSATLPRNYKV,Q8WUF5,PPP1R13L,T(4): 0.0;S(5): 0.0;T(7): 100.0,Q8WUF5,T7(Phospho),1
0,0.05,0.75,0.72,-0.06,-0.10,0.01,0.01,K13(iTRAQ8plex);N-Term(iTRAQ8plex);T8(Phospho),MAPKAPK2 kinase substrate motif,+,0.0002446,27,1,1,96300000,0,5.46,1,4.785029259,Brain-specific angiogenesis inhibitor 1-associated protein 2 (BAI-associated protein 2) (BAI1-associated protein 2) (Protein BAP2) (Fas ligand-associated factor 3) (FLAF3) (Insulin receptor substrate p53/p58) (IRS-58) (IRSp53/58) (Insulin receptor substrate protein of 53 kDa) (IRSp53) (Insulin receptor substrate p53),LSDSYSNTLPVRK,LSDSYSNTLPVRKSV,Q9UQB8,BAIAP2,S(2): 0.0;S(4): 0.0;Y(5): 0.0;S(6): 0.0;T(8): 100.0,Q9UQB8,T8(Phospho),1
0,0.02,-0.79,-0.72,-0.58,-0.46,-0.52,-0.55,N-Term(iTRAQ8plex);T8(Phospho),"b-Adrenergic Receptor kinase substrate motif;Cdc2 kinase substrate motif;CDK1,2,4,6 kinase substrate motif;ERK1,2 kinase substrate motif;GSK3, Erk1, Erk2 and CDK5 kinase motif;GSK-3, ERK1, ERK2, CDK5 substrate motif;WW domain binding motif",+,0.02224,12,1,1,30200000,0,3.63,0,3.326492177,Integrin beta-4 (GP150) (CD antigen CD104),LTAGVPDTPTR,LTAGVPDTPTRLVFS,P16144,ITGB4,T(2): 0.0;T(8): 88.4;T(10): 11.6,P16144,T8(Phospho),1
0,-0.01,-0.16,-0.07,0.28,0.29,0.43,0.49,N-Term(iTRAQ8plex);T8(Phospho),"b-Adrenergic Receptor kinase substrate motif;GSK-3, ERK1, ERK2, CDK5 substrate motif;WW domain binding motif",+,0.007292,23,1,1,34300000,0,4.24,0,3.435133767,LIM and SH3 domain protein 1 (LASP-1) (Metastatic lymph node gene 50 protein) (MLN 50),GFSVVADTPELQR,GFSVVADTPELQRIK,Q14847,LASP1,S(3): 0.0;T(8): 100.0,Q14847,T8(Phospho),1
0,0.14,-1.56,-1.44,-0.14,-0.16,0.19,0.22,N-Term(iTRAQ8plex);T8(Phospho),"Casein kinase II substrate motif;ERK1,2 kinase substrate motif;G protein-coupled receptor kinase 1 substrate motif;Growth associated histone HI kinase substrate motif;GSK3 kinase substrate motif;GSK-3, ERK1, ERK2, CDK5 substrate motif;Pyruvate dehydrogenase kinase substrate motif;WW domain binding motif",+,0.005251,34,1,1,6460000,0,4.33,1,4.374202084,Drebrin (Developmentally-regulated brain protein),MAPTPIPTRSPSDSSTASTPVAEQIER,PTPIPTRSPSDSSTA,Q16643,DBN1,T(4): 0.0;T(8): 49.0;S(10): 49.0;S(12): 1.8;S(14): 0.1;S(15): 0.0;T(16): 0.1;S(18): 0.0;T(19): 0.1,Q16643,T8(Phospho),1
0,0.10,0.52,0.65,0.06,0.18,0.31,0.21,K18(iTRAQ8plex);N-Term(iTRAQ8plex);T9(Phospho),"Casein kinase I substrate motif;Casein kinase II substrate motif;G protein-coupled receptor kinase 1 substrate motif;GSK-3, ERK1, ERK2, CDK5 substrate motif;MDC1 BRCT domain binding motif;Plk1 PBD domain binding motif;WW domain binding motif",+,0.003038,43,2,1,22700000,0,5.23,0,1.977898334,Annexin A2 (Annexin II) (Annexin-2) (Calpactin I heavy chain) (Calpactin-1 heavy chain) (Chromobindin-8) (Lipocortin II) (Placental anticoagulant protein IV) (PAP-IV) (Protein I) (p36),LSLEGDHSTPPSAYGSVK,SLEGDHSTPPSAYGS,P07355,ANXA2,S(2): 0.1;S(8): 3.1;T(9): 96.8;S(12): 0.0;Y(14): 0.0;S(16): 0.0,P07355,T9(Phospho),1
0,0.25,-0.49,-0.88,0.39,0.06,0.47,0.50,N-Term(iTRAQ8plex);T9(Phospho),"ERK1,2 kinase substrate motif;GSK-3, ERK1, ERK2, CDK5 substrate motif;WW domain binding motif",+,5.79E-05,14,1,1,211000,0,4.13,0,1.766185251,Far upstream element-binding protein 1 (FBP) (FUSE-binding protein 1) (DNA helicase V) (hDH V),QQAAYYAQTSPQGMPQHPPAPQGQ,AAYYAQTSPQGMPQH,Q96AE4,FUBP1,Y(5): 0.0;Y(6): 0.1;T(9): 84.8;S(10): 15.0,Q96AE4,T9(Phospho),1
0,-0.02,1.13,1.43,0.81,0.44,0.68,0.76,C3(Carbamidomethyl);K26(iTRAQ8plex);K27(iTRAQ8plex);Y10(Phospho),JAK2 kinase substrate motif;Shb SH2 domain binding motif;SHIP2 SH2 domain binding motif;SHP1 SH2 domain binding motif;SHP2 CSH2 domain binding motif;SHP2 N-terminal SH2 domain binding motif;Src family kinase substrate motif;Src kinase substrate motif,+,0.2055,2,1,1,25800000,0.009008,3.52,1,2.126152874,Solute carrier family 35 member G1 (Partner of STIM1) (Transmembrane protein 20),APCPGLGLFYTLLSAFLFSVGSLFVKK,CPGLGLFYTLLSAFL,Q2M3R5,SLC35G1,Y(10): 98.3;T(11): 1.5;S(14): 0.1;S(19): 0.0;S(22): 0.0,Q2M3R5,Y10(Phospho),1
0,0.11,-0.55,-0.69,-0.06,-0.09,-0.30,-0.21,N-Term(iTRAQ8plex);Y10(Phospho),14-3-3 domain binding motif;Calmodulin-dependent protein kinase II substrate motif;Casein kinase II substrate motif;CLK1 kinase substrate motif;G protein-coupled receptor kinase 1 substrate motif;GSK3 kinase substrate motif;PKA kinase substrate motif;PKC kinase substrate motif,+,0.08918,2,1,1,13300000,0.00264,2.59,0,2.587399116,Emerin,DSAYQSITHYRPVSASR,ITHYRPVSASRSSLD,P50402,EMD,S(2): 0.0;Y(4): 0.0;S(6): 0.0;T(8): 2.2;Y(10): 12.1;S(14): 73.6;S(16): 12.1,P50402,Y10(Phospho),1
0,0.01,-1.30,-0.89,-1.56,-1.61,-2.39,-2.09,K14(iTRAQ8plex);N-Term(iTRAQ8plex);Y13(Phospho),SHP1 phosphatase substrate motif,+,0.1918,2,1,1,0,0.009606,3.05,0,2.980929747,Protein bicaudal D homolog 1 (Bic-D 1),MAAEEVLQTVDHYK,VLQTVDHYKTEIERL,Q96G01,BICD1,T(9): 0.0;Y(13): 100.0,Q96G01,Y13(Phospho),1
0,0.03,1.32,1.44,0.11,-0.06,0.06,0.16,K16(iTRAQ8plex);N-Term(iTRAQ8plex);Y13(Phospho),SHP1 phosphatase substrate motif,+,0.1855,2,1,1,0,0.009264,2.2,1,3.769448672,RasGAP-activating-like protein 1,ALFPPSAIVREGYLLK,SAIVREGYLLKRKEE,O95294,RASAL1,S(6): 0.0;Y(13): 100.0,O95294,Y13(Phospho),1
0,-0.15,-0.77,-1.15,-0.21,-0.27,-0.30,-0.25,K7(iTRAQ8plex);Y15(Phospho),EGFR kinase substrate motif;JAK2 kinase substrate motif;TC-PTP phosphatase substrate motif,+,0.2916,2,1,1,0,0.003,3.77,1,1.890515717,FYVE and coiled-coil domain-containing protein 1 (Zinc finger FYVE domain-containing protein 7),NQLLEGKLQALQADYQALQQR,LQALQADYQALQQRE,Q9BQS8,FYCO1,,Q9BQS8,Y15(Phospho),1
0,0.04,-0.06,-0.06,0.53,0.38,0.43,0.51,N-Term(iTRAQ8plex);Y16(Phospho),,+,0.01164,4,1,1,644000,0,4.16,0,2.743008083,"Heterogeneous nuclear ribonucleoprotein H2 (hnRNP H2) (FTP-3) (Heterogeneous nuclear ribonucleoprotein H') (hnRNP H') [Cleaved into: Heterogeneous nuclear ribonucleoprotein H2, N-terminally processed]",GAYGGGYGGYDDYGGYNDGYGFGSDR,GYDDYGGYNDGYGFG,P55795,HNRNPH2,Y(3): 0.1;Y(7): 4.1;Y(10): 1.0;Y(13): 17.4;Y(16): 77.1;Y(20): 0.3;S(24): 0.0,P55795,Y16(Phospho),1
0,0.12,-1.68,-1.39,-0.06,0.16,-0.25,-0.35,N-Term(iTRAQ8plex);Y17(Phospho),,+,0.3109,2,1,1,0,0.004,3.03,0,3.053379158,Leucine-rich repeat-containing protein 42,MSYYLSSENHLDPGPIYMR,HLDPGPIYMRENGQL,Q9Y546,LRRC42,,Q9Y546,Y17(Phospho),1
0,-0.02,-0.57,-1.03,0.68,0.39,-0.33,-0.13,C2(Carbamidomethyl);N-Term(iTRAQ8plex);Y18(Phospho),"Dual specificity protein phosphatase 6 substrate motif;GSK-3, ERK1, ERK2, CDK5 substrate motif;MAPK 11,13,14 kinase substrate motif;PP2C delta substrate motif;RAF1 kinase substrate motif;WW domain binding motif",+,0.000492,6,1,1,607000,0,4.69,0,1.879764455,Serine/threonine-protein kinase PRP4 homolog (EC 2.7.11.1) (PRP4 kinase) (PRP4 pre-mRNA-processing factor 4 homolog),LCDFGSASHVADNDITPYLVSR,HVADNDITPYLVSRF,Q13523,PRPF4B,S(6): 0.0;S(8): 0.0;T(16): 49.9;Y(18): 49.9;S(21): 0.1,Q13523,Y18(Phospho),1
0,0.08,0.98,1.19,-0.09,-0.35,-0.27,-0.02,K21(iTRAQ8plex);N-Term(iTRAQ8plex);Y2(Phospho),G protein-coupled receptor kinase 1 substrate motif;PKA kinase substrate motif;PKC kinase substrate motif,+,0.002181,8,2,1,3430000,0,4.45,0,2.557854471,Phosphoglycerate mutase 1 (EC 3.1.3.13) (EC 5.4.2.11) (EC 5.4.2.4) (BPG-dependent PGAM 1) (Phosphoglycerate mutase isozyme B) (PGAM-B),SYDVPPPPMEPDHPFYSNISK,QVKIWRRSYDVPPPP,P18669,PGAM1,S(1): 86.3;Y(2): 13.7;Y(16): 0.0;S(17): 0.0;S(20): 0.0,P18669,Y2(Phospho),1
0,-0.36,0.80,0.62,0.23,0.27,0.88,0.77,C2(Carbamidomethyl);K23(iTRAQ8plex);Y3(Phospho),ALK kinase substrate motif;JAK2 kinase substrate motif;Shb SH2 domain binding motif;SHIP2 SH2 domain binding motif;SHP1 phosphatase substrate motif;SHP1 SH2 domain binding motif;SHP2 CSH2 domain binding motif;SHP2 N-terminal SH2 domain binding motif;Src family kinase substrate motif,+,0.1804,2,1,1,65900,0.002301,2.78,0,2.11848853,POTE ankyrin domain family member I,LCYVALDFEQEMAMAASSSSLEK,DIKEKLCYVALDFEQ,P0CG38,POTEI,Y(3): 96.1;S(17): 2.6;S(18): 0.9;S(19): 0.4;S(20): 0.1,P0CG38,Y3(Phospho),1
0,-0.03,-1.85,-1.85,-1.56,-1.67,-1.67,-1.66,K9(iTRAQ8plex);N-Term(iTRAQ8plex);Y3(Phospho),,+,0.01664,343,3,1,30800000000,0,3.63,0,5.445012109,"Keratin, type II cytoskeletal 6A (Cytokeratin-6A) (CK-6A) (Cytokeratin-6D) (CK-6D) (Keratin-6A) (K6A) (Type-II keratin Kb6) (allergen Hom s 5)",SLYGLGGSK,GAGFGSRSLYGLGGS,P02538,KRT6A,S(1): 99.8;Y(3): 0.2;S(8): 0.0,P02538,Y3(Phospho),1
0,-0.01,-2.08,-1.90,-2.53,-2.88,-2.88,-2.84,K9(iTRAQ8plex);N-Term(iTRAQ8plex);Y3(Phospho),,+,0.03474,279,1,1,37500000000,0,3.61,0,3.967441361,"Keratin, type II cytoskeletal 5 (58 kDa cytokeratin) (Cytokeratin-5) (CK-5) (Keratin-5) (K5) (Type-II keratin Kb5)",SLYNLGGSK,GAGFGSRSLYGLGGS,P13647,KRT5,S(1): 99.7;Y(3): 0.3;S(8): 0.0,P13647,Y3(Phospho),1
0,-0.13,-2.27,-2.19,-0.29,-0.65,-1.83,-1.25,K12(iTRAQ8plex);Y5(Phospho),,+,0.1517,2,1,1,0,0.004533,1.03,1,2.531992758,Protein FAM183B,LHTQYHVNPLRK,TQKLHTQYHVNPLRK,Q6ZVS7,FAM183B,T(3): 23.3;Y(5): 76.7,Q6ZVS7,Y5(Phospho),1
0,0.34,-0.76,-0.83,0.20,0.51,0.00,-0.02,K15(iTRAQ8plex);K21(iTRAQ8plex);N-Term(iTRAQ8plex);Y8(Phospho),Casein kinase I substrate motif;Casein kinase II substrate motif;DNA dependent Protein kinase substrate motif;Dual specificity protein phosphatase 6 substrate motif;PP2C delta substrate motif,+,0.02424,6,1,1,37800000,0,3.59,2,2.093683592,Membrane-associated progesterone receptor component 1 (mPR),EGEEPTVYSDEEEPKDESARK,LKEGEEPTVYSDEEE,O00264,PGRMC1,T(6): 79.2;Y(8): 6.0;S(9): 13.1;S(18): 1.7,O00264,Y8(Phospho),1
0,0.11,-0.04,-0.06,0.53,0.77,0.91,0.77,K13(iTRAQ8plex);N-Term(iTRAQ8plex);Y8(Phospho),ALK kinase substrate motif;Crk SH2 domain binding motif;RasGAP C-terminal SH2 domain binding motif;Src kinase substrate motif,+,0.008983,9,1,1,30100000,0,4.78,0,2.593244889,Paxillin,VGEEEHVYSFPNK,VGEEEHVYSFPNKQK,P49023,PXN,Y(8): 99.9;S(9): 0.1,P49023,Y8(Phospho),1
0,-0.05,-0.89,-0.89,-0.10,-0.18,0.02,-0.05,N-Term(iTRAQ8plex);Y8(Phospho),"Casein kinase II substrate motif;ERK1,2 kinase substrate motif;G protein-coupled receptor kinase 1 substrate motif;GSK-3, ERK1, ERK2, CDK5 substrate motif;WW domain binding motif",+,0.2904,4,1,1,0,0.003,3,2,4.232402895,WW domain-binding protein 11 (WBP-11) (Npw38-binding protein) (NpwBP) (SH3 domain-binding protein SNP70) (Splicing factor that interacts with PQBP-1 and PP1),RRDEDMLYSPELAQR,RDEDMLYSPELAQRG,Q9Y2W2,WBP11,,Q9Y2W2,Y8(Phospho),1
0,-0.06,-1.01,-1.10,-0.13,-0.21,-0.16,-0.12,K9(iTRAQ8plex);N-Term(iTRAQ8plex);S5(Phospho);Y2(Phospho),Src kinase substrate motif,+,0.03437,36,1,1,452000000,0,3.59,1,3.977658994,Serine/arginine repetitive matrix protein 1 (SR-related nuclear matrix protein of 160 kDa) (SRm160) (Ser/Arg-related nuclear matrix protein),RYSPSPPPK,SPPIQRRYSPSPPPK,Q8IYB3,SRRM1,Y(2): 92.3;S(3): 7.7;S(5): 100.0,Q8IYB3,"S5(Phospho),Y2(Phospho)",2
0,0.07,0.12,0.10,0.60,0.68,0.83,0.77,N-Term(iTRAQ8plex);S2(Phospho),Casein kinase I substrate motif;Casein kinase II substrate motif;G protein-coupled receptor kinase 1 substrate motif;GSK3 kinase substrate motif,+,0.04227,8,1,1,13900000,0.0006395,3.3,0,3.865523869,Tensin-4 (C-terminal tensin-like protein),SSSESLIFSGNQGR,DVPRETRSSSESLIF,Q8IZW8,TNS4,S(1): 2.2;S(2): 93.5;S(3): 2.2;S(5): 2.2;S(9): 0.0,Q8IZW8,S2(Phospho),1
0,-0.20,0.50,0.73,0.73,1.00,0.70,0.64,K17(iTRAQ8plex);N-Term(iTRAQ8plex);S3(Phospho),14-3-3 domain binding motif;Akt kinase substrate motif;Calmodulin-dependent protein kinase II substrate motif;Casein kinase II substrate motif;MAPKAPK1 kinase substrate motif;PKA kinase substrate motif;PKC kinase substrate motif,+,0.1262,1,1,1,0,0.008,2.44,0,2.02796162,E3 ubiquitin-protein ligase NEDD4-like (EC 6.3.2.-) (NEDD4.2) (Nedd4-2),SLSSPTVTLSAPLEGAK,IRRPRSLSSPTVTLS,Q96PU5,NEDD4L,,Q96PU5,S3(Phospho),1
0,0.26,-1.50,-0.96,0.59,0.41,0.42,0.52,C14(Carbamidomethyl);N-Term(iTRAQ8plex);T4(Phospho),Casein kinase II substrate motif,+,0.1071,2,1,1,9800000,0.002329,3.36,0,2.388659734,Cysteinyl leukotriene receptor 1 (CysLTR1) (Cysteinyl leukotriene D4 receptor) (LTD4 receptor) (G-protein coupled receptor HG55) (HMTMF81),MDETGNLTVSSATCHDTIDDFR,ETGNLTVSSATCHDT,Q9Y271,CYSLTR1,T(4): 22.8;T(8): 2.2;S(10): 6.8;S(11): 22.8;T(13): 22.8;T(17): 22.8,Q9Y271,T4(Phospho),1
0,-0.14,1.47,1.58,0.42,0.26,0.93,1.01,K23(iTRAQ8plex);N-Term(iTRAQ8plex);S10(Phospho),,+,0.01624,2,1,1,0,0,4.87,0,3.634227785,Phosphoglucomutase-1 (PGM 1) (EC 5.4.2.2) (Glucose phosphomutase 1),AIGGIILTASHNPGGPNGDFGIK,GGIILTASHNPGGPN,P36871,PGM1,T(8): 50.0;S(10): 50.0,P36871,S10(Phospho),1
0,0.00,-1.45,-1.16,2.67,2.56,2.33,2.44,K7(iTRAQ8plex);N-Term(iTRAQ8plex);T4(Phospho),b-Adrenergic Receptor kinase substrate motif;Casein kinase II substrate motif;PKA kinase substrate motif;PKC kinase substrate motif;Pyruvate dehydrogenase kinase substrate motif,+,0.04678,10,1,1,311000000,0.0002738,2.16,0,4.904638105,Sulfate transporter (Diastrophic dysplasia protein) (Solute carrier family 26 member 2),ESSTDFK,HLELQRESSTDFKQF,P50443,SLC26A2,S(2): 99.4;S(3): 0.3;T(4): 0.3,P50443,T4(Phospho),1
0,0.26,-1.31,-1.35,0.04,0.19,-0.26,-0.33,N-Term(iTRAQ8plex);S6(Phospho);S8(Phospho),"Casein kinase II substrate motif;DNA dependent Protein kinase substrate motif;ERK1,2 kinase substrate motif;GSK-3, ERK1, ERK2, CDK5 substrate motif;PKA kinase substrate motif;PKC kinase substrate motif;WW domain binding motif",+,0.01779,3,1,1,0,0,3.64,0,3.292517832,Serine/arginine repetitive matrix protein 2 (300 kDa nuclear matrix antigen) (Serine/arginine-rich splicing factor-related nuclear matrix protein of 300 kDa) (SR-related nuclear matrix protein of 300 kDa) (Ser/Arg-related nuclear matrix protein of 300 kDa) (Splicing coactivator subunit SRm300) (Tax-responsive enhancer element-binding protein 803) (TaxREB803),SATRPSPSPER,EKSATRPSPSPERSS,Q9UQ35,SRRM2,,Q9UQ35,"S6(Phospho),S8(Phospho)",2